货号:A175546 同义名: 氟达拉宾 / F-ara-A;NSC 118218
Fludarabine(NSC 118218) 是一种 DNA 合成抑制剂和氟化嘌呤类似物,在淋巴增殖性恶性肿瘤中具有抗肿瘤活性。它抑制细胞因子诱导的 STAT1 激活及其在正常静止或活化淋巴细胞中的依赖 STAT1 的基因转录。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | DNA synthesis ↓ ↑ | helicase ↓ ↑ | RdRp ↓ ↑ | ribonucleotide reductase ↓ ↑ | tRNA synthetase ↓ ↑ | YB-1 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fexinidazole | ✔ | 98% | |||||||||||||||||
Daptomycin | ✔ | 98% | |||||||||||||||||
Blasticidin S·HCl | ✔ | 98% | |||||||||||||||||
Metronidazole | ✔ | 98% | |||||||||||||||||
Daunorubicin HCl |
+++
DNA synthesis, Ki: 20 nM |
98% | |||||||||||||||||
Triglycidyl isocyanurate | ✔ | p53 | 98+% | ||||||||||||||||
Nedaplatin | ✔ | 99%+ | |||||||||||||||||
Bendamustine | ✔ | 98+% | |||||||||||||||||
Trifluridine | ✔ | 98% | |||||||||||||||||
Robinetin | ✔ | 99%+ | |||||||||||||||||
Carboplatin | ✔ | 99% | |||||||||||||||||
Cidofovir | ✔ | 99% | |||||||||||||||||
Cisplatin | ✔ | 99% | |||||||||||||||||
Cytarabine |
++++
DNA synthesis, IC50: 16 nM |
98% | |||||||||||||||||
Acelarin |
++++
DNA synthesis, EC50: 0.2 nM |
99%+ | |||||||||||||||||
Oxaliplatin | ✔ | 98% | |||||||||||||||||
YK-4-279 | ✔ | 99%+ | |||||||||||||||||
ML216 |
+
BLMfull-length, IC50: 2.98 μM BLM636-1298, IC50: 0.97 μM |
99%+ | |||||||||||||||||
RK-33 | ✔ | 98% | |||||||||||||||||
Brr2-IN-3 | ✔ | 99%+ | |||||||||||||||||
Phen-DC3 Trifluoromethanesulfonate | ✔ | 98% | |||||||||||||||||
Favipiravir | ✔ | 97% | |||||||||||||||||
Suramin sodium salt |
++
RdRp, IC50: 0.26 μM |
99%+ | |||||||||||||||||
Clofarabine |
++
Ribonucleotide reductase, IC50: 65 nM |
97% | |||||||||||||||||
Didox | ✔ | 98% | |||||||||||||||||
(E)-3-AP | ✔ | 97% | |||||||||||||||||
Halofuginone |
+++
prolyl-tRNA synthetase, Ki: 18.3nM |
99%+ | |||||||||||||||||
BC-LI-0186 |
+++
Leucyl-tRNA synthetase, Kd: 42.1 nM Leucyl-tRNA synthetase, IC50: 46.11 nM |
98% | |||||||||||||||||
SU056 |
+
YB-1, IC50: 1.73 μM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Fludarabine (2-F-ARAA, 2-fluoro ARA-A) is a chemotherapy drug used in the treatment of chronic lymphocytic leukemia (see https://www.fda.gov/) for targeting on DNA synthesis. It can also work as an inhibitor of STAT1 activation. The mechanism of Fludarabine action against to DNA synthesis is similar to other nucleotide analogues. Fludarabine can be phosphorylated to form as the Fludarabine triphosphate and then compete with natural nucleotides to inhibit DNA polymeraseα and incorporate into DNA strand. It can also act on ribonucleotide reductase and thus deplete the dATP pool[1]. Fludarabine can also cause a specific depletion of STAT1, but not of other STATs, as well as cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in lymphocytes[2]. |
作用机制 | Fludarabine can inhibit DNA synthesis through targeting to ribonucleotide reductase and DNA polymerase. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
624.38mel | 50 μM | Function Assay | 24 h | decreases IDO expression | 24911872 |
624.38mel | 50-200 μM | Function Assay | 24 h | inhibits IDO activity independently of mRNA levels | 24911872 |
A549 | Growth Inhibition Assay | IC50=15.7±2.8 µM | 23377192 | ||
A549 | Growth Inhibition Assay | IC20=5.48 × 10−8 μM | 18661380 | ||
Dose | Mice (i.p.): min = 0.3 mg/kg[4], max = 200 mg/kg[5] | ||||||||||||||||||||||||||||||||||||||||
Administration | i.p. | ||||||||||||||||||||||||||||||||||||||||
Pharmacokinetics |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00006251 | Acute Undifferentiated Leukemi... 展开 >>a Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Multiple Myeloma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT01723839 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Active, not recruiting | August 2018 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States, 07601 收起 << |
NCT00544466 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 2019 | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010-3000 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.51mL 0.70mL 0.35mL |
17.53mL 3.51mL 1.75mL |
35.06mL 7.01mL 3.51mL |
CAS号 | 21679-14-1 |
分子式 | C10H12FN5O4 |
分子量 | 285.232 |
别名 | 氟达拉宾 ;F-ara-A;NSC 118218;HSDB 6964;Fludarabinum |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,2-8°C |
溶解度 |
DMSO: 25 mg/mL(87.65 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
5%DMSO+40%PEG300+5%Tween80+50%water 8 mg/mL |
Tags: Fludarabine | 21679-14-1 | F-ara-A | NSC 118218 | NSC118218 | NSC 118218 | NSC-118218 | DNA Synthesis Inhibitor | Cell Cycle/DNA Damage | Stem Cell/Wnt | JAK/STAT Signaling | Apoptosis | Nucleoside Antimetabolite/Analog | DNA/RNA Synthesis | STAT | Apoptosis | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Fludarabine 纯度/质量文件 | Fludarabine 亚型比较 | Fludarabine 生物活性 | Fludarabine 细胞研究 | Fludarabine 动物研究 | Fludarabine 临床数据 | Fludarabine 参考文献 | Fludarabine 实验方案 | Fludarabine 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
STAT1 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
624.38mel | 50 μM | Function Assay | 24 h | decreases IDO expression | 24911872 |
624.38mel | 50-200 μM | Function Assay | 24 h | inhibits IDO activity independently of mRNA levels | 24911872 |
A549 | Growth Inhibition Assay | IC50=15.7±2.8 µM | 23377192 | ||
A549 | Growth Inhibition Assay | IC20=5.48 × 10−8 μM | 18661380 | ||
A549 GAPDH-deficient | Growth Inhibition Assay | IC50=18.5±2.3 µM | 23377192 | ||
AN3CA | 100-500 μM | Growth Inhibition Assay | 24 h | inhibits cell growth in a dose-dependent manner | 23595697 |
AN3CA | 20/100 μM | Apoptosis Assay | 24 h | induces apoptosis in a dose-dependent manner | 23595697 |
BJAB | 5 μM | Apoptosis Assay | 24 h | induces cell apoptosis | 24057147 |
BW-225 | Growth Inhibition Assay | IC20=1.37 ×10−8 μM | 18661380 | ||
CaSki | Growth Inhibition Assay | IC20=1.37 × 10−7 μM | 18661380 | ||
CEM | Growth Inhibition Assay | IC50=2.4 ± 0.4 μM | 21948264 | ||
CLL | 10 μM | Apoptosis Assay | 24-96 h | induces apoptotic cell death | 22207686 |
Daudi | 20 μM | Apoptosis Assay | 96 h | induces apoptosis slightly | 22023523 |
DU-145 | 0-10 μg/ml | Growth Inhibition Assay | 48 h | inhibits cell growth in a dose-dependent manner | 23734815 |
EHEB | 40 μM | Apoptosis Assay | 24 h | induces apoptosis | 23497075 |
EHEB | 5-50 μM | Function Assay | 24 h | decreases p21 expression significantly | 21168391 |
GR-145 | Growth Inhibition Assay | IC20=2.74 × 10−8 μM | 18661380 | ||
HEC1A | 100-500 μM | Growth Inhibition Assay | 24 h | inhibits cell growth in a dose-dependent manner | 23595697 |
HEC1A | 20/100 μM | Apoptosis Assay | 24 h | induces apoptosis in a dose-dependent manner | 23595697 |
HEC50B | 100-500 μM | Growth Inhibition Assay | 24 h | inhibits cell growth slightly | 23595697 |
HEC50B | 20/100 μM | Apoptosis Assay | 24 h | induces apoptosis slightly | 23595697 |
HLE-B3 | 25 μM | Function Assay | 48 h | blocks IFN-γ–induced STAT1 phosphorylation and IDO expression | 20435158 |
HMECs | 100 μM | Function Assay | 36 h | inhibits IFNγ and LPS induced STAT1 phosphorylation and IRF1 expression | 24211327 |
HMECs | 100 μM | Function Assay | 36 h | inhibits IFNα mediated phosphorylation of STAT1 and STAT3, but not of STAT2 | 24211327 |
I-83 | 5 μM | Apoptosis Assay | 24 h | induces cell apoptosis | 24057147 |
J45.01 | 1 μM | Apoptosis Assay | 96 h | induces apoptosis slightly | 22023523 |
Jeko-1 | 20 μM | Function Assay | 24 h | inhibits expression of IDO | 25940712 |
JMV-3 | 10 μM | Apoptosis Assay | 24 h | induces cell apoptosis slightly | 21699383 |
JVM-2 | 30 μM | Function Assay | 24 h | decreases p21 expression | 21168391 |
K562 | Growth Inhibition Assay | IC50=0.44 ± 0.05 μM | 21948264 | ||
K562 | Growth Inhibition Assay | 72 h | IC50=3.3 nM | 20307198 | |
KBM3/Bu2506 | 2.5 μM | Apoptosis Assay | 48 h | induces apoptosis slightly | 25111583 |
KBM3/Bu2506 | Growth Inhibition Assay | IC20=0.67 µM | 20933509 | ||
KBM3/Bu2506 | 0.6 μM | Growth Inhibition Assay | 24 h | increases the cell fraction in S-phase | 20933509 |
MCF-7 | Growth Inhibition Assay | IC50=15.0 μM | 20447390 | ||
MDA-231 | 100 μM | Function Assay | 24 h | decreases IDO expression | 24911872 |
MDA-231 | 50-200 μM | Function Assay | 24 h | inhibits IDO activity independently of mRNA levels | 24911872 |
MDA-MB-231 | Growth Inhibition Assay | IC50=4.0 μM | 20447390 | ||
MEC1 | 100 μM | Apoptosis Assay | 72 h | induces apoptosis significantly | 22132973 |
Mec-1 | Growth Inhibition Assay | IC50>500 μM | 25061101 | ||
MM.1R | Growth Inhibition Assay | 48 h | IC50=33.79 μM | 17976186 | |
MM.1S | Growth Inhibition Assay | 48 h | IC50=13.48 μM | 17976186 | |
MOLM 13 | 2.5 μM | Apoptosis Assay | 48 h | induces apoptosis slightly | 25111583 |
Molt-4 | Growth Inhibition Assay | IC50=180 μM | 25061101 | ||
MV-4-11 | 2.5 μM | Apoptosis Assay | 48 h | induces apoptosis slightly | 25111583 |
NALM6 | 5 μM | Apoptosis Assay | 24 h | induces cell apoptosis | 24057147 |
Nalm-6 | Growth Inhibition Assay | IC50=18 μM | 25061101 | ||
Nalm-6 | 10 μM | Function Assay | 1/2/4 h | induces autophagy | 23681223 |
Nalm-6 | Growth Inhibition Assay | IC50 ∼10 μM | 23681223 | ||
NALM-6 | 10 μM | Apoptosis Assay | 24 h | induces cell apoptosis slightly | 21699383 |
Nalm-6-FluR | Growth Inhibition Assay | IC50=250 μM | 25061101 | ||
OH-65 | Growth Inhibition Assay | IC20=1.37 ×10−8 μM | 18661380 | ||
PBMC | 50/100 μM | Function Assay | 24 h | inhibits STAT1 phosphorylation | 24911872 |
Raji | 3 μM | Function Assay | 24/48/72 h | induces accumulations of p53, p63 and p73 | 24940695 |
Raji | Growth Inhibition Assay | IC50=0.47 ± 0.04 μM | 21948264 | ||
Reh | Growth Inhibition Assay | IC50=30 μM | 25061101 | ||
Reh | 10 μM | Function Assay | 1/2/4 h | induces autophagy | 23681223 |
Reh | Growth Inhibition Assay | IC50 ∼10 μM | 23681223 | ||
RPMI 8226 | Growth Inhibition Assay | IC50=25.9 ± 3.7 μM | 21948264 | ||
RPMI 8226 | Growth Inhibition Assay | 24 h | IC50=1.54 μM | 17976186 | |
RPMI-8226 | Growth Inhibition Assay | IC50=500 μM | 25061101 | ||
SKW6.4 | 0.01-10 μM | Apoptosis Assay | 24/48 h | induces cell death in both time- and dose- dependent manner | 18092340 |
THP-1 | 2.5 μM | Apoptosis Assay | 48 h | induces apoptosis slightly | 25111583 |
U2937 | Growth Inhibition Assay | IC50=16 μM | 25061101 | ||
U937 | 0.8 μM | Apoptosis Assay | 4-48 h | induces apoptosis slightly | 22074700 |
U937 | 1 μM | Apoptosis Assay | 96 h | induces apoptosis slightly | 22023523 |
U937 | Growth Inhibition Assay | IC50=0.24 ± 0.04 μM | 21948264 | ||
U937 | Growth Inhibition Assay | IC50=3,200 ± 560 nM | 15930361 | ||
ZMK-1 | Growth Inhibition Assay | IC20=1.37 × 10−6 μM | 18661380 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00006251 | Acute Undifferentiated Leukemi... 展开 >>a Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Multiple Myeloma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT01723839 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Active, not recruiting | August 2018 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States, 07601 收起 << |
NCT00544466 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 2019 | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010-3000 收起 << |
NCT02328950 | - | Unknown | December 2017 | China, Fujian ... 展开 >> Union Hospital,Fujian Medical University Recruiting Fuzhou, Fujian, China, 350001 Contact: Ting Yang, Prof. +86-591-83357896 ext 8041 yang.hopeting@gmail.com Contact: Jianda Hu, Prof. +86-591-83357896 ext 8041 jdhu@medmail.com.cn Principal Investigator: Jianda Hu, Dr. Sub-Investigator: Ting Yang, Dr. 收起 << | |
NCT01703364 | CLL Chronic L... 展开 >>ymphocytic Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | Austria ... 展开 >> Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie Innsbruck, Tirol, Austria, 6020 Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III Salzburg, Austria, 5020 收起 << |
NCT00688883 | Lymphoma | Phase 2 | Completed | - | Japan ... 展开 >> Nagoya-shi, Aichi, Japan, 464-8681 Nagoya-shi, Aichi, Japan, 466-8560 Kashiwa-shi, Chiba, Japan, 277-8577 Fukuoka-shi, Fukuoka, Japan, 812-0033 Fukuoka-shi, Fukuoka, Japan, 812-8582 Sapporo-shi, Hokkaido, Japan, 003-0006 Akashi-shi, Hyogo, Japan, 673-8558 Kagoshima-shi, Kagoshima, Japan, 890-0064 Isehara-shi, Kanagawa, Japan, 259-1193 Kyoto-shi, Kyoto, Japan, 602-0841 Sendai-shi, Miyagi, Japan, 980-0872 Nagasaki-shi, Nagasaki, Japan, 852-8523 Okayama-shi, Okayama, Japan, 700-8558 Moriguchi-shi, Osaka, Japan, 570-8540 Hamamatsu-shi, Shizuoka, Japan, 431-3192 Chuo-ku, Tokyo, Japan, 104-0045 Shinjuku-ku, Tokyo, Japan, 160-8582 收起 << |
NCT00475020 | Myelofibrosis | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00860457 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Lombardi Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 收起 << |
NCT01088724 | Post-transplant Lymphoprolifer... 展开 >>ative Disease (PTLD) Non Burkitt 收起 << | Phase 4 | Completed | - | Italy ... 展开 >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24121 收起 << |
NCT00860457 | - | Completed | - | - | |
NCT00641095 | Lymphoma | Phase 2 Phase 3 | Completed | - | - |
NCT00824265 | Leukaemia, Lymphocytic, Chroni... 展开 >>c 收起 << | Phase 3 | Completed | - | - |
NCT00475020 | - | Completed | - | - | |
NCT00824265 | - | Completed | - | - | |
NCT00068315 | Extranodal Marginal Zone B-cel... 展开 >>l Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Mercy Medical Center Canton, Ohio, United States, 44708 Case Western Reserve University Cleveland, Ohio, United States, 44106 Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States, 44130 UHHS-Chagrin Highlands Medical Center Orange Village, Ohio, United States, 44122 University Suburban Medical Center South Euclid, Ohio, United States, 44121 UHHS-Westlake Medical Center Westlake, Ohio, United States, 44145 收起 << |
NCT02083250 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | March 30, 2021 | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01316549 | - | Recruiting | July 2021 | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Janel R Long-Boyle, PharmD, PhD 415-514-2746 long-boylej@pharmacy.ucsf.edu Principal Investigator: Janel R Long-Boyle, PharmD, PhD 收起 << | |
NCT00281892 | Chronic Lymphocytic Leukemia ... 展开 >> Anemia 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg Augsburg, Germany, 86150 Onkologische Schwerpunktpraxis und Tagesklinik Dres Bad Soden, Germany, 65812 Internistische Gemeinschaftspraxis - Berlin Berlin, Germany, 13347 Charite - Campus Charite Mitte Berlin, Germany, D-10117 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, D-44791 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Internistische Praxis - Dusseldorf Dusseldorf, Germany, 40211 Hans - Susemihl - Krankenhaus Emden, Germany, D-26721 Universitaetsklinikum Essen Essen, Germany, D-45122 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, D-15236 Internistische Praxis - Gerlingen Gerlingen, Germany, 70839 Internistische Praxisgemeinschaft Germering, Germany, 82110 Universitaetsklinikum Göttingen Göttingen, Germany, 37075 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, D-67653 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 Klinikum Kempten Oberallgaeu Kempten, Germany, D-87439 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Internistische Praxis - Landshut Landshut, Germany, 84028 Caritas - Krakenhaus Lebach Lebach, Germany, 66822 Onkologische Schwerpunktpraxis - Leer Leer, Germany, D-26789 Staedtisches Klinikum Magdeburg Magdeburg, Germany, D-39130 Hospital Maria-Hilf II Monchengladbach, Germany, D-41063 Hamatologie/Onkologie Praxisgemeinschaft - Muenchen Munchen, Germany, 81245 Munich Oncologic Practice at Elisenhof Munich, Germany, D-80335 I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-81377 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Haematologische Schwerpunktpraxis Munich, Germany, D-81679 Klinikum Schwaebisch Gmuend Stauferklinik Mutlangen, Germany, D-73557 Haematologische-onkologische GemeinschaftspraxisSchick - Schick - Schmidt - Wiesmeier München, Germany, D-81241 Onkologische Schwerpunktpraxis Dr. Schmidt Neunkirchen, Germany, D-66538 Praxis fuer Haematologie und Interne Onkologie Norderstedt, Germany, 22844 Internistische Gemeinschaftspraxis - Oldenburg Oldenburg, Germany, D-26121 Pforzheim, Germany, 75179 Scherpunktpraxis fur Hematologie und Onkologie Regensburg, Germany, 93053 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Schwerpunktpraxis fuer Haematologie und Onkologie Saarbruecken, Germany, 66113 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 St. Marienhospital - Vechta Vechta, Germany, D-49377 Haematologische Praxis Weiden, Germany, D-92637 Helios Kliniken Wuppertal University Hospital Wuppertal, Germany, D-42283 Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 收起 << |
NCT01423032 | Chronic Lymphocytic Leukemia | Phase 2 Phase 3 | Completed | - | Germany ... 展开 >> Prof. Dr. Norbert Niederle Leverkusen, NRW, Germany, D-51375 收起 << |
NCT00002779 | Lymphoma | Phase 2 | Completed | - | United States, Arizona ... 展开 >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 收起 << |
NCT00004857 | Leukemia | Phase 2 | Completed | - | - |
NCT01263704 | Lymphocytic Leukemia, Chronic | Phase 2 | Completed | - | Israel ... 展开 >> Haemek Medical Center; Hematology Department Afula, Israel, 18101 Soroka Medical Center; Hematology Deptartment Beer Sheva, Israel, 8410101 Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel, 3109601 Bnei-Zion Medical Center; Hematology Dept Haifa, Israel, 3339419 Shaare Zedek Medical Center; Hematology Dept. Jerusalem, Israel, 9103102 Hadassah Ein Karem Hospital; Haematology Jerusalem, Israel, 9112001 Meir Medical Center; Internal Dept A Kfar Saba, Israel, 44281 Western Galilee Hospital - Nahariya Nahariya, Israel, 22100 Beilinson Medical Center; Haematology Petach Tikva, Israel, 49100 Kaplan Medical Center Rehovot, Israel, 7661041 ASSAF Harofe; Department of Hematology Rishon Lezion, Israel, 70300 Ichilov Sourasky Medical Center; Heamatology Tel Aviv, Israel, 6423906 收起 << |
NCT01263704 | - | Completed | - | - | |
NCT00943319 | Leukemia Lymp... 展开 >>homa Myeloma 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT00262795 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT01173679 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00727415 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Italy ... 展开 >> Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Divisione di Ematologia Ospedale "Santa Maria Goretti" Latina, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy (SA) U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani Nocera Inferiore, Italy Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S. M. delle Croci Ravenna, Italy, I-48100 Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Ospedale "Infermi" Rimini, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia - Ospedale S.Eugenio Rome, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy 收起 << |
NCT03121014 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | April 24, 2024 | United States, Illinois ... 展开 >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD 312-413-3547 drond@uic.edu 收起 << |
NCT00612612 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Leukemia Prolymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 1 | Terminated | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00794820 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00774280 | Leukemia Myel... 展开 >>odysplastic Syndrome 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT00794820 | - | Completed | - | - | |
NCT02319135 | Acute Myeloid Leukemia | Phase 3 | Active, not recruiting | October 2019 | Spain ... 展开 >> Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 收起 << |
NCT00474747 | Aplastic Anemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03609814 | - | Recruiting | April 2019 | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Danna D Chan, Pharm.D. 415-596-4594 danna.chan@ucsf.edu Contact: Janel R Long-Boyle, PharmD, PhD 415-514-2746 long-boylej@pharmacy.ucsf.edu 收起 << | |
NCT00738829 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 1 Phase 2 | Completed | - | Austria ... 展开 >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria, A-4010 Krankenhaus der Elisabethinen Linz GmbH Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 收起 << |
NCT01173679 | - | Terminated(Slow accrual) | - | - | |
NCT00452374 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University of California-San Diego La Jolla, California, United States, 92093 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00469014 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome Chronic Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00452374 | - | Completed | - | - | |
NCT00009984 | Recurrent Small Lymphocytic Ly... 展开 >>mphoma Refractory Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Terminated | - | United States, New York ... 展开 >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 收起 << |
NCT03494569 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Hematopoietic Cell Transplantation Recipient Minimal Residual Disease Myelodysplastic Syndrome Secondary Acute Myeloid Leukemia 收起 << | Phase 1 | Recruiting | July 2020 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki 626-301-4673 malmalki@coh.org Principal Investigator: Monzr M. Al Malki 收起 << |
NCT00850499 | Follicular Lymphoma | Phase 2 | Terminated | - | - |
NCT00143065 | Lymphoma, Small Lymphocytic ... 展开 >> Lymphocytic Leukemia, Chronic 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT00472329 | Graft Failure | Phase 2 | Recruiting | December 2020 | United States, Colorado ... 展开 >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Contact: Juli Murphy 303-285-5087 Juli.Murphy@usoncology.com Contact: Nicole Stephens 303-336-2183 Nicole.Stephens@usoncology.com Principal Investigator: Mark W Brunvand, MD Sub-Investigator: Robert M Rifkin, MD Sub-Investigator: Jeffrey V Matous, MD Sub-Investigator: Peter A McSweeney, MD Sub-Investigator: Scott I Bearman, MD Sub-Investigator: Michael B Maris, MD 收起 << |
NCT00850499 | - | Terminated | - | - | |
NCT01991457 | Adult Lymphoblastic Lymphoma | Phase 2 | Recruiting | June 2019 | United States, Alabama ... 展开 >> UAB Bone Marrow Transplantation and Cellular Therapy Program Recruiting Birmingham, Alabama, United States, 35249 Contact: Tiffany D Hill, RN 205-996-8023 tiffanydhill@uabmc.edu Contact: Lindsey M Stephens, RN 205-975-2713 lmeggs@uabmc.edu Principal Investigator: Ayman A Saad, MD Sub-Investigator: Shin Mineishi, MD Sub-Investigator: Donna Salzman, MD Sub-Investigator: Racquel D Innis-Shelton, MD Sub-Investigator: Ruby Meredith, MD, PhD Sub-Investigator: Lawrence S Lamb, PhD Sub-Investigator: Antonio Di Stasi, MD Sub-Investigator: Luciano Costa, MD 收起 << |
NCT01271010 | Lymphocytic Leukemia, Chronic | Phase 4 | Terminated | - | Russian Federation ... 展开 >> The order of Honour pin Irkutsk regional clinical hospital; Hematology Department Irkutsk, Russian Federation, 664079 Kemerovo Regional Clinical Hospital Kemerovo, Russian Federation, 650066 Regional Clinical Oncology Despensary #1; Hematology Department Krasnodar, Russian Federation, 350040 N.N.Blokhin Russian Cancer Research Center; Dept. of Chemotherapy & Hemoblastosis Moscow, Russian Federation, 115478 City Clinical Hospital After Botkin; Hematology Moscow, Russian Federation, 125101 City Clinical Hospital #15; Hematology department Saint-Petersburg, Russian Federation, 198205 Leningrad Regional Clinical Hospital; Hematology #1 St Petersburg, Russian Federation Saint-Petersburg SHI City Clinical Hospital #31 St. Petersburg, Russian Federation, 197110 GUZ Tula Regioanal Clinical Hospital; Hematology Tula, Russian Federation, 300053 Republican clinical hospital named after G.G. Kuvatov UFA, Russian Federation, 450005 收起 << |
NCT00230282 | Leukemia B-ce... 展开 >>ll Leukemia Chronic Leukemia Chronic Lymphocytic Leukemia (CLL) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT01131169 | Multiple Myeloma | Phase 2 | Active, not recruiting | May 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01271010 | - | Terminated | - | - | |
NCT02928991 | Bone Marrow Failure Syndromes | Early Phase 1 | Recruiting | April 2020 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Timothy Olson, MD, PhD OLSONT@email.chop.edu Contact: Barbara McGlynn, RN, BSN MCGLYNN@email.chop.edu Principal Investigator: Timothy Olson, MD 收起 << |
NCT00536341 | - | Completed | - | - | |
NCT00230282 | - | Completed | - | - | |
NCT01572662 | Leukemia Acut... 展开 >>e Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Diseases Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | April 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01883323 | Metastatic, Stage III or Stage... 展开 >> IV, Melanoma 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00918723 | Chronic Lymphocytic Leukemia ... 展开 >> Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | October 2019 | United States, Washington ... 展开 >> Swedish Cancer Institute-Breast Center at First Hill Campus Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00566332 | Waldenström Macroglobulinemia ... 展开 >> Lymphoplasmacytic Lymphoma Splenic Marginal Zone Lymphoma 收起 << | Phase 3 | Completed | - | France ... 展开 >> Hôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital Paris, France, 75013 收起 << |
NCT00918723 | - | Active, not recruiting | - | - | |
NCT00480987 | Myelodysplastic Syndromes ... 展开 >> Acute Myeloid Leukemia Leukemia 收起 << | Phase 1 Phase 2 | Terminated(Lack of support.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00840385 | T-Cell Lymphomas ... 展开 >> Chemotherapy 收起 << | Phase 2 | Unknown | November 2010 | China, Shanghai ... 展开 >> Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaojian Liu, PhD 8613816983809 ext 1107 Xiaojian_liu068@hotmail.com 收起 << |
NCT00480987 | - | Terminated(Lack of support.) | - | - | |
NCT03071276 | Acute Myeloid Leukemia (AML) | Phase 2 | Recruiting | September 2019 | United States, Arizona ... 展开 >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Jessica Boklan, MD 602-933-0920 jboklan@phoenixchildrens.com Principal Investigator: Jessica Boklan, MD United States, California Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD 650-497-8953 lacayon@stanford.edu Principal Investigator: Normal J. Lacayo, MD United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer McNeer, MD 773-834-7424 jmcneer@peds.uchicago.edu Principal Investigator: Jennifer McNeer, MD United States, Michigan Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey W. Taub, MD 313-745-5515 jtaub@med.wayne.edu Principal Investigator: Jeffrey W. Taub, MD United States, North Carolina Duke University Medical Center Completed Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jeffrey E. Rubnitz, MD, PhD 866-278-5833 referralinfo@stjude.org Principal Investigator: Jeffrey E. Rubnitz, MD, PhD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 kenneth.heym@cookchildrens.org Principal Investigator: Kenneth M. Heym, MD 收起 << |
NCT01499147 | - | Completed | - | - | |
NCT01499147 | Acute Myeloid Leukemia ... 展开 >> Acute Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Multiple Myeloma Lymphocytic Leukemia Myeloproliferative Disorder Polycythemia Vera Myelofibrosis Aplastic Anemia 收起 << | Not Applicable | Completed | - | United States, Illinois ... 展开 >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 收起 << |
NCT00117156 | - | Completed | - | - | |
NCT00543114 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Leukemia 收起 << | Phase 1 | Terminated(lack of efficacy an... 展开 >>d tolerability) 收起 << | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00117156 | Lymphoma, Non-Hodgkin ... 展开 >> MALT Lymphoma 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14627 收起 << |
NCT00536341 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 收起 << |
NCT02250937 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00276848 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT01772953 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) 收起 << | Phase 2 | Completed | - | - |
NCT00800839 | Hematologic Diseases ... 展开 >> Leukemia Lymphoma Myeloma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01322776 | Mantle Cell Lymphoma Recurrent | Phase 1 Phase 2 | Unknown | October 2013 | China, Guang Dong ... 展开 >> SunYat-sen University Cancer Centre Recruiting Guang Zhou, Guang Dong, China Contact: Huiqiang Huang huanghq@sysucc.org.cn Principal Investigator: Huiqiang Huang Sub-Investigator: Xiaoxiao Wang 收起 << |
NCT00800839 | - | Completed | - | - | |
NCT00577161 | Non-Hodgkin's Lymphoma | Phase 3 | Terminated(closed to enrollmen... 展开 >>t) 收起 << | July 2012 | United States, Alabama ... 展开 >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, California Ventura County Hematology Oncology Specialist Oxnard, California, United States, 93030 United States, Missouri Capitol Comprehensive Cancer Care Jefferson City, Missouri, United States, 65109 Heartland Hematology Oncology Associates Kansas City, Missouri, United States, 64118 United States, New York Cancer Care Center New Albany, New York, United States, 47150 Interlakes Foundation, Inc. Rochester, New York, United States, 14623 United States, Ohio Hematology Oncology Consultants Columbus, Ohio, United States, 43235 United States, Utah Utah Hematology Oncology, P.C. Ogden, Utah, United States, 84403 收起 << |
NCT00772811 | Chronic Lymphocytic Leukemia ... 展开 >> Lymphoma Multiple Myeloma 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT00206726 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 2 | Completed | - | - |
NCT00382694 | Multiple Myeloma | Phase 2 | Unknown | - | Denmark ... 展开 >> Department of Haematology B, Aalborg Hospital, University of Aarhus Aalborg, Denmark, 9000 Department of Haematology, Herlev University Hospital Herlev, Denmark, 2730 Department of Haematology, Rigshospitalet København Ø, Denmark, 2100 Department of Haematology X, Odense University Hospital Odense, Denmark, 5000 Department of Haematology, Vejle Hospital Vejle, Denmark, 7100 Dept. of Haematology, Århus University Hospital Århus, Denmark, 8000 收起 << |
NCT01658319 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Chronic Lymphocytic Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT00925873 | Acute Myeloid Leukemia | Phase 3 | Completed | - | France ... 展开 >> GOELAMS Tours, France, 37000 收起 << |
NCT00881933 | Aplastic Anemia | Phase 1 Phase 2 | Unknown | September 2012 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D 82 2 2072 3625 hsahn@snu.ac.kr 收起 << |
NCT00924170 | Adult T-Cell Leukemia (ATL) | Phase 1 Phase 2 | Active, not recruiting | January 1, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03613532 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable) Hematopoietic Stem Cell Transplant 收起 << | Phase 1 | Recruiting | February 1, 2021 | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacqueline S Garcia, MD 617-632-1906 jacqueline_garcia@dfci.harvard.edu Principal Investigator: Jacqueline S Garcia, MD 收起 << |
NCT00206726 | - | Completed | - | - | |
NCT00098670 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT00472849 | Richter's Transformation ... 展开 >> Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00086580 | B-Cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Completed | - | - |
NCT00924170 | - | Active, not recruiting | - | - | |
NCT03335241 | Ovarian Cancer | Phase 2 | Recruiting | December 2022 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jundong Li +86-20-87343104 lijd@sysucc.org.cn Contact: Yin Wang +86-20-87343104 wangyin@sysucc.org.cn 收起 << |
NCT00098670 | - | Completed | - | - | |
NCT00572897 | - | Completed | - | - | |
NCT00572897 | Myelofibrosis | Phase 2 | Completed | - | United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21205 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Ohio State Univesity Columbus, Ohio, United States, 43210 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Italy University of Florence Florence, IL, Italy, 60302 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 University of San Martino San Martino, Italy Sweden Regionala etikprovningsnamnden Goteborg Goteborg, Sweden, 60302 收起 << |
NCT00472849 | - | Completed | - | - | |
NCT00625430 | Prostate Cancer | Phase 1 | Unknown | December 2012 | Australia, New South Wales ... 展开 >> St Vincent's Hospital, Sydney Recruiting Darlinghurst, New South Wales, Australia, 2010 收起 << |
NCT01366612 | Myeloid Malignancies ... 展开 >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myeloproliferative Disorders Myelodysplastic Syndrome 收起 << | Phase 3 | Recruiting | November 2018 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Mariefel Vendivil, RN 551-996-5828 Mariefel.Vendivil@HackensackMeridian.org Contact: Andrea Ortega, RN 551-996-3923 Andrea.Ortega@HackensackMeridian.org Principal Investigator: Michele Donato, MD Sub-Investigator: Melissa Baker, APN Sub-Investigator: Michele Boonstra, APN Sub-Investigator: Phyllis McKiernan, APN Sub-Investigator: Scott Rowley, MD Sub-Investigator: Alan Skarbnik, MD Sub-Investigator: David Vesole, MD, PhD 收起 << |
NCT02212561 | Acute Myeloid Leukemia (AML) ... 展开 >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Mixed Phenotype Acute Leukemia (MPAL) 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, California Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 收起 << |
NCT03247088 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | July 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations CR_Study_Registration@mdanderson.org 收起 << |
NCT00506857 | - | Completed | - | - | |
NCT00004246 | Head and Neck Cancer | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 收起 << |
NCT00086580 | - | Completed | - | - | |
NCT01814475 | Myelofibrosis | Phase 2 | Completed | - | Italy ... 展开 >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy Ospedale Ferrarotto - Ematologia Catania, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy AOU IRCCS San Martino - IST Genova, Italy Ospedale Panico Lecce, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli Reggio Calabria, Italy Arciospedale S. M. Novella Reggio Emilia, Italy Cattedra di Ematologia - Università La Sapienza Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Ematologia 2 - ASO San Giovanni Battista Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy 收起 << |
NCT03016988 | Mantle Cell Lymphoma | Phase 2 | Not yet recruiting | December 2020 | - |
NCT00815568 | AML MDS ... 展开 >> ALL CML Lymphoma 收起 << | Phase 2 | Unknown | December 2012 | Korea, Republic of ... 展开 >> Dong Hwan Kim Recruiting Seoul, Korea, Republic of, 135-710 收起 << |
NCT00502905 | Leukemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00502905 | - | Completed | - | - | |
NCT00506857 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01019317 | Leukemia AML ... 展开 >> MDS CML 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01019317 | - | Completed | - | - | |
NCT01186458 | Lymphoma, Non-Hodgkin | Phase 2 | Terminated(Slow accrual) | - | United States, Indiana ... 展开 >> Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 United States, New Jersey Virtua Health Cancer Program Mount Holly, New Jersey, United States, 08060 South Jersey Health Care Vineland, New Jersey, United States, 08360 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Case Comprehensive Cancer Center - University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Reading Hospital Regional Cancer Center W. Reading, Pennsylvania, United States, 19611 收起 << |
NCT00208975 | Lymphoma | Phase 2 | Terminated(slow accrual) | - | United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << |
NCT02514083 | CLL (Chronic Lymphocytic Leuke... 展开 >>mia) SLL (Small Lymphocytic Lymphoma) 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT00208975 | - | Terminated(slow accrual) | - | - | |
NCT03342196 | Leukemia | Phase 2 | Recruiting | June 2022 | United States, Ohio ... 展开 >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Leland Metheny, MD 216-983-4946 Leland.Metheny@uhhospitals.org Principal Investigator: Leland Metheny 收起 << |
NCT01186458 | - | Terminated(Slow accrual) | - | - | |
NCT00278265 | T-Cell Large Granular Lymphocy... 展开 >>tic Leukemia 收起 << | Phase 2 | Terminated(slow recruitment) | - | Germany ... 展开 >> Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13125 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-80337 Klinikum Schwaebisch Gmuend Stauferklinik Mutlangen, Germany, D-73557 Praxis fuer Haematologie und Interne Onkologie Norderstedt, Germany, 22844 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 收起 << |
NCT02024308 | Acute Myeloid Leukemia ... 展开 >> AML1-ETO Fusion Protein Expression 收起 << | Phase 4 | Unknown | December 2016 | China ... 展开 >> Department of Hematology, Changhai Hospital Recruiting Shanghai, China, 200433 Contact: Xianmin Song 86-21-31161285 shongxm@gmail.com Principal Investigator: Xianmin Song 收起 << |
NCT01310179 | Head and Neck Cancer | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212 收起 << |
NCT00882323 | Aplastic Anemia | Phase 2 | Unknown | October 2012 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D 82 2 2072 3625 hsahn@snu.ac.kr 收起 << |
NCT01310179 | - | Completed | - | - | |
NCT02128945 | Untreated B-Chronic Lymphocyti... 展开 >>c Leukemia or Diffuse Large B Cells Lymphoma Patients 收起 << | Phase 1 | Completed | - | France ... 展开 >> University Hospital Caen, France, 14000 收起 << |
NCT02926586 | Acute Myeloid Leukemia ... 展开 >> Core-Binding Factor 收起 << | Phase 4 | Recruiting | July 2020 | China, Shanghai ... 展开 >> Xianmin Song Recruiting Shanghai, Shanghai, China, 200080 Contact: Xianmin Song, Doctor 86-21-63240090-3932 shongxm@sjtu.edu.cn 收起 << |
NCT03696537 | Acute Myeloid Leukemia ... 展开 >> Chronic Myeloid Leukemia Acute Lymphatic Leukemia Myelodysplastic Syndromes 收起 << | Phase 1 Phase 2 | Recruiting | March 31, 2024 | United States, Indiana ... 展开 >> Indiana University Melvin & Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN 317-274-3782 chuntley@iu.edu 收起 << |
NCT02718755 | Hematologic Malignancy | Phase 2 | Withdrawn(Problem with drug su... 展开 >>pply) 收起 << | May 2022 | - |
NCT01472055 | Acute Leukemia ... 展开 >> Chronic Leukemia Severe Aplastic Anemia 收起 << | Phase 2 | Unknown | September 2014 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD +82 2 2072 0177 kanghj@snu.ac.kr Contact: Ji Won Lee, MD +82 2 2072 3452 agnesjw@hanmail.net Principal Investigator: Hyoung Jin Kang, MD, PhD 收起 << |
NCT02649764 | Leukemia | Phase 1 | Active, not recruiting | May 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03754933 | Recurrent Head and Neck Cancer | Phase 1 Phase 2 | Not yet recruiting | August 2021 | United States, California ... 展开 >> Stanford University Not yet recruiting Stanford, California, United States, 94305 Contact: Stefania U Chirita 650-723-1423 schirita@stanford.edu Contact: A Dimitrios Colevas, MD 650-724-9707 colevas@stanford.edu 收起 << |
NCT01096992 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00044954 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Unknown | - | United States, Colorado ... 展开 >> Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States, 80218 United States, Florida Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342-4777 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1009 United States, Missouri Kansas City Cancer Centers - Central Kansas City, Missouri, United States, 64111 United States, New Jersey Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 United States, New York James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Tennessee Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville, Tennessee, United States, 37212 United States, Texas Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75235-8590 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 收起 << |
NCT03524235 | Multiple Myeloma ... 展开 >> CLL Chronic Lymphocytic Leukemia Lymphoma 收起 << | Phase 1 | Recruiting | May 2023 | United States, California ... 展开 >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman 310-967-4376 hannah.coleman@cshs.org 收起 << |
NCT00450983 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Terminated | - | United States, Washington ... 展开 >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00450983 | - | Terminated | - | - | |
NCT00732316 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00093743 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Fanconi Anemia Previously Treated Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01824693 | Juvenile Myelomonocytic Leukem... 展开 >>ia 收起 << | Phase 2 | Completed | - | - |
NCT01824693 | - | Completed | - | - | |
NCT00281983 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, 12200 Universitaetsklinikum Essen Essen, Germany, 45122 Universitaetsklinikum Goettingen Goettingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, 24116 University Hospital of Leipzig Leipzig, Germany, 04103 Klinikum der Universitaet Regensburg Regensburg, Germany, 93053 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, 89081 收起 << |
NCT00226512 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 3 | Withdrawn(the PI is no longer ... 展开 >>work at Hadassah) 收起 << | - | Israel ... 展开 >> Hadassah Medical Organization Jerusalem, Israel, 91120 收起 << |
NCT02916979 | Leukemia, Lymphoid ... 展开 >> Leukemia, Myeloid Myelodysplastic Syndromes Myelofibrosis Lymphoma, Malignant Multiple Myeloma Waldenstrom Macroglobulinemia 收起 << | Phase 1 | Recruiting | December 2019 | United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse 800-639-6918 cancer.research.nurse@dartmouth.edu Principal Investigator: Kenneth Meehan, MD 收起 << |
NCT00311129 | Lymphoma, Low-Grade | Phase 2 | Completed | - | Japan ... 展开 >> Nagoya-shi, Aichi, Japan, 464-8681 Nagoya-shi, Aichi, Japan, 466-0814 Kashiwa-shi, Chiba, Japan, 277-8577 Isehara-shi, Kanagawa, Japan, 259-1193 Kyoto-shi, Kyoto, Japan, 602-0841 Sendai-shi, Miyagi, Japan, 980-0872 Hamamatsu-shi, Shizuoka, Japan, 431-3192 Chuo-ku, Tokyo, Japan, 104-0045 收起 << |
NCT01509300 | Acute Leukemia ... 展开 >> Myelodysplastic Syndrome Solid Tumors 收起 << | Phase 1 Phase 2 | Unknown | March 2014 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD 82-2-3010-3371 hojim@amc.seoul.kr Principal Investigator: Ho Joon Im, MD & PhD 收起 << |
NCT00488709 | Acute Myeloid Leukemia | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Juan Canalejo A Coruña, Spain Hospital Ntra. Sra. de Sonsoles Avila, Spain Hospital germans Trias i Pujol Badalona, Spain Centro Médico Teknon Barcelona, Spain Hospital Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital de Jerez Cadiz, Spain Complejo hospitalario Xeral-Calde Lugo, Spain Hospital Clínico Universitario San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Virgen de la Victoria Málaga, Spain Hosptal Joan XXIII Tarragona, Spain Hospital Verge de la Cinta Tortosa, Spain Hospital Rio Hortega Valladolid, Spain Hospital Clinico Lozano Blesa Zaragoza, Spain 收起 << |
NCT00119392 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01336712 | - | Completed | - | - | |
NCT00208923 | Hematologic Malignancies | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Emory Universtiy Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << |
NCT00354822 | Lymphoma, Non-Hodgkin | Phase 2 | Terminated(Inability to recrui... 展开 >>t in time a sufficient number of patients) 收起 << | - | Italy ... 展开 >> USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 U.O. Ematologia Ospedali Civili Brescia Brescia, BS, Italy Medicina Nucleare ed Oncologia Medica AOU Policlinico Universitario di Messina Messina, ME, Italy, 98125 Istituto per la Ricerca e la Cura del Cancro IRCC Candiolo, TO, Italy, 10060 SC Ematologia 2 ASO S. Giovanni Battista Torino, TO, Italy U.O. Ematologia Ospedale Cà Foncello Treviso, TV, Italy, 31100 收起 << |
NCT00003635 | Leukemia | Phase 2 | Completed | - | - |
NCT00119392 | - | Completed | - | - | |
NCT01983761 | Blood And Marrow Transplantati... 展开 >>on Leukemia Lymphoma Transplantation Infection Myelodysplastic Syndrome (MDS) Non-Hodgkin's Lymphoma (NHL) Hodgkin's Lymphoma 收起 << | Phase 1 Phase 2 | Unknown | - | United States, California ... 展开 >> Scripps Green Hospital La Jolla, California, United States, 92037 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 收起 << |
NCT00349349 | Leukaemia, Lymphocytic, Chroni... 展开 >>c 收起 << | Phase 2 | Completed | - | - |
NCT00358657 | Immunodeficiency Syndrome ... 展开 >> Non-Cancer Diagnosis Severe Aplastic Anemia 收起 << | Phase 2 | Recruiting | - | United States, Tennessee ... 展开 >> The Children's Hospital at TriStar Centennial Recruiting Nashville, Tennessee, United States, 37203 Contact: Haydar A. Frangoul 615-329-7339 Haydar.Frangoul@hcahealthcare.com Principal Investigator: Haydar A. Frangoul Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: James Connelly 615-936-1762 james.a.connelly@vanderbilt.edu Principal Investigator: James Connelly United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs 206-667-2396 lburroug@fredhutch.org Principal Investigator: Lauri M. Burroughs 收起 << |
NCT01336712 | Chronic Leukemia ... 展开 >> Acute Leukemia Hodgkin's Disease Non-Hodgkin's Lymphoma Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT00349349 | - | Completed | - | - | |
NCT00274976 | Leukemia | Phase 2 | Completed | - | Austria ... 展开 >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany, 91522 Specialist Practice for Oncology Aschaffenburg, Germany, 63739 Humaine - Clinic Bad Saarow, Germany, 15526 Haematolo-Onkologische Schwerpunktpraxis - Berlin Berlin, Germany, 13357 Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany, D-13122 Hospital Kuchwald Chemnitz Chemnitz, Germany, 09113 Universitaetsklinikum Essen Essen, Germany, D-45122 Staedtische Kliniken Esslingen Esslingen, Germany, 73730 Krankenhaus Nordwest Frankfurt, Germany, D-60488 Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Universitaetsklinikum Goettingen Goettingen, Germany, D-37075 Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet Greifswald, Germany, D-17487 St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH Hagen, Germany, 58095 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 Praxis fur Innere Medizin - Hamburg Hamburg, Germany, 22457 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Evangelische Krankenhaus Hamm Hamm, Germany, DOH-59063 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Marienhospital at Ruhr University Bochum Herne, Germany, D-44625 Universitaetsklinikum des Saarlandes Homburg, Germany, D-66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Internistische Gemeinschaftspraxis - Kassel Kassel, Germany, 34117 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Internistische Praxis - Landshut Landshut, Germany, 84028 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Klinikum Oldenburg Oldenburg, Germany, D-26133 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Universitaetsklinikum Ulm Ulm, Germany, D-89081 Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg Wuerzburg, Germany, D- Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 收起 << |
NCT00800150 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 | Terminated(Protocol objective ... 展开 >>could not be met. A new study with amended eligibility criteria will be developed.) 收起 << | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT00070135 | - | Completed | - | - | |
NCT02178683 | Graft Versus Host Disease | Phase 3 | Unknown | December 2018 | United States, Colorado ... 展开 >> Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Juli B Murphy 720-754-4890 Juli.Murphy@healthonecares.com Contact: Mark Brunvand, MD 720-754-4800 Mark.Brunvand@healthonecares.com Principal Investigator: Mark Brunvand, MD Sub-Investigator: Peter McSweeney, MD Sub-Investigator: Michael Maris, MD Sub-Investigator: Jeff Matous, MD Sub-Investigator: Scott Bearman, MD Sub-Investigator: Tara Gregory, MD Sub-Investigator: Richard Nash, MD 收起 << |
NCT00290511 | Lymphoma | Phase 2 | Active, not recruiting | August 24, 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00070135 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber/Brigham and Women's Cancer Center Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Monter Cancer Center of the North Shore-LIJ Health System Lake Success, New York, United States, 11042 CCOP - North Shore University Hospital Manhasset, New York, United States, 11030 Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset, New York, United States, 11030 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 收起 << |
NCT00525603 | Leukemia Chro... 展开 >>nic Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00069992 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Terminated(Closed due to compe... 展开 >>ting protocols) 收起 << | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT00038831 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome Chronic Lymphocytic Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00110058 | Leukemia | Phase 2 | Completed | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT01560117 | Follicular T-NHL Lymphoma ... 展开 >> Rituximab Maintenance 收起 << | Phase 2 | Completed | - | - |
NCT00525603 | - | Completed | - | - | |
NCT01392079 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | December 2016 | Austria ... 展开 >> Hanuschkrankenhaus Wien Wien, Austria University Hospital Wien, Austria France Centre Hospitalier de la Côte Basque Bayonne, France Hopital Avicenne Bobigny Cedex, France, 93009 CHU Estaing Clermont-Ferrand, France Hôpital Henri Mondor, Creteil -APHP CRETEIL Cedex, France CHU de Grenoble Grenoble, France CHU Claude Huriez Lille, France Hôpital Edouard Herriot Lyon Lyon, France CHU de Nancy NANCY Cedex, France CHU Nantes Nantes, France Hôpital Pitié Salpêtrière Paris-APHP Paris, France Hôpital Saint-Louis Paris -APHP Paris, France Centre Hospitalier Marechal Joffre Hôpital Saint-Jean Perpignan PERPIGNAN Cedex, France CHU de Poitiers POITIERS Cedex, France CHU Robert-Debre Reims, France, 51092 CHU de Tours Tours, France Germany Charité CBF Berlin Berlin, Germany University of Cologne Cologne, Germany Dresden Universtiy Hospital Dresden, Germany Essen University Essen, Germany Freiburg University Freiburg, Germany Goettingen University Goettingen, Germany LMU Munich Grosshadern, Germany AK St. Georg Hamburg Hamburg, Germany Hannover medical school (MHH) Hannover, Germany Heidelberg University Heidelberg, Germany Homburg/Saar University Homburg/Saar, Germany Dr. Soeling Kassel Kassel, Germany Kiel University Kiel, Germany Mainz University Mainz, Germany TU Munich Munich, Germany Nuernberg University Hospital Nuernberg, Germany OncoProGbR Regensburg Regensburg, Germany Universtiy of Tuebingen Tuebingen, Germany University of ulm Ulm, Germany, 89081 Dr. Schlag Wuerzburg Wuerzburg, Germany University Hospital Wuerzburg Wuerzburg, Germany 收起 << |
NCT01313689 | Leukaemia | Phase 3 | Completed | - | - |
NCT03455504 | Acute Myeloid Leukemia | Phase 2 | Not yet recruiting | September 2020 | Italy ... 展开 >> Ematologia - ASST Papa Giovanni XXIII Not yet recruiting Bergamo, Italy Contact: Alessandro Rambaldi Principal Investigator: Alessandro Rambaldi Spedali Civili - Azienda Ospedaliera U.O. Ematologia Not yet recruiting Brescia, Italy Contact: Giuseppe Rossi Principal Investigator: Giuseppe Rossi Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Not yet recruiting Catania, Italy Contact: Francesco Di Raimondo Principal Investigator: Francesco Di Raimondo A.O.U. Careggi - Ematologia Not yet recruiting Firenze, Italy Contact: Alberto Bosi Principal Investigator: Alberto Bosi Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori IRST Not yet recruiting Meldola, Italy Contact: Giovanni Martinelli Principal Investigator: Giovanni Martinelli Ospedale Niguarda "Ca Granda" SC Ematologia Not yet recruiting Milano, Italy Contact: Roberto Cairoli Principal Investigator: Roberto Cairoli U.O. Ematologia e Trapianto di Midollo Ist. Scientifico Ospedale San Raffaele Not yet recruiting Milano, Italy Contact: Fabio Ciceri Principal Investigator: Fabio Ciceri U.O.C. Ematologia e CTMO Az Ospedaliero Universitaria Not yet recruiting Parma, Italy Contact: Giovanni Roti Principal Investigator: Giovanni Roti Dipartimento Oncologico - Ospedale S. Maria delle Croci Not yet recruiting Ravenna, Italy Contact: Francesco Lanza Principal Investigator: Francesco Lanza Università degli Studi "Sapienza" Dip. Biotecnologie Cellulari ed Ematologia Not yet recruiting Roma, Italy Contact: Roberto Foà Principal Investigator: Roberto Foà Dipartimento di Oncologia ed Ematologia S.C. -Città della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Ernesta Audisio Principal Investigator: Ernesta Audisio 收起 << |
NCT01683123 | - | Unknown | October 2012 | - | |
NCT02251548 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 2 | Active, not recruiting | January 2022 | United States, Florida ... 展开 >> University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States, 33146 University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States, 33442 Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States, 33136 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT00719888 | Acute Biphenotypic Leukemia ... 展开 >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Adult Acute Lymphoblastic Leukemia in Complete Remission Aggressive Non-Hodgkin Lymphoma Beta-2-Microglobulin Greater Than 3 g/mL Blasts Under 5 Percent of Bone Marrow Nucleated Cells Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission Chromosome 13 Abnormality Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Lymphoblastic Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelofibrosis Pancytopenia Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Non-Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey 206-764-2199 tchaunce@u.washington.edu Principal Investigator: Thomas R. Chauncey Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ann E. Dahlberg 206-667-1959 adahlber@fredhutch.org Principal Investigator: Ann E. Dahlberg 收起 << |
NCT00381004 | - | Completed | - | - | |
NCT00346359 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00381004 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02047578 | Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 4192 agnesjw@hanmail.net 收起 << |
NCT00772486 | Chronic Lymphocytic Leukemia | Phase 1 | Unknown | - | United States, California ... 展开 >> University of California, San Diego Moores Cancer Center San Diego, California, United States, 92093 收起 << |
NCT00301912 | Anemia Chroni... 展开 >>c Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Withdrawn(Withdrawn because st... 展开 >>udy never opened to accrual) 收起 << | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00027820 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndrome Childhood Renal Cell Carcinoma Chronic Myelomonocytic Leukemia Clear Cell Renal Cell Carcinoma de Novo Myelodysplastic Syndrome Metastatic Renal Cell Cancer Previously Treated Myelodysplastic Syndrome Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Renal Medullary Carcinoma Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Arizona ... 展开 >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, California Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Baylor Medical Center at Garland Garland, Texas, United States, 75042 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00529880 | Acute Myeloid Leukemia | Phase 2 | Unknown | October 2007 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Songpa-gu, Seoul, Korea, Republic of, 138-833 Contact: Keun-Hee Kim, nurse 82-2-3010-7290 kuny9847@naver.com 收起 << |
NCT03235973 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute 收起 << | Phase 1 | Recruiting | April 2021 | France ... 展开 >> Institut Paoli-Calmettes Recruiting Marseille, Bouches-du-Rhône, France, 13009 Contact: Dominique Genre, MD +33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Raynier Devillier, MD,PhD 收起 << |
NCT00119340 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Veterans Affairs Medical Center - Seattle Seattle, Washington, United States, 98108 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00868413 | Chronic Lymphocytic Leukemia | Phase 1 | Completed | - | United States, California ... 展开 >> Site Reference ID/Investigator# 17841 La Jolla, California, United States, 92093 Site Reference ID/Investigator# 25899 Stanford, California, United States, 94305-5821 United States, Maryland Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States, 21231-1000 United States, Ohio Site Reference ID/Investigator# 21621 Columbus, Ohio, United States, 43210 United States, Pennsylvania Site Reference ID/Investigator# 39613 Philadelphia, Pennsylvania, United States, 19111 United States, Texas Site Reference ID/Investigator# 17943 Houston, Texas, United States, 77030-4009 收起 << |
NCT01145469 | - | Completed | - | - | |
NCT00027560 | - | Completed | - | - | |
NCT00027560 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT01861002 | Lymphoblastic Leukemia, Acute,... 展开 >> Childhood Myelogenous Leukemia, Acute, Childhood 收起 << | Phase 1 | Completed | - | - |
NCT02158091 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Active, not recruiting | July 2021 | United States, Massachusetts ... 展开 >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00280241 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT00968162 | Bone Marrow Transplantation ... 展开 >> Sickle Cell Disease 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama-Birmingham Birmingham, Alabama, United States United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States United States, Florida All Children's Research Institute Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Michigan Wayne State University Detroit, Michigan, United States, 48202 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States United States, New York Montefiore Medical Center The Bronx, New York, United States United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27516 United States, Texas University of Texas Southwestern Dallas, Texas, United States 收起 << |
NCT00280241 | - | Completed | - | - | |
NCT01313689 | - | Completed | - | - | |
NCT00513747 | Leukemia | Phase 3 | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | - |
NCT00396968 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT00397800 | Lymphoma | Phase 1 Phase 2 | Unknown | May 2013 | Germany ... 展开 >> Medizinische Klinik, Klinikum Augsburg Augsburg, Germany, D-86156 Medizinische Klinik III - Universitaetsklinikum Erlangen Erlangen, Germany, D-91054 Universitaetsklinikum Goettingen Goettingen, Germany, D-37075 Universitaetsklinikum Schleswig-Holstein - Campus Luebeck Luebeck, Germany, D-23538 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, D-55101 LMU-Klinikum Grosshadern Munich, Germany, D-81366 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Klinikum der Universitaet Regensburg Regensburg, Germany, D-93042 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg Wuerzburg, Germany, D-97080 收起 << |
NCT02034630 | Genetic Rare Disease | Phase 1 Phase 2 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 3452 agnesjw@hanmail.net 收起 << |
NCT02158091 | - | Active, not recruiting | - | - | |
NCT00565981 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 A.ö. Landeskrankenhaus Fürstenfeld Fürstenfeld, Austria, A-8280 Universitätsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria, A-6020 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus der Stadt Linz Linz, Austria, A-4020 St. Johanns LK Salzburg, Austria, A-5020 A.ö. Krankenhaus der Landeshauptstadt St. Pölten St. Poelten, Austria, A-3100 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, A-4600 收起 << |
NCT00024440 | Leukemia | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Genta Incorporated Berkeley Heights, New Jersey, United States, 07922 收起 << |
NCT00112567 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 收起 << |
NCT00393107 | Follicular Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> Ospedale di Arezzo Arezzo, Italy, 52100 Ospedale Maggiore di Milano Milano, Italy, 20100 Ospedale Monteluce Perugia, Italy, 06110 Ospedale di Pescara Pescara, Italy, 89100 Ospedale di Piacenza Piacenza, Italy, 29100 Ospedale di Pisa Pisa, Italy, 56100 Ospedale di Reggio Calabria Reggio Calabria, Italy, 89100 Ospedale S. Maria Nuova Reggio Emilia, Italy, 42100 Ospedale Molinette Torino, Italy, 10100 收起 << |
NCT00845104 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Refractory Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Withdrawn(No patients enrolled... 展开 >>.) 收起 << | - | - |
NCT00053287 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT00577993 | Lymphoma | Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02859402 | T-cell Non-Hodgkin Lymphoma ... 展开 >> Lymphoma, Extranodal NK-T-Cell 收起 << | Phase 2 | Recruiting | December 2021 | Korea, Republic of ... 展开 >> Dong-A University Recruiting Busan, Korea, Republic of, 602-713 Contact: Ji Hyun Lee, MD., Ph.D. +82-10-9397-5694 hidrleejh@dau.ac.kr Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Young Rok Do, MD., Ph.D. +82-10-3541-1160 dyr1160@dsmc.or.kr 收起 << |
NCT00429026 | - | Terminated(Slow accrual, study... 展开 >> terminated.) 收起 << | - | - | |
NCT00003145 | Accelerated Phase of Disease ... 展开 >> Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Disease 收起 << | Phase 2 | Active, not recruiting | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT01283386 | Lymphocytic Leukemia, Chronic | Phase 4 | Completed | - | Russian Federation ... 展开 >> Irkutsk, Russian Federation, 664079 Kemerovo, Russian Federation, 650066 Moscow, Russian Federation, 115478 Moscow, Russian Federation, 125284 Saint-Petersburg, Russian Federation, 198205 St. Petersburg, Russian Federation, 197110 Tula, Russian Federation, 300053 UFA, Russian Federation, 450005 收起 << |
NCT00577278 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma 收起 << | Phase 2 | Active, not recruiting | March 2019 | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010-3000 收起 << |
NCT00801060 | Chronic Lymphocytic Leukemia | Phase 2 | Terminated | - | - |
NCT00301834 | - | Completed | - | - | |
NCT01105273 | Aplastic Anemia | Phase 1 Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT00125606 | Acute Myeloid Leukemia | Phase 3 | Terminated(insufficient patien... 展开 >>t recruitement) 收起 << | - | Germany ... 展开 >> Department of Medicine/Hematology and Oncology Muenster, NRW, Germany, 48149 收起 << |
NCT00169208 | Follicular Lymphoma | Phase 2 | Completed | - | France ... 展开 >> Service de médecine D - Maladies du Sang CHU Angers Angers, France, 49033 Service d'Hématologie Hôpital Jean Minjoz Besançon, France, 25030 Hôpital Henri Mondor Créteil, France, 94010 Hôpital A. Michallon BP 217X Grenoble, France, 38043 Service Oncologie - Centre Victor Hugo Le Mans, France, 72015 Service d'hématologie clinique - Centre Hospitalier du Dr Schaffner Lens, France, 62307 Hôpital Claude Huriez - Sce des Maladies du Sang - Place Verdun Lille, France, 59037 Centre Hospitalier Lyon-sud Lyon, France, 69310 Centre régional de lutte contre le cancer Léon Bérard Lyon, France, 69373 Service d'hématologie Institut Paoli Calmette Marseille, France, 13273 Service d'hématologie - Hôpital Necker Paris, France, 75015 Service d'Hématologie Hôpital St Louis Paris, France, 75475 Service d'hématologie clinique - Hôpital de Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Service Oncologie CHU Bretonneau Tours, France, 37044 Service d'hématologie Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT00118352 | Acute Undifferentiated Leukemi... 展开 >>a Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00429026 | Renal Cell Cancer | Phase 2 | Terminated(Slow accrual, study... 展开 >> terminated.) 收起 << | - | United States, Texas ... 展开 >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00193466 | Non-Hodgkins Lymphoma | Phase 2 | Completed | - | - |
NCT00086775 | Leukemia | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Mississippi Jackson Oncology Associates, PLLC Jackson, Mississippi, United States, 39202 United States, New Jersey Cancer Institute of New Jersey at Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania Western Pennsylvania Cancer Institute Pittsburgh, Pennsylvania, United States, 15224 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT00005799 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) B-cell Chronic Lymphocytic Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Childhood Renal Cell Carcinoma Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Splenic Marginal Zone Lymphoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Waldenström Macroglobulinemia 收起 << | Not Applicable | Active, not recruiting | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 收起 << |
NCT00499889 | - | Terminated(Support issue.) | - | - | |
NCT00118352 | - | Completed | - | - | |
NCT00499889 | Leukemia | Phase 2 | Terminated(Support issue.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01255319 | - | Unknown | November 2014 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse 82-2-3010-6378 redpin75@paran.com 收起 << | |
NCT03303950 | Anemia ASXL1 ... 展开 >>Gene Mutation EZH2 Gene Mutation IDH1 Gene Mutation IDH2 Gene Mutation Plasma Cell Myeloma Primary Myelofibrosis Recurrent Plasma Cell Myeloma Secondary Myelofibrosis Thrombocytopenia 收起 << | Phase 2 | Recruiting | October 2022 | United States, Utah ... 展开 >> Huntsman Cancer Institute/University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Catherine Lee, MD 801-587-0231 Catherine.Lee@hci.utah.edu Principal Investigator: Catherine Lee, MD 收起 << |
NCT00301834 | Congenital Amegakaryocytic Thr... 展开 >>ombocytopenia Diamond-blackfan Anemia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 收起 << |
NCT00253513 | - | Completed | - | - | |
NCT00553098 | Immunodeficiency Syndrome ... 展开 >> Non-Cancer Diagnosis 收起 << | Phase 2 | Active, not recruiting | - | United States, California ... 展开 >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609-1809 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 收起 << |
NCT00253513 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00075478 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia in Remission Aggressive Non-Hodgkin Lymphoma Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic/Myeloproliferative Neoplasm Plasma Cell Myeloma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 3 | Completed | - | United States, Oregon ... 展开 >> OHSU Cancer Institute-Southern Region Medford, Oregon, United States, 97504 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00887042 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Unknown | May 2012 | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Chongno-gu, Korea, Republic of, 110-744 收起 << |
NCT00553098 | - | Active, not recruiting | - | - | |
NCT00008177 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00075478 | - | Completed | - | - | |
NCT00416884 | Leukemia | Phase 2 | Terminated(Low enrollment) | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT00416884 | - | Terminated(Low enrollment) | - | - | |
NCT00860574 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver, Colorado, United States, 80217-3364 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00619645 | - | Completed | - | - | |
NCT00019838 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 收起 << |
NCT00014235 | Acute Myeloid Leukemia/Transie... 展开 >>nt Myeloproliferative Disorder Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Multiple Myeloma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Waldenström Macroglobulinemia 收起 << | Not Applicable | Active, not recruiting | - | United States, Arizona ... 展开 >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, California City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert Hospital Milwaukee, Wisconsin, United States, 53226-3596 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00619645 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California Davis Cancer Center Sacramento, California, United States, 95817 收起 << |
NCT00281931 | Prolymphocytic Leukemia | Phase 2 | Terminated | - | Germany ... 展开 >> Helios Klinikum Erfurt Erfurt, Germany, 99012 收起 << |
NCT00410163 | - | Completed | - | - | |
NCT00005580 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 收起 << |
NCT00228852 | T-Cell Immune Deficiency Disea... 展开 >>ses Severe Combined Immunodeficiency 收起 << | Phase 1 Phase 2 | Completed | - | United States, Georgia ... 展开 >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 收起 << |
NCT00020800 | Lymphoma | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, District of Columbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307-5000 United States, Illinois Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242-1009 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Tuft-New England Medical Center Boston, Massachusetts, United States, 02111 Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Barrett Cancer Center Cincinnati, Ohio, United States, 45267-0502 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Chedoke-McMaster Hospitals Hamilton, Ontario, Canada, L8N 3Z5 Sweden Huddinge University Hospital Stockholm, Sweden, SE-141 86 United Kingdom Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE 收起 << |
NCT00003829 | Leukemia | Phase 2 | Completed | - | United States, Arizona ... 展开 >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 收起 << |
NCT00809276 | Lymphoma Mult... 展开 >>iple Myeloma Leukemia Myelodysplastic Syndrome 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> The Sydney Kimmel Comprehensive Cancer center Baltimore, Maryland, United States, 21231 United States, Texas Marcos deLima, MD Houston, Texas, United States, 77030 United States, Washington Paul V. O'Donnell, M.D., Ph.D. Seattle, Washington, United States, 98109 收起 << |
NCT00410163 | Leukaemia, Lymphocytic, Chroni... 展开 >>c 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Houston, Texas, United States, 77030 United Kingdom GSK Investigational Site Plymouth, Devon, United Kingdom, PL68DH 收起 << |
NCT01503242 | Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 1 | Active, not recruiting | December 6, 2019 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00880815 | CD20 Positive ... 展开 >> Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Recurrent Diffuse Large B-Cell Lymphoma T-Cell Non-Hodgkin Lymphoma 收起 << | Phase 1 | Active, not recruiting | February 28, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00809276 | - | Completed | - | - | |
NCT00987480 | Aplastic Anemia ... 展开 >> Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 The Rockefeller University New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States 收起 << |
NCT00987480 | - | Completed | - | - | |
NCT00789776 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Previously Treated Myelodysplastic Syndrome Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | May 18, 2021 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT00096382 | Melanoma (Skin) | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 收起 << |
NCT00096382 | - | Completed | - | - | |
NCT00453388 | Acute Myeloid Leukemia in Remi... 展开 >>ssion de Novo Myelodysplastic Syndrome Fanconi Anemia Previously Treated Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | - | United States, California ... 展开 >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609-1809 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Brazil Universidade Federal do Paraná Curitiba, Paraná, Brazil, 80060-000 收起 << |
NCT03690011 | T-cell Acute Lymphoblastic Leu... 展开 >>kemia T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma 收起 << | Phase 1 | Not yet recruiting | May 1, 2038 | United States, Texas ... 展开 >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: LaQuisa HIll, MD 832-824-4670 LaQuisa.Hill@bcm.edu Contact: Jacqueline Castello 713-441-1450 jxcastel@txch.org Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD 832-824-4716 rhrouce@txch.org Contact: Jacqueline Castello 832-824-4391 jxcastel@txch.org 收起 << |
NCT00453388 | - | Active, not recruiting | - | - | |
NCT00324623 | Melanoma (Skin) | Phase 1 | Completed | - | Switzerland ... 展开 >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 收起 << |
NCT00603954 | Hematological Malignancies | Phase 2 | Completed | - | Belgium ... 展开 >> UZA Edeghem, Antwerpen, Belgium AZ Gasthuisberg Leuven Leuven, Flamish Brabant, Belgium, 3000 UZ Gent Gent, Flanders Oost, Belgium University Hospital Mont-Godinne Godinne, Namur, Belgium AZ St-Jan Brugge, West Flanders, Belgium UZA Stuyvenberg Antwerpen, Belgium Bordet Institute Brussels, Belgium St Luc UCL Brussels, Belgium UZ Brussels Brussels, Belgium CHU Sart Tilman Liege, Belgium, 4000 Netherlands University Hospital Maastricht Maastricht, Limburg, Netherlands, 6200 收起 << |
NCT00010361 | Metabolism, Inborn Errors ... 展开 >> Granulomatous Disease, Chronic 收起 << | Not Applicable | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00579137 | Severe Combined Immunodeficien... 展开 >>cy Disease Severe Primary Immunodeficiency Disorder Undefined T Cell Deficiency Disorder Wiskott-Aldrick Syndrome 收起 << | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00579137 | - | Terminated(slow accrual) | - | - | |
NCT02333838 | Leukemia, Myeloid | Phase 2 | Active, not recruiting | May 2019 | France ... 展开 >> Hôpital de Brabois, Hématologie Clinique et thérapie cellulaire Vandoeuvre les Nancy, France, 54511 收起 << |
NCT00085449 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT03190733 | Chronic Graft-versus-host-dise... 展开 >>ase Leukemia Relapse 收起 << | Phase 4 | Not yet recruiting | September 30, 2021 | - |
NCT00698009 | Neuroblastoma | Phase 2 | Terminated(Slow accrual.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00698009 | - | Terminated(Slow accrual.) | - | - | |
NCT01390402 | - | Completed | - | - | |
NCT01390402 | Leukemia Chro... 展开 >>nic Myelogenous Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03192397 | Acute Myeloid Leukemia in Remi... 展开 >>ssion Adult Acute Lymphoblastic Leukemia in Complete Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission Chronic Myelomonocytic Leukemia in Remission Graft Versus Host Disease Hodgkin Lymphoma Minimal Residual Disease Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Plasma Cell Myeloma Severe Aplastic Anemia Waldenstrom Macroglobulinemia 收起 << | Phase 2 | Recruiting | July 1, 2022 | United States, New York ... 展开 >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park 877-275-7724 ASKRPCI@roswellpark.org Principal Investigator: Christine M. Ho 收起 << |
NCT03600909 | Fanconi Anemia ... 展开 >> Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) 收起 << | Phase 2 | Recruiting | May 2022 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Farid Boulad, MD 212-639-6684 Contact: Maria Cancio, MD 212-639-2446 Principal Investigator: Faird Boulad, MD 收起 << |
NCT00613561 | Severe Immunodeficiency Diseas... 展开 >>es 收起 << | Phase 2 | Unknown | December 2017 | United States, Illinois ... 展开 >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 收起 << |
NCT01582048 | Patients Receiving Mismatched ... 展开 >>Allogeneic HCT 收起 << | Phase 2 | Terminated(slow enrollment) | - | Germany ... 展开 >> Hematology/Oncology Medical Center University Hospital of Mainz Mainz, Germany, D-55101 Bone Marrow Transplantation Unit Medical Center University Hospital of Nuernberg Nuernberg, Germany, D-90419 Department of Hematology/Oncology Medical Center University Hospital of Tuebingen Tuebingen, Germany, D-72076 BMT-Unit Deutsche Klinik für Diagnostik Wiesbaden, Germany, D-65191 收起 << |
NCT00006252 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Veterans Affairs Medical Center - San Diego San Diego, California, United States, 92161 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Massachusetts UMASS Memorial Cancer Center - University Campus Worcester, Massachusetts, United States, 01655 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Elmhurst Hospital Center Elmhurst, New York, United States, 11373 Queens Cancer Center of Queens Hospital Jamaica, New York, United States, 11432 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 收起 << |
NCT01292135 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Small Lymphocytic Lymphoma 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, New York CLL Research and Treatment Program New Hyde Park, New York, United States, 11042 Weill Medical College of Cornell University New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Houston, Texas, United States, 77030 收起 << |
NCT01292135 | - | Completed | - | - | |
NCT02161783 | - | Recruiting | July 2021 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Troy C Lund, MD, PhD 收起 << | |
NCT00078065 | Multiple Myeloma | Phase 2 | Completed | - | United States, California ... 展开 >> Oncotherapeutics Los Angeles, California, United States, 90067 University of California, San Diego San Diego, California, United States, 92093 University of California, San Francisco San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins Medical Institute Baltimore, Maryland, United States, 21231 Center for Cancer & Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 收起 << |
NCT01434472 | Post-Transplant Lymphoprolifer... 展开 >>ative Disorder Recurrent Adult Diffuse Large Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma 收起 << | Phase 2 | Recruiting | September 24, 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal 206-288-2037 agopal@u.washington.edu Principal Investigator: Ajay K. Gopal 收起 << |
NCT00559221 | Acute Myeloid Leukemia | Phase 2 | Unknown | June 2008 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Yae-Eun , Jang 82-2-3010-7290 redpin75@paran.com Principal Investigator: Hawk Kim, professor 收起 << |
NCT01110031 | Leukaemia, Lymphocytic, Chroni... 展开 >>c 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> GSK Investigational Site La Jolla, California, United States, 92093 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Auckland, New Zealand, 1150 GSK Investigational Site Christchurch, New Zealand, 8011 收起 << |
NCT00408447 | Sickle Cell Disease ... 展开 >> Beta Thalassemia 收起 << | Phase 2 | Recruiting | December 2018 | United States, New York ... 展开 >> Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University Recruiting New York, New York, United States, 10032 Contact: Monica Bhatia, MD 212-305-9138 mb2476@columbia.edu Principal Investigator: Monica Bhatia, MD 收起 << |
NCT02096614 | Solid Tumors | Phase 1 | Recruiting | - | Japan ... 展开 >> Mie University Hospital Recruiting Tsu, Mie, Japan Contact: Yasuyuki Ota, Ph.D. Contact: Chisato Minamide, RN 收起 << |
NCT00104858 | Chronic Lymphocytic Leukemia ... 展开 >> Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma T-Cell Large Granular Lymphocyte Leukemia 收起 << | Phase 2 | Active, not recruiting | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Denmark Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT02366546 | Solid Tumors | Phase 1 | Active, not recruiting | - | Japan ... 展开 >> Mie University Hospital Tsu, Mie, Japan 收起 << |
NCT02145039 | Acute Leukemias ... 展开 >> Burkitt's Lymphoma Chronic Myelogenous Leukemia 收起 << | Not Applicable | Active, not recruiting | June 2020 | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01471067 | Blood And Marrow Transplantati... 展开 >>on Leukemia Lymphoma Transplantation Infection Transplantation, Bone Marrow 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00060424 | B-Cell Prolymphocytic Leukemia... 展开 >> Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00902044 | Sarcoma | Phase 1 | Recruiting | July 2031 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD 832-824-4611 nmahmed@txch.org Contact: Catherine Robertson 832-824-4594 csrobert@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD 832-824-4611 nmamed@txch.org Contact: Meenakshi Hegde, MD 832-824-4840 mghegde@txch.org 收起 << |
NCT00060424 | - | Completed | - | - | |
NCT00863330 | Melanoma (Skin) | Phase 2 | Terminated(administrative deci... 展开 >>sion- PI retired and treating physician left the institution) 收起 << | - | United States, Wisconsin ... 展开 >> Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 收起 << |
NCT00796068 | Acute Biphenotypic Leukemia ... 展开 >> Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Myelodysplastic Syndrome Blasts Under 5 Percent of Bone Marrow Nucleated Cells Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Myelodysplastic Syndrome Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-2 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Filippo Milano 206-667-5925 fmilano@fredhutch.org Principal Investigator: Filippo Milano 收起 << |
NCT00863330 | - | Terminated(administrative deci... 展开 >>sion- PI retired and treating physician left the institution) 收起 << | - | - | |
NCT00909948 | Non Hodgkin's Lymphoma ... 展开 >> Hodgkin Disease Multiple Myeloma 收起 << | Phase 1 | Terminated(Slow Accrual) | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT01168219 | Acute Myeloid Leukemia ... 展开 >> Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Active, not recruiting | November 15, 2018 | United States, Delaware ... 展开 >> Beebe Medical Center Lewes, Delaware, United States, 19958 Christiana Care Health System-Christiana Hospital Newark, Delaware, United States, 19718 United States, Florida Florida Hospital Orlando Orlando, Florida, United States, 32803 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, New York Northwell Health NCORP Lake Success, New York, United States, 11042 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT02118285 | Ovarian Cancer ... 展开 >> Fallopian Tube Carcinoma Primary Peritoneal Carcinoma 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01274195 | Hematopoietic Stem Cell Transp... 展开 >>lantation 收起 << | Phase 2 | Unknown | December 2013 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 0177 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 0177 agnesjw@hanmail.net Principal Investigator: Hyo Seop Ahn, MD, PhD 收起 << |
NCT00255684 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Not Applicable | Terminated(low accrual) | - | United States, New York ... 展开 >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 收起 << |
NCT02252107 | Acute Myeloid Leukemia (AML) | Phase 2 | Active, not recruiting | October 2019 | Belgium ... 展开 >> University of Liège Liège, Belgium Netherlands University Medical Center Groningen (UMCG) Groningen, Netherlands Radboud university medical center Nijmegen, Netherlands, 6500 HB 收起 << |
NCT01168219 | - | Active, not recruiting | - | - | |
NCT00156858 | Hematologic Malignancy | Not Applicable | Unknown | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Rachel Syme, PhD clinical_trials_tbcc@cancerboard.ab.ca Sub-Investigator: Chris Brown Sub-Investigator: Ron Anderson Principal Investigator: James Russell Sub-Investigator: Victor Lewis 收起 << |
NCT00255684 | - | Terminated(low accrual) | - | - | |
NCT00045513 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... 展开 >> McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 London Health Sciences Centre London, Ontario, Canada, N6A 465 Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00121186 | Lymphoma | Phase 2 | Terminated(poor accrual) | - | United States, Illinois ... 展开 >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services, Incorporated Richmond, Indiana, United States, 47374 United States, Kansas Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States, 66720 Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States, 67801 Cancer Center of Kansas, PA - El Dorado El Dorado, Kansas, United States, 67042 Cancer Center of Kansas, PA - Kingman Kingman, Kansas, United States, 67068 Southwest Medical Center Liberal, Kansas, United States, 67901 Cancer Center of Kansas, PA - Newton Newton, Kansas, United States, 67114 Cancer Center of Kansas, PA - Parsons Parsons, Kansas, United States, 67357 Cancer Center of Kansas, PA - Pratt Pratt, Kansas, United States, 67124 Cancer Center of Kansas, PA - Salina Salina, Kansas, United States, 67042 Cancer Center of Kansas, PA - Wellington Wellington, Kansas, United States, 67152 Associates in Womens Health, PA - North Review Wichita, Kansas, United States, 67203 Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas, United States, 67208 Cancer Center of Kansas, PA - Wichita Wichita, Kansas, United States, 67214 CCOP - Wichita Wichita, Kansas, United States, 67214 Via Christi Cancer Center at Via Christi Regional Medical Center Wichita, Kansas, United States, 67214 Cancer Center of Kansas, PA - Winfield Winfield, Kansas, United States, 67156 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 Interlakes Oncology/Hematology PC Rochester, New York, United States, 14623 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 Veterans Affairs Medical Center - Dayton Dayton, Ohio, United States, 45428 CCOP - Dayton Dayton, Ohio, United States, 45429 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 Middletown Regional Hospital Middletown, Ohio, United States, 45044 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 United States Air Force Medical Center - Wright-Patterson Wright-Patterson Afb, Ohio, United States, 45433-5529 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 收起 << |
NCT03246178 | Severe Aplastic Anemia | Not Applicable | Enrolling by invitation | December 1, 2020 | China ... 展开 >> Department of Hematology, 304th Clinical Division, Chinese PLA General Hospital Beijing, China, 100048 收起 << |
NCT00121186 | - | Terminated(poor accrual) | - | - | |
NCT01247688 | Lymphoid Hematological Maligna... 展开 >>ncies Umbilical Cord Blood Transplant 收起 << | Not Applicable | Withdrawn(This study was withd... 展开 >>rawn due to low accrual.) 收起 << | - | - |
NCT00416910 | Chronic Lymphocytic Leukemia | Phase 3 | Terminated(low recruitment) | - | - |
NCT01659606 | Dyskeratosis Congenita ... 展开 >> Hoyeraal Hreidarsson Syndrome Revesz Syndrome Aplastic Anemia 收起 << | Phase 2 | Recruiting | December 2034 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Kimberly Arieli 323-361-5744 karieli@chla.usc.edu Principal Investigator: Michael Pulsipher, MD United States, Massachusetts Boston Children's Hospital (pediatric patients) Recruiting Boston, Massachusetts, United States, 02115 Contact: Suneet Agarwal, MD, PHD 617-919-7579 suneet.agarwal@childrens.harvard.edu Contact: Leslie Lehmann, MD leslie_lehmann@dfci.harvard.edu Principal Investigator: Suneet Agarwal, MD, PHD Sub-Investigator: Leslie Lehmann, MD Dana-Farber Cancer Institute (adult patients) Recruiting Boston, Massachusetts, United States, 02115 Contact: Suneet Agarwal, MD, PHD suneet.agarwal@childrens.harvard.edu Contact: Joseph Antin, MD Joseph_Antin@dfci.harvard.edu Principal Investigator: Suneet Agarwal, MD, PHD Sub-Investigator: Joseph Antin, MD United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Farid Boulad, MD 212-639-6684 bouladf@mskcc.org Principal Investigator: Farid Boulad, MD United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Kasiani Myers, MD Kasiani.Myers@cchmc.org Principal Investigator: Kasiani Myers, MD United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barb McGlynn 215-590-1303 MCGLYNN@email.chop.edu Principal Investigator: Tim Olson, MD, PHD United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Ghadir Sasa, MD 832-824-4524 gssasa@txch.org Principal Investigator: Ghadir Sasa, MD United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri Burroughs, MD 206-667-2396 lburroug@fhcrc.org Principal Investigator: Lauri Burroughs, MD United States, Wisconsin University of Wisconsin Hospital and Clinics, American Family Children's Hospital Recruiting Madison, Wisconsin, United States, 53792 Contact: Jenny Weiland 608-890-8070 jlweiland@pediatrics.wisc.edu Contact: Peds Hem Onc Main Office 608-263-6200 PedsHemOncResearch@lists.wisc.edu Principal Investigator: Inga Hoffman, MD Sweden Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Mikael Sundin, MD, PHD +46 8 585 848 43 mikael.c.sundin@sll.se Principal Investigator: Mikael Sundin, MD, PHD 收起 << |
NCT00427336 | Aplastic Anemia | Not Applicable | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00427336 | - | Completed | - | - | |
NCT00937625 | Melanoma | Phase 1 Phase 2 | Completed | - | Denmark ... 展开 >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 收起 << |
NCT00134004 | - | Completed | - | - | |
NCT00134004 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 收起 << |
NCT01807182 | Stage III Skin Melanoma ... 展开 >> Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma 收起 << | Phase 2 | Active, not recruiting | June 30, 2019 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00309842 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelofibrosis MDS Refractory Anemia Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Non-Hodgkin's Lymphoma Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT03648697 | Nasopharyngeal Carcinoma | Phase 2 | Not yet recruiting | October 10, 2020 | China, Fujian ... 展开 >> Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350014 Contact: Jianji Pan 0591-83660063 panjianji@126.com 收起 << |
NCT00937300 | Squamous Cell Carcinoma ... 展开 >> Head and Neck Cancer 收起 << | Phase 1 | Withdrawn(The patients eligibl... 展开 >>e for this trial do not exist anymore due to change in procedures.) 收起 << | - | Denmark ... 展开 >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 收起 << |
NCT02461316 | - | Completed | - | Serbia ... 展开 >> Belgrade, Serbia, 11000 Kragujevac, Serbia, 34000 Novi Sad, Serbia, 21000 收起 << | |
NCT02412475 | Leukemia, Acute Myeloid | Phase 1 | Active, not recruiting | February 2019 | United States, Minnesota ... 展开 >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT00919503 | Hematopoietic Cell Transplanta... 展开 >>tion Recipient Non-Malignant 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> Children's Hospital Colorado Active, not recruiting Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Active, not recruiting Nashville, Tennessee, United States, 37232 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Lauri M. Burroughs 206-667-2396 lburroug@fhcrc.org Principal Investigator: Lauri M. Burroughs Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs 206-667-2396 lburroug@fhcrc.org Principal Investigator: Lauri M. Burroughs United States, Wisconsin Children's Hospital of Wisconsin Suspended Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT01005576 | - | Completed | - | - | |
NCT03513328 | Bone Marrow Failure Syndrome ... 展开 >> Thalassemia Sickle Cell Disease Diamond Blackfan Anemia Acquired Neutropenia in Newborn Acquired Anemia Hemolytic Acquired Thrombocytopenia Hemophagocytic Lymphohistiocytoses Wiskott-Aldrich Syndrome Chronic Granulomatous Disease Common Variable Immunodeficiency X-linked Lymphoproliferative Disease Severe Combined Immunodeficiency Hurler Syndrome Mannosidosis Adrenoleukodystrophy 收起 << | Phase 1 Phase 2 | Recruiting | June 2022 | United States, Florida ... 展开 >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32608 收起 << |
NCT00789776 | - | Active, not recruiting | - | - | |
NCT00506129 | Lymphoma Bone... 展开 >> Marrow Transplantation 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01005576 | Severe Thalassemia | Phase 2 | Completed | - | United States, California ... 展开 >> Regents of University of California- UCLA Los Angeles, California, United States, 90095 Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida University of Miami Miami, Florida, United States, 33136 All Children's Research Institute, Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio The Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75390 Methodist Healthcare System of San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT00963872 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Myelodysplastic Syndromes 收起 << | Phase 1 Phase 2 | Terminated(Lack of efficacy af... 展开 >>ter interim analysis) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Medical Center - Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03337568 | - | Recruiting | March 30, 2021 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Kyoo-Hyung Lee, MD 82-2-3010-3213 khlee2@amc.seoul.kr Contact: Inpyo Choi, PhD 82-42-860-4223 ipchoi@kribb.re.kr 收起 << | |
NCT00004862 | Leukemia | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 收起 << |
NCT00510887 | Lymphoma, Follicular | Phase 2 | Terminated(Low accrual.) | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02143830 | Fanconi Anemia ... 展开 >> Severe Marrow Failure Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) 收起 << | Phase 2 | Recruiting | May 2020 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10174 Contact: Jessica Chaisson 646-888-5718 chaissoj@mskcc.org Principal Investigator: Farid Boulad, MD United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Principal Investigator: Parinda Mehta, MD United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Sheri Ballard 206-667-4222 sballard@fredhutch.org Principal Investigator: K. Scott Baker, MD 收起 << |
NCT00963872 | - | Terminated(Lack of efficacy af... 展开 >>ter interim analysis) 收起 << | - | - | |
NCT00001586 | - | Completed | - | - | |
NCT03530085 | Acute Myeloid Leukemia ... 展开 >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Elderly 收起 << | Phase 2 Phase 3 | Recruiting | April 2022 | China, Guangdong ... 展开 >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan +86-020-62787883 356135708@qq.com Principal Investigator: Qifa Liu 收起 << |
NCT00510887 | - | Terminated(Low accrual.) | - | - | |
NCT00391066 | Chronic Lymphocytic Leukemia | Phase 2 | Terminated | - | - |
NCT00001586 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00525876 | Lymphoma | Not Applicable | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00373594 | Cold Agglutinin Disease | Phase 2 | Completed | - | Norway ... 展开 >> Haukeland University Hospital Bergen, Norway Haugesund Hospital Haugesund, Norway Ullevaal University Hospital Oslo, Norway, 0407 Rikshospitalet-Radiumhospitalet University Hospital Oslo, Norway Sykehuset i Vestfold Tonsberg, Norway Russian Federation BMT Clinic, St Petersburg Pavlov State Medical University St Petersburg, Russian Federation, 197089 收起 << |
NCT01592981 | Waldenstrom's Macroglobulinaem... 展开 >>ia 收起 << | Phase 2 | Active, not recruiting | July 2021 | United Kingdom ... 展开 >> Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom Royal United Hospital Bath, United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS City Hospital Birmingham, United Kingdom Pilgrim Hospital Boston, United Kingdom Colchester General Hospital Colchester, United Kingdom Darent Valley Hospital Dartford, United Kingdom Derriford Hospital Derriford, United Kingdom Dewsbury and District Hospital Dewsbury, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Grantham and District Hospital Grantham, United Kingdom St James University Hospital Leeds, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartolomew's Hospital London, United Kingdom, EC1A 7BE University College Hospital London, United Kingdom, NW1 2BU King's College Hospital London, United Kingdom Northwick Park Hospital London, United Kingdom Royal Free Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom Pontefract Hospital Pontefract, United Kingdom Queen's Hospital Romford, United Kingdom Salisbury District Hospital Salisbury, United Kingdom Musgrove Park Hospital Taunton, United Kingdom Torbay Hospital Torbay, United Kingdom Tunbridge Wells Hospital Tunbridge Wells, United Kingdom Pinderfields Hospital Wakefield, United Kingdom Sandwell Hospital West Bromwich, United Kingdom Royal Hampshire County Hospital Winchester, United Kingdom 收起 << |
NCT00402558 | Myelodysplastic Syndrome ... 展开 >> Leukemia 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00812669 | Leukemia | Phase 2 | Active, not recruiting | September 2022 | Ireland ... 展开 >> St. James's Hospital Dublin, Ireland, 8 University College Hospital Galway, Ireland Mid-Western Cancer Centre at Mid-Western Regional Hospital Limerick, Ireland, 0009 Midland Regional Hospital at Tullamore Tullamore, Ireland Waterford Regional Hospital Waterford, Ireland United Kingdom St. George's Hospital London, England, United Kingdom, SW17 ORE 收起 << |
NCT01203722 | Hematologic Malignancies | Phase 1 Phase 2 | Recruiting | December 2023 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce 410-955-8804 jhcccro@jhmi.edu 收起 << |
NCT00525876 | - | Completed | - | - | |
NCT00112593 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Aggressive NK-cell Leukemia AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Primary CNS Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma HIV Infection HIV-associated Hodgkin Lymphoma Intraocular Lymphoma Isolated Plasmacytoma of Bone Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Meningeal Chronic Myelogenous Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Central Nervous System Lymphoma Primary Myelofibrosis Primary Systemic Amyloidosis Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage 0 Chronic Lymphocytic Leukemia Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Hodgkin Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Multiple Myeloma Stage I Small Lymphocytic Lymphoma Stage IA Mycosis Fungoides/Sezary Syndrome Stage IB Mycosis Fungoides/Sezary Syndrome Stage II Adult Hodgkin Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Hodgkin Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Multiple Myeloma Stage IIA Mycosis Fungoides/Sezary Syndrome Stage IIB Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IIIA Mycosis Fungoides/Sezary Syndrome Stage IIIB Mycosis Fungoides/Sezary Syndrome Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IVA Mycosis Fungoides/Sezary Syndrome Stage IVB Mycosis Fungoides/Sezary Syndrome T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Waldenström Macroglobulinemia 收起 << | Not Applicable | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01186640 | T-cell-prolymphocytic Leukemia | Phase 2 | Completed | - | Germany ... 展开 >> University Hospital Cologne Cologne, Germany, 50924 收起 << |
NCT00521859 | Hematologic Malignancies | Phase 1 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00150878 | Acute Myeloid Leukemia | Phase 3 | Terminated(Insurance coverage ... 展开 >>reached) 收起 << | - | Germany ... 展开 >> Medizinische Klinik und Poliklinik I Dresden, Germany, 01307 收起 << |
NCT00597519 | Cancer Leukem... 展开 >>ia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00309881 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | Germany ... 展开 >> Kreiskrankenhaus Bad Hersfeld, Germany, 36251 DIAKO Ev. Diakonie Krankenhaus gGmbH Bremen, Germany, 28239 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Universitaetsklinikum Essen Essen, Germany, D-45122 Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie Giessen, Germany, 35392 St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH Hagen, Germany, 58095 Allgemeines Krankenhaus Hagen Hagen, Germany, D-58095 Praxis fur Innere Medizin - Hamburg Hamburg, Germany, 22457 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Marienhospital at Ruhr University Bochum Herne, Germany, D-44625 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Internistische Gemeinschaftspraxis - Kassel Kassel, Germany, 34117 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Oldenburg Oldenburg, Germany, D-26133 Marienhospital Stuttgart Stuttgart, Germany, 70199 Haematologische Praxis Weiden, Germany, D-92637 Medizinische Poliklinik, Universitaet Wuerzburg Wuerzburg, Germany, D-97070 收起 << |
NCT02776202 | Sickle Cell Disease | Phase 2 | Recruiting | December 2019 | Saudi Arabia ... 展开 >> King Abdul Aziz Medical City for National Guard Recruiting Riyadh, Saudi Arabia Contact: Nagham RZ Sheblaq 009668011111 ext 53352 sheblaqn@ngha.med.sa Contact 009668011111 ext 53352 sheblaqn@ngha.med.sa Principal Investigator: Nagham RZ Sheblaq, BS.c 收起 << |
NCT00112593 | - | Completed | - | - | |
NCT03056339 | B-Lymphoid Malignancies ... 展开 >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non-hodgkin Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | June 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations krezvani@mdanderson.org 收起 << |
NCT02932956 | Solid Tumors | Phase 1 | Not yet recruiting | February 2037 | United States, Texas ... 展开 >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras A Heczey, M.D. axheczey@txch.org 收起 << |
NCT00597519 | - | Completed | - | - | |
NCT00587054 | - | Completed | - | - | |
NCT00787761 | - | Completed | - | - | |
NCT00787761 | Myeloproliferative Disorders ... 展开 >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT00289549 | Leukemia, Lymphocytic, Chronic | Phase 2 | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 收起 << |
NCT01664910 | Lymphoma Leuk... 展开 >>emia 收起 << | Phase 1 Phase 2 | Recruiting | October 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00091143 | Melanoma (Skin) | Phase 1 | Completed | - | United States, Oregon ... 展开 >> Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 收起 << |
NCT03434769 | Non-Hodgkin Lymphoma | Phase 1 | Recruiting | July 2021 | United States, Ohio ... 展开 >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Paolo F. Caimi, MD 800-241-6422 paolo.caimi@case.edu Principal Investigator: Paolo F. Caimi, MD 收起 << |
NCT00802113 | Non-Hodgkin's Lymphoma ... 展开 >> Hodgkins Disease 收起 << | Phase 1 Phase 2 | Completed | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02275663 | Acute Myeloid Leukemia | Phase 2 | Unknown | October 2018 | Saudi Arabia ... 展开 >> King Fahad Medical City Recruiting Riyadh, Saudi Arabia, 11525 Contact: Ibraheem Motabi, MD +966112889999 ext 11998 imotabi@kfmc.med.sa 收起 << |
NCT00587054 | Allogeneic Stem Cell Transplan... 展开 >>t Leukemia Non-Hodgkins Lymphoblastic Lymphoma Myelodysplastic Syndrome Paroxysmal Nocturnal Hemoglobinuria (PNH) 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00167180 | Leukemia, Myeloid, Chronic ... 展开 >> Lymphomas Multiple Myeloma Myelodysplastic Syndrome Leukemia, Lymphocytic, Acute Leukemia, Lymphocytic, Chronic AML 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00859001 | Follicular Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> Istituto di Ematologia e Oncologia Medica Seràgnoli Bologna, BO, Italy, 40138 收起 << |
NCT00167180 | - | Completed | - | - | |
NCT03294954 | Neuroblastoma | Phase 1 | Recruiting | August 10, 2034 | United States, Texas ... 展开 >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD 832-824-4233 axheczey@txch.org 收起 << |
NCT01370772 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia CLL 收起 << | Phase 2 | Completed | - | France ... 展开 >> Stephane LEPRETRE Rouen, CLCC Henri Becquerel, France, 76038 Guillaume CARTRON Montpellier, Regional university Hospital, France, 34295 收起 << |
NCT00008151 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00731328 | Leukemia Myel... 展开 >>odysplastic Syndromes Nonmalignant Neoplasm Paroxysmal Nocturnal Hemoglobinuria 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00082940 | Leukemia | Phase 2 | Completed | - | United States, California ... 展开 >> St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States, 92868-3849 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Medical Center Vincennes Vincennes, Indiana, United States, 47591 United States, Louisiana Cancer Care Specialists Houma, Louisiana, United States, 70360 Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport, Louisiana, United States, 71130-3932 United States, Michigan Josephine Ford Cancer Center at Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Southeastern Medical Oncology Center Goldsboro, North Carolina, United States, 27534 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, South Carolina Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States, 37404 United States, Texas Southwest Regional Cancer Center - Central Austin, Texas, United States, 78705 收起 << |
NCT01894477 | Acute Myeloid Leukemia in Remi... 展开 >>ssion Chronic Myelomonocytic Leukemia Minimal Residual Disease Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable 收起 << | Phase 2 | Active, not recruiting | January 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00607854 | Diffuse Large B-Cell Lymphoma ... 展开 >> Mantle Cell Lymphoma 收起 << | Phase 2 | Completed | - | France ... 展开 >> Service d'hématologie - CHU de Besançon Besançon, France, 25030 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Bordeaux - Pessac, France, 33600 Service d'hématologie - CHU Hôtel Dieu Clermont-Ferrand Clermont-Ferrand, France, 63000 Service de médecine nucléaire - Centre de Lutte contre le Cancer de la Région Auvergne Jean Perrin Clermont-Ferrand, France, 63011 Hôpital Edouard Herriot Lyon, France, 69437 Service d'Oncologie Hématologie, Institut Paoli Calmettes - 232 Bd Ste Marguerite Marseille, France, 13009 Hématologie et Oncologie médicale - CHU Lapeyronie Montpellier, France, 34295 Service d'Hématologie, Hôpital Hôtel Dieu, CHU Nantes - 1 Place Alexis Ricordeau Nantes, France, 44093 Service d'hématologie clinique - Hôpital l'Archet 1 Nice, France, 06202 Service d'Hématologie Adultes - Hôpital Necker-Enfants Malade Paris, France, 75015 Pôle hématologie et immunologie clinique - Hôpital Saint-Louis Paris, France, 75475 Département d'hématologie et d'Oncologie - CHRU Hautepierre Strasbourg, France, 67098 收起 << |
NCT01894477 | - | Active, not recruiting | - | - | |
NCT02498912 | Solid Tumors | Phase 1 | Recruiting | August 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roisin O'Cearbhaill, MD 646-888-4227 Contact: Jae Park, MD 212-639-4048 Principal Investigator: Roisin O'Cearbhaill, MD 收起 << |
NCT00005851 | Recurrent Renal Cell Cancer ... 展开 >> Stage IV Renal Cell Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Arizona ... 展开 >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, Colorado Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States, 80012 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT01410344 | Leukemia Lymp... 展开 >>homa HIV 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, Arizona ... 展开 >> Mayo Clinic - Phoenix Phoenix, Arizona, United States, 85054 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 University of CA, SF San Francisco, California, United States, 94143-0324 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Blood & Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas/MD Anderson CRC Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 收起 << |
NCT00005898 | Fanconi's Anemia | Phase 1 Phase 2 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00328861 | - | Completed | - | - | |
NCT00328861 | Metastatic Melanoma ... 展开 >> Metastatic Kidney Cancer 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT03448978 | Multiple Myeloma | Phase 1 | Recruiting | March 1, 2020 | United States, District of Col... 展开 >>umbia Georgetown University Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 United States, Maryland The Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Virginia Virgina Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 收起 << |
NCT01410344 | - | Active, not recruiting | - | - | |
NCT00025038 | Juvenile Myelomonocytic Leukem... 展开 >>ia 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Oncology Group Arcadia, California, United States, 91006-3776 收起 << |
NCT01666080 | Hematologic Disorders ... 展开 >> Hemoglobinopathies Immunodeficiencies 收起 << | Not Applicable | Recruiting | June 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Weston P. Miller, M.D. 612-626-2778 mill4991@umn.eud Principal Investigator: Weston P. Miller, M.D. 收起 << |
NCT00578643 | - | Completed | - | - | |
NCT00618540 | - | Terminated(Slow accrual) | - | - | |
NCT00618540 | Histiocytosis, Langerhans-cell | Phase 2 | Terminated(Slow accrual) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00959231 | Hematopoietic/Lymphoid Cancer | Phase 2 | Unknown | - | United Kingdom ... 展开 >> Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8BJ Contact: Contact Person 44-117-342-8044 Cancer Research UK Clinical Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS16 6QB Contact: Contact Person 44-113-206-6020 University College of London Hospitals Recruiting London, England, United Kingdom, NW1 2PQ Contact: Rachael Hough, MD 44-845-155-5000 ext. 5239 UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person 44-207-830-2301 Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person 44-207-813-8335 University of Newcastle-Upon-Tyne Northern Institute for Cancer Research Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE2 4HH Contact: Contact Person 44-191-222-7785 收起 << |
NCT00578643 | Chronic Granulomatous Disease | Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00615589 | - | Terminated(Low accrual) | - | - | |
NCT02581007 | Chronic Myelogenous Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myelofibrosis CMML Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | October 2019 | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT02065362 | EBV-positive Nasopharyngeal Ca... 展开 >>rcinoma 收起 << | Phase 1 | Active, not recruiting | February 2033 | United States, Texas ... 展开 >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00615589 | Multiple Myeloma ... 展开 >> Plasma Cell Leukemia 收起 << | Phase 2 | Terminated(Low accrual) | - | United States, Michigan ... 展开 >> University of Michigan,Department of Internal Med. Hematology- Oncology Ann Arbor, Michigan, United States, 48109 收起 << |
NCT02784561 | Leukemia | Phase 4 | Not yet recruiting | July 2020 | - |
NCT00627666 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT02171104 | Mucopolysaccharidosis Disorder... 展开 >>s Hurler Syndrome Hunter Syndrome Maroteaux Lamy Syndrome Sly Syndrome Alpha-Mannosidosis Fucosidosis Aspartylglucosaminuria Glycoprotein Metabolic Disorders Sphingolipidoses Recessive Leukodystrophies Globoid Cell Leukodystrophy Metachromatic Leukodystrophy Niemann-Pick B Niemann-Pick C Subtype 2 Sphingomyelin Deficiency Peroxisomal Disorders Adrenoleukodystrophy With Cerebral Involvement Zellweger Syndrome Neonatal Adrenoleukodystrophy Infantile Refsum Disease Acyl-CoA Oxidase Deficiency D-Bifunctional Enzyme Deficiency Multifunctional Enzyme Deficiency Alpha-methylacyl-CoA Racmase Deficiency Mitochondrial Neurogastrointestingal Encephalopathy Severe Osteopetrosis Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation) Inherited Metabolic Disorders 收起 << | Phase 2 | Recruiting | September 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT00623935 | - | Completed | - | - | |
NCT01051115 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | January 2016 | Netherlands ... 展开 >> Maastricht university medical center Not yet recruiting Maastricht, Limburg, Netherlands, 6229 HX Contact: Michel van Gelder, MD, PhD +31-43 - 387 6543 m.van.gelder@mumc.nl Academic Medical Center Recruiting Amsterdam, NH, Netherlands, 1105 AZ Contact: Marjolein Spiering, Ms +31-20-5669111 m.spiering@amc.nl Contact: Arnon P Kater, MD, PhD +31-20-5669111 a.p.kater@amc.nl Erasmus MC-Daniel den Hoed Cancer Center Recruiting Rotterdam, ZH, Netherlands, 3015 CE Contact: Jeanette K Doorduijn, MD, PhD +31-10 7040704 j.doorduijn@erasmusmc.nl University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Simon MG Daenen, MD, PhD +31-50 3616161 s.m.g.j.daenen@int.umcg.nl 收起 << |
NCT00623935 | Acute Myelogenous Leukemia | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << |
NCT03173417 | Leukemia | Phase 1 Phase 2 | Recruiting | December 1, 2020 | China ... 展开 >> Hebei Yanda Ludaopei Hospital Recruiting Beijing, China Contact: Xinan lu, Dr luxinan@immunochina.com Contact 86-189-1157-6946 收起 << |
NCT01955460 | Melanoma | Phase 1 | Recruiting | October 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT03287674 | Metastatic Ovarian Cancer | Phase 1 Phase 2 | Active, not recruiting | October 2020 | Denmark ... 展开 >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Denmark, 2730 收起 << |
NCT03579888 | Acute Lymphoblastic Leukemia ... 展开 >> Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Blasts More Than 5 Percent of Peripheral Blood White Cells CD19 Positive Chronic Lymphocytic Leukemia Minimal Residual Disease Non-Hodgkin Lymphoma Small Lymphocytic Lymphoma 收起 << | Phase 1 | Not yet recruiting | December 2021 | United States, Texas ... 展开 >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact pkebriae@mdanderson.org 收起 << |
NCT01653717 | Advanced Cancers ... 展开 >> Leukemia 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02287311 | Hodgkin Disease ... 展开 >> Non-Hodgkin Lymphoma Severe Chronic Active Epstein Barr Virus T/NK-lymphoproliferative Disease 收起 << | Phase 1 | Recruiting | March 2023 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Helen E Heslop 832-824-4662 hheslop@bcm.edu Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne H Rouce, MD 832-824-4716 rouce@bcm.edu 收起 << |
NCT01082133 | Fanconi Anemia | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 << |
NCT00693927 | Hematologic Malignancies | Phase 2 | Completed | - | Belgium ... 展开 >> CHU Sart Tilman Liege, Belgium, B4000 收起 << |
NCT01350232 | - | Terminated(Poor accrual) | - | - | |
NCT00636155 | Lymphoma, Small Lymphocytic ... 展开 >> Leukemia, Lymphocytic, Chronic 收起 << | Phase 2 | Terminated(funding) | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT00841724 | Hematological Malignancies | Phase 2 | Completed | - | France ... 展开 >> Institut Paoli Calmettes Marseille, France, 13273 CHU de Nantes Nantes, France, 44093 CHU de Bordeaux Pessac, France, 33604 收起 << |
NCT00636155 | - | Terminated(funding) | - | - | |
NCT00074269 | Breast Cancer | Phase 2 | Terminated(Terminated early du... 展开 >>e to poor enrollment) 收起 << | - | United States, California ... 展开 >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 收起 << |
NCT01019876 | Bone Marrow Failure ... 展开 >> Osteopetrosis Fanconi Anemia Severe Combined Immunodeficiency 收起 << | Phase 2 Phase 3 | Unknown | May 2013 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: James Garvin, MD, PhD 212-305-5872 jhg1@columbia.edu Contact: William A Kim, PhD 212-305-7213 billkim@columbia.edu Principal Investigator: James Garvin, MD, PhD 收起 << |
NCT00523809 | Breast Cancer ... 展开 >> Ovarian Cancer 收起 << | Phase 2 | Terminated(Slow accrual.) | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00523809 | - | Terminated(Slow accrual.) | - | - | |
NCT00739141 | Leukemia Myel... 展开 >>odysplastic Syndrome Non-Hodgkins Lymphoma Chronic Myelogenous Leukemia Hodgkins Lymphoma 收起 << | Phase 2 | Active, not recruiting | August 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00090051 | - | Completed | - | - | |
NCT01350232 | Sickle Cell Anemia ... 展开 >> Sickle Cell-hemoglobin C Disease Sickle Cell-β0-thalassemia 收起 << | Not Applicable | Terminated(Poor accrual) | - | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT00907036 | Lymphoma | Phase 2 | Unknown | - | - |
NCT00074269 | - | Terminated(Terminated early du... 展开 >>e to poor enrollment) 收起 << | - | - | |
NCT00090051 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT03208556 | Relapsed or Refractory B-cell ... 展开 >>Lymphoma 收起 << | Phase 1 | Recruiting | June 1, 2020 | China ... 展开 >> Beijing Cancer Hosptical Recruiting Beijing, China Contact: Zhitao Ying, MD yingzhitao001@163.com Principal Investigator: Jun Zhu, MD Sub-Investigator: Zhitao Ying, MD Sub-Investigator: Xiaoyu Xiang, PhD 收起 << |
NCT03658785 | Recurrence Tumor ... 展开 >> Metastatic Cancer Solid Tumor 收起 << | Phase 1 Phase 2 | Not yet recruiting | December 31, 2024 | China, Hubei ... 展开 >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430000 Contact: Wang 收起 << |
NCT00091104 | Melanoma (Skin) | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 收起 << |
NCT02482090 | Metastatic Ovarian Cancer | Phase 1 | Completed | - | Denmark ... 展开 >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Herlev, Denmark, 2730 收起 << |
NCT00354172 | - | Terminated(Competing study was... 展开 >> started.) 收起 << | - | - | |
NCT01271907 | Metastatic Cutaneous Melanoma | Phase 2 | Terminated(Study was terminate... 展开 >>d due to withdrawal of CRADA partner.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00354172 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Terminated(Competing study was... 展开 >> started.) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00301951 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 收起 << |
NCT00043810 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01292603 | Lymphocytic Leukemia, Chronic | Phase 1 | Completed | - | - |
NCT03126864 | Hematopoietic/Lymphoid Cancer ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 1 | Recruiting | August 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact wwierda@mdanderson.org 收起 << |
NCT02274506 | Blood And Marrow Transplantati... 展开 >>on Leukemia Lymphoma 收起 << | Phase 1 | Withdrawn | - | - |
NCT01292603 | - | Completed | - | - | |
NCT00036738 | - | Active, not recruiting | - | - | |
NCT01271907 | - | Terminated(Study was terminate... 展开 >>d due to withdrawal of CRADA partner.) 收起 << | - | - | |
NCT00036738 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Remission Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Blastic Phase Childhood Acute Lymphoblastic Leukemia in Remission Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Disease 收起 << | Phase 2 | Active, not recruiting | September 2018 | United States, Colorado ... 展开 >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02049580 | Lymphoma | Phase 2 | Unknown | November 2016 | Italy ... 展开 >> Istituto Clinico Humanitas Recruiting Rozzano, MI, Italy, 20089 Contact: Luca Castagna, MD +39028224 ext 4587 luca.castagna@humanitas.it Principal Investigator: Luca Castagna, MD 收起 << |
NCT00062036 | Melanoma (Skin) | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 收起 << |
NCT02844062 | Glioblastoma Multiforme | Phase 1 | Recruiting | July 2019 | China ... 展开 >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD +86-10-13905918963 lzx1967@sina.com 收起 << |
NCT00305708 | Congenital Amegakaryocytic Thr... 展开 >>ombocytopenia Diamond-blackfan Anemia Fanconi Anemia Leukemia Severe Congenital Neutropenia Thrombocytopenia 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00827099 | Myeloproliferative Disorders ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Terminated(Unacceptable morbid... 展开 >>ity & mortality) 收起 << | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT01359254 | - | Terminated(did not accrue enou... 展开 >>gh patients.) 收起 << | - | - | |
NCT01359254 | Hematological Disease | Phase 2 | Terminated(did not accrue enou... 展开 >>gh patients.) 收起 << | - | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT00589316 | Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts 收起 << | Phase 1 | Active, not recruiting | October 1, 2024 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00562640 | Fallopian Tube Cancer ... 展开 >> Ovarian Cancer Primary Peritoneal Cavity Cancer 收起 << | Phase 1 | Active, not recruiting | December 2019 | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00167206 | Fanconi Anemia | Phase 1 Phase 2 | Terminated(Treatment with thym... 展开 >>ic shielding found safe, another study started.) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00827099 | - | Terminated(Unacceptable morbid... 展开 >>ity & mortality) 收起 << | - | - | |
NCT03096782 | Hematopoietic/Lymphoid Cancer | Phase 2 | Recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations alolson@mdanderson.org 收起 << |
NCT00034528 | Hemoglobinopathies ... 展开 >> Anemia, Sickle Cell Hemoglobin SC Disease Thalassemia Thalassemia Major 收起 << | Phase 2 | Terminated(Due to slow recruit... 展开 >>ment) 收起 << | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute/Harvard Cancer Center, Brigham and Women's Hospital and Massachusetts General Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00167206 | - | Terminated(Treatment with thym... 展开 >>ic shielding found safe, another study started.) 收起 << | - | - | |
NCT00337246 | Leukemia | Phase 2 | Completed | - | United Kingdom ... 展开 >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Blackpool Victoria Hospital Blackpool, England, United Kingdom, FY3 8NR Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR St Helier Hospital Carshalton, England, United Kingdom, SM5 1AA Darent Valley Hospital Dartford Kent, England, United Kingdom, DA2 8DA Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Leeds General Infirmary at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS1 3EX Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom, L7 8XP Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ Kent and Sussex Hospital Tunbridge Wells, Kent, England, United Kingdom, TN4 8AT Wishaw General Hospital Wishaw, England, United Kingdom, ML2 0DP Monklands General Hospital Airdrie, Scotland, United Kingdom, ML6 0JF University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW 收起 << |
NCT02917083 | Hodgkin's Lymphoma ... 展开 >> Non-Hodgkin Lymphoma 收起 << | Phase 1 | Recruiting | February 2035 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Munu Bilgi, MS 832-824-1518 mxbilgi@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Munu Bilgi, MS 832-824-1518 mxbilgi@txch.org 收起 << |
NCT00448201 | - | Completed | - | - | |
NCT00448201 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 收起 << |
NCT01071239 | Fanconi Anemia | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT00582894 | Hematological Neoplasms ... 展开 >> Hematopoietic Stem Cell Transplantation 收起 << | Not Applicable | Completed | - | United States, Oklahoma ... 展开 >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT00582894 | - | Completed | - | - | |
NCT02156726 | - | Unknown | July 2015 | Czech Republic ... 展开 >> Department of Hematology - Oncology, University Hospital Brno, Czech Republic, 60500 Department of Hemato-Oncology, University Hospital Olomouc, Czech Republic, 77520 Department of Hematology, University Hospital Plzen, Czech Republic, 30599 Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Praha, Czech Republic, 10034 1st Department of Medicine - Hematology, University General Hospital Praha, Czech Republic, 12808 Institute for Hematology and Blood Transfusion Praha, Czech Republic, 12820 4th Department of Medicine - Hematology, University Hospital Hradec Kralove, ČR, Czech Republic, 50005 收起 << | |
NCT01435343 | Acute Myeloblastic Leukemia | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Hospital Universitari Germans Trials i Pujol Badalona, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau. Barcelona, Spain Hospital Duran i Reynals - ICO L'Hospitalet Barcelona, Spain Hospital Universitario Vall d'Hebron Barcelona, Spain Hospital Universitario Reina Sofía Córdoba, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitari La Fe Valencia, Spain 收起 << |
NCT01247701 | Myeloid Hematological Malignan... 展开 >>cies 收起 << | Not Applicable | Recruiting | November 2027 | United States, Texas ... 展开 >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD 832-824-4692 camartin@txch.org Contact: Marlen Dinu 832-824-4881 mxdinu@txch.org 收起 << |
NCT00243009 | Kidney Cancer | Phase 2 | Terminated(Due to a lack of a ... 展开 >>referal base, study was terminated.) 收起 << | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT02809092 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | September 2020 | Brazil ... 展开 >> Centro Terapia e Tecnologia Celular Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Contact: Lucia Silla, PhD 55 51 33597516 dralucia.silla@gmail.com Contact: Vanessa Valim, Msc 55 51 33598850 vanessavalim@gmail.com 收起 << |
NCT03384225 | High Risk Acute Myeloid Leukem... 展开 >>ia Allogeneic Hematopoeitic Stem Cell Transplantation 收起 << | Phase 3 | Recruiting | July 31, 2020 | China, Shanghai ... 展开 >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D. 86-21-63069298 sfph_edu2@163.com Contact: Yanhong Zhu 86-21-63240090 ext 6213 sfph_edu2@shumu.edu.cn Sub-Investigator: Jieling Jiang, M.D. Principal Investigator: Xiaoxia Hu, M.D. Principal Investigator: Qiang Liu, M.D. Principal Investigator: Yajing Xu, M.D. Principal Investigator: Ting Yang, M.D. Principal Investigator: Huangfang Wang, M.D. Sub-Investigator: Yang Cao, M.D. 收起 << |
NCT03384212 | High Risk Acute Myeloid Leukem... 展开 >>ia Allogeneic Hematopoeitic Stem Cell Transplantation 收起 << | Phase 3 | Recruiting | July 31, 2020 | China, Shanghai ... 展开 >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D. 86-21-63069298 sfph_edu2@163.com Contact: Yanhong Zhu 86-21-63240090 ext 6213 sfph_edu2@shumu.edu.cn Sub-Investigator: Jieling Jiang, M.D. Principal Investigator: Xiaoxia Hu, M.D. Principal Investigator: Qiang Liu, M.D. Principal Investigator: Yajing Xu, M.D. Principal Investigator: Ting Yang, M.D. Principal Investigator: Huangfang Wang, M.D. Sub-Investigator: Yang Cao, M.D. 收起 << |
NCT00242931 | Prostate Cancer | Phase 2 | Withdrawn(Unable to successful... 展开 >>ly recruit subjects to this study.) 收起 << | - | - |
NCT03635632 | Relapsed Neuroblastoma ... 展开 >> Refractory Neuroblastoma 收起 << | Phase 1 | Not yet recruiting | December 2037 | United States, Texas ... 展开 >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Bilal Omer, MD 832-824-6855 bomer@bcm.edu Contact: Jacqueline Castello 832-824-4391 jxcastel@texaschildrens.org 收起 << |
NCT00056979 | Inherited Metabolic Storage Di... 展开 >>seases 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States The Methodist Hospital Houston, Texas, United States 收起 << |
NCT00920972 | Metabolic Disorders ... 展开 >> Hematologic, Immune, or Bone Marrow Disorders Hemoglobinopathies Non-malignant Disorders 收起 << | Phase 1 Phase 2 | Recruiting | December 2021 | United States, Arizona ... 展开 >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Principal Investigator: Roberta Adams, MD United States, California University of California Recruiting San Diego, California, United States, 92123 Principal Investigator: Eric Anderson, MD United States, District of Columbia George Washington University School of Medicine Recruiting Washington, District of Columbia, United States, 20010 Principal Investigator: David Jacobsohn, MD United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 Principal Investigator: Martin Andreansky, MD Miami Children's Hospital Recruiting Miami, Florida, United States, 33155 Principal Investigator: Kamar Godder, MD All Children's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Principal Investigator: Gregory Hale, MD United States, Illinois Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Sonali Chaudhury, MD United States, Indiana Indiana University School of Medicine Recruiting Indianapolis, Indiana, United States, 46202 Principal Investigator: Paul Haut, MD United States, Louisiana Louisiana State University Recruiting New Orleans, Louisiana, United States, 70112 Principal Investigator: Lolie Yu, MD United States, Missouri Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Principal Investigator: Jignesh Dalal, MD St. Louis University Recruiting Saint Louis, Missouri, United States, 63104 Contact: Deepika Bhatla, MD Principal Investigator: Deepika Bhatla, MD Washington University School of Medicine (in St. Louis) Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD 314-454-6018 shenoy@wustl.edu Contact: Lisa Murray, MA, CCRP 3144544240 Murray_L@kids.wustl.edu United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Principal Investigator: Alfred Gillio, MD United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Monica Bhatia, MD Principal Investigator: Monica Bhatia, MD United States, North Carolina Carolinas Medical Center Recruiting Charlotte, North Carolina, United States, 28232 Principal Investigator: Michael Eckrich, MD Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Principal Investigator: Suhag Parikh, MD United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Principal Investigator: Troy Quigg, MD Canada, Manitoba University of Manitoba Active, not recruiting Winnipeg, Manitoba, Canada, R3E 0W3 Canada University of Calgary Recruiting Calgary, Canada Contact: Gregory Guilcher, MD Principal Investigator: Gregory Guilcher, MD 收起 << |
NCT03766126 | Acute Myeloid Leukemia, in Rel... 展开 >>apse Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Refractory 收起 << | Phase 1 | Recruiting | December 3, 2033 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed 855-216-0098 PennCancerTrials@emergingmed.com Contact: Saar Gill, MD, PhD Saar.Gill@pennmedicine.upenn.edu 收起 << |
NCT00073879 | Kidney Cancer | Not Applicable | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT00579111 | Myelodysplastic and Myeloproli... 展开 >>ferative Disorders Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Multiple Myeloma Plasma Cell Dyscrasia Lymphoproliferative Disorders Hematologic Diseases 收起 << | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT00579111 | - | Terminated(slow accrual) | - | - | |
NCT00968461 | Leukemia Lymp... 展开 >>hoproliferative Disorders 收起 << | Phase 1 | Withdrawn | - | - |
NCT00802568 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT01212887 | Breast Cancer ... 展开 >> Colorectal Cancer Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 1 | Terminated(due to safety conce... 展开 >>rns and lack of efficacy) 收起 << | - | United Kingdom ... 展开 >> Christie Hospital Manchester, England, United Kingdom, M20 4BX 收起 << |
NCT00651781 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Hospital Germans Trias I Pujol Badalona, Spain Hospital Clinic y Provincial de Barcelona Barcelona, Spain Hospital Santa Creu y Sant Pau.Barcelona Barcelona, Spain Hospital Vall d´hebron Barcelona, Spain Hospital Juan Canalejo La Coruña, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos. Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain 收起 << |
NCT00644371 | Non-Hodgkin Lymphoma | Phase 2 | Completed | - | Spain ... 展开 >> H. Santa Creu i Sant Pau. Barcelona, Barcelona., Spain Clinica Universitaria de Navarra Pamplona, Navarra, Spain H.U. 12 de Octubre Madrid, Spain H.U. Gregorio Marañón Madrid, Spain H.U. La Princesa Madrid, Spain H.U. Ramón y Cajal. Madrid, Spain H. Morales Meseguer. Murcia, Spain H. Virgen de la Arrixaca Murcia, Spain H. Central de Asturias Oviedo, Spain H. Clinico de Salamanca Salamanca, Spain H. U. Marqués de Valdecilla. Santander, Spain H. Clínico Valencia Valencia, Spain H. La Fe Valencia, Spain H.U. Miguel Servet Zaragoza., Spain 收起 << |
NCT01135329 | - | Terminated(The stopping rule w... 展开 >>as met and hence the study was closed) 收起 << | - | - | |
NCT00806767 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT00427661 | - | Completed | - | - | |
NCT01135329 | Lymphoma Leuk... 展开 >>emia Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(The stopping rule w... 展开 >>as met and hence the study was closed) 收起 << | - | United States, Maryland ... 展开 >> The Sydney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 收起 << |
NCT00750126 | Solid Tumors ... 展开 >>Hematologic Neoplasms 收起 << | Phase 2 | Unknown | April 2009 | France ... 展开 >> Paillard Catherine Recruiting Clermont-Ferrand, France, 63003 Contact: Paillard Catherine, Dr cpaillard@chu-clermontferrand.fr 收起 << |
NCT00462332 | - | Completed | - | - | |
NCT00462332 | Leukemia | Phase 2 | Completed | - | Italy ... 展开 >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Universita Degli Studi di Bari Bari, Italy, 70124 Universita Cattolica del Sacro Cuore - Campobasso Campobasso, Italy, 86100 Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy, 95124 Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Ospedale Civile Cosenza Cosenza, Italy, 87100 Universita di Ferrara Ferrara, Italy, 44100 Azienda Ospedaliera di Firenze Firenze, Italy, 50011 Ospedale San Martino Genova, Italy, 16132 ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Azienda Ospedaliera Papardo Messina, Italy Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Ospedale Maggiore Policlinico Milano, Italy, 20122 Azienda Ospedaliera - Universitaria di Modena Modena, Italy, 41100 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy, 00133 Ospedale Sant' Eugenio Rome, Italy, 00144 Università Degli Studi "La Sapienza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Siena, Italy Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Turin, Italy, 10126 Policlinico Universitario Udine Udine, Italy, 33100 收起 << |
NCT00385788 | - | Completed | - | - | |
NCT00427661 | Sickle Cell Disease ... 展开 >> Thalassemia Hemoglobinopathies 收起 << | Not Applicable | Completed | - | United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT00385788 | Hodgkin's Disease | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03774654 | Refractory B-Cell Non-Hodgkin ... 展开 >>Lymphoma Refractory B-Cell Small Lymphocytic Lymphoma Relapsed Adult ALL Relapsed CLL Relapsed Non Hodgkin Lymphoma 收起 << | Phase 1 | Not yet recruiting | March 2034 | United States, Texas ... 展开 >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD 832-824-4817 caramos@bcm.edu Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD 832-824-4817 caramos@bcm.edu 收起 << |
NCT00138229 | Melanoma (Skin) | Phase 2 | Terminated | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 收起 << |
NCT02483325 | Hematological Diseases | Phase 2 | Recruiting | September 2018 | France ... 展开 >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Principal Investigator: FURST Sabine, MD 收起 << |
NCT02905188 | Hepatocellular Carcinoma | Phase 1 | Not yet recruiting | October 2036 | United States, Texas ... 展开 >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD axheczey@txch.org 收起 << |
NCT00053092 | Lymphoma | Phase 2 | Completed | - | Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 United Kingdom Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH 收起 << |
NCT03081910 | T-cell Acute Lymphoblastic Lym... 展开 >>phoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia 收起 << | Phase 1 | Recruiting | June 1, 2036 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD 832-824-4716 rhrouce@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD 832-824-4716 rhrouce@txch.org 收起 << |
NCT00093522 | Kidney Cancer | Phase 2 | Unknown | - | United States, Wisconsin ... 展开 >> Midwest Heart Surgery Institute, Limited Milwaukee, Wisconsin, United States, 53215 Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 收起 << |
NCT03142646 | Leukemia | Phase 1 Phase 2 | Recruiting | October 1, 2018 | China ... 展开 >> Beijing hospital Recruiting Beijing, China Contact: hui liu, md 15801390058 espinas@163.com Peking University People's Hospital (PKUPH) Recruiting Peking, China Contact: Xiaojun Huang, MD Principal Investigator: Xiaojun Huang, MD 收起 << |
NCT00769522 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | Germany ... 展开 >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 收起 << |
NCT01300247 | - | Completed | - | - | |
NCT00397813 | - | Active, not recruiting | - | - | |
NCT00397813 | Atypical Chronic Myeloid Leuke... 展开 >>mia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Essential Thrombocythemia Myeloproliferative Neoplasm Paroxysmal Nocturnal Hemoglobinuria Polycythemia Vera Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary Myelofibrosis Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts 收起 << | Phase 2 | Active, not recruiting | September 2022 | United States, Utah ... 展开 >> LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01300247 | Lymphocytic Leukemia, Chronic | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Huntsville, Alabama, United States, 35805 United States, California Duarte, California, United States, 91010 La Jolla, California, United States, 92093 Los Angeles, California, United States, 90095 United States, Connecticut Southington, Connecticut, United States, 06489 United States, Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Atlanta, Georgia, United States, 30322 Marietta, Georgia, United States, 30060 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Boston, Maryland, United States, 02115 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Minnesota St. Louis Park, Minnesota, United States, 55426 United States, Missouri Springfield, Missouri, United States, 65807 United States, New York Rochester, New York, United States, 14642 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98109 Tacoma, Washington, United States, 98405 United States, Wisconsin Madison, Wisconsin, United States, 53705 收起 << |
NCT00429572 | Breast Cancer | Phase 2 | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00429572 | - | Completed | - | - | |
NCT01787474 | Recurrent Adult Acute Myeloid ... 展开 >>Leukemia Refractory Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | May 30, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Stefan O. Ciurea 713-792-8750 Principal Investigator: Stefan O. Ciurea 收起 << |
NCT01679041 | Multiple Sclerosis | Phase 2 | Terminated(Insufficient accrua... 展开 >>ls; PI leaving site) 收起 << | - | United States, Texas ... 展开 >> Amarillo Diagnostic Clinic Amarillo, Texas, United States, 79106 Dr Ruby Saulog Amarillo, Texas, United States, 79106 Texas Oncology Amarillo, Texas, United States, 79106 收起 << |
NCT00006184 | Multiple Myeloma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02379520 | Human Papillomavirus-Related C... 展开 >>arcinoma Human Papillomavirus Positive Oropharyngeal Carcinoma Human Papillomavirus Positive Cervical Carcinoma Human Papillomavirus Positive Anal Carcinoma Human Papillomavirus Positive Vulvar Carcinoma Human Papillomavirus Positive Penile Carcinoma 收起 << | Phase 1 | Recruiting | October 2033 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Vicky Torrano 832-824-7821 vtorrano@bcm.edu 收起 << |
NCT00006184 | - | Completed | - | - | |
NCT02933775 | CD19 Positive Malignant B-cell... 展开 >> Leukemia and Lymphoma 收起 << | Phase 1 | Not yet recruiting | January 2020 | China, Shanghai ... 展开 >> Renji Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Honghui Huang, MD honghui_huang@163.com Principal Investigator: Fangyuan Chen, MD Sub-Investigator: Honghui Huang, MD 收起 << |
NCT02937844 | Glioblastoma Multiforme | Phase 1 | Recruiting | July 2019 | China ... 展开 >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD +86-10-13905918963 lzx1967@sina.com 收起 << |
NCT02456350 | Chronic Lymphocytic Leukemia ... 展开 >> Acute Lymphocytic Leukemia Lymphoma 收起 << | Phase 1 | Recruiting | December 2019 | China, Guangdong ... 展开 >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D. 15814723218 mingjunw429@163.com Contact: Weihong Chen, M.D., Ph.D. 13923871697 whitney-cindy@hotmail.com Principal Investigator: Xin Du, M.D., Ph.D. Principal Investigator: Mingjun Wang, M.D., Ph.D. Principal Investigator: Geng Tian, M.D., Ph.D. Principal Investigator: Weihong Chen, M.D., Ph.D. 收起 << |
NCT00467961 | - | Completed | - | - | |
NCT02601313 | Relapsed/Refractory Mantle Cel... 展开 >>l Lymphoma 收起 << | Phase 2 | Recruiting | March 2034 | - |
NCT03076437 | Acute Lymphocytic Leukemia ... 展开 >> Chronic Lymphocytic Leukemia Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2019 | China, Guangdong ... 展开 >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Yirong Jiang, MD 13688967985 dgjyr0769@163.com Contact: Mingjun Wang, MD, PhD 15814723218 mingjunw429@163.com Principal Investigator: Yirong Jiang, MD 收起 << |
NCT00467961 | CML (Chronic Myelogenous Leuke... 展开 >>mia) CLL (Chronic Lymphocytic Leukemia) AML (Acute Myelogenous Leukemia) Acute Lymphocytic Leukemia MDS (Myelodysplastic Syndrome) 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02390739 | Metastatic Thyroid Cancer | Phase 1 Phase 2 | Withdrawn | - | - |
NCT03412877 | Glioblastoma ... 展开 >>Non-Small Cell Lung Cancer Ovarian Cancer Breast Cancer Gastrointestinal/Genitourinary Cancer 收起 << | Phase 2 | Recruiting | March 23, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT01455051 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | October 2017 | Spain ... 展开 >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Christelle Ferra, MD CHRISTELLE.FERRA@telefonica.net Principal Investigator: Christelle Ferra, MD, PhD Hospital de la Santa Creu Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Carolina Moreno, MD, PhD cmorenoa@santpau.cat Principal Investigator: Carolina Moreno, MD, PhD Hospital Vall d'Hebron Recruiting Barcelona, Spain Contact: Francesc Bosch, MD, PhD fbosch@vhebron.net Principal Investigator: Francesc Bosch, MD, PhD Institut Catala d'Oncologia Recruiting Hospitalet de Llobregat, Spain Contact: Rafael Duarte, MD, PhD rduarte@iconcologia.net Principal Investigator: Rafael Duarte, MD, PhD Hospital La Princesa Recruiting Madrid, Spain Contact: Javier Loscertales, MD javlos@yahoo.com Principal Investigator: Javier Loscertales, MD Hospital Puerta de Hierro Recruiting Madrid, Spain Contact: Jose Angel Garcia-Marco, MD, PhD jagarciam@medynet.com Principal Investigator: Jose Angel Garcia-Marco, MD, PhD Hospital Central de Asturias Recruiting Oviedo, Spain Contact: Carlos Vallejo, MD Principal Investigator: Carlos Vallejo Hospital Clinico Recruiting Valencia, Spain Contact: Maria Jose Terol terol39@ono.com Principal Investigator: Maria Jose Terol, MD, PhD Hospital La Fe Recruiting Valencia, Spain Contact: Jaime Sanz Principal Investigator: Jaime Sanz 收起 << |
NCT02447055 | Multiple Myeloma ... 展开 >> Myeloma-Multiple 收起 << | Early Phase 1 | Withdrawn | - | - |
NCT02771197 | Acute Myeloid Leukemia | Phase 2 | Recruiting | June 30, 2021 | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD 404-255-1930 Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott Solomon, MD 404-255-1930 ssolomon@bmtga.com Contact: Stacey Brown, BA 404-851-8238 stacey.brown@northside.com Principal Investigator: Scott Solomon, MD Sub-Investigator: H. Kent Holland, MD Sub-Investigator: Asad Bashey, MD, PHD Sub-Investigator: Lawrence E Morris, MD 收起 << |
NCT03322735 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | December 2019 | China, Henan ... 展开 >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song +86-13521186987 ph200811@163.com Principal Investigator: Yongping Song 收起 << |
NCT02489266 | Metastatic Melanoma | Phase 1 | Withdrawn | - | - |
NCT00176865 | Hemophagocytic Lymphohistiocyt... 展开 >>osis X-Linked Lymphoproliferative Disorders Chediak-Higashi Syndrome Griscelli Syndrome Immunologic Deficiency Syndromes Langerhans-Cell Histiocytosis 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00426517 | Inherited Immune Deficiencies | Early Phase 1 | Recruiting | January 8, 2026 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT00475384 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome Leukemia 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Florida University of Florida Shands Hospital Gainesville, Florida, United States, 32610-0278 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00176865 | - | Completed | - | - | |
NCT00602693 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01853631 | Non-Hodgkin Lymphoma ... 展开 >> Chronic Lymphocytic Leukemia Acute Lymphocytic Leukemia 收起 << | Phase 1 | Recruiting | February 2033 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Catherine Robertson 832-824-4594 csrobert@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Catherine Robertson 832-824-4594 csrobert@txch.org 收起 << |
NCT01145209 | Small Lymphocytic Lymphoma ... 展开 >> CLL (Chronic Lymphocytic Leukemia) 收起 << | Phase 2 | Active, not recruiting | December 31, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03049449 | Lymphoma, Large-Cell, Anaplasi... 展开 >>tc Hodgkin Disease Lymphoma, Hodgkins Enteropathy-Associated T-Cell Lymphoma Lymphoma, Extranodal NK-T-Cell 收起 << | Phase 1 | Recruiting | June 30, 2022 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT02614066 | Acute Lymphoblastic Leukemia | Phase 1 Phase 2 | Recruiting | March 2034 | - |
NCT01251575 | Adult Acute Lymphoblastic Leuk... 展开 >>emia Adult Acute Myeloid Leukemia Adult Diffuse Large B-Cell Lymphoma Adult Myelodysplastic Syndrome Adult Non-Hodgkin Lymphoma Aggressive Non-Hodgkin Lymphoma Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia Childhood Diffuse Large B-Cell Lymphoma Childhood Myelodysplastic Syndrome Childhood Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia in Remission Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm Mantle Cell Lymphoma Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> Presbyterian - Saint Lukes Medical Center - Health One Recruiting Denver, Colorado, United States, 80218 Contact: Michael B. Maris 720-754-4800 Michael.Maris@healthonecares.com Principal Investigator: Michael B. Maris United States, Utah Huntsman Cancer Institute/University of Utah Completed Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey 206-762-1010 thomas.chauncey@va.gov Principal Investigator: Thomas R. Chauncey Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier 206-667-4961 bsandmai@fredhutch.org Principal Investigator: Brenda M. Sandmaier Denmark Rigshospitalet University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Niels Anderson 45 35 45 1134 niels.smedegaard.andersen@rh.regionh.dk Principal Investigator: Niels Anderson 收起 << |
NCT01823198 | Leukemia | Phase 1 Phase 2 | Recruiting | June 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01273181 | Metastatic Cancer ... 展开 >> Metastatic Renal Cancer Metastatic Melanoma 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01273181 | - | Terminated | - | - | |
NCT03393611 | Myelodysplastic Syndromes ... 展开 >> Leukemia, Myeloid, Acute Leukemia, Relapsed Adult Acute Myeloid Myelodysplastic Syndromes, Previously Treated 收起 << | Phase 1 | Recruiting | November 30, 2021 | United States, New York ... 展开 >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN 212-746-2844 jeb9097@med.cornell.edi Contact: Usama Gergis, MD 646-962-7950 usg2001@med.cornell.edu Principal Investigator: Usama Gergis, MD Sub-Investigator: Koen van Besien, MD Sub-Investigator: Tsiporah Shore, MD Sub-Investigator: Sebastian Mayer, MD 收起 << |
NCT02431988 | Diffuse Large B-Cell Lymphoma | Phase 1 | Recruiting | December 2020 | United Kingdom ... 展开 >> University College London Hospital Recruiting London, United Kingdom Contact: Karl Peggs +44 2076796236 k.peggs@ucl.ac.uk Principal Investigator: Karl Peggs 收起 << |
NCT02625480 | Acute Lymphoblastic Leukemia | Phase 1 Phase 2 | Recruiting | October 2034 | - |
NCT00813124 | Stem Cell Transplantation ... 展开 >> Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03706547 | Multiple Myeloma in Relapse ... 展开 >> Multiple Myeloma Progression 收起 << | Phase 1 | Not yet recruiting | December 2021 | China ... 展开 >> Department of Hematology ,Fudan University Zhongshan Hospital Active, not recruiting Shanghai, China, 200032 收起 << |
NCT01063647 | Hematological Malignancies | Phase 1 Phase 2 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital Helsinki, Finland, FIN-00290 Germany Charité University Hospital Berlin Berlin, Germany, 12203 University Hospital Hamburg Eppendorf Hamburg, Germany, 20246 5th Medical Clinic, Clinic North Nuremberg, Germany, 90340 University Hospital Rostock Rostock, Germany, 18057 Poland Silesian Medical University Katowice, Poland, 40-029 Sweden Karolinska University Hospital & Karolinska Institute Stockholm, Sweden, 141 86 收起 << |
NCT03191773 | Acute Lymphocytic Leukemia ... 展开 >> Chronic Lymphocytic Leukemia Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2020 | China, Guangdong ... 展开 >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China Contact: Yirong Jiang, MD 0086 13688967985 dgjyr0769@163.com Principal Investigator: Yirong Jiang, MD Department of Hematology, the First People's Hospital of Foshan Recruiting Foshan, Guangdong, China Contact: Zhuowen Chen, MD 0086 18928617712 czwen@fsyyy.com Contact: Wei Luo, MD 0086 18038865996 luowei_421@163.com Principal Investigator: Zhuowen Chen, MD Department of Hematology, Guangzhou First People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang 0086 13437801998 drwangshq@medmail.com.cn Principal Investigator: Shunqing Wang, MD Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University Recruiting Guangzhou, Guangdong, China Contact: Xueyi Pan 0086 13922217835 xypan88@163.com Principal Investigator: Xueyi Pan, MD Department of Hematology,the Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Ying Feng, MD 0086 13602723030 fyzlply@163.com Principal Investigator: Ying Feng, MD 收起 << |
NCT00455312 | - | Completed | - | - | |
NCT03602612 | Myeloma-Multiple ... 展开 >> Myeloma, Plasma-Cell 收起 << | Phase 1 | Recruiting | January 1, 2024 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT01496547 | Acute Leukemia | Phase 2 | Unknown | June 2018 | China ... 展开 >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D. Principal Investigator: Ling Wang, M.D. 收起 << |
NCT02348216 | Refractory Diffuse Large B Cel... 展开 >>l Lymphoma (DLBCL) Relapsed Diffuse Large B-Cell Lymphoma Transformed Follicular Lymphoma (TFL) Primary Mediastinal B-cell Lymphoma (PMBCL) High Grade B-cell Lymphoma (HGBCL) 收起 << | Phase 1 Phase 2 | Recruiting | October 2034 | - |
NCT00048399 | Graft Failure | Phase 1 Phase 2 | Terminated | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT00455312 | Dyskeratosis Congenita ... 展开 >> Aplastic Anemia 收起 << | Phase 2 Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00049504 | - | Completed | - | - | |
NCT00049504 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00076752 | Lupus Erythematosus, Systemic | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02724904 | Lymphoma | Phase 1 Phase 2 | Withdrawn(Drug logistics) | December 2021 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT00045435 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia 收起 << | Phase 2 | Active, not recruiting | - | United States, Oregon ... 展开 >> OHSU Cancer Institute Portland, Oregon, United States, 97210 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03016377 | Acute Lymphoblastic Leukemia ... 展开 >> Immune System Diseases Immunoproliferative Disorders 收起 << | Phase 1 | Recruiting | October 2036 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing (919) 445-4208 spencer.laing@med.unc.edu Principal Investigator: Matthew Foster, MD 收起 << |
NCT00045435 | - | Active, not recruiting | - | - | |
NCT03624036 | Relapsed/Refractory Chronic Ly... 展开 >>mphocytic Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | September 2035 | United States, Tennessee ... 展开 >> Sarah Cannon Research Center Recruiting Nashville, Tennessee, United States, 37203 Contact: Renee Thompson Renee.Thompson@sarahcannon.com Principal Investigator: Ian Flinn 收起 << |
NCT03761056 | B-cell Lymphoma | Phase 2 | Recruiting | December 2034 | United States, Texas ... 展开 >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo LNVallejo@mdanderson.org Contact: Yiming Chen Yichen@mdanderson.org Principal Investigator: Sattva Neelapu 收起 << |
NCT00357565 | Leukemia Myel... 展开 >>odysplastic Syndromes Childhood Acute Myeloid Leukemia in Remission Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Previously Treated Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Excess Blasts Refractory Anemia De Novo Myelodysplastic Syndrome Childhood Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | February 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Christen Ebens, MD 612-624-0123 ebens012@umn.edu 收起 << |
NCT03743246 | Precursor Cell Lymphoblastic L... 展开 >>eukemia-Lymphoma Lymphoma, Non-Hodgkin 收起 << | Phase 1 Phase 2 | Recruiting | December 1, 2023 | Spain ... 展开 >> Hospital Infantil Universitario Niño Jesús Recruiting Madrid, Spain, 28009 收起 << |
NCT01141959 | - | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << | |
NCT02678143 | Sickle Cell Disease | Phase 1 | Recruiting | May 31, 2020 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mark A Schroeder, M.D. 314-454-8304 markschroeder@wustl.edu Principal Investigator: Mark A Schroeder, M.D. Sub-Investigator: Bader Alahmari, M.D. Sub-Investigator: Morey Blinder, M.D. Sub-Investigator: Allison King, M.D. 收起 << |
NCT00343798 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Colorado, United States, 80217-3364 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02194374 | Leukemia | Phase 1 | Withdrawn(Study closed with no... 展开 >> enrollment due to unavailability of reagent.) 收起 << | - | - |
NCT02400281 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Active, not recruiting | April 2020 | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00076752 | - | Completed | - | - | |
NCT03573700 | Acute Lymphoblastic Leukemia, ... 展开 >>in Relapse Acute Lymphoblastic Leukemia, Refractory 收起 << | Phase 1 Phase 2 | Recruiting | July 1, 2024 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Aimee C. Talleur, MD 866-278-5833 referralinfo@stjude.org Principal Investigator: Aimee C. Talleur, MD 收起 << |
NCT00946023 | - | Terminated(Funding was unavail... 展开 >>able to complete the study as originally planned.) 收起 << | - | - | |
NCT01175785 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02320383 | Chronic Lymphocytic Leucemia | Phase 2 | Active, not recruiting | September 2022 | Germany ... 展开 >> German CLL Study Group Cologne, Germany, 50923 收起 << |
NCT00028418 | Hematologic Neoplasms ... 展开 >> Lymphoproliferative Disorders Leukemia Leukemia, Lymphocytic, Chronic 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00946023 | Lymphoma B-ce... 展开 >>ll Lymphoma Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Terminated(Funding was unavail... 展开 >>able to complete the study as originally planned.) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 收起 << |
NCT00048737 | Lymphoma Leuk... 展开 >>emia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00303719 | Kidney Cancer ... 展开 >> Leukemia Lymphoma Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | December 2021 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00988715 | Chronic Myelomonocytic Leukemi... 展开 >>a Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts Secondary Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00048737 | - | Completed | - | - | |
NCT00392782 | - | Terminated | - | - | |
NCT03615144 | Non-Malignant Hematologic Diso... 展开 >>rders 收起 << | Phase 2 | Recruiting | July 2021 | United States, New York ... 展开 >> Memorial SloanKettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Maria Cancio, MD 212-639-2446 Contact: Farid Boulad, MD 212-639-6684 Principal Investigator: Maria Cancio, MD 收起 << |
NCT03399773 | Acute Biphenotypic Leukemia ... 展开 >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | August 2021 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 收起 << |
NCT00392782 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Terminated | - | United States, Florida ... 展开 >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Midwest Children's Cancer Center at Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT01369875 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01369875 | - | Completed | - | - | |
NCT02423915 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00622895 | - | Completed | - | - | |
NCT00303667 | - | Completed | - | - | |
NCT00670410 | Neuroblastoma | Phase 1 | Terminated(Poor accrual) | - | United States, New York ... 展开 >> Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian New York, New York, United States, 10032 收起 << |
NCT03585764 | Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Primary Peritoneal Carcinoma 收起 << | Phase 1 | Recruiting | October 2035 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Health System Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Payal D Shah, MD 855-216-0098 PennCancerTrials@emergingmed.com 收起 << |
NCT00622895 | Systemic Scleroderma ... 展开 >> Severe Systemic Sclerosis 收起 << | Phase 1 Phase 2 | Completed | - | United States, Colorado ... 展开 >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02774291 | HLA-A2 Positive Cells Present ... 展开 >> Metastatic Malignant Neoplasm Metastatic Malignant Neoplasm in the Brain 收起 << | Not Applicable | Recruiting | February 2020 | United States, New York ... 展开 >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Ira Braunschweig 718-920-4826 aecc@aecom.yu.edu Principal Investigator: Ira Braunschweig 收起 << |
NCT02354690 | Metastatic Melanoma | Phase 1 Phase 2 | Active, not recruiting | August 2020 | Denmark ... 展开 >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 收起 << |
NCT00303667 | Acute Myelogenous Leukemia | Phase 1 Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00764829 | - | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << | |
NCT02707393 | Chronic Myeloid Leukemia | Phase 2 Phase 3 | Recruiting | January 2024 | Austria ... 展开 >> Universitätsklinik für Kinder- und Jugendheilkunde Not yet recruiting Graz, Austria, 8036 Contact: Christian Urban, Prof., MD 0043-316-385 ext 3485 christian.urban@medunigraz.at Principal Investigator: Christian Urban, Prof., MD St. Anna Kinderspital Recruiting Wien, Austria, 1050 Contact: Susanne Matthes, MD 0043-1-40170 ext 3100 susanne.matthes@stanna.at Contact: Christina Peters, Prof., MD 0043-1-40170 ext 3100 christina.peters@stanna.at Principal Investigator: Susanne Matthes, MD Czechia Hospital Motol, Department of Pediatric Hematology and Oncology, BMT Unit Recruiting Praha, Czechia, 15006 Contact: Petr Sedlacek, MD 00420-22443 ext 6552 Petr.Sedlacek@fnmotol.cz Principal Investigator: Petr Sedlacek, MD Italy Clinica Pediatrica Recruiting Monza, Italy, 20052 Contact: Adriana Balduzzi, MD abalduzzi@fondazionembbm.it 收起 << |
NCT00427557 | Multiple Myeloma ... 展开 >> Leukemia Lymphoma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00427557 | - | Completed | - | - | |
NCT01946373 | Melanoma | Phase 1 | Recruiting | December 2018 | Sweden ... 展开 >> Karolinska University Hospital Recruiting Stockholm, Sweden, SE-171 76 Contact: Roger Tell, MD, PhD +46760293911 roger.tell@ki.se Principal Investigator: Roger Tell, MD, PhD 收起 << |
NCT02661035 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Myeloproliferative Syndromes Hematological Diseases 收起 << | Phase 2 | Recruiting | March 2023 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Erica Warlick, MD 收起 << |
NCT01339910 | Leukemia, Myelocytic, Acute | Phase 3 | Terminated(Accrual terminated ... 展开 >>as recommended by the data and safety monitoring board.) 收起 << | - | - |
NCT01010217 | Blood Stem Cell Transplant Fai... 展开 >>lure Leukemia Hematologic Malignancies 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00027924 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT02666898 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 2 | Completed | - | France ... 展开 >> Sponsor FILO Tours, France, 37054 收起 << |
NCT00652899 | Fallopian Tube Cancer ... 展开 >> Ovarian Cancer Peritoneal Cavity Cancer 收起 << | Phase 2 | Terminated(Withdrawn due to to... 展开 >>xicity) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00652899 | - | Terminated(Withdrawn due to to... 展开 >>xicity) 收起 << | - | - | |
NCT01339910 | - | Terminated(Accrual terminated ... 展开 >>as recommended by the data and safety monitoring board.) 收起 << | - | - | |
NCT00645606 | Leukemia | Phase 3 | Completed | - | France ... 展开 >> French Innovative leukemia Organization TOURS Cedex, France, 37044 收起 << |
NCT03696784 | Lymphoma Lymp... 展开 >>homa, B-Cell Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases 收起 << | Phase 1 | Not yet recruiting | October 30, 2033 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 ssblaing@email.unc.edu Principal Investigator: Grover Natalie, MD 收起 << |
NCT02385955 | Hematologic Malignancy | Phase 2 | Not yet recruiting | April 2019 | - |
NCT03549442 | Multiple Myeloma | Phase 1 | Recruiting | May 2021 | United States, Pennsylvania ... 展开 >> Univ. of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Alfred Garfall, MD 收起 << |
NCT00489281 | Sickle Cell Disease | Phase 2 | Active, not recruiting | December 2018 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT01319565 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Active, not recruiting | June 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01875237 | Leukemia Myel... 展开 >>oma Myeloproliferative Diseases 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00038844 | Lymphoma Leuk... 展开 >>emia 收起 << | Not Applicable | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00924001 | Melanoma Mali... 展开 >>gnant Melanoma Melanoma, Experimental 收起 << | Phase 1 Phase 2 | Terminated(study was stopped d... 展开 >>ue to low accrual) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02867800 | Sickle Cell Disease ... 展开 >> Graft Versus Host Disease 收起 << | Phase 1 | Recruiting | December 2019 | United States, District of Col... 展开 >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Shahleen Ahmed, CRC 202-476-6850 szahmed@childrensnational.org Principal Investigator: Allistair Abraham, MD United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelsey Rogowski, MPH 404-785-7749 Kelsey.Rogowski@choa.org Principal Investigator: Ann Haight, MD United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Nicole Fisher, CRC 312-227-4871 nfisher@luriechildrens.org Principal Investigator: Sonali Chaudhury, MD United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Danielle Dietzen, NP 212-305-8443 dad9025@nyp.org Contact: Jean Sosna, RN MS 212-305-2050 js4403@cumc.columbia.edu Principal Investigator: Monica Bhatia, MD United States, North Carolina North Carolina Cancer Hospital Not yet recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Juanita Cuffee 919-962-8733 cuffee@med.unc.edu Principal Investigator: Kimberly Kasow, MD United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mary Beth Scholz, RN 614-722-3654 Mary.Scholz@nationwidechildrens.org Principal Investigator: Hemalatha Rangarajan, MD 收起 << |
NCT00924001 | - | Terminated(study was stopped d... 展开 >>ue to low accrual) 收起 << | - | - | |
NCT00376519 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Secondary Myelofibrosis 收起 << | Phase 1 | Terminated(Slow accrual) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01995344 | Metastatic Melanoma | Phase 2 | Unknown | December 2018 | United Kingdom ... 展开 >> The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M20 4BX 收起 << |
NCT00988013 | Acute Myeloid Leukemia ... 展开 >> Lymphoblastic Leukemia Acute Leukemia Non Hodgkins Lymphoma Chronic Myeloid Leukemia 收起 << | Phase 1 | Unknown | September 2017 | United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 收起 << |
NCT00006090 | Leukemia | Phase 2 | Withdrawn(No enrollment.) | - | - |
NCT00304720 | Multiple Myeloma ... 展开 >> Lymphoma Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Unknown | - | United States, Colorado ... 展开 >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Contact: Peter A McSweeney, MD 303-336-2184 Peter.McSweeney@usoncology.com Contact: Juli B Murphy 303-285-5087 Juli.Murphy@usoncology.com Sub-Investigator: Robert M Rifkin, MD Principal Investigator: Peter A McSweeney, MD Sub-Investigator: Jeffrey V Matous, MD Sub-Investigator: Scott I Bearman, MD Sub-Investigator: Mark W Brunvand, MD Sub-Investigator: Michael B Maris, MD 收起 << |
NCT00448357 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 收起 << |
NCT01821781 | Immune Deficiency Disorders ... 展开 >> Severe Combined Immunodeficiency Chronic Granulomatous Disease X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Hyper-IgM DiGeorge Syndrome Chediak-Higashi Syndrome Common Variable Immune Deficiency Immune Dysregulatory Disorders Hemophagocytic Lymphohistiocytosis IPEX Autoimmune Lymphoproliferative Syndrome X-linked Lymphoproliferative Syndrome 收起 << | Phase 2 | Recruiting | March 2021 | United States, Missouri ... 展开 >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jeffrey Bednarski, MD 314-454-6018 Bednarski_J@kids.wustl.edu Contact: Lisa Murray, CCRP 314-454-4240 Murray_L@kids.wustl.edu Principal Investigator: Jeffrey Bednarski, MD United States, Texas Methodist Heathcare Recruiting San Antonio, Texas, United States, 78229 Contact: Troy Quigg, DO, MS Troy.Quigg@mhshealth.com 收起 << |
NCT01585428 | - | Completed | - | - | |
NCT02766868 | Lymphoblastic Leukemia, Acute,... 展开 >> Adult 收起 << | Phase 2 | Recruiting | July 2019 | China ... 展开 >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Ling Wang 86-21-64370045 ext 601818 cclingjar@163.com 收起 << |
NCT00448357 | - | Completed | - | - | |
NCT01585428 | Cervical Cancer ... 展开 >> Oropharyngeal Cancer Vaginal Cancer Anal Cancer Penile Cancer 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02441803 | Leukemia | Phase 2 | Active, not recruiting | September 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00875667 | Mantle Cell Lymphoma ... 展开 >> Lymphoma, Mantle-Cell 收起 << | Phase 2 | Active, not recruiting | July 5, 2019 | - |
NCT02507479 | Non Hodgkin Lymphoma ... 展开 >> Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma 收起 << | Phase 2 | Recruiting | July 2019 | Israel ... 展开 >> Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel, 52621 Contact: Arnon Nagler, MD 972 3 530 5830 a.nagler@sheba.health.gov.il Contact: Avichai Shimoni, MD 972 3 530 5303 ashimoni@sheba.health.gov.il Sub-Investigator: Avichai Shimoni, MD Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel Principal Investigator: Arnon Nagler, MD 收起 << |
NCT03687463 | - | Enrolling by invitation | April 10, 2020 | - | |
NCT03171220 | Advanced Malignant Solid Tumor | Phase 1 Phase 2 | Recruiting | December 31, 2020 | China, Jiangsu ... 展开 >> The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Baorui Liu, M.D. & Ph.D +86-25-83304616 ext 61331 baoruiliu@nju.edu.cn Contact: Zhengyun Zou, M.D. & Ph.D +86-25-83304616 ext 61331 zouzhengyun@medmail.com.cn 收起 << |
NCT01079013 | Non Hodgkin Lymphoma ... 展开 >> Hodgkin Lymphoma 收起 << | Phase 2 | Unknown | April 2018 | Israel ... 展开 >> Chaim Sheba Medical Center Tel-Hashomer, Israel, 52621 收起 << |
NCT03509961 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia 收起 << | Phase 2 | Recruiting | April 1, 2022 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Aunsha Williamson 323-361-7551 awilliamson@chla.usc.edu Principal Investigator: Hisham Abdel-Azim, MD United States, Texas Methodist Healthcare System Recruiting San Antonio, Texas, United States, 78229 Contact: Candace Taylor 210-575-7379 Candace.taylor@mhshealth.com Principal Investigator: Troy Quigg, DO 收起 << |
NCT00091611 | Kidney Neoplasms | Phase 1 | Terminated(This study was term... 展开 >>inated due to low accrual.) 收起 << | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT01534143 | - | Terminated(Data was not collec... 展开 >>ted, because funding was unavailable to continue study.) 收起 << | - | - | |
NCT02626338 | Relapsed/Refractory Acute Myel... 展开 >>oid Leukemia (AML) 收起 << | Phase 1 Phase 2 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Houston Methodist Houston, Texas, United States, 77030 收起 << |
NCT02833805 | Severe Aplastic Anemia ... 展开 >> Aplastic Anemia Bone Marrow Failure Immunosuppression 收起 << | Phase 2 | Recruiting | August 2020 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy E DeZern, MD 410-502-7208 adezern1@jhmi.edu 收起 << |
NCT00509288 | Melanoma Skin... 展开 >> Cancer 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00473551 | Leukemia Lymp... 展开 >>homa Myeloma 收起 << | Phase 1 | Terminated(Terminated due to s... 展开 >>low accrual.) 收起 << | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01534143 | Refractory Multiple Myeloma ... 展开 >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Terminated(Data was not collec... 展开 >>ted, because funding was unavailable to continue study.) 收起 << | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 收起 << |
NCT02614560 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Terminated | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Case Western Reserve University / University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Cancer Center / University of Texas Houston, Texas, United States, 77030-4095 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00314106 | - | Completed | - | - | |
NCT00509288 | - | Completed | - | - | |
NCT00001832 | - | Completed | - | - | |
NCT00314106 | Metastatic Melanoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT00946374 | Mantle-Cell Lymphoma | Phase 2 | Unknown | June 2011 | Germany ... 展开 >> University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Markus Munder, MD 收起 << |
NCT00001832 | Melanoma Neop... 展开 >>lasm Metastasis 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT00871689 | - | Terminated(Due to graft failur... 展开 >>e.) 收起 << | - | - | |
NCT00871689 | Leukemia | Phase 2 | Terminated(Due to graft failur... 展开 >>e.) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02529839 | Multiple Sclerosis | Not Applicable | Unknown | October 2017 | - |
NCT00625729 | - | Terminated(No patients exhibit... 展开 >>ed natural killer cell expansion (primary endpoint).) 收起 << | - | - | |
NCT02556931 | Myelodysplastic Syndrome ... 展开 >> Chronic Myelomonocytic Leukemia Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Chronic Myeloid Leukemia Chronic Myeloproliferative Disorders Multiple Myeloma Plasma Cell Neoplasm Plasma Cell Dyscrasia Myelofibrosis Polycythemia Vera Essential Thrombocythemia Plasma Cell Leukemia 收起 << | Phase 2 | Active, not recruiting | December 2019 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 收起 << |
NCT00423709 | Hodgkin's Disease | Not Applicable | Completed | - | United States, Texas ... 展开 >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01119066 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Multiple Myeloma 收起 << | Phase 2 | Recruiting | May 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Richard O'Reilly, MD 212-639-5957 Contact: Sergio Giralt, MD 212-639-3859 Principal Investigator: Richard O'Reilly, MD 收起 << |
NCT00625729 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 Phase 2 | Terminated(No patients exhibit... 展开 >>ed natural killer cell expansion (primary endpoint).) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00176852 | Sickle Cell Disease ... 展开 >> Thalassemia Severe Congenital Neutropenia Diamond-Blackfan Anemia Shwachman-Diamond Syndrome 收起 << | Phase 2 Phase 3 | Active, not recruiting | January 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00943293 | Preleukemia M... 展开 >>yeloproliferative Disorders Lymphoma Myeloma Graft Versus Host Disease 收起 << | Phase 1 | Terminated(Poor accrual; did n... 展开 >>ot enter phase 2) 收起 << | - | United States, Illinois ... 展开 >> The Uniiversity of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT03710421 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 1 | Not yet recruiting | December 10, 2021 | United States, California ... 展开 >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD 626-218-2405 htut@coh.org Principal Investigator: Myo Htut, MD 收起 << |
NCT00176852 | - | Active, not recruiting | - | - | |
NCT01701323 | Acute Leukemia of Ambiguous Li... 展开 >>neage Acute Myeloid Leukemia 收起 << | Phase 1 | Terminated | - | United States, Georgia ... 展开 >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02053545 | Leukemia Lymp... 展开 >>homa MDS 收起 << | Phase 1 Phase 2 | Unknown | December 2018 | United States, Illinois ... 展开 >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Joseph Laskowski jlaskowski@luriechildrens.org Principal Investigator: Reggie Duerst 收起 << |
NCT00006261 | Breast Cancer | Phase 2 | Withdrawn | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT01828619 | - | Unknown | - | China ... 展开 >> Peking University People's Hospital Beijing, China, 100044 收起 << | |
NCT01312376 | Ovarian Carcinoma ... 展开 >> Fallopian Tube Cancer Primary Peritoneal Cancer 收起 << | Phase 1 | Unknown | - | United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00603460 | Ovarian Cancer ... 展开 >> Primary Peritoneal Cancer 收起 << | Phase 1 Phase 2 | Withdrawn | March 2013 | United States, Pennsylvania ... 展开 >> University of Pennsylania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT03467256 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia Acute Lymphocytic Leukemia, Pediatric 收起 << | Phase 1 Phase 2 | Recruiting | March 2023 | Russian Federation ... 展开 >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117198 Contact: Zhanna Shekhovtsova 4956647078 zhanna.shekhovtsova@fccho-moscow.ru Contact: Eugene Pashanov, Prof. PhD +79262205578 e.pashanov@gmail.com Sub-Investigator: Olga Molostvova 收起 << |
NCT00894049 | Allograft All... 展开 >>ogeneic Cell Transplantaion Hematological Malignancy Solid Tumor 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU Bordeaux Pessac, France CHU Clermont Ferrand, France CHU Lyon, France Institut Paoli-Calmettes Marseille, France CHU Montpellier, France 收起 << |
NCT01068301 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma 收起 << | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00526292 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00526292 | - | Completed | - | - | |
NCT03434704 | Transplant-Related Hematologic... 展开 >> Malignancy Leukemia, Acute Myelodysplastic Syndromes Graft Vs Host Disease Fungal Infection 收起 << | Phase 2 | Recruiting | September 15, 2022 | Italy ... 展开 >> Ospedale San Raffaele Recruiting Milano, Lombardia, Italy, 20132 Contact: Fabio Ciceri, MD 0039022643 ext 4289 ciceri.clinicaltrials@hsr.it Sub-Investigator: Raffaella Greco, MD Sub-Investigator: Jacopo Peccatori, MD Sub-Investigator: Maria Teresa Lupo Stanghellini, MD Sub-Investigator: Andrea Assanelli, MD Sub-Investigator: Consuelo Corti, MD 收起 << |
NCT01622556 | Hematologic Malignancies | Phase 2 | Terminated | January 2017 | United States, Virginia ... 展开 >> University of Virginia Charlottesville, Virginia, United States, 22908 收起 << |
NCT03318861 | Multiple Myeloma | Phase 1 | Recruiting | October 2032 | United States, California ... 展开 >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90024 Contact: Bruck Habtemariam bhabtemariam@mednet.ucla.edu Contact: Cynthia Courtney clcourtney@mednet.ucla.edu United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott matthew.scott@moffitt.org United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Tolu Adewuya tolu.adewuya@emory.edu United States, Illinois University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Becky Malloy rmalloy@medicine.bsd.uchicago.edu Contact: Linda Schroeder lschroed@medicine.bsd.uchicago.edu United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD 617-724-4000 NRAJE@mgh.harvard.edu Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: David Avigan, MD davigan@bidmc.harvard.edu United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tracee Shevlin shevlin.tracee@mayo.edu United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sergio Giralt, MD GiraltS@mskcc.org United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cancer Trials Information Program 800-811-8480 Contact: CAR-T Cell Line 615-936-2102 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ashley Morphey alandry1@mdanderson.org 收起 << |
NCT02724163 | Acute Myeloid Leukaemia | Phase 3 | Recruiting | December 2032 | United Kingdom ... 展开 >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Aberdeen Royal Infirmary, NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN Belfast City Hospital, Belfast Health and Social Care Trust Not yet recruiting Belfast, United Kingdom, BT9 7AB Birmingham Children's Hospital NHS Foundation Trust Recruiting Birmingham, United Kingdom, B4 6NH University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Cardiff and Vale University Health Board, Noah's Ark Children's Hospital for Wales Recruiting Cardiff, United Kingdom, CF14 4XW NHS Lothian, Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF NHS Greater Glasgow and Clyde, The Royal Hospital for Children Recruiting Glasgow, United Kingdom, G51 4TF Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, United Kingdom, L12 2AP University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Great Ormond Street Hospital For Children NHS Trust Recruiting London, United Kingdom, WC1N 3JH Royal Manchester Childrens' Hospital , Central Manchester University Hospitals NHS Foundation Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie NHS Foundation Not yet recruiting Manchester, United Kingdom, M20 4BX The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital, Oxford Radcliffe Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 9DU Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2TH Southampton University Hospitals NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01962415 | Primary Immunodeficiency (PID)... 展开 >> Congenital Bone Marrow Failure Syndromes Inherited Metabolic Disorders (IMD) Hereditary Anemias Inflammatory Conditions 收起 << | Phase 2 | Recruiting | November 2020 | United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jason Rowan, RN 412-692-6195 jason.rowan@chp.edu Sub-Investigator: Maria Escolar, MD Sub-Investigator: Randy Windreich, MD Sub-Investigator: Jessie Barnum, MD Sub-Investigator: Craig Byersdorfer, MD Sub-Investigator: Beth Carella, DO 收起 << |
NCT01328496 | Hematologic Malignancies ... 展开 >> Disorder Related to Transplantation Hematopoietic Malignancy 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT02457650 | Bladder Carcinoma ... 展开 >> Breast Cancer Esophagus Carcinoma Lung Cancer Melanoma Multiple Myeloma Neuroblastoma Ovarian Cancer Synovial Sarcoma Other Metastatic Solid Cancers 收起 << | Phase 1 | Recruiting | December 2019 | China, Guangdong ... 展开 >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D. 15814723218 mingjunw429@163.com Contact: Geng Tian, M.D., Ph.D. 13724395569 tiangeng666@aliyun.com Principal Investigator: Geng Tian, M.D., Ph.D. Principal Investigator: Mingjun Wang, M.D., Ph.D. 收起 << |
NCT01338675 | Chronic Granulomatous Disease | Phase 1 Phase 2 | Unknown | December 2013 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 0177 agnesjw@hanmail.net 收起 << |
NCT01328496 | - | Completed | - | - | |
NCT03105336 | Follicular Lymphoma ... 展开 >> Marginal Zone Lymphoma Indolent Non-Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | March 2034 | United States, Arizona ... 展开 >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States, 85234 Contact: Andrea Winkle 480-256-3421 andrea.winkle@bannerhealth.com Principal Investigator: Javier Munoz, MD United States, California USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Kevin Kelly, MD 323-865-3828 kevin.kelly@med.usc.edu Principal Investigator: Kevin Kelly, MD University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Sven de Vos, MD, PhD 310-267-2756 devos@mednet.ucla.edu Principal Investigator: Sven de Vos, MD, PhD United States, District of Columbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20057 Contact: Pashna Munshi, MD 202-444-1212 pashna.n.munshi@gunet.georgetown.edu Principal Investigator: Pashna Munshi, MD United States, Florida University of Miami Hospital and Clinics Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis 305-243-7648 nluis@med.miami.edu Principal Investigator: Joseph Rosenblatt, MD H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott 813-745-7227 matthew.scott@moffitt.org Principal Investigator: Julio Chavez, MD United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Krystle Benedict 617-582-8713 Krystle_Benedict@dfci.harvard.edu Principal Investigator: Caron Jacobson, MD United States, New Jersey Hackensack University Medical Center - John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara Yannotti 551-996-5168 kara.yannotti@hackensackmeridian.org Principal Investigator: Lori Leslie, MD United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10037 Contact: Julia Gould 212-342-3849 jg3686@cumc.columbia.edu Principal Investigator: Ran Reshef, MD University of Rochester Medical Center (URMC) Recruiting Rochester, New York, United States, 14642 Contact: Erin Enfield 585-276-4404 erin_enfield@urmc.rochester.edu Principal Investigator: Carla Casulo, MD United States, Ohio Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski 614-688-9796 nicole.szuminski@osumc.edu Principal Investigator: Basem William, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Elisabeth Giraud Elisabeth.Giraud@fccc.edu Contact: Laura McIntyre Laura.McIntyre@fccc.edu Principal Investigator: Henry Fung, MD UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Linda Fukas 412-623-6037 fukaslj@upmc.edu Principal Investigator: Alison Sehgal, MD United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Ask Sarah 615-339-4214 asksarah@sarahcannon.com Principal Investigator: Ian Flinn, MD, PhD Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Delia Darst 615-343-7190 delia.h.darst@vumc.org Principal Investigator: Olalekan Oluwole, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo 713-563-4167 lnvallejo@mdanderson.org Contact: Sherry Adkins 713-745-3035 sadkins@mdanderson.org Principal Investigator: Sattva Neelapu, MD United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake 206-606-4668 immunotherapy@seattlecca.org Principal Investigator: David Maloney, MD, PhD France Centre Hospitalier Régional Universitaire de Lille Recruiting Lille, France, 59037 Principal Investigator: Ibrahim Yakoub-Agha, MD Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Principal Investigator: Gilles Salles, MD 收起 << |
NCT03348033 | Chronic Myeloid Leukemia | Phase 1 Phase 2 | Enrolling by invitation | March 2020 | - |
NCT00344825 | - | Completed | - | Italy ... 展开 >> Many locations, Italy 收起 << | |
NCT03110640 | B-cell Adult Acute Lymphoblast... 展开 >>ic Leukemia B-cell Chronic Lymphocytic Leukemia Adult Acute Lymphoblastic Leukemia in Remission Hematopoietic/Lymphoid Cancer Refractory Chronic Lymphocytic Leukemia 收起 << | Phase 1 | Not yet recruiting | September 2020 | - |
NCT02959905 | Metastatic Melanoma | Phase 1 | Unknown | March 2018 | China, Guangdong ... 展开 >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510030 Contact: Ye Cao, Doctor 86-20-87343826 contact@sysucc.org.cn Principal Investigator: Xiao Sh Zhang, Doctor 收起 << |
NCT02680951 | Acute Myeloid Leukemia | Phase 1 | Withdrawn(Withdrawn due to lac... 展开 >>k of participants.) 收起 << | - | - |
NCT03128359 | Acute Leukemia ... 展开 >> Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Follicular Lymphoma Graft Versus Host Disease Hodgkin Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | June 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD 626-256-4673 malmalki@coh.org Principal Investigator: Monzr M. Al Malki, MD 收起 << |
NCT00941928 | - | Terminated(Slow accrual) | - | - | |
NCT03166397 | Malignant Melanoma Stage IV | Phase 2 | Recruiting | June 1, 2021 | Israel ... 展开 >> Sheba Medical Center Recruiting Ramat Gan, Israel, 5262100 Contact: Meital Bar 972-3-5305201 meital.bar@sheba.health.gov.il Principal Investigator: Jacob Schachter, MD 收起 << |
NCT02310997 | Leukaemia Lym... 展开 >>phoma Other Haematological Diseases 收起 << | Phase 2 | Terminated(Trial closed early ... 展开 >>due to poor recruitment) 收起 << | - | United Kingdom ... 展开 >> University College London Hospital London, Greater London, United Kingdom, W1T 4TJ University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ St James' University Hospital Leeds, United Kingdom, LS9 7TF St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children London, United Kingdom, WC1N 3JH Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham City Hospital Nottingham, United Kingdom, NG5 1PB Royal Hallamshire Hospital Sheffield, United Kingdom, S10 2JF Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT 收起 << |
NCT03704298 | Refractory Large B-cell Lympho... 展开 >>ma 收起 << | Phase 1 Phase 2 | Recruiting | June 2035 | United States, Florida ... 展开 >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 收起 << |
NCT03412526 | Metastatic Ovarian Cancer | Phase 2 | Not yet recruiting | February 1, 2022 | Israel ... 展开 >> Sheba medical Center Not yet recruiting Ramat Gan, Israel, 5262100 Contact: Jacob Schachter, Prof. 972-3-5304907 jacob.scachter@sheba.health.gov.il Contact: Meital Bar 972-3-5305201 meital.bar@sheba.health.gov.il 收起 << |
NCT00182650 | Lymphoma | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT01583686 | Cervical Cancer ... 展开 >> Pancreatic Cancer Ovarian Cancer Mesothelioma Lung Cancer 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2029 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00941928 | Leukemia Pedi... 展开 >>atric Cancer 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02153905 | Breast Cancer ... 展开 >> Cervical Cancer Renal Cancer Melanoma Bladder Cancer 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03139370 | Solid Tumor | Phase 1 | Recruiting | November 2034 | United States, California ... 展开 >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Anna Crosetti ACrosetti@mednet.ucla.edu Principal Investigator: Alexandra Drakaki, MD United States, Florida University of Miami Health System Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis 301-243-7648 nluis@med.miami.edu Principal Investigator: Peter Hosein, MD Moffitt Cancer Center Recruiting Tampa, Florida, United States, 12902 Contact: Jeffrey Edelman jeffrey.edelman@moffitt.org Principal Investigator: Benjamin Creelan, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jami Brown 617-724-9190 jbrown56@mgh.harvard.edu Principal Investigator: Marcela Maus, MD, PhD United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Cynthia Knauer, RN 212-241-9955 Cynthia.knauer@mountsinai.org Contact: Ash Tewari, MD 1-212-241-9955 Ash.tewari@mountsinai.org Principal Investigator: Ash Tewari, MD Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Geoffrey Noah 646-888-4593 Contact: Shanette Bourne 646-888-4593 Principal Investigator: Chris Klebanoff, MD United States, Texas Baylor Scott and White Health Recruiting Dallas, Texas, United States, 75246 Contact: Carlos Becerra, MD 214-370-1254 carlos.becerra@usoncology.com Contact: Delia Graham 1-214-820-5424 delia.graham@bswhealth.com Principal Investigator: Carlos Becerra, MD MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ly Nguyen 713-563-2169 lmnguyen1@mdanderson.org Principal Investigator: Partow Kebriaei, MD 收起 << |
NCT00923364 | MDS Immunodef... 展开 >>iciency GATA2 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00923364 | - | Completed | - | - | |
NCT02105116 | - | Terminated(No patients were el... 展开 >>igible to receive the experimental component of the protocol therapy.) 收起 << | - | - | |
NCT01300572 | Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Secondary Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | July 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03190941 | Pancreatic Cancer ... 展开 >> Gastric Cancer Gastrointestinal Cancer Colon Cancer Rectal Cancer 收起 << | Phase 1 Phase 2 | Recruiting | June 29, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT02133196 | Advanced Non-Small Cell Lung C... 展开 >>ancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas 收起 << | Phase 2 | Recruiting | October 23, 2025 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00640796 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphocytic, Acute, T-Cell Juvenile Myelomonocytic Leukemia Lymphoblastic T-cell Lymphoblastic Lymphoma Myelodysplastic Syndrome 收起 << | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01810926 | Graft Versus Host Disease | Phase 2 | Unknown | October 2016 | Italy ... 展开 >> University of Cagliari Active, not recruiting Cagliari, Italy, 09126 San Raffaele Scientific Institute Active, not recruiting Milano, Italy, 20132 University of Milano-Bicocca San Gerardo Hospital Active, not recruiting Monza, Italy, 20052 Bambino Gesù Hospital and Research Institute Recruiting Rome, Italy, 00165 Contact: Maria Ester Bernardo, MD mebernardo@gmail.com Principal Investigator: Franco Locatelli 收起 << |
NCT01454596 | Malignant Glioma ... 展开 >> Glioblastoma Brain Cancer Gliosarcoma 收起 << | Phase 1 Phase 2 | Recruiting | December 28, 2029 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00948922 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 收起 << |
NCT02105116 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Not Applicable | Terminated(No patients were el... 展开 >>igible to receive the experimental component of the protocol therapy.) 收起 << | - | United States, New Jersey ... 展开 >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 << |
NCT03745326 | Gastrointestinal Cancer ... 展开 >> Pancreatic Cancer Gastric Cancer Colon Cancer Rectal Cancer 收起 << | Phase 1 Phase 2 | Recruiting | December 1, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00948922 | - | Active, not recruiting | - | - | |
NCT02062359 | Metastatic Cancer ... 展开 >> Metastatic Melanoma 收起 << | Phase 2 | Terminated(Study was closed du... 展开 >>e to poor accrual.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00782379 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT00782379 | - | Completed | - | - | |
NCT01028716 | Acute Biphenotypic Leukemia ... 展开 >> Acute Erythroid Leukemia in Remission Acute Leukemia in Remission Acute Megakaryoblastic Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Multilineage Dysplasia Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Myelodysplastic Syndrome Recurrent Anaplastic Large Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Acute Myeloid Leukemia T Lymphoblastic Lymphoma 收起 << | Phase 2 | Recruiting | - | United States, Washington ... 展开 >> VA Puget Sound Health Care System Not yet recruiting Seattle, Washington, United States, 98101 Contact: Thomas Chauncey 206-764-2969 thomas.chauncey@va.gov Principal Investigator: Thomas Chauncey Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit 206-667-1317 rsalit@fredhutch.org Principal Investigator: Rachel B. Salit 收起 << |
NCT02062359 | - | Terminated(Study was closed du... 展开 >>e to poor accrual.) 收起 << | - | - | |
NCT01814046 | Metastatic Ocular Melanoma ... 展开 >> Metastatic Uveal Melanoma 收起 << | Phase 2 | Terminated(Investigator left t... 展开 >>he National Institutes of Health (NIH)) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00897260 | Hematological Malignancy ... 展开 >> Bone Marrow Failure Syndrome 收起 << | Not Applicable | Completed | - | Canada, British Columbia ... 展开 >> Vancouver General Hospital, Leukemia/BMT Program of BC Vancouver, British Columbia, Canada, V5Z 1M9 收起 << |
NCT03121001 | Sickle Cell Disease | Phase 2 | Recruiting | October 28, 2026 | United States, Illinois ... 展开 >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD 312-413-3547 drond@uic.edu 收起 << |
NCT00305682 | Myeloproliferative Disorders ... 展开 >> Leukemia Lymphoma Myelodysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | June 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02410551 | Myeloproliferative Diseases | Phase 2 | Terminated | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02410551 | - | Terminated | - | - | |
NCT01814046 | - | Terminated(Investigator left t... 展开 >>he National Institutes of Health (NIH)) 收起 << | - | - | |
NCT00322101 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Acute Myeloid Leukemia/Transient Myeloproliferative Disorder Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes 收起 << | Phase 3 | Completed | - | United States, Colorado ... 展开 >> HealthOne Presbyterian St. Lukes Medical Center Denver, Colorado, United States United States, Georgia Emory University Altanta, Georgia, United States, 30322 United States, New York Weill Cornell University New York, New York, United States, 10021 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College Wisconsin Milwaukee, Wisconsin, United States Germany Technical University Dresden Dresden, Saxony, Germany, 01307 收起 << |
NCT01468818 | - | Terminated(Study was closed pr... 展开 >>ematurely due to slow and insufficient accrual.) 收起 << | - | - | |
NCT02917096 | Primary Myelofibrosis ... 展开 >> Secondary Myelofibrosis 收起 << | Not Applicable | Recruiting | October 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Haris Ali 626-256-4673 Principal Investigator: Haris Ali 收起 << |
NCT03448393 | Acute Lymphoid Leukemia ... 展开 >> B-Cell Leukemia Leukemia, Lymphocytic, B Cell B-Cell Lymphoma Lymphoma, Non-Hodgkin 收起 << | Phase 1 | Recruiting | December 1, 2032 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT03412409 | Acute Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | March 1, 2020 | China ... 展开 >> Peking University, Institute of Hematolgoy Recruiting Beijing, China Contact: Xiao-Dong Mo 收起 << |
NCT03466320 | AML MDS | Phase 1 | Recruiting | August 2021 | United States, Colorado ... 展开 >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 United States, New York New York School of Medicine Recruiting New York, New York, United States, 10016 Belgium Institute Jules Bordet Recruiting Brussels, Belgium UZ Gent Recruiting Gent, Belgium 收起 << |
NCT03412266 | Myelodysplastic Syndromes | Phase 2 | Recruiting | March 1, 2020 | China, Beijing ... 展开 >> Peking University Institute of Hematology,Beijing Recruiting Beijing, Beijing, China, 100044 Contact: Xiao-Dong Mo mxd453@163.com Principal Investigator: Xiao-Jun Huang, MD 收起 << |
NCT00509496 | Skin Cancer M... 展开 >>elanoma 收起 << | Phase 2 | Terminated(Low accrual) | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00322101 | - | Completed | - | - | |
NCT01468818 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Terminated(Study was closed pr... 展开 >>ematurely due to slow and insufficient accrual.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00509496 | - | Terminated(Low accrual) | - | - | |
NCT02830724 | Pancreatic Cancer ... 展开 >> Renal Cell Cancer Breast Cancer Melanoma Ovarian Cancer 收起 << | Phase 1 Phase 2 | Recruiting | January 1, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT02497404 | Leukemia, Erythroblastic, Acut... 展开 >>e Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | July 2021 | United States, New York ... 展开 >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN 212-746-2844 jeb9097@med.cornell.edu Principal Investigator: Sebastian Mayer, MD Sub-Investigator: Koen van Besien, MD Sub-Investigator: Tsiporah Shore, MD Sub-Investigator: Usama Gergis, MD Sub-Investigator: Adrienne Phillips, MD Sub-Investigator: Jingmei Hsu, MD Sub-Investigator: Joseph Scandura, MD 收起 << |
NCT00038857 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00781170 | Multiple Myeloma ... 展开 >> Stem Cell Transplantation 收起 << | Phase 2 | Completed | - | - |
NCT03538613 | Gastrointestinal Epithelial Ca... 展开 >>ncer Gastrointestinal Neoplasm Cancer of Gastrointestinal Tract Cancer, Gastrointestinal 收起 << | Phase 1 Phase 2 | Withdrawn(NCI not moving forwa... 展开 >>rd with study execution.) 收起 << | - | - |
NCT00188136 | Acute Myeloid Leukemia | Phase 2 | Completed | - | Germany ... 展开 >> University hospital Carl Gustav Carus Dresden, Germany, 01307 收起 << |
NCT03084380 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Not yet recruiting | May 31, 2020 | China, Chongqing ... 展开 >> Department of Oncology, Xinqiao Hospital ChongQing, Chongqing, China, 400037 收起 << |
NCT00054353 | - | Completed | - | - | |
NCT02111850 | Cervical Cancer ... 展开 >> Renal Cancer Urothelial Cancer Melanoma Breast Cancer 收起 << | Phase 1 Phase 2 | Recruiting | December 27, 2024 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00054353 | Refractory Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT00038857 | - | Completed | - | - | |
NCT02446964 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Complete Remission Acute Myeloid Leukemia in Remission Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Complete Remission 收起 << | Phase 1 | Active, not recruiting | November 2019 | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 收起 << |
NCT02443831 | Acute Lymphoblastic Leukemia ... 展开 >> Burkitt Lymphoma 收起 << | Phase 1 | Recruiting | December 2030 | United Kingdom ... 展开 >> Great Ormond Street Hospital Recruiting London, United Kingdom Contact: Prof. Persis Amrolia University College Hospital Recruiting London, United Kingdom Contact: Dr Rachael Hough Royal Manchester Infirmary Not yet recruiting Manchester, United Kingdom Contact: Eleni Tholouli Royal Manchester Royal Children's Hopsital (part of MRI) Recruiting Manchester, United Kingdom Contact: Dr Rob Wynn 收起 << |
NCT02876978 | Lung Squamous Cell Carcinoma | Phase 1 | Recruiting | April 2019 | China, Shanghai ... 展开 >> Shanghai Chest Hospital,Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200030 收起 << |
NCT00790413 | Neuroblastoma | Early Phase 1 | Active, not recruiting | - | Sweden ... 展开 >> Lund University Hospital, Department of Pediatric Oncology and Bone Marrow Transplantation Lund, Sweden, 221 85 收起 << |
NCT01967823 | Melanoma Meni... 展开 >>ngioma Breast Cancer Non-Small Cell Lung Cancer Hepatocellular Cancer 收起 << | Phase 2 | Recruiting | July 28, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00990496 | Glioblastoma Multiforme | Phase 1 | Terminated(Accrual goals not m... 展开 >>et) 收起 << | - | - |
NCT02472392 | EWINGS SARCOMA | Phase 1 | Completed | - | United States, Kentucky ... 展开 >> University of Louisville Louisville, Kentucky, United States, 40202 收起 << |
NCT03396575 | Diffuse Intrinsic Pontine Glio... 展开 >>ma (DIPG) 收起 << | Phase 1 | Recruiting | June 2022 | United States, Florida ... 展开 >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Contact: Marcia Hodik, RN 352-273-6971 marcia.hodik@neurosurgery.ufl.edu Principal Investigator: Sridharan Gururangan, FRCP University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 收起 << |
NCT01640301 | Recurrent Adult Acute Myeloid ... 展开 >>Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | October 1, 2030 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Daniel Egan 206-667-4971 degan@fredhutch.org Principal Investigator: Daniel Egan 收起 << |
NCT02215967 | Myeloma, Plasma-Cell ... 展开 >> Myeloma-Multiple 收起 << | Phase 1 | Active, not recruiting | October 31, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01457131 | Metastatic Cancer ... 展开 >> Metastatic Melanoma Metastatic Renal Cancer 收起 << | Phase 1 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01163201 | Hematologic Malignancy ... 展开 >> Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia in Blast Crisis Anemia, Refractory, With Excess of Blasts Chronic Myeloproliferative Disease Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Lymphoma Large Cell Non-Hodgkin's Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma High Grade Non-Hodgkin's Lymphoma 收起 << | Phase 1 Phase 2 | Withdrawn(Replaced by a new st... 展开 >>udy) 收起 << | January 2015 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55445 收起 << |
NCT00282412 | Rheumatoid Arthritis | Phase 1 | Terminated(No participant enro... 展开 >>lled for three years. No plan to continue study.) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT00282412 | - | Terminated(No participant enro... 展开 >>lled for three years. No plan to continue study.) 收起 << | - | - | |
NCT00593554 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia Myelodysplasia Chronic Myeloid Leukemia 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Indiana ... 展开 >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT02659943 | Lymphoma, B-Cell ... 展开 >> Lymphoma, Non-hodgkins 收起 << | Phase 1 | Active, not recruiting | December 1, 2021 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02988466 | Hematologic Malignancies | Phase 2 | Recruiting | January 2021 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski 612-273-2800 tkrepsk1@fairview.org 收起 << |
NCT00593554 | - | Terminated(Slow accrual) | - | - | |
NCT03093168 | Multiple Myeloma | Phase 1 | Recruiting | February 2020 | China, Henan ... 展开 >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D. +(86)-139-3852-6995 clinicaltrials.chengzhi@outlook.com 收起 << |
NCT02181478 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Myelofibrosis Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Lymphoid Malignancies Chronic Myelogenous Leukemia 收起 << | Early Phase 1 | Recruiting | November 2018 | United States, Ohio ... 展开 >> Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Leland Metheny, MD 216-983-4946 Leland.Metheny@uhhospitals.org Contact: Marcos de Lima, MD 216-286-6869 Marcos.deLima@uhhospitals.org Principal Investigator: Leland Metheny 收起 << |
NCT02685670 | Hematopoietic/Lymphoid Cancer ... 展开 >> Adult Acute Lymphoblastic Leukemia in Remission B-cell Adult Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Adult Diffuse Large Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | December 2019 | China, Henan ... 展开 >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D. 收起 << |
NCT02621021 | Melanoma | Phase 2 | Recruiting | June 16, 2026 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT01020539 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia 收起 << | Phase 1 | Active, not recruiting | March 2018 | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT03721068 | Neuroblastoma | Phase 1 | Not yet recruiting | April 1, 2036 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 收起 << |
NCT02653196 | Neuroepithelial Tumor ... 展开 >> Solid Tumor Allogeneic Hematopoietic Stem Cell Transplantation 收起 << | Early Phase 1 | Terminated(The Principal Inves... 展开 >>tigator left the institution.) 收起 << | - | United States, New York ... 展开 >> The Children's Hospital at Montefiore The Bronx, New York, United States, 10467 收起 << |
NCT00187096 | Acute Myeloid Leukemia | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00338377 | Melanoma | Phase 2 | Recruiting | February 2019 | United States, Texas ... 展开 >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Patrick Hwu, MD 713-792-2921 phwu@mdanderson.org Principal Investigator: Patrick Hwu, MD 收起 << |
NCT01045382 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute Leukemia, Myelocytic, Chronic Myeloproliferative Disorders Myelodysplastic Syndromes Multiple Myeloma Leukemia, Lymphocytic, Chronic Hodgkin's Disease Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Recruiting | July 2023 | Belgium ... 展开 >> UZA Recruiting Edeghem, Antwerpen, Belgium, 2650 Contact: Wilfried Schroyens, MD, PhD 32 382 204111 wilfried.schroyens@uza.be Principal Investigator: Wilfried Schroyens, MD, PhD St-Luc UCL Recruiting Brussels, Brabant, Belgium, 1200 Contact: Augustin Ferrant, MD, PhD 32 27641880 ferrant@sang.ul.ac.be Principal Investigator: Augustin Ferrant, MD, PhD AZ Gasthuisberg Leuven Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD 32- 16 33 22 11 johan.maertens@uz.kuleuven.ac.be Principal Investigator: Johan Maertens, MD UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD, PhD 32(09) 332 21 31 Lucien.Noens@Ugent.be Principal Investigator: Lucien Noens, MD, PhD Sub-Investigator: Tessa Kerre, MD, PhD AZ St-Jan Recruiting Brugge, Flanders West, Belgium, 8000 Contact: Dominik Selleslag, MD 00/32/50 453060 dominik.selleslag@azbrugge.be Principal Investigator: Dominik Selleslag, MD Cliniques Universitaires Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD 32(081)423831 carlos.graux@uclouvain.be Contact: Chantal Doyen, MD 32(081)423831 chantal.doyen@sang.ucl.ac.be Principal Investigator: Chantal Doyen, MD, PhD Sub-Investigator: Carlos Graux, MD, PhD Hôpital Stuyvenberg Recruiting Antwerpen, Belgium, 2060 Contact: Pierre Zachée, MD, PhD 32(03)2177111 pierre.zachee@zna.be Principal Investigator: Pierre Zachée, MD, PhD Bordet Institute Recruiting Brussels, Belgium, 1000 Contact: Philippe Lewalle, MD, PhD 00/32/2 5417208 plewalle@ulb.ac.be Contact: Dominique Bron, MD, PhD 00/32/ 2 5417208 bron@ulb.ac.be Principal Investigator: Philippe Lewalle, MD, PhD Sub-Investigator: Dominique Bron, MD, PhD Vrije Universiteit Brussel Recruiting Brussels, Belgium, 1050 Contact: Rik Schots, MD 00/32/2 4763105 Rik.Schots@uzbrussel.be Principal Investigator: Rik Schots, MD CHU-ULg Recruiting Liège, Belgium, 4000 Contact: Yves Beguin, MD, PhD 00/32/4 3667201 yves.beguin@chu.ulg.ac.be Contact: Frédéric Baron, MD, PhD 00/32/4 3667201 F.Baron@chu.ulg.ac.be Principal Investigator: Yves Beguin, MD, PhD Sub-Investigator: Frédéric Baron, MD, PhD Sub-Investigator: Chantal Lechanteur, PhD Sub-Investigator: Etienne Baudoux, MD Sub-Investigator: Evelyne Willems, MD 收起 << |
NCT03633773 | Intrahepatic Cholangiocarcinom... 展开 >>a 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2024 | China, Zhejiang ... 展开 >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Qi Zhang, MD 8613819137113 收起 << |
NCT00187096 | - | Completed | - | - | |
NCT00520130 | - | Active, not recruiting | - | - | |
NCT00909168 | Acute Myeloid Leukemia | Phase 2 Phase 3 | Completed | - | Italy ... 展开 >> University Hospital, Udine Udine, Italy, 33100 收起 << |
NCT00043979 | Sarcoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01063660 | Acute Myeloid Leukaemia | Phase 2 | Completed | - | Germany ... 展开 >> University of Rostock Rostock, Germany, 18057 收起 << |
NCT02761915 | Relapsed or Refractory Neurobl... 展开 >>astoma 收起 << | Phase 1 | Recruiting | February 2023 | United Kingdom ... 展开 >> University College London (UCL), Not yet recruiting London, United Kingdom, WC1E 6BT Contact: Person rachael.hough@uclh.nhs.uk; Principal Investigator: Rachel Hough, Dr Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) Recruiting London, United Kingdom, WC1N 3JH Contact: Person j.anderson@ucl.ac.uk Principal Investigator: John Anderson, Prof 收起 << |
NCT00004135 | Kidney Cancer ... 展开 >> Melanoma (Skin) 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 收起 << |
NCT02757885 | Sickle Cell Disease | Phase 2 | Recruiting | December 2020 | United States, Georgia ... 展开 >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30033 Contact: Lakshmanan Krishnamurti, MD 404-785-1441 lakshmanan.krishnamurti@emory.edu 收起 << |
NCT00520130 | Myelodysplastic Syndrome ... 展开 >> Hodgkin's Lymphoma Non-Hodgkin's Disease Acute Leukemia Multiple Myeloma 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00002833 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00043979 | - | Completed | - | - | |
NCT01598025 | Acute Leukemia ... 展开 >> Chronic Leukemia Myelodysplastic Syndrome Non-Hodgkins Lymphoma 收起 << | Not Applicable | Terminated(Closed due to poor ... 展开 >>accrual) 收起 << | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065-0009 收起 << |
NCT00002838 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02918292 | Severe Aplastic Anemia | Phase 2 | Recruiting | February 2022 | - |
NCT03367546 | Sickle Cell Disease ... 展开 >> Thalassemia High Risk Hematologic Disorders Cerebral Adrenoleukodystrophy Inherited Metabolic Disorders 收起 << | Phase 2 | Recruiting | November 2025 | United States, Minnesota ... 展开 >> Masonic Caner Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT00478244 | Epidermolysis Bullosa | Not Applicable | Terminated(Competing studies) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01176006 | DOCK8 Deficiency | Phase 2 | Recruiting | December 31, 2022 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 收起 << |
NCT00160355 | Wiskott-Aldrich Syndrome | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01598025 | - | Terminated(Closed due to poor ... 展开 >>accrual) 收起 << | - | - | |
NCT03263559 | Sickle Cell Disease | Phase 2 | Recruiting | December 2024 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Hilary Haines, MD hhaines@peds.uab.edu United States, California UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Mark C. Walters, MD 925-783-5070 mwalters@mail.cho.org United States, Florida University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 Contact: Lucien Black vblack@ufl.edu Nicklaus Children's Hospital/University of Miami Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Kamar Godder kamar.godder@nicklaushealth.org H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Michael L. Nieder, MD 813-745-2191 michael.nieder@moffitt.org United States, Georgia Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD 404-255-1930 msolh@bmtga.com United States, Missouri Washington University, St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy shalinishenoy@wustl.edu United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jennifer Krajewski jennifer.krajewski@hackensackmeridian.org United States, New York Northwell Health/Monter Cancer Center Recruiting Lake Success, New York, United States, 11042 Contact: Ruthee-Lu Bayer rbayer@northwell.edu United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Contact: Paul J. Shaughnessy, MD 210-575-6904 Paul.Shaughnessy@MHShealth.com 收起 << |
NCT00914940 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | December 2019 | United States, Connecticut ... 展开 >> Yale University School of Medicine/Yale New Haven Hospital New Haven, Connecticut, United States, 06520 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT02880293 | Hematologic Malignancy | Not Applicable | Recruiting | August 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD 212-639-2212 Principal Investigator: Brian Shaffer, MD 收起 << |
NCT01993719 | Metastatic Melanoma | Phase 2 | Recruiting | September 28, 2029 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00478244 | - | Terminated(Competing studies) | - | - | |
NCT02159495 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Acute Biphenotypic Leukemia Early Relapse of Acute Myeloid Leukemia Late Relapse of Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Blastic Plasmacytoid Dendritic Cell Neoplasm Acute Myeloid Leukemia Adult Acute Lymphoblastic Leukemia Interleukin-3 Receptor Subunit Alpha Positive Minimal Residual Disease Refractory Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Recruiting | December 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Lihua E. Budde 800-826-4673 ebudde@coh.org Principal Investigator: Lihua E. Budde 收起 << |
NCT01532700 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT03338972 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma TNFRSF17 Positive 收起 << | Phase 1 | Recruiting | December 15, 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA 206-606-4668 immunotherapy@seattlecca.org Principal Investigator: Damian J. Green 收起 << |
NCT00003553 | Kidney Cancer | Phase 2 | Unknown | - | United States, Maryland ... 展开 >> NIH - Warren Grant Magnuson Clinical Center Recruiting Bethesda, Maryland, United States, 20892-1182 Contact: Patient Recruitment 800-411-1222 收起 << |
NCT00536978 | - | Completed | - | - | |
NCT00874315 | Neuroblastoma | Phase 2 | Withdrawn(lack of accrual) | - | United States, Illinois ... 展开 >> Children's Memorial Hospital Chicago, Illinois, United States United States, New York Morgan Stanley Children's Hospital of NY New York, New York, United States United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Wisconsin Children's Hopsital of Wisconsin Milwaukee, Wisconsin, United States 收起 << |
NCT02057770 | Leukemia, Myeloid, Acute | Phase 1 | Terminated(Low accrual rate) | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT03302403 | B Cell Lymphoma ... 展开 >> B Cell Leukemia Myeloma Hepatocellular Carcinoma Pancreatic Carcinoma Adenocarcinoma of Esophagogastric Junction 收起 << | Not Applicable | Not yet recruiting | December 2020 | China, Zhejiang ... 展开 >> First Affiliated Hospital of Wenzhou Medical University Not yet recruiting Wenzhou, Zhejiang, China, 325000 Contact: Kang Yu, MD +86-13806681379 yukang62@126.com Principal Investigator: Mengtao Zhou, MD Principal Investigator: Kang Yu, MD Principal Investigator: Songfu Jiang, MD 收起 << |
NCT03277729 | CD20 Positive ... 展开 >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Transformed Indolent Non-Hodgkin Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | November 16, 2037 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mazyar Shadman 206-667-5467 mshadman@uw.edu Principal Investigator: Mazyar Shadman 收起 << |
NCT02828592 | Severe Aplastic Anemia | Phase 2 | Recruiting | April 2022 | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD 404-255-1930 msolh@bmtga.com Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD 404-255-1930 msolh@bmtga.com Contact: Stacey Brown 404-851-8238 stacey.brown@northside.com Sub-Investigator: Scott Solomon, MD Sub-Investigator: H. Kent Holland, MD Sub-Investigator: Asad Bashey, MD, PhD Sub-Investigator: Lawrence Morris, MD Principal Investigator: Melhem Solh, MD 收起 << |
NCT01144403 | - | Terminated | - | - | |
NCT01144403 | Diffuse Large B-Cell Lymphoma | Phase 2 | Terminated | - | Romania ... 展开 >> Brasov, Romania, 500326 Bucharest, Romania, 005098 Bucharest, Romania, 022328 Bucuresti, Romania, 030171 Cluj-Napoca, Romania, 400015 Iasi, Romania, 700111 Targu-mures, Romania, 540136 Timisoara, Romania, 300079 收起 << |
NCT00923390 | Renal Cancer ... 展开 >>Kidney Cancer 收起 << | Phase 1 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01905943 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT03711864 | Multiple Myeloma | Phase 1 | Recruiting | December 20, 2020 | China, Beijing ... 展开 >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Jian Li, M.D. +86-18610852525 lijian@pumch.cn Contact: Lu Zhang, M.D. +86-18610728815 pumczhanglu@163.com 收起 << |
NCT03765177 | Acute Lymphoblastic Leukemia ... 展开 >> Non-Hodgkin's Lymphoma 收起 << | Phase 1 Phase 2 | Not yet recruiting | March 31, 2022 | - |
NCT01905943 | - | Completed | - | - | |
NCT00536978 | Lymphoma Leuk... 展开 >>emia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01758328 | Multiple Myeloma | Phase 1 | Active, not recruiting | December 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT03019666 | Multiple Myeloma ... 展开 >> Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Mantle-Cell Lymphoma Follicular Lymphoma Indolent B Cell Lymphoma Primary Mediastinal Lymphoma Lymphoplasmacytic Lymphoma 收起 << | Phase 1 | Recruiting | March 31, 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Veronika Bachanova, MD, PhD 收起 << |
NCT00058825 | Hematologic Malignancies | Phase 1 Phase 2 | Terminated(Slow accrual due to... 展开 >> practice changes meant study would take too long to finish) 收起 << | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT02845999 | Gastrointestinal Metastatic Ca... 展开 >>ncer 收起 << | Phase 1 | Completed | - | France ... 展开 >> University hospital of Besançon Besançon, France, 25000 收起 << |
NCT00067002 | Leukemia, Lymphocytic, Acute ... 展开 >> Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 770030 收起 << |
NCT00058825 | - | Terminated(Slow accrual due to... 展开 >> practice changes meant study would take too long to finish) 收起 << | - | - | |
NCT00053989 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT01369888 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 1 Phase 2 | Terminated(Closed this protoco... 展开 >>l due to autoimmune toxicity.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01369888 | - | Terminated(Closed this protoco... 展开 >>l due to autoimmune toxicity.) 收起 << | - | - | |
NCT00634881 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Germany ... 展开 >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany, 16225 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69115 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 收起 << |
NCT01759732 | Acquired Aplastic Anemia | Phase 2 | Unknown | December 2015 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD, PhD 82-2-3010-3371 hojim@amc.seoul.kr Sub-Investigator: Kyung Nam Koh, MD, PhD 收起 << |
NCT00108108 | Chronic Lymphocytic Leukemia | Phase 1 | Terminated(Slow enrollment and... 展开 >> minimal preliminary biological and clinical efficacy.) 收起 << | - | United States, California ... 展开 >> University of California San Diego StudyCoordinator:CHCD122A2101 La Jolla, California, United States, 92093-0658 United States, Indiana St. Francis Cancer Research Foundation Beech Grove, Indiana, United States, 46107 United States, Maryland The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Div Of HematologicMalignancies Baltimore, Maryland, United States, 21231 United States, Ohio OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 Columbus, Ohio, United States, 43210 United States, Texas MD Anderson Cancer Center/University of Texas Dept of MD Anderson CancerCent Houston, Texas, United States, 77030-4009 收起 << |
NCT00608517 | - | Terminated(slow accrual) | - | - | |
NCT00825149 | Non-Hodgkin's Lymphoma | Phase 1 | Completed | - | - |
NCT00513604 | Melanoma Mali... 展开 >>gnant Melanoma Melanoma, Experimental Experimental Melanomas 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01181258 | Non-Hodgkin Lymphoma ... 展开 >> Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01181258 | - | Completed | - | - | |
NCT02644655 | Recurrent B-Cell Tumor ... 展开 >> Refractory B-Cell Tumor 收起 << | Phase 1 Phase 2 | Unknown | September 2017 | China ... 展开 >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, China, 200438 Contact: Huajun Jin, PHD +86-21-81875372 hj-jin@hotmail.com Principal Investigator: Qijun Qian, PHD Principal Investigator: Huajun Jin, PHD Principal Investigator: Zhengang Yuan, PHD Sub-Investigator: Yao Huang, MD Sub-Investigator: Fuping Zhou, MD Sub-Investigator: Yongmei Ding, MD 收起 << |
NCT02722668 | Acute Leukemia ... 展开 >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia/Lymphoma Burkitt's Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndrome Large-cell Lymphoma Hodgkin Lymphoma Multiple Myeloma Relapsed Chronic Lymphocytic Leukemia Relapsed Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-cell Lymphoma Prolymphocytic Leukemia Bone Marrow Failure Syndromes Myeloproliferative Neoplasms/Myelofibrosis Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Leukemia or MDS in Aplasia Relapsed T-Cell Lymphoma Relapsed Multiple Myeloma Plasma Cell Leukemia 收起 << | Phase 2 | Recruiting | December 2029 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD 612-625-3918 bruns072@umn.edu 收起 << |
NCT00608517 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Not Applicable | Terminated(slow accrual) | - | United States, Tennessee ... 展开 >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37067-1631 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37067-5615 Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 收起 << |
NCT00513604 | - | Completed | - | - | |
NCT03594162 | - | - | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 收起 << | |
NCT00186966 | Acute Myeloid Leukemia | Phase 3 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00589563 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT01585415 | Metastatic Cancer ... 展开 >> Melanoma 收起 << | Phase 1 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00708721 | Cancer Chroni... 展开 >>c Myelomonocytic Leukemia 收起 << | Phase 1 Phase 2 | Terminated(Data analysis revea... 展开 >>led sufficient data for safety and efficacy) 收起 << | - | United States, Utah ... 展开 >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 收起 << |
NCT00589563 | - | Completed | - | - | |
NCT02722135 | Leukemia, Myeloid, Acute | Phase 1 | Withdrawn | September 2018 | Belgium ... 展开 >> Boehringer Ingelheim Investigational Site Gent, Belgium 收起 << |
NCT00708721 | - | Terminated(Data analysis revea... 展开 >>led sufficient data for safety and efficacy) 收起 << | - | - | |
NCT02167958 | Leukemia MDS ... 展开 >> Myelofibrosis Lymphoma 收起 << | Phase 1 | Recruiting | July 2020 | United States, Pennsylvania ... 展开 >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN 412-647-8571 Johnsonr1@upmc.edu Sub-Investigator: Annie P Im, MD Sub-Investigator: Alison R Sehgal, MD Sub-Investigator: Mounzer E Agha, MD Sub-Investigator: Jing-Zhou Hou, MD Sub-Investigator: Mounzer Agha, MD Sub-Investigator: Kathleen Dorritie, MD Sub-Investigator: Anastasios Raptis, MD 收起 << |
NCT02375984 | Metastatic Melanoma | Phase 2 | Terminated(PI changed institut... 展开 >>ions) 收起 << | - | United States, California ... 展开 >> John Wayne Cancer Institute Santa Monica, California, United States, 90404 收起 << |
NCT00491634 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | Israel ... 展开 >> Chaim Sheba Medical Center Tel-Hashomer, Israel 收起 << |
NCT03330834 | Advanced Lung Cancer | Phase 1 | Not yet recruiting | September 30, 2019 | - |
NCT00487448 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloblastic Leukemia 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Hospital de la Ribera Alzira, Spain Hospital Germans Trias i Pujol Badalona, Spain Hospital del Mar Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Puerta del Mar Cadiz, Spain Hospital del SAS Jerez de la Frontera, Spain Hospital de Leon Leon, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Dr. Pesset Valencia, Spain Hospital Universitario La Fe Valencia, Spain 收起 << |
NCT01904136 | Leukemia Myel... 展开 >>oproliferative Diseases 收起 << | Phase 1 Phase 2 | Recruiting | April 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01495572 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Terminated(Due to slow accrual... 展开 >>, the investigator decided to close the study.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01495572 | - | Terminated(Due to slow accrual... 展开 >>, the investigator decided to close the study.) 收起 << | - | - | |
NCT00021151 | Leukemia | Not Applicable | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT00849745 | Systemic Lupus Erythematosus ... 展开 >> Systemic Sclerosis 收起 << | Phase 1 | Terminated(low accrual) | - | United States, North Carolina ... 展开 >> Duke University Health System Durham, North Carolina, United States, 27705 收起 << |
NCT00004145 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 收起 << |
NCT00352976 | Fanconi Anemia | Phase 2 Phase 3 | Recruiting | December 2018 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Margaret L MacMillan, M.D. 612-626-2778 macmi002@umn.edu 收起 << |
NCT01153971 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia Pescara, Abruzzo, Italy, 65100 Ospedale Civile; Divisione Di Oncologia Pescara, Abruzzo, Italy, 65124 Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia Rionero in Vulture, Basilicata, Italy, 85028 Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy, 89100 A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica Modena, Emilia-Romagna, Italy, 41100 Az. Osp. Arcispedale S. Maria Nuova; U.O. Di Ematologia Reggio Emilia, Emilia-Romagna, Italy, 42100 Universita' Degli Studi La Sapienza-Ist.Di Ematologia;Dip. Biotecnologie Cel CELLULARI ED EMATOLOGIA Roma, Lazio, Italy, 00161 A.O. Spedali Civili Di Brescia-P.O. Spedali Civili;U.O. Ematologia Brescia, Lombardia, Italy, 25123 Ospedale Maggiore Di Milano; U.O. Ematologia I - Padiglione Marcora Milano, Lombardia, Italy, 20122 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Az. Osp. S. Croce Ospedale Generale; Sezione Di Ematologia Cuneo, Piemonte, Italy, 12100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1 Torino, Piemonte, Italy, 10126 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 Az. Osp. Di Careggi; Divisione Di Ematologia Firenze, Toscana, Italy, 50135 收起 << |
NCT01153971 | - | Completed | - | - | |
NCT00412360 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Natural Killer Cell Lymphoblastic Leukemia/Lymphoma 收起 << | Phase 3 | Completed | - | - |
NCT00179790 | Leukemia Canc... 展开 >>er 收起 << | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60625 收起 << |
NCT00412360 | - | Completed | - | - | |
NCT03215810 | Non-Small Cell Lung Cancer ... 展开 >> Metastatic Non-small Cell Lung Cancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas 收起 << | Phase 1 | Recruiting | March 2021 | United States, Florida ... 展开 >> University of Florida Health Cancer Center. Not yet recruiting Gainesville, Florida, United States, 32608 H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Ben Creelan, M.D. 813-745-3050 thoraciccro@moffitt.org Principal Investigator: Ben Creelan, M.D. Sub-Investigator: Scott Antonia, M.D., Ph.D. Sub-Investigator: Alberto Chiappori, M.D. Sub-Investigator: Jhanelle Gray, M.D. Sub-Investigator: Eric Haura, M.D. Sub-Investigator: Amod Sarnaik, M.D. Sub-Investigator: Tawee Tanvetyanon, M.D. 收起 << |
NCT00278213 | Prolymphocytic Leukemia | Phase 2 | Completed | - | Austria ... 展开 >> Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria, A-1090 Hanuschkrankenhaus Vienna, Austria, A-1140 Germany Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany, 29223 St. Johannes Hospital - Medical Klinik II Duisburg, Germany, D-47166 Helios Klinikum Erfurt Erfurt, Germany, D-99089 Universitaetsklinikum Essen Essen, Germany, D-45147 Klinikum Garmisch - Partenkirchen GmbH Garmisch-Partenkirchen, Germany, N 82467 Sana Klinikum Hof Hof, Germany, 95032 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24116 Internistische Praxis - Ludwigsburg Ludwigsburg, Germany, 71638 Sana Kliniken Luebeck Luebeck, Germany, D-23560 Haematologische Praxis - Moenchengladbach Moenchengladbach, Germany, 41239 Gemeinschaftliche Schwerpunktpraxis - Osnabrueck Osnabrueck, Germany, 49074 Caritasklinik St. Theresia Saarbrucken, Germany, D-66113 Schwerpunktpraxis fuer Haematologie und Onkologie Saarbruecken, Germany, 66113 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 Klinikum des Landkreises Loebau-Zittau GmbH Zittau, Germany, 02763 收起 << |
NCT02440464 | Multiple Myeloma | Phase 2 | Active, not recruiting | March 2023 | United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 BMT Northside Atlanta, Georgia, United States, 30342 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Texas University of Texas /MD Anderson CRC Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 United States, Wisconsin University of Wisconsin Hospital & Clinics Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 收起 << |
NCT03475134 | Metastatic Melanoma | Phase 1 | Recruiting | June 1, 2024 | Switzerland ... 展开 >> CHUV Oncology Department Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: George Coukos +41213140627 george.coukos@chuv.ch 收起 << |
NCT02799147 | Leukemia, Acute Lymphoblastic ... 展开 >> Acute Myeloid Leukemia Mixed-Lineage Acute Leukemias 收起 << | Phase 1 Phase 2 | Recruiting | June 2020 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, PhD +79217961951 moisiv@mail.ru Contact: Olga A. Slesarchuk, PhD +79111910003 olga.slesarchuk@gmail.com Sub-Investigator: Olga V. Pirogova, M.S. 收起 << |
NCT02548468 | Cutaneous T-Cell Non-Hodgkin L... 展开 >>ymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Stage IIB Mycosis Fungoides and Sezary Syndrome Stage IIIA Mycosis Fungoides and Sezary Syndrome Stage IIIB Mycosis Fungoides and Sezary Syndrome Stage IVA Mycosis Fungoides and Sezary Syndrome Stage IVB Mycosis Fungoides and Sezary Syndrome 收起 << | Phase 1 | Withdrawn(Slow accrual) | - | - |
NCT00186797 | Aplastic Anemia | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00578292 | Thalassemia | Not Applicable | Terminated(Over the course of ... 展开 >>this study stem cell transplant was determined to be standard of care for this disease and as such the study is no longer relevant.) 收起 << | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02435901 | Sickle Cell Disease ... 展开 >> Beta Thalassemia-Major 收起 << | Phase 1 Phase 2 | Completed | - | United States, New York ... 展开 >> Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 收起 << |
NCT00931645 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | France ... 展开 >> DBIM Hopital Saint Louis Paris, France, 75000 收起 << |
NCT01564784 | Acute Lymphoblastic Leukemia | Phase 3 | Completed | - | - |
NCT01564784 | - | Completed | - | - | |
NCT00301860 | Leukemia Lymp... 展开 >>homa 收起 << | Not Applicable | Terminated(lack of efficacy) | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00017108 | Leukemia | Phase 3 | Unknown | - | Belgium ... 展开 >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 Czech Republic University Hospital - Olomouc Olomouc, Czech Republic, 775 20 Hungary County Hospital Kaposvar, Hungary, H-7400 Italy Azienda Ospedaliera Papardo Messina, Italy Ospedale Sant' Eugenio Rome, Italy, 00144 Macedonia, The Former Yugoslav Republic of Clinical Center Skopje Skopje, Macedonia, The Former Yugoslav Republic of, 91000 Netherlands Leyenburg Ziekenhuis 's-Gravenhage, Netherlands, 2545 CH Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Portugal Hospital Escolar San Joao Porto, Portugal, 4200 收起 << |
NCT03622788 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Aplastic Anemia Bone Marrow Failure Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Follicular Lymphoma Hematopoietic Cell Transplantation Recipient Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Near Complete Response of Multiple Myeloma or Plasma Cell Leukemia Non-Hodgkin Lymphoma Partial Response of Multiple Myeloma or Plasma Cell Leukemia Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Not yet recruiting | April 1, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Richard E. Champlin 713-792-8750 Principal Investigator: Richard E. Champlin 收起 << |
NCT01773395 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia 收起 << | Phase 2 | Recruiting | January 2033 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Yi-Bin Chen, MD 617-726-5765 YCHEN6@partners.org Principal Investigator: Yi-Bin Chen, MD Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD 617-632-5938 vtho@partners.org Principal Investigator: Vincent Ho, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD 617-632-5938 vtho@partners.org Principal Investigator: Vincent Ho, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacalyn Rosenblatt, MD 617-667-9920 jrosenb1@bidmc.harvard.edu Principal Investigator: Jacalyn Rosenblatt, MD 收起 << |
NCT00053196 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 收起 << |
NCT01597219 | Hodgkin's Lymphoma ... 展开 >> Non-Hodgkin's Lymphoma Acute Myeloid Leukaemia Acute Lymphoblastic Leukaemia Myelodysplastic Syndrome Chronic Myeloid Leukaemia Chronic Lymphocytic Leukaemia Acquired Bone Marrow Failure Syndromes Other Haematological Malignancies; Unrelated HSCT Indicated 收起 << | Phase 2 | Recruiting | March 2020 | United Kingdom ... 展开 >> Birmingham Heartlands Recruiting Birmingham, United Kingdom Contact: Dr Shankara Paneesha Bristol Royal Infirmary Recruiting Bristol, United Kingdom Principal Investigator: Dr Rachel Protheroe Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Dr Ben Uttenthal Beatson Hospital Recruiting Glasgow, United Kingdom Principal Investigator: Dr Dave Irvine St James' University Hospital Recruiting Leeds, United Kingdom Principal Investigator: Dr Maria Gilleece Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Dr Rahuman Salim King's College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Kavita Raj St Bartholomew's Hospital Active, not recruiting London, United Kingdom University College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Panagiotis Kottaridis Manchester Royal Infirmary Recruiting Manchester, United Kingdom Principal Investigator: Dr Eleni Tholouli Freeman Hospital Recruiting Newcastle, United Kingdom Principal Investigator: Prof Matthew Colin Royal Hallamshire, Sheffield & Weston Park Recruiting Sheffield, United Kingdom Principal Investigator: Prof John Snowden 收起 << |
NCT03171831 | Thalassemia Major | Phase 4 | Recruiting | April 1, 2022 | China, Guangxi ... 展开 >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 510515 Contact: Yongrong Lai, MD +86(0771)5356510 laiyongrong@hotmail.com 收起 << |
NCT03591510 | FLT3-mutated Acute Myeloid Leu... 展开 >>kemia 收起 << | Phase 2 | Not yet recruiting | April 21, 2025 | Korea, Republic of ... 展开 >> Novartis Investigative Site Seoul, Korea, Republic of, 03080 收起 << |
NCT01707004 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT03500731 | Idiopathic Pulmonary Fibrosis ... 展开 >> Emphysema or COPD 收起 << | Phase 1 Phase 2 | Recruiting | December 2026 | United States, Pennsylvania ... 展开 >> UPMC Presbyterian Recruiting Pittsburgh, Pennsylvania, United States, 15214 Contact: John McDyer, MD 412-648-6161 mcdyerjf@upmc.edu Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jason Rowan, RN 412-692-6195 jason.rowan@chp.edu Principal Investigator: Paul Szabolcs, MD 收起 << |
NCT02127892 | - | Terminated(Closed due to slow ... 展开 >>accrual. Nine subjects enrolled over 7 years.) 收起 << | - | - | |
NCT03152526 | Acute Myelogenous Leukemia | Not Applicable | Recruiting | June 2022 | United States, Illinois ... 展开 >> Universtiy of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Preeti Karmali 773-702-9440 pkarmali@medicine.bsd.uchicago.edu Principal Investigator: Satyajit Kosuri, MD United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Erica Orcholski 612-626-5174 eorchols@umn.edu Principal Investigator: Sarah Cooley, MD 收起 << |
NCT02127892 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 1 Phase 2 | Terminated(Closed due to slow ... 展开 >>accrual. Nine subjects enrolled over 7 years.) 收起 << | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 收起 << |
NCT02349906 | Primary Immunodeficiencies ... 展开 >> Inborn Errors of Metabolism Haemoglobinopathies Bone Marrow Failure Syndromes 收起 << | Phase 2 | Recruiting | December 2019 | Austria ... 展开 >> St. Anna Children's Hospital Withdrawn Vienna, Austria, 1090 Czechia University Hospital Motol, Dep. of Paediatric Haematology and Oncology Recruiting Prague, Czechia Contact: Petr Sedlacek, MD, Prof. +42060672 ext 6550 Germany Department of Pediatric Oncology & Hematology, Charite Berlin Not yet recruiting Berlin, Germany, 13353 Contact: Johannes Schulte, MD, Prof. Duesseldorf University Hospital Withdrawn Duesseldorf, Germany, 40225 University Children's Hospital Essen Pediatric stem cell transplantation Not yet recruiting Essen, Germany, 45122 Contact: Rita Beier, MD University Hospital Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Peter Bader, MD, Prof. University Medical Center Hamburg-Eppendorf Withdrawn Hamburg, Germany, 20246 Hannover Medical University, Dep. of Paediatrics, Paediatric Haematology and Oncology Recruiting Hannover, Germany Contact: Karl-Walter Sykora, MD, Prof. +49(0)511532 ext 5830 Heidelberg University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Johann Greil, MD, Prof. University of Jena, Department of Pediatrics Not yet recruiting Jena, Germany, 07747 Contact: Bernd Gruhn, MD, Prof. University Hospital Regensburg Withdrawn Regensburg, Germany, 93053 Ulm, University Hospital, Clinic for Children and Adolescents Recruiting Ulm, Germany, 89075 Contact: Ansgar Schulz, MD, Prof. +49(0)731500 ext 57154 University Hospital of Wuerzburg Withdrawn Wuerzburg, Germany, 97080 Italy SC Oncoematologia Pediatrica Ospedale Pediatrico Microcitemico "Antonio Cao" A.O. Brotzu Not yet recruiting Cagliari, Italy, 09121 Contact: Maria Grazia Orofino, MD UOC Ematologia ed Oncologia Pediatrica con TMO AOU Policlinico Vittorio Emanuele Not yet recruiting Catania, Italy, 95123 Contact: Giovanna Russo, MD Reparto Trapianti Midollo Osseo Clinica Pediatrica Universitaria Fondazione MBBM-Ospedale San Gerardo Not yet recruiting Monza, Italy, 20900 Contact: Sonia Bonanomi, MD S.C. Oncoematologia Pediatrica Fondazione IRCCS Policlinico San Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Marco Zecca, MD Oncoematologia Pediatrica A.O. di Perugia Ospedale S. Maria della Misericordia Not yet recruiting Perugia, Italy, 06156 Contact: Maurizio Caniglia, MD U.O. Oncoematologia Pediatrica Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara Not yet recruiting Pisa, Italy, 56100 Contact: Mariacristina Menconi, MD Ospedale Bambino Gesu Roma Recruiting Rome, Italy, 00165 Contact: Franco Locatelli, MD, Prof. Ospedale Infantile Regina Margherita Torino Recruiting Turin, Italy, 10126 Contact: Franca Fagioli, MD, Prof. U.O.C. Oncoematologia Pediatrica Policlinico "G.B. Rossi" - AOUI Verona Recruiting Verona, Italy, 37134 Contact: Simone Cesaro, MD Poland Szpital Uniwersytecki im. dr Antoniego Jurasza Recruiting Bydgoszcz, Poland, 85-094 Contact: Jan Styczynski, MD, Prof Uniwersytecki Szpital Dzieciecy w Krakowie Recruiting Krakow, Poland, 30-663 Contact: Jolanta Gozdzik, MD Dzieciecy Szpital Kliniczny im. A. Gebali w Lublinie Not yet recruiting Lublin, Poland, 20-093 Contact: Katarzyna Drabko, MD Wroclaw Medical University, Department of Pediatric Hematology/Oncology and BMT Recruiting Wroclaw, Poland, 50-368 Contact: Krzysztof Kałwak, MD, PhD, Prof. (48)-71 ext 7703170 收起 << |
NCT02858310 | Papillomavirus Infections ... 展开 >> Cervical Intraepithelial Neoplasia Carcinoma In Situ Vulvar Neoplasms Vulvar Diseases 收起 << | Phase 1 Phase 2 | Recruiting | January 1, 2026 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT01370213 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | January 2019 | United States, Georgia ... 展开 >> Emory University Atlanta, Georgia, United States, 30322 United States, Minnesota University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT00393029 | - | Completed | - | - | |
NCT00598624 | Leukemia Chro... 展开 >>nic Myeloid Leukemia Myelodysplastic Syndrome Diffuse Large Cell Lymphoma Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma 收起 << | Phase 2 | Unknown | December 2010 | Italy ... 展开 >> Ematologia, Ospedale Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Foggia, Italy Contact: Angelo Michele Carella, MD am.carella@operapadrepio.it Contact: Marzia Tricarico, DM m.tricarico@operapadrepio.it Principal Investigator: Nicola Cascavilla, MD IRCCS San Raffaele; Unità Operativa di Ematologia Recruiting Milano, MI, Italy, 20100 Contact: Alessandro Crotta, MD +39 0226433903 a.crotta@hsr.it Contact: Stefania Trinca +39 0226434289 stefania.trinca@hsr.it Principal Investigator: Jacopo Peccatori, MD USC Ematologia, Ospedali Riuniti Recruiting Bergamo, Italy Contact: Anna Grassi, MD agrassi@ospedaliriuniti.bergamo.it Contact: Maria Luisa Ferrari, DM mlferrari@ospedaliriuniti.bergamo.it Principal Investigator: Alessandro Rambaldi, MD Ospedale centrale di Bolzano - Reparto di Ematologia Recruiting Bolzano, Italy Contact: Enrico Morello, MD +390471908807 enrico.morello@asbz.it Principal Investigator: Enrico Morello, MD PO "R.Binaghi" - CTMO Recruiting Cagliari, Italy Contact: Adriana Vacca, MD +393285452813 vaadriana@tiscali.it Principal Investigator: Giorgio La Nasa, MD AO "Santa Croce" e Carle - Reparto di Ematologia Recruiting Cuneo, Italy Contact: Laura Bertolotti, Data Manager +390171642229 laura.bertolotti@libero.it Principal Investigator: Andrea Gallamini, MD Istituto Europeo di Oncologia - Divisione di Ematologia Recruiting Milano, Italy Contact: Liliana Calabrese, Data Manager +390257489536 liliana.calabrese@ieo.it Principal Investigator: Giovanni Martinelli, MD Ospedale Civile - UTI ematologia per il trapianto emopoietico Recruiting Pescara, Italy Contact: Paolo Di Bartolomei, MD pescaratmo@virgilio.it Principal Investigator: Paolo Di Bartolomei, MD Arcispedale Santa Maria Nuova - SC di Ematologia Recruiting Reggio Emilia, Italy Contact: Alessandro Bonini, MD bonini.alessandro@asmn.re.it Principal Investigator: Luigi Gugliotta, MD Dipartimento Biotecnologie Cellulari ed Ematologia; Azienda Policlinico Umberto I Recruiting Roma, Italy, 00100 Contact: Emilia Iannella, MD +39 3202233365 emiliaiannella@libero.it Contact: Roberto Ricci +39 3477578735 r.ricci@bce.uniroma1.it Principal Investigator: Roberto Foa, MD AO San Camillo Forlanini - UOC ematologia e trapianto Recruiting Roma, Italy Contact: Beatrice Pinazzi, MD mpinazzi@scamilloforlanini.rm.it Principal Investigator: Ignazio Majolino, MD AOU Santa Maria della Misericordia - Clinica Ematologica Recruiting Udine, Italy Contact: Francesca Patriarca, MD patriarca.francesca@aoud.sanita.fvg.it Principal Investigator: Michela Cerno, MD 收起 << |
NCT00003620 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 收起 << |
NCT03653338 | Sickle Cell Anemia ... 展开 >> Beta-thalassemia Major Diamond-blackfan Anemia 收起 << | Phase 1 Phase 2 | Recruiting | August 1, 2025 | United States, Pennsylvania ... 展开 >> Children's Hosptial of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Principal Investigator: Beth Carella, DO 收起 << |
NCT02278887 | Metastatic Melanoma | Phase 3 | Recruiting | September 2020 | Denmark ... 展开 >> CCIT Department of Oncology and Haematology Herlev Hospital Recruiting Copenhagen, Denmark Contact: Inge Marie Svane, Prof. Inge.Marie.Svane@regionh.dk Contact: Troels H. Borch troels.holz.borch@regionh.dk Principal Investigator: Inge Marie Svane, Prof. Netherlands Netherlands Cancer Institute Recruiting Amsterdam, NH, Netherlands, 1066CX Contact: Maartje Rohaan +31205126186 m.rohaan@nki.nl Principal Investigator: John B.A.G. Haanen, Prof. 收起 << |
NCT01062490 | Myelodysplastic Syndrome | Phase 2 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital Helsinki, Finland, 00029 收起 << |
NCT02461121 | Acute Myeloid Leukemia | Phase 3 | Completed | - | China, Beijing ... 展开 >> Affiliated Hospital of Academy of Military Medical Sciences , Beijing, Beijing, China, 100071 收起 << |
NCT00393029 | Anti-p53 TCR-Gene | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Bethesda, Maryland, United States, 20892 收起 << |
NCT01050439 | Leukemia Lymp... 展开 >>homa Bone Marrow Failure Syndromes Immunodeficiencies Histiocytosis 收起 << | Phase 2 | Terminated(PI left the institu... 展开 >>tion) 收起 << | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00704938 | Kidney Cancer ... 展开 >> Melanoma (Skin) Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 2 | Terminated(Terminated due to w... 展开 >>ithdrawal of support from our collaborator.) 收起 << | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 收起 << |
NCT00704938 | - | Terminated(Terminated due to w... 展开 >>ithdrawal of support from our collaborator.) 收起 << | - | - | |
NCT00001830 | Chronic Lymphocytic Leukemia ... 展开 >> Graft vs Host Disease Hodgkin's Disease Multiple Myeloma Non Hodgkin's Lymphoma 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01719341 | - | Unknown | - | Singapore ... 展开 >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Zi Yi Lim, MB ChB 65 6779 5555 Zi_Yi_Lim@nuhs.edu.sg Principal Investigator: Zi Yi Lim, MB ChB 收起 << | |
NCT00006413 | Mastocytosis | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00686556 | Acute Lymphoblastic Leukemia ... 展开 >> Myelodysplastic Syndrome Multiple Myeloma 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00006379 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Small Intestine Cancer 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT03455517 | Chronic Myeloid Leukemia | Phase 2 | Not yet recruiting | March 2021 | - |
NCT03642626 | Acute Lymphoblastic Leukemia ... 展开 >> Large B-cell Lymphoma 收起 << | Phase 2 | Not yet recruiting | July 2028 | - |
NCT03257241 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 31, 2020 | Poland ... 展开 >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof. Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof. +48426895191 agawierzbowska@wp.pl 收起 << |
NCT00001765 | Chronic Granulomatous Disease | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT02660281 | Hematological Disease ... 展开 >> Immune Deficiencies Solid Tumors Myelofibrosis Multiple Myeloma Lymphoma 收起 << | Phase 1 | Recruiting | October 2026 | United States, New York ... 展开 >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jeffrey Andolina, MD 585-275-2981 jeffrey_andolina@urmc.rochester.edu Contact: Jessica Mavor 585-275-9680 jessica_mavor@urmc.rochester.edu 收起 << |
NCT00005785 | Hematologic Neoplasm ... 展开 >> HIV Infection 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 收起 << |
NCT00003552 | Stage IV Melanoma ... 展开 >> Recurrent Melanoma 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Maryland ... 展开 >> National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 收起 << |
NCT00281879 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood 收起 << | Phase 2 | Terminated | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT00031005 | Leukocyte-Adhesion Deficiency ... 展开 >>Syndrome 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT00353860 | Immunosuppression ... 展开 >> Leukemia 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03720457 | CD19-positive ... 展开 >> Diffuse Large B-cell Lymphoma Follicular Lymphoma 收起 << | Phase 1 | Recruiting | October 2023 | China, Shanghai ... 展开 >> Fudan University Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Peng Liu, Professor 021-60267405 Liu.peng@zs-hospital.sh.cn 收起 << |
NCT00006417 | Chronic Granulomatous Disease | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT01244451 | Patients With CLL Relapsing Af... 展开 >>ter an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines 收起 << | Phase 2 | Completed | - | Italy ... 展开 >> Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy Azienda ASL di Cagliari Cagliari, Italy, 9121 U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Campobasso, Italy Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza Cosenza, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Policlinico di Careggi, Università delgi studi di Firenze Firenze, Italy Clinica Ematologica - Università degli Studi Genova, Italy ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia Lecce, Italy, 73100 Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Messina Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy Unità Trapianto di Midollo Ist. Nazionale Tumori Milano, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Ospedale San Gennaro - ASL Napoli 1 Napoli, Italy, 80143 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Dipartimento Emato-Oncologia A.O. "Bianchi-Melacrino-Morelli" Reggio Calabria, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Università degli studi di Roma La Cattolica Roma, Italy Ospedale S.Eugenio Rome, Italy, 00144 Ospedale Casa Sollievo della sofferenza San Giovanni Rotondo, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Div. di Ematologia "Molinette" Osp. Maggiore S. G. Battista Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Policlinico G.B. Rossi Verona, Italy, 37134 收起 << |
NCT00763490 | Hematological Malignancies | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00079391 | Hematologic Malignancies ... 展开 >> Bone Marrow Transplant Rejection 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00763490 | - | Completed | - | - | |
NCT00079391 | - | Completed | - | - | |
NCT01174121 | Metastatic Colorectal Cancer ... 展开 >> Metastatic Gastric Cancer Metastatic Pancreatic Cancer Metastatic Hepatocellular Carcinoma Progressive Glioblastoma Metastatic Ovarian Cancer Metastatic Breast Cancer 收起 << | Phase 2 | Recruiting | December 27, 2024 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center 866-820-4505 irc@nih.gov 收起 << |
NCT00086203 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 United States, Florida Ocala Oncology Center Ocala, Florida, United States, 34474 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Indiana Indiana Oncology/Hematology Consultants Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Montana Hematology/Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Queens Medical Associates, PC Fresh Meadows, New York, United States, 11365 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 NYU Medical Center New York, New York, United States, 10016 James P. Wilmot Cancer Center/University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Raleigh Hematology/Oncology Clinic Cary, North Carolina, United States, 27511 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Oklahoma Cancer Care Associates/Oklahoma City Oklahoma City, Oklahoma, United States, 73112 Cancer Care Associates--Tulsa Tulsa, Oklahoma, United States, 74136 United States, South Carolina Cancer Centers of the Carolinas Seneca, South Carolina, United States, 29672 United States, Texas Texas Cancer Center/Abilene Abilene, Texas, United States, 79606-5208 MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Oncology Associates-Lake Wright Cancer Center Norfolk, Virginia, United States, 23502 收起 << |
NCT00040651 | Scleroderma S... 展开 >>ystemic Sclerosis 收起 << | Phase 1 | Terminated | - | United States, Pennsylvania ... 展开 >> UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT01098188 | Chronic Lymphocytic Leukemia | Phase 1 | Completed | - | France ... 展开 >> Clinique Victor Hugo Le Mans, France, 72000 Hôpital Hurriez Lille, France, 59037 Institut Paoli Calmettes Marseille, France, 13273 Hôpital Saint Eloi Montpellier, France, 34295 CH Lyon Sud Pierre Bénite, France, 69495 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital de Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 收起 << |
NCT01459211 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United Kingdom ... 展开 >> Royal Liverpool University Hospital Liverpool, United Kingdom University College London London, United Kingdom, W1T 4TJ 收起 << |
NCT02277392 | Ovarian, Fallopian Tube and Pe... 展开 >>ritoneal Cancer 收起 << | Phase 1 | Withdrawn | - | United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00413478 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 2 | Terminated(Slow accrual.) | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00562965 | Lymphoma, Follicular | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00562965 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01580228 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 3 | Completed | - | - |
NCT00413478 | - | Terminated(Slow accrual.) | - | - | |
NCT00061581 | Acute Lymphocytic Leukemia ... 展开 >> Chronic Myeloid Leukemia Acute Myelocytic Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03314974 | Acute Leukemia ... 展开 >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma Chronic Myelogenous Leukemia Plasma Cell Leukemia Myeloproliferative Neoplasms Myelofibrosis Myelodysplasia Refractory Anemia High Risk Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large Cell Non Hodgkins Lymphoma Lymphoblastic Lymphoma Burkitt Lymphoma High Grade Non-Hodgkin's Lymphoma, Adult Multiple Myeloma Juvenile Myelomonocytic Leukemia Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Natural Killer Cell Malignancies Acquired Bone Marrow Failure Syndromes 收起 << | Phase 2 | Recruiting | November 10, 2023 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55337 Contact: Timothy Krepski, RN 612-273-2800 tkrepsk1@Fairview.org 收起 << |
NCT00927797 | Immunocytoma/Morbus Waldenströ... 展开 >>m B-Cell Non-Hodgkin's Lymphoma B-Cell Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Unknown | January 2012 | - |
NCT00382759 | Hematological Malignancies | Phase 2 Phase 3 | Completed | - | Italy ... 展开 >> Ospedale San Giovanni Battista Torino, Italy, 10126 收起 << |
NCT01678430 | Chronic Lymphocytic Leukaemia | Phase 3 | Unknown | December 2017 | United Kingdom ... 展开 >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt 收起 << |
NCT00281879 | - | Terminated | - | - | |
NCT01393366 | Chronic Lymphocytic Leukemia | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier de la côte basque Bayonne, France, 64109 CH Saint Jean Perpignan, France, 66046 CHU Purpan Toulouse, France, 31059 收起 << |
NCT03240861 | HLA-A*0201 Positive Cells Pres... 展开 >>ent Locally Advanced Malignant Neoplasm NY-ESO-1 Positive Unresectable Malignant Neoplasm 收起 << | Phase 1 | Recruiting | September 1, 2022 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas 310-206-3928 aribas@mednet.ucla.edu Principal Investigator: Antoni Ribas 收起 << |
NCT00822393 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 3 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital, Dept. of Medicine Helsinki, Finland, 00290 France Centre Hospitalier Lyon Sud Lyon, France, 69495 Hopital Saint-Louis Paris, France, 75475 Germany Universitätsklinikum Carl Gustav Carus Dresden, Med. Klinik I Dresden, Germany, 01307 Klinik für Knochenmarktransplantation Essen, Germany, 45122 Malteser Krankenhaus St. Franziskus-Hospital Flensburg, Germany, 24939 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Universitätsmedizin Goettingen, Haematolgie und Onkologie Göttingen, Germany, 37075 Asklepios Kliniken Hamburg GmbH Hamburg, Germany, 20099 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Friedrich-Schiller-Universität Jena Jena, Germany, 07747 Universitätsklinikum Koeln, Stammzelltransplantation Koeln, Germany, 50937 Universitätsklinikum Leipzig, Haematologie, internistische Onkologie Leipzig, Germany, 04109 Johannes-Gutenberg-Universität Mainz, III. Medizinische Klinik Mainz, Germany, 55131 Klinikum Rechts der Isar der TU München, III. Med. Klinik Muenchen, Germany, 81675 Universitätsklinikum Münster Münster, Germany, 48129 Klinikum Nürnberg, 5. Medizinische Klinik Nürnberg, Germany, 90419 Klinikum Oldenburg gGmbH Oldenburg, Germany, 26133 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universität Rostock Rostock, Germany, 18057 Universität Tübingen Tübingen, Germany, 72076 Stiftung Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 Klinikum der Universität Würzburg Würzburg, Germany, 97070 Hungary St. Istvan and St. Laszlo Hospital of Budapest Budapest, Hungary, 1097 Italy Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy, 24127 Hematology University of Brescia Brescia, Italy, 1-25123 Scientific Institute H. San Raffaele Milan, Italy, 20132 Ospedale Civile Pescara Pescara, Italy, 65123 Policlinico Umberto I Univ. La Sapienza Rome, Italy, 00161 Clinica Ematologica ed Unita di Terapie Cellulari 'Carlo Melzi' Udine, Italy, 33100 Policlinico GB Rossi (Borgo Roma), Div. di Ematologia Verona, Italy, 37134 Poland Medical University of Gdansk Gdansk, Poland, 80-952 Silesian Medical University Katowice, Poland, 40-032 收起 << |
NCT00006100 | Lymphoma | Phase 1 | Unknown | - | United States, Pennsylvania ... 展开 >> Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 收起 << |
NCT00027573 | Kidney Cancer | Phase 2 | Completed | - | United States, Arizona ... 展开 >> CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Oklahoma CCOP - Oklahoma Tulsa, Oklahoma, United States, 74136 收起 << |
NCT00282425 | Scleroderma | Phase 1 | Terminated(No subject enrolled... 展开 >> since 2009) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT01754870 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) Small Lymphocytic Lymphoma (SLL) 收起 << | Phase 2 | Withdrawn(slow accrual) | - | United States, Wisconsin ... 展开 >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 收起 << |
NCT00801931 | Leukemia Lymp... 展开 >>homa Neuroblastoma Immunodeficiencies Anemia 收起 << | Phase 1 Phase 2 | Terminated(Poor accrual) | - | United States, New York ... 展开 >> Columbia Presbyterian Medical Center New York, New York, United States, 10032 收起 << |
NCT01220544 | Acute Myeloid Leukemias ... 展开 >> Advanced Hematological Malignancies Indication for Allogeneic Stem Cell Transplantation no HLA-identical Donor Available 收起 << | Phase 1 Phase 2 | Unknown | October 2011 | Germany ... 展开 >> Charite Campus Benjamin FRanklin, Medical Clinic III, Department of Hematology/Oncology Recruiting Berlin, Germany, 12200 Contact: Lutz Uharek, Prof. +49308445 ext 4550 lutz.uharek@charite.de Contact: Birte Friedrichs, Dr. +49308445 ext 4574 birte.friedrichs@charite.de Medical Clinic II, Department of Hematology/Oncology, University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser, Prof. +4934197 ext 13050 dietger@medizin.uni-leipzig.de Contact: Nadezda Basara, Dr. Nadezda.Basara@medizin.uni-leipzig.de 收起 << |
NCT01350258 | Hematologic Malignancies ... 展开 >> Acute Leukemia Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myeloma Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy 收起 << | Phase 1 Phase 2 | Terminated(Poor accrual) | - | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT00393185 | Primary Biliary Cirrhosis | Phase 1 | Withdrawn | - | - |
NCT01350258 | - | Terminated(Poor accrual) | - | - | |
NCT00863148 | MDS AML ... 展开 >> ALL BAL 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Edouard Herriot Lyon, France, 69437 Institut Paoli Calmettes Marseille, France, 13273 Nantes University hospital Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 CHU Haut-Lévêque Pessac, France, 33604 CHRU Hautepierre Strasbourg, France, 67098 收起 << |
NCT00303836 | Recurrent Melanoma ... 展开 >> Stage IV Melanoma 收起 << | Phase 2 | Terminated | - | United States, Maryland ... 展开 >> National Cancer Institute Surgery Branch Bethesda, Maryland, United States, 20892-1201 收起 << |
NCT03182244 | Acute Myeloid Leukemia With FM... 展开 >>S-like Tyrosine Kinase (FLT3) Mutation 收起 << | Phase 3 | Recruiting | June 2020 | - |
NCT00466674 | Myeloma | Phase 2 | Completed | - | France ... 展开 >> Mohamad Sobh Lyon, France, 69437 收起 << |
NCT00274846 | Leukemia | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01105650 | Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Primary Peritoneal Cancer Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01105650 | - | Completed | - | - | |
NCT00274846 | - | Completed | - | - | |
NCT02782546 | Acute Myeloid Leukemia | Phase 2 | Recruiting | February 28, 2022 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D. 314-454-8323 acashen@wustl.edu Principal Investigator: Amanda Cashen, M.D. Sub-Investigator: Todd Fehniger, M.D., Ph.D. Sub-Investigator: John DiPersio, M.D., Ph.D. Sub-Investigator: Peter Westervelt, M.D., Ph.D. Sub-Investigator: Geoffrey Uy, M.D. Sub-Investigator: Ravi Vij, M.D. Sub-Investigator: Camille Abboud, M.D. Sub-Investigator: Meagan Jacoby, M.D., Ph.D. Sub-Investigator: Iskra Pusic, M.D. Sub-Investigator: Armin Ghobadi, M.D. Sub-Investigator: Mark Schroeder, M.D. Sub-Investigator: Keith Stockerl-Goldstein, M.D. 收起 << |
NCT00943800 | Leukemia Myel... 展开 >>odysplastic Syndrome Multiple Myeloma Lymphoma 收起 << | Not Applicable | Active, not recruiting | September 2018 | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT01701674 | Metastatic Melanoma | Not Applicable | Active, not recruiting | February 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT03118492 | Secondary Myelofibrosis | Phase 1 | Recruiting | October 2020 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD 626-256-4673 ext 62405 malmalki@coh.org Principal Investigator: Monzr M. Al Malki, MD 收起 << |
NCT01701674 | - | Active, not recruiting | - | - | |
NCT02690545 | Lymphoma Lymp... 展开 >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type 收起 << | Phase 1 Phase 2 | Recruiting | October 2034 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 ssblaing@email.unc.edu Principal Investigator: Anne Beaven, MD 收起 << |
NCT01540812 | - | Recruiting | December 2019 | Spain ... 展开 >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr jmribera@iconcologia.com 收起 << | |
NCT00048412 | Myelodysplastic Disorders ... 展开 >> Leukemia Multiple Myeloma Plasma Cell Dyscrasia Lymphoproliferative Disorders 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT01118091 | Skin Cancer M... 展开 >>elanoma Metastatic Melanoma 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01118091 | - | Completed | - | - | |
NCT00564200 | Multiple Myeloma | Phase 2 | Completed | - | Spain ... 展开 >> H. Clinic I Provincial Barcelona, Spain H. de la Santa Creu I Sant Pau Barcelona, Spain Instituto Catalán de Oncología Barcelona, Spain H. de Jerez Jerez de la Frontera, Spain H. 12 de Octubre Madrid, Spain H. Univ. Gregorio Marañón Madrid, Spain H. Univ. La Princesa Madrid, Spain H. Univ. Morales Meseguer Murcia, Spain H. Univ. Son Dureta Palma de Mallorca, Spain H. Univ. de Salamanca Salamanca, Spain 收起 << |
NCT00723099 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Indolent Non-Hodgkin Lymphoma Lymphoma Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Chronic Lymphocytic Leukemia Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Follicular Lymphoma Refractory Hodgkin Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Non-Hodgkin Lymphoma 收起 << | Phase 2 | Active, not recruiting | November 13, 2019 | United States, Colorado ... 展开 >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT02775292 | Adult Solid Neoplasm ... 展开 >> Childhood Solid Neoplasm Metastatic Neoplasm 收起 << | Phase 1 | Recruiting | June 2019 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Siwen Hu-Lieskovan 310-794-4955 Principal Investigator: Antoni Ribas 收起 << |
NCT02528877 | Acute Myeloid Leukemia in Remi... 展开 >>ssion Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Secondary Acute Myeloid Leukemia Secondary Myelofibrosis 收起 << | Phase 1 | Withdrawn(The study design was... 展开 >> revised so a new protocol will be opened.) 收起 << | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 收起 << |
NCT00013533 | Hodgkin Lymphoma ... 展开 >> Lymphocytic Leukemia Mixed Cell Leukemia Myelodysplastic Syndrome Non Hodgkin's Lymphoma CML ALL AML Lymphoma 收起 << | Early Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01047072 | Systemic Scleroderma | Phase 2 | Withdrawn | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01565616 | - | Completed | - | - | |
NCT01570348 | Crohn Disease | Phase 2 | Active, not recruiting | February 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00610311 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Terminated(The study was termi... 展开 >>nated due to low accrual.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01850108 | Sickle Cell Disease ... 展开 >> Hemoglobinopathies 收起 << | Not Applicable | Recruiting | November 2020 | United States, Tennessee ... 展开 >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Clinical Trials Information Program 800-811-8480 Principal Investigator: Adetola A Kassim, MD 收起 << |
NCT03399448 | Multiple Myeloma ... 展开 >> Melanoma Synovial Sarcoma Myxoid/Round Cell Liposarcoma 收起 << | Phase 1 | Recruiting | January 2033 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed 855-216-0098 PennCancerTrials@emergingmed.com 收起 << |
NCT02638428 | Relapsed Pediatric Solid Tumor... 展开 >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML 收起 << | Phase 2 | Recruiting | December 2023 | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung 82-2-3410-3529 kwsped@skku.edu Principal Investigator: Ki Woong Sung 收起 << |
NCT00610311 | - | Terminated(The study was termi... 展开 >>nated due to low accrual.) 收起 << | - | - | |
NCT01565616 | Sickle Cell Disease | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Hospital of Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Chidren's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT01858740 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Active, not recruiting | January 30, 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00586274 | FANCONI ANEMIA | Phase 1 | Terminated(Poor accrual) | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT02845596 | Severe Aplastic Anemia | Not Applicable | Recruiting | May 2020 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Nini Huynh 323-361-5286 huhuynh@chla.usc.edu Principal Investigator: Michael Pulsipher, MD United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Wendy Moore 720-777-6353 Wendy.moore2@childrenscolorado.org Principal Investigator: Taizo Nakano, MD United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Maggie Malsch, MSN maggie.malsch@childrens.harvard.edu Contact: Leah Cheng leah.cheng@childrens.harvard.edu Principal Investigator: David A Williams, MD United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh 551-996-3457 jeanette.haugh@hackensackmeridian.org Principal Investigator: Alfred Gillio, MD United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn 215-590-1303 mcglynn@email.chop.edu Principal Investigator: Timothy Olson, MD United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Margaret Nagel 832-824-1538 menagel@texaschildrens.org Principal Investigator: Alison Bertuch, MD United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Bernie McLaughlin 206-667-4916 bmclaugh@fredhutch.org Principal Investigator: Lauri Burroughs, MD 收起 << |
NCT01462396 | Neuroblastoma | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 收起 << |
NCT01303887 | Follicular Lymphoma | Phase 3 | Unknown | September 2016 | - |
NCT00143845 | - | Completed | - | - | |
NCT01044745 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage I Small Lymphocytic Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Waldenström Macroglobulinemia 收起 << | Phase 2 | Active, not recruiting | March 2018 | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7830 收起 << |
NCT03615105 | Acute Lymphoid Leukemia (ALL) ... 展开 >> Acute Myeloid Leukemia (AML) Chronic Myeloid Leukemia (CML) Hodgkin Lymphoma Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Recruiting | July 2021 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD 212-639-2212 Contact: Miguel-Angel Perales, MD 212-639-8682 Principal Investigator: Brian Shaffer, MD 收起 << |
NCT02702960 | Fibrolamellar Hepatocellular C... 展开 >>arcinoma Hepatocellular Carcinoma (Fibrolamellar Variant) Hepatocellular Carcinoma 收起 << | Phase 2 | Withdrawn(This study was withd... 展开 >>rawn due to lack of necessary resources from the liver transplant surgical group.) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 收起 << |
NCT00143845 | Multiple Myeloma ... 展开 >> Lymphocytic Leukemia, Chronic Lymphoma, Low-Grade 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> The University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
NCT02061800 | Chronic Myeloid Leukemia (CML)... 展开 >> Acute Myelogenous Leukemia (AML) Myelodysplastic Syndrome (MDS) Juvenile Myelomonocytic Leukemia (JMML) Acute Lymphoblastic Leukemia (ALL) Lymphoma (Hodgkin's and Non-Hodgkin's) 收起 << | Phase 1 Phase 2 | Recruiting | December 2018 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN 212-305-2050 Principal Investigator: Diane George, MD 收起 << |
NCT02793544 | Myelodysplastic Syndrome (MDS)... 展开 >> Chronic Lymphocytic Leukemia (CLL) Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML) Acute Biphenotypic Leukemia (ABL) Acute Undifferentiated Leukemia (AUL) 收起 << | Phase 2 | Recruiting | December 2019 | United States, Florida ... 展开 >> Shands HealthCare & University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Maxim Norkin, MD Maxim.Norkin@medicine.ufl.edu Contact: Meghan Vazquez meghan.vazquez@medicine.ufl.edu Principal Investigator: Maxim Norkin, MD University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Antonio Jimenez, MD amjimenez@miami.edu Contact: Kirenia Correa k.correa@med.miami.edu Principal Investigator: Antonio Jimenez, MD H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD Farhad.Khimani@moffitt.org Contact: Carmen Patton Carmen.Patton@moffitt.org Principal Investigator: Farhad Khimani, MD United States, Maryland University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Hardy, MD nhardy1@umm.edu Contact: Sherri Bauman sphilip1@umm.edu Principal Investigator: Nancy Hardy, MD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Javier Bolanos Meade, MD fbolano2@jhmi.edu Contact: Leo Luznik, MD luznile@jhmi.edu Principal Investigator: Javier Bolanos Meade, MD Principal Investigator: Leo Luznik, MD United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Asif Alavi, MD alavia@karmanos.org Contact: Charlotte Brown brownc@karmanos.org Principal Investigator: Asif Alavi, MD United States, New York Memorial Sloan Kettering Cancer Center - Adults Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD shaffeb1@mskcc.org Contact: Stephanie Chinapen chinapes@mskcc.org Principal Investigator: Brian Shaffer, MD United States, North Carolina University of North Carolina Hospitals Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katarzyna Jamieson, MD katarzyna_jamieson@med.unc.edu Contact: Mary Owen mary_owen@med.unc.edu Principal Investigator: Katarzyna Jamieson, MD United States, Ohio Ohio State Medical Center, James Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Hannah Choe, MD Contact: Nicole Szuminski Nicole.Szuminski@osumc.edu Principal Investigator: Hannah Choe, MD United States, Virginia Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program Recruiting Richmond, Virginia, United States, 23298 Contact: John McCarty, MD john.mccarty@vcuhealth.org Contact: Kathy Candler kcandler@mcvh-vcu.edu Principal Investigator: John McCarty, MD United States, Wisconsin Froedtert Memorial Lutheran Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Bronwen Shaw, MD, PhD beshaw@mcw.edu Contact: Sharon Yim syim@mcw.edu Principal Investigator: Bronwen Shaw, MD, PhD 收起 << |
NCT02029638 | - | Terminated(Slow accrual) | - | - | |
NCT02029638 | Kidney Transplantation | Phase 2 | Terminated(Slow accrual) | - | United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21205 收起 << |
NCT03128034 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome With Excess Blasts Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | April 19, 2026 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier 206-667-4961 bsandmai@fredhutch.org Principal Investigator: Brenda M. Sandmaier 收起 << |
NCT02652468 | Lymphoma | Not Applicable | Active, not recruiting | March 15, 2020 | United States, Wisconsin ... 展开 >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53705 收起 << |
NCT01427881 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Myeloid Leukemia in Remission Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Multiple Myeloma Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00387959 | - | Completed | - | - | |
NCT01427881 | - | Completed | - | - | |
NCT00008307 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Unknown | - | United States, New York ... 展开 >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 收起 << |
NCT01118013 | Leukemia Lymp... 展开 >>homa Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Terminated | - | United States, Delaware ... 展开 >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Florida Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States, 32803-1273 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 收起 << |
NCT01118013 | - | Terminated | - | - | |
NCT00376480 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 | Unknown | - | United States, California ... 展开 >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Neena Kapoor, MD 323-669-2434 nkapoor@chla.usc.edu United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Clinical Trials Office - Massachusetts General Hospital 877-726-5130 Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02115 Contact: Eva Guinan, MD 617-632-4932 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Eva Guinan, MD 617-632-4932 United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U 713-792-3245 收起 << |
NCT00176878 | - | Completed | - | - | |
NCT00304018 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00740467 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition 收起 << | Phase 2 | Unknown | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Contact Person 33-4-91-22-37-54 收起 << |
NCT02508038 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia Hodgkin Lymphoma Non-Hodgkin Lymphoma Myelodysplastic Syndrome Myeloproliferative Syndrome Rhabdomyosarcoma Ewing Sarcoma Primitive Neuroectodermal Tumor Osteosarcoma Neuroblastoma 收起 << | Phase 1 | Recruiting | November 2023 | United States, Wisconsin ... 展开 >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Pediatric HemOnc Main Line 608-263-6200 PEDSHemOncResearch@lists.wisc.edu Contact: Research Office 608-890-8070 PEDSHemOncResearch@lists.wisc.edu Principal Investigator: Mario Otto, MD, PhD 收起 << |
NCT00176878 | Diamond-Blackfan Anemia ... 展开 >> Kostmann's Neutropenia Shwachman-Diamond Syndrome 收起 << | Phase 2 Phase 3 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01697527 | Malignant Neoplasm | Phase 2 | Recruiting | November 2, 2019 | United States, California ... 展开 >> University of California at Los Angeles (UCLA ) Recruiting Los Angeles, California, United States, 90095 Contact: Arun Singh 310-829-5471 asingh@mednet.ucla.edu Principal Investigator: Arun Singh 收起 << |
NCT00079144 | Melanoma (Skin) | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 收起 << |
NCT00829647 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 1 Phase 2 | Withdrawn(Unable to enroll) | - | - |
NCT00209209 | Lymphoma, Mantle-Cell | Phase 3 | Active, not recruiting | December 2018 | Czech Republic ... 展开 >> General University Hospital, 1St Department of Medicine Praha, Czech Republic, CZ-12808 Denmark Nordic Lymphoma Group Copenhagen, Denmark, DK-2100 France Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Paris, France, F-75743 Germany German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Italy Ospedale Ferratotto, Divisione Di Ematologia Catania, Italy, I-95124 Netherlands HOVON - Dutch Haemato-Oncology Association (HOVON-Datacenter) Rotterdam, Netherlands, NL-3008 AE Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Warszawa, Poland, PL-02-781 收起 << |
NCT01954784 | Refractory Multiple Myeloma ... 展开 >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 1 | Terminated(Funding unavailable... 展开 >>) 收起 << | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00387959 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02070406 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Recruiting | July 17, 2020 | United States, California ... 展开 >> Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas 310-206-3928 aribas@mednet.ucla.edu Principal Investigator: Antoni Ribas 收起 << |
NCT01652014 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Withdrawn(Funding unavailable) | January 2017 | United States, New Jersey ... 展开 >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 收起 << |
NCT00296023 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 收起 << |
NCT00498316 | Myelodysplastic Syndrome ... 展开 >> Leukemia 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00612222 | - | Terminated(The study was termi... 展开 >>nated due to low accrual.) 收起 << | - | - | |
NCT02926833 | Refractory Diffuse Large B Cel... 展开 >>l Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | June 2023 | United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Hormoz Mirshkarlo hmirshkarlo@coh.org Stanford Cancer Center Recruiting Stanford, California, United States, 94305 Contact: Juliana K Craig jkcraig@stanford.edu United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott matthew.scott@moffitt.org United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Guadalupe De Maeyer gdemaeyer@partners.org United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sherry Adkins sadkins@mdanderson.org 收起 << |
NCT01203228 | Myelodysplastic Syndromes ... 展开 >> Secondary Acute Myeloid Leukemia 收起 << | Phase 3 | Terminated | - | Germany ... 展开 >> University Hospital Düsseldorf, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany University Hospital Eppendorf Hamburg, Germany University Hospital Heidelberg, Germany UKSH Campus Kiel Kiel, Germany University Hospital Köln, Germany University Hospital Leipzig, Germany Universitätsklinikum Munster Munster, Germany University Hospital Tübingen, Germany Italy Santi Antonio e Biagio Alessandria, Italy Ospedale di Careggi Firenze, Italy Ospedale Maggiore di Milano Milano, Italy Netherlands Radboud University MC Nijmegen, Netherlands Russian Federation SPb State I. Pavlov Medical University St. Petersburg, Russian Federation 收起 << |
NCT01663766 | GVHD (Acute or Chronic) ... 展开 >> Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) Myelodysplastic Syndrome Chronic Myelogenous Leukemia (CML) Multiple Myeloma (MM) Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL) 收起 << | Phase 1 | Unknown | January 2017 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00023192 | Chronic Granulomatous Disease | Phase 3 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT02169791 | Acute Leukemia ... 展开 >> Chronic Leukemia Myelodysplastic Syndrome Lymphomas Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | August 30, 2020 | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT00612222 | Metastatic Melanoma ... 展开 >> Skin Cancer 收起 << | Phase 2 | Terminated(The study was termi... 展开 >>nated due to low accrual.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03520647 | Severe Aplastic Anemia (SAA) ... 展开 >> Hypo-Plastic Myelodysplastic Syndrome (MDS) 收起 << | Phase 2 | Recruiting | June 1, 2028 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT00004114 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes 收起 << | Phase 1 | Withdrawn(Study never opened) | - | - |
NCT00047060 | Mycosis Fungoides ... 展开 >> Sezary Syndrome 收起 << | Phase 1 | Active, not recruiting | July 1, 2021 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02806375 | Primary Myelofibrosis ... 展开 >> Myeloproliferative Disorders 收起 << | Phase 1 Phase 2 | Active, not recruiting | June 2019 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT03236129 | Hematological Malignancies ... 展开 >> Regulatory T Cell Depletion Relapse 收起 << | Phase 3 | Not yet recruiting | September 2021 | France ... 展开 >> Henri Mondor Hospital Not yet recruiting Creteil, France, 94010 Contact: Damien VANHOYE, PhD (0)1 44 84 17 93 ext +33 damien.vanhoye@drc.aphp.fr Contact: Laetitia GREGOIRE, M. Sc (0)1 49 81 41 64 ext +33 Laetitia.gregoire@aphp.fr 收起 << |
NCT00080353 | Melanoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT01659151 | Metastatic Melanoma | Phase 2 | Active, not recruiting | December 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01050946 | Leukemia, Lymphocytic, Acute ... 展开 >> Leukemia, Lymphocytic, Chronic Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin Lymphoma, Hodgkins 收起 << | Phase 2 | Terminated(Only one patient wa... 展开 >>s enrolled. Due to low accrual study was terminated) 收起 << | - | - |
NCT03287817 | Diffuse Large B Cell Lymphoma ... 展开 >> Relapsed Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma DLBCL 收起 << | Phase 1 Phase 2 | Recruiting | March 2021 | United Kingdom ... 展开 >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Kirit Ardeshna The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Principal Investigator: Dr Adrian Bloor Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Wendy Osborne 收起 << |
NCT01050946 | - | Terminated(Only one patient wa... 展开 >>s enrolled. Due to low accrual study was terminated) 收起 << | - | - | |
NCT00002798 | Childhood Acute Erythroleukemi... 展开 >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> Children's Oncology Group Arcadia, California, United States, 91006-3776 收起 << |
NCT03585517 | AML | Phase 1 | Recruiting | November 1, 2020 | China ... 展开 >> Xian Lu Recruiting Beijing, China Contact: xian lu 86 ext 86 luxinan@immunochina.com 收起 << |
NCT00780988 | Colorectal Neoplasms ... 展开 >> Anal, Colon, and Rectal Cancers 收起 << | Phase 1 | Withdrawn | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT03430011 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | March 2021 | United States, Alabama ... 展开 >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Tiffany D Hill, RN, BSN 205-996-8023 tiffanydhill@uabmc.edu Principal Investigator: Luciano Costa, MD, PhD United States, California City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD 626-218-2405 ext 82405 mhtut@coh.org Principal Investigator: Myo Htut, MD University of California Recruiting San Francisco, California, United States, 94143 Contact: Helen Diller Family Comprehensive Cancer Center HDFCCC.CIP@ucsf.edu Principal Investigator: Sandy Wong, MD United States, Georgia Winship Cancer Institute at Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Jonathan Kaufman, MD 404-778-1900 jlkaufm@emory.edu Principal Investigator: Jonathan Kaufman, MD United States, Illinois The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Rebecca Malloy 773-834-1475 rmalloy@medicine.bsd.uchicago.edu Principal Investigator: Andrzej Jakubowiak, MD, PhD United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Leah Cappadona, RN 551-996-5078 Leah.Cappadona@hackensackmeridian.org Principal Investigator: David Siegel, MD, PhD United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14203 Contact: Lisa Martin 716-845-4892 Lisa.Martin@RoswellPark.org Contact: Aaron Pry 716-845-2910 Aaron.Pry@RoswellPark.org Principal Investigator: Kelvin Lee, MD Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Claudia Diamonte, RN 212-639-5317 diamontc@mskcc.org Principal Investigator: Sham Mailankody, MD United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Tenzin Tsomo 206-386-2831 Tenzin.Tsomo@swedish.org Principal Investigator: William Bensinger, MD 收起 << |
NCT00852163 | Leukemia Myel... 展开 >>odysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor University Medical Center Dallas, Texas, United States, 75246 收起 << |
NCT00333190 | Hematologic Malignancy ... 展开 >> AML ALL CML Multiple Myeloma NHL Hodgkin's Lymphoma 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT02421939 | Leukemia, Acute Myeloid (AML) | Phase 3 | Active, not recruiting | December 2020 | - |
NCT00001144 | Chronic Myeloid Leukemia ... 展开 >> Graft vs Host Disease 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 收起 << |
NCT01947322 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service d'Hématologie Clinique du Pr. Leblond- Hôpital Pitié salpêtrière Paris, France, 75013 Service d'Hématologie adultes du Pr. Hermine - Hôpital Necker Enfants Malades Paris, France, 75015 Service d'Hématologie oncologie du Pr. Mohty -Hôpital Saint Antoine Paris, France, 75571 Service d'Hématologie Clinique du Pr. Cordonnier-Hôpital Henri Mondor Paris, France, 94010 收起 << |
NCT03153462 | - | - | - | United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 Contact: Elizabeth Budde, MD ebudde@coh.org Stanford Cancer Institute Stanford, California, United States, 94305 Contact: Julianna Craig jkcraig@stanford.edu United States, Florida H. Lee Moffitt Cancer and Research Institute Tampa, Florida, United States, 33612 Contact: Matthew Scott matthew.scott@moffitt.org United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 Contact: Linda Schroeder lschroed@medicine.bsd.uchicago.edu Principal Investigator: Peter Reidell, MD United States, Kansas The University of Kansas Hospital Investigational Drug Services Westwood, Kansas, United States, 66205 Contact: Renee Sol rsol@kumc.edu United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Contact: Michael Rocchio michaelj_rocchio@dfci.harvard.edu United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Contact: Kristin Arends arends.kristen@mayo.edu United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6840 Contact: Susan Blumel 402-559-9183 sblumel@unmc.edu United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Contact: Miguel-Angel Perales, MD peralesm@MSKCC.ORG United States, Ohio James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski nicole.szuminski@osumc.edu United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Contact: Sherry Adkins sadkins@mdanderson.org Contact: Liliana Vallejo lnvallejo@mdanderson.org 收起 << | |
NCT03616470 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 2023 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel J DeAngelo, MD, PhD 617-632-2645 Daniel_Deangelo@dfci.harvard.edu Principal Investigator: Daniel DeAngelo, MD, PhD United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Brandon DeLorme 585-275-5295 Brandon_Delorme@URMC.Rochester.edu Principal Investigator: Jane Liesveld, MD United States, Ohio The Ohio State University Wexner Medical Center and James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Dienno 614-293-0752 Jennifer.Dienno@osumc.edu Principal Investigator: Alice Mims, MD United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver, MD 713-794-4392 NDaver@mdanderson.org Principal Investigator: Naval Daver, MD United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Niall Curley 206-606-1231 Ncurley8@seattlecca.org Principal Investigator: Pamela Becker, MD, PhD 收起 << |
NCT01453062 | - | Completed | - | - | |
NCT03497533 | Non-hodgkin Lymphoma,B Cell | Phase 1 Phase 2 | Recruiting | December 31, 2020 | China, Hunan ... 展开 >> Hunan Provincial People's Hospital Recruiting Changsha, Hunan, China, 410005 Contact: Jianjun Chen +86 0731 83928147 Contact: Ming Zhou +86 0731 83928145 zhouming_0321@163.com 收起 << |
NCT00077922 | - | Completed | - | - | |
NCT03289455 | B Acute Lymphoblastic Leukemia... 展开 >> Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia B-cell Acute Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | December 2021 | United Kingdom ... 展开 >> Great Ormond Street Hospital for Children NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Professor Persis Amrolia University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rachael Hough Royal Manchester Children's Hospital Recruiting Manchester, United Kingdom Principal Investigator: Professor Robert Wynn 收起 << |
NCT00423826 | - | - | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << | |
NCT00077922 | Leukemia Lymp... 展开 >>hocytic Chronic 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00334074 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndromes Chronic Myelogenous Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor University Medical Center Dallas, Texas, United States, 75246 收起 << |
NCT00818961 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(terminated early du... 展开 >>e to meeting end point with fewer patients than anticipated) 收起 << | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT03720496 | Non-hodgkin Lymphoma,B Cell | Phase 1 | Recruiting | December 1, 2021 | China, Hainan ... 展开 >> The Second Affiliated Hospital of Hainan Medical University Recruiting Haikou, Hainan, China, 570100 Contact: Haifeng Lin +86 13322060949 13322060949@163.com Contact: Yasong Wu +86 18020091931 yasong.wu@timmune.com 收起 << |
NCT03638206 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia Lymphoma Myeloid Leukemia Multiple Myeloma Hepatoma Gastric Cancer Pancreatic Cancer Mesothelioma Colorectal Cancer Esophagus Cancer Lung Cancer Glioma Melanoma Synovial Sarcoma Ovarian Cancer Renal Carcinoma 收起 << | Phase 1 Phase 2 | Recruiting | March 1, 2023 | China, Henan ... 展开 >> The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Yi Zhang, MD, PhD 86-15138928971 yizhang@zzu.edu.cn 收起 << |
NCT01174108 | Severe Aplastic Anemia ... 展开 >> MDS (Myelodysplastic Syndrome) 收起 << | Phase 2 | Recruiting | June 30, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov University of Maryland at Baltimore/MPRC Recruiting Catonsville, Maryland, United States, 21228 Contact: Nancy Hardy, M.D. 410-328-1230 nhardy12@umm.edu 收起 << |
NCT00366418 | Refractory Chronic Lymphocytic... 展开 >> Leukemia 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00334074 | - | Completed | - | - | |
NCT01013441 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Pennsylvania ... 展开 >> Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 收起 << |
NCT00818961 | - | Terminated(terminated early du... 展开 >>e to meeting end point with fewer patients than anticipated) 收起 << | - | - | |
NCT00383448 | Adrenoleukodystrophy ... 展开 >> Metachromatic Leukodystrophy Globoid Cell Leukodystrophy Tay Sachs Disease Sandhoffs Disease Wolman Disease I-Cell Disease Sanfilippo Syndrome GM1 Gangliosidosis 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03290664 | Acute Myelogenous Leukemia | Phase 2 | Terminated(Slow accrual) | - | United States, Minnesota ... 展开 >> University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00130754 | Stem Cell Transplantation ... 展开 >> Graft Vs Host Disease 收起 << | Phase 3 | Completed | - | Israel ... 展开 >> Hadassah Medical Organization Jerusalem, Israel, 91120 收起 << |
NCT01534702 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Unknown | September 2015 | Germany ... 展开 >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD andrea.kuendgen@med.uni-duesseldorf.de Principal Investigator: Andrea Kuendgen, MD Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD m.wattad@kliniken-essen-sued.de Principal Investigator: Mohammad Wattad, MD Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD luebbert@mm11.ukl.uni-freiburg.de Principal Investigator: Michael Luebbert, MD Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD fiedler@uke.uni-hamburg.de Principal Investigator: Walter Fiedler, MD Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD +49-511-532-3720 Krauter.Juergen@MH-Hannover.de Principal Investigator: Juergen Krauter, MD Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster justus.duyster@lrz.tum.de Principal Investigator: Justus Duyster, MD Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD Richard.Schlenk@uniklinik-ulm.de Principal Investigator: Richard Schlenk, MD 收起 << |
NCT03229876 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) Non Hodgkin Lymphoma (NHL) 收起 << | Not Applicable | Recruiting | December 30, 2020 | China, Henan ... 展开 >> First Affliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Xinfeng Chen, PhD Principal Investigator: Yi Zhang, Professor China, Hunan Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD Principal Investigator: Yunxiao Xu, Professor 收起 << |
NCT00604201 | Myelodysplastic Syndrome (MDS)... 展开 >> Severe Aplastic Anemia (SAA) 收起 << | Phase 2 | Recruiting | December 31, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT00859586 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute Leukemia, Myelocytic, Chronic 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03752541 | Multiple Myeloma | Not Applicable | Recruiting | November 20, 2020 | China, Hunan ... 展开 >> Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD Principal Investigator: Yunxiao Xu, Professor 收起 << |
NCT01295593 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Unknown | April 2013 | Belgium ... 展开 >> Clinique Sud Luxembourg Recruiting Arlon, Belgium, 6700 Contact: Pascal Pierre, MD Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Dominique Bron, MD, PhD ULB Erasme Recruiting Brussels, Belgium, 1070 Contact: Alain Kentos, MD Cliniques universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Eric Van Den Neste, MD, PhD Grand Hôpital de Charleori - Site notre Dame Recruiting Charleroi, Belgium, 6000 Contact: Marc André, MD Clinique Notre-Dame de Grâce Recruiting Gosselies, Belgium, 6041 Contact: Marie Maerevoet, MD Hôpital de Jolimont Recruiting Haine-St-Paul, Belgium, 7100 Contact: Valérie Delrieu, MD CHU ULg Recruiting Liège, Belgium, 4000 Contact: Bernard De Prijck, MD Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Contact: Thierry Connerotte, MD, PhD Heilig-Hartziekenhuis Recruiting Roeselaere, Belgium, 8800 Contact: Hilde Demuynck, MD Cliniques de Mont Godinne Recruiting Yvoir, Belgium, 5530 Contact: Christian Chatelain, MD, PhD 收起 << |
NCT02701517 | Unrecognized Condition: Mature... 展开 >> B or T-cell Neoplasm 收起 << | Phase 2 | Terminated(The trial was stopp... 展开 >>ed before the targeted number of patients was reached due to lack of support.) 收起 << | - | Poland ... 展开 >> Department of Propedeutic Oncology, Medical University of Gdansk Gdansk, Poland Spain Clinical Hematology Department. ICO-Hospital Germans Trias i Pujol. Jose Carreras Research Institute Badalona, Barcelona, Spain Hospital Clinic I Provincial Barcelona, Spain Santa Creu I Sant Pau Hospital Barcelona, Spain Hospital Universitario de Salamanca Salamanca, Spain 收起 << |
NCT00859586 | - | Completed | - | - | |
NCT00202917 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | Germany ... 展开 >> University of Dresden Medical Center Dresden, Germany, D-01307 Center for Marrow Transplantation Essen, Germany, 45122 Medical Center University of Hamburg Hamburg, Germany, 20246 Medical Center University of Muenster Muenster, Germany, 48129 South West German Cancer Center, University of Tuebingen Medical Center Tuebingen, Germany, 72076 Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 University of Wuerzburg Medical Center Wuerzburg, Germany, D-97070 收起 << |
NCT02165007 | Sickle Cell-thalassemia Diseas... 展开 >>e Thalassemia 收起 << | Phase 1 | Recruiting | April 2023 | United States, District of Col... 展开 >>umbia Childrens National Medical Center Recruiting Washington, District of Columbia, United States, 20010 收起 << |
NCT01521689 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | June 2015 | France ... 展开 >> Institut Paoli Calmettes Marseille, France, 13009 收起 << |
NCT00337519 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | April 2009 | Germany ... 展开 >> Klinikum Chemnitz gGmbH Chemnitz, Germany, 09113 Uniklinikum Carl Gustav Carus Dresden, Germany, 01307 Deutsche Klinik für Diagnostik GmbH Wiesbaden, Germany, 65191 收起 << |
NCT00074490 | Lymphoma Leuk... 展开 >>emia Myeloproliferative Disorders Multiple Myleoma Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States 收起 << |
NCT02592577 | Non-Small Cell Lung Cancer ... 展开 >> Carcinoma 收起 << | Phase 1 | Recruiting | April 2019 | United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Cara Nolan 626-256-4673 ext 32341 canolan@coh.org Principal Investigator: Karen Reckamp, MD Stanford Cancer Center Recruiting Palo Alto, California, United States, 94304 Contact: Jordan S Preiss, BA 650-723-1002 jpreiss2@stanford.edu Contact: Melanie G San Pedro-Salcedo Principal Investigator: Joel W Neal, MD PhD United States, Florida University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Michelle Liendo 305-243-0864 mliendo@med.miami.edu Principal Investigator: Raja Mudad, M.D. H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Jeff L Edelman, MS 813-745-1040 Jeffrey.Edelman@moffitt.org Contact: Matt Taddeo Matt.Taddeo@moffitt.org Principal Investigator: Ben Creelan, MD, MS United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Shantina N Walls, BS 404-778-4995 shantina.n.walls@emory.edu Contact: Ellie C Butler Principal Investigator: Taofeek K Owonikoko, MD, PhD United States, Indiana Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46033 Contact: Margaret M Uhrich, RN 317-274-4505 muhrich@iu.edu Contact: Namratha Kolur 317-278-2356 nkolur@iu.edu Principal Investigator: Shadia I Jalal, MD United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21157 Contact: Brett Goldberger, MS 410-328-1160 brett.goldberger@umm.edu Contact: Maha Khalil Principal Investigator: Nancy Hardy, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Justin F Gainor, M.D. 617-724-4000 jgainor@partners.org Principal Investigator: Justin F Gainor, M.D. United States, Missouri Washington University, School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Usha Rawat 314-286-2098 rawat@wustl.edu Principal Investigator: Ramaswamy Govindan, MD United States, North Carolina Duke University Medical Center, Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Shawna Savage, RN, BSN 919-668-1462 shawna.savage@duke.edu Principal Investigator: Jeffrey M Clarke, MD United States, Ohio Ohio State University Wexner Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Catherine Schweitzer 614-685-5414 catherine.schweitzer@osumc.edu Principal Investigator: Kai He, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly 215-728-2195 patricia.murphy@fccc.edu Principal Investigator: Martin Edelman, MD United States, Tennessee Tennessee Oncology- Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7400 asksarah@sarahcannon.com Principal Investigator: Melissa Johnson, MD United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Matthew Parker, RN 713-745-6767 mrparker@mdanderson.org Contact: Sara Nasser SNasser@mdanderson.org Principal Investigator: Vincent K Lam, MD Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Penelope Bradbury, MD 416-946-4501 ext 3544 TIP@uhn.ca Contact: Ausmeema Hossain 416-946-4501 ext 8084 Ausmeema.Hossain@uhn.ca Principal Investigator: Penelope Bradbury, MD Spain Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain, 28040 Contact: Adriana Armellini 91 550 48 00 ext 2486 adriana.armellini@start.stoh.com Contact: Raquel Martinez raquel.garcia@startmadrid.com Principal Investigator: Victor Moreno, MD Hospital Universitario 12 Octubre Avda. de Córdoba s/n Recruiting Madrid, Spain, 28041 Contact: Sara Gomez +34 91 4692313 abecia@@h12o.es Contact: Carlos Gonzalez Principal Investigator: Luis Paz-Ares Rodríguez, MD United Kingdom University College Hospital Macmillan Cancer Centre Recruiting London, United Kingdom, WC1E 6AG Contact: Gemma Hector 07852219920 Gemma.Hector@uclh.nhs.uk Contact: Krishna Patel krishna.patel@uclh.nhs.uk Principal Investigator: Martin D Forster, MBBS, FRCP, PhD The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Shweta Vyas +44 (0) 161 918 2323 Shweta.vyas@christie.nhs.uk Contact: Kate Armitage +44 (0) 161 918 7887 Kate.Armitage@christie.nhs.uk Principal Investigator: Fiona Thistlethwaite, MD 收起 << |
NCT00547196 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes 收起 << | Not Applicable | Active, not recruiting | September 2019 | United States, Arizona ... 展开 >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT02577094 | Lymphocyte B CD22 Positive Acu... 展开 >>te Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT01457885 | Acute Myeloblastic Leukemia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama, Birmingham Birmingham, Alabama, United States, 35233 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Michigan University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University at St Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbuilt University Nashville, Tennessee, United States, 37232 United States, Washington University of Washington Seattle, Washington, United States, 98109 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00855452 | Metastatic Breast Cancer ... 展开 >> Malignant Melanoma Renal Cell Cancer Gastrointestinal Cancer 收起 << | Phase 2 | Completed | - | Israel ... 展开 >> Hadassah University Hospital Jerusalem, Israel, 91120 收起 << |
NCT00799799 | Myeloblastic Leukemia | Phase 1 | Unknown | December 2009 | Italy ... 展开 >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Bo, Italy, 40138 收起 << |
NCT02989064 | Urinary Bladder Cancer ... 展开 >> Head and Neck Cancer Melanoma 收起 << | Phase 1 | Recruiting | May 2020 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryan Sullivan, MD 617-724-4000 rsullivan7@partners.org Principal Investigator: Ryan Sullivan, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly 215-728-2195 patriciamurphy@fccc.edu Principal Investigator: Anthony Olszanski, MD, RPh United States, Tennessee Tennessee Oncology - Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact 615-339-4214 asksarah@sarahcannon.com Principal Investigator: Melissa Johnson, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Danxia Ke 713-792-4384 dke@mdanderson.org Contact: Ly M Nguyen Principal Investigator: David S Hong, MD Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Marcus Butler, MD 416-946-4501 TIP@uhn.ca Contact: Anna Spreafico Principal Investigator: Marcus Butler, MD 收起 << |
NCT01457885 | - | Completed | - | - | |
NCT02935257 | Leukemia, Lymphoblastic, Acute | Phase 1 | Recruiting | November 2024 | United Kingdom ... 展开 >> University College London Hospital Recruiting London, United Kingdom Contact: Prof. Karl Peggs Principal Investigator: Prof. Karl Peggs 收起 << |
NCT00453206 | - | Completed | - | - | |
NCT00453206 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 收起 << |
NCT03164057 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | June 2027 | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD 800-826-4673 weilisun@coh.org Principal Investigator: Weili Sun, MD,PhD Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD 866-353-5437 frazzaqi@valleychildrens.org Principal Investigator: Faisal Razzaqi, MD Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD 714-509-4348 jfrediani@choc.org Principal Investigator: Jamie Frediani, MD Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD 650-497-8953 lacayon@stanford.edu Principal Investigator: Norman J. Lacayo, MD Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD 858-966-5983 dschiff@chsd.org Principal Investigator: Deborah Schiff, MD United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD 866-278-5833 tanja.gruber@stjude.org Contact: Referral Office 866-278-5833 referralinfo@stjude.org Principal Investigator: Tanja A. Gruber, MD, PhD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 kenneth.heym@cookchildrens.org Principal Investigator: Kenneth M. Heym, MD 收起 << |
NCT03053206 | Acute Myeloid Leukemia, in Rel... 展开 >>apse 收起 << | Phase 2 | Not yet recruiting | December 31, 2019 | - |
NCT01966510 | Patients With Advanced Lymphoi... 展开 >>d Malignancies in the Absence of an HLA Identical or Mismatch Donor 收起 << | Phase 2 | Completed | - | France ... 展开 >> Saint Louis hospital Paris, France, 75010 收起 << |
NCT00282282 | Graft Versus Host Disease ... 展开 >> GVHD 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00282282 | - | Completed | - | - | |
NCT00676806 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Aplastic Anemia 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Massachusetts ... 展开 >> Tufts Medical Center Boston, Massachusetts, United States, 02111 收起 << |
NCT00986518 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service hépato-gastro-enterologie, Pitié-Salpêtrière Hospital Paris, France, 75013 收起 << |
NCT01428973 | Graft-Versus-Host Disease ... 展开 >> Hematological Malignancies 收起 << | Phase 2 | Recruiting | September 2020 | Belgium ... 展开 >> Ziekenhuis Netwerk Antwerpen (ZNA) Recruiting Antwerpen,, Antwerpen, Belgium, 2060 Contact: Pierre Zachee, MD; PhD 32-3-2177111 pierre.zachee@zna.be University Hospital, Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Wilfried Schroyens, MD; PhD 32-03-2204111 wilfried.schroyens@uza.be Jules Bordet Institute Recruiting Brussels, Brabant, Belgium, 1000 Contact: Philippe Lewalle, MD; PhD 32-02-5417208 plewalle@ulb.ac.be Cliniques universitaires Saint-Luc- Université Catholique de Louvain Recruiting Brussels,, Brussels Region Capital, Belgium, 1200 Contact: Xavier Poiré, MD; PhD 32-02-7641880 xavier.poire@uclouvain.be AZ VUB Jette Recruiting Brussels, Brussels Region Capital, Belgium, 1090 Contact: Rik Schots, MD; PhD 32-02-4763105 Rik.Schots@uzbrussel.be Queen Fabiola Children's University Hospital Recruiting Brussels, Brussels, Region Capital, Belgium, 1020 Contact: Alice Fester, MD 32-02-4772678 afester@ulb.ac.be University Hospital, Gasthuisberg Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD 32-16-33 22 11 johan.maertens@uz.kuleuven.ac.be UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD; PhD 32-09-332 21 31 Lucien.Noens@Ugent.be Contact: Tessa Kerre, MD; PhD 32-09-3323464 Tessa.Kerre@Ugent.be Jolimont Hospital Haine Saint Paul Recruiting Haine St-Paul, Hainaut, Belgium, 7100 Contact: Nicole Straetmans, MD 32-64-233989 nicole.straetmans@scarlet.be Cliniques Universitaires de Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD; PhD 32-081-423831 carlos.graux@uclouvain.be AZ Sint-Jan AV Recruiting Brugge, West Flanders, Belgium, 8000 Contact: Dominik Selleslag, MD 32-50-453060 dominik.selleslag@azbrugge.be H.-Hart Hospital Roeselare-Menen Recruiting Roeselare, Western Flanders, Belgium, 8800 Contact: Dries Deeren, MD 32-51-237437 ddeeren@hhr.be CHU Sart Tilman Recruiting Liège, Belgium, 4000 Principal Investigator: Frédéric Baron, MD; PhD Sub-Investigator: Yves Beguin, MD; PhD Sub-Investigator: Evelyne Willems, MD; PhD 收起 << |
NCT00129155 | Hematological Malignancies ... 展开 >> Allogeneic Transplantation 收起 << | Phase 2 | Unknown | - | France ... 展开 >> Hôpital Edouard Herriot Recruiting Lyon, France, 69437 Contact: Mauricette MICHALLET, MD 33 472 117 329 mauricette.michallet@chu-lyon.fr Principal Investigator: Mauricette Michallet, MD 收起 << |
NCT00676806 | - | Terminated(Slow accrual) | - | - | |
NCT00429416 | - | Completed | - | - | |
NCT01240525 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | June 2020 | United Kingdom ... 展开 >> Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Principal Investigator: Richard Lovell, Dr Bristol Royal Hospital for Children Recruiting Bristol, United Kingdom Principal Investigator: Stephen Robinson, Dr Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Ben Uttenthal, Dr Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Principal Investigator: Andrew Clark, Dr St James's University Hospital Recruiting Leeds, United Kingdom Principal Investigator: Maria Gilleece, Dr Leicester Royal Infirmary Recruiting Leicester, United Kingdom Principal Investigator: Ann Hunter, Dr University College Hospital London (UCLH) Recruiting London, United Kingdom Contact r.chakraverty@ucl.ac.uk Principal Investigator: Ronjon Chakraverty, Prof Christie Hospital Recruiting Manchester, United Kingdom Principal Investigator: Adrian Bloor, Dr Nottingham City Hospital Recruiting Nottingham, United Kingdom Principal Investigator: Nigel Russell, Prof Royal Hallamshire Hospital Recruiting Sheffield, United Kingdom Principal Investigator: John Snowden, Professor University Hospitals Southampton Recruiting Southampton, United Kingdom Principal Investigator: Debbie Richardson, Dr 收起 << |
NCT03295058 | Severe Aplastic Anemia | Phase 2 Phase 3 | Not yet recruiting | June 2020 | - |
NCT00429416 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Thomas Jefferson University` Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT00145626 | - | Completed | - | - | |
NCT00535912 | Leukemia, Lymphocytic, Chronic | Phase 3 | Completed | - | - |
NCT00145626 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphocytic Leukemia Myelodysplasia Chronic Myeloid Leukemia Histiocytosis 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00342316 | Acute Myeloid Leukemia | Phase 3 | Unknown | December 2017 | - |
NCT00006250 | Lymphoma | Phase 3 | Unknown | - | - |
NCT02920008 | Acute Myeloid Leukemia | Phase 3 | Active, not recruiting | December 2019 | - |
NCT03016806 | Acute Leukemia ... 展开 >> Immune Deficiency Disorder Congenital Hematological Disorder Metabolism Disorder Aplastic Anemia Myelodysplastic Syndromes Chronic Leukemia Lymphoma Multiple Myeloma Solid Tumor 收起 << | Phase 1 | Recruiting | June 2026 | United States, New York ... 展开 >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jane L Liesveld, MD 585-275-4099 jane_liesveld@urmc.rochester.edu Contact: Michael W Becker, MD 585-275-4099 michael_becker@urmc.rochester.edu 收起 << |
NCT03349502 | Acute Myeloid Leukemia | Phase 2 | Recruiting | January 1, 2020 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Sang-A Kim, MD +82 10 3026 0621 sanga0906@naver.com Principal Investigator: Youngil Koh, MD Sub-Investigator: Sung soo Yoon, MD, PhD Sub-Investigator: In ho Kim, MD Sub-Investigator: Dong-Yeop Shin, MD 收起 << |
NCT00636909 | AML ALL ... 展开 >> CML Chronic Phase, Accelerated Phase, or Blast Crisis CLL MDS RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA APLASTIC ANEMIA MULTIPLE MYELOMA MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) 收起 << | Phase 2 | Completed | - | - |
NCT01362452 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00149006 | Tumors | Phase 2 | Unknown | - | Israel ... 展开 >> Hadassah Medical Organization Recruiting Jerusalem, Israel, 91120 Contact: Shimon Slavin, MD +972-2-6776561 slavin@hadassah.org.il 收起 << |
NCT00886522 | Hematological Malignancies | Phase 2 | Completed | - | Italy ... 展开 >> Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy, 40138 收起 << |
NCT00338494 | B-Cell Lymphoma | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT03198195 | - | Enrolling by invitation | July 10, 2020 | - | |
NCT01690520 | Acute Biphenotypic Leukemia ... 展开 >> Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Stanford Cancer Institute Palo Alto Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01828489 | Pediatric Acute Myeloblastic L... 展开 >>eukemia 收起 << | Phase 3 | Recruiting | March 2023 | Belgium ... 展开 >> HUDERF, L'Hôpital des Enfants Hématologie / Oncologie Recruiting Brussel, Belgium, 1020 Contact: Laurence Dedeken, MD, PhD +32 2 4773311 laurence.dedeken@huderf.be UZ Brussel, Pediatrische Hemato-Oncologie F930 Recruiting Brussel, Belgium, 1090 Contact: Jutte Van der Werff ten Bosch, MD, PhD +32 2 4774111 JVDWerff@uzbrussel.be UCL, Cliniques Universitaires Saint-Luc Recruiting Brussel, Belgium, 1200 Contact: Sophie Dupont, MD, PhD +32 2 7641111 sophie.dupont@uclouvain.be Ghent University Hospital, Children´s Hospital, Princess Elisabeth, Department of Pediatric Hematology-Oncology Recruiting Ghent, Belgium, 9000 Contact: Barbara de Moerloose, MD, PhD barbara.demoerloose@uzgent.be UZ Leuven, Kinder Hemato-Oncologie Recruiting Leuven, Belgium, 3000 Contact: Anne Uyttebroeck, MD, PhD +32 16 33 22 11 anne.uyttebroeck@uzleuven.be CHR Citadelle Recruiting Liège, Belgium Contact: Marie-Françoise Dresse, MD, PhD +32 42238980 marie.francoise.dresse@chrcitadelle.be CHC Espérance Recruiting Montegnée, Belgium Contact: Pierre Philippet, MD, PhD +32 42249111 pierre.philippet@chc.be Denmark Department of Pediatrics, Aarhus University Hospital Skejby Recruiting Aarhus, Denmark, 8200 Contact: Henrik Hasle, MD, PhD hasle@dadlnet.dk Dept of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen Recruiting Copenhagen, Denmark Contact: Birgitte Lausen, MD, PhD birgitte.lausen@rh.regionh.dk Estonia Tallinn Children's Hospital, Dep. Hematology oncology Not yet recruiting Tallinn, Estonia, 13419 Contact: Kadri Saks, MD, PhD kadri.saks@lastehaigla.ee Finland Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Kirsi Jahnukainen, MD, PhD kirsi.jahnukainen@ki.se Department of Pediatrics, Kuopio University Hospital Recruiting Kuopio, Finland, 70211 Contact: Pekka Riikonen +358 447172392 pekka.riikonen@kuh.fi Principal Investigator: Pekka Riikonen Department of Pediatrics, Oulu University Hospital Recruiting Oulu, Finland, 90029 Contact: Merja Möttönen +358 83155251 merja.mottonen@ppshp.fi Principal Investigator: Merja Möttönen Department of Pediatrics, Tampere University Central Hospital Recruiting Tampere, Finland, 33521 Contact: Mikko Arola +358 3 31164386 mikko.arola@pshp.fi Principal Investigator: Mikko Arola Department of Pediatrics, Turku University Central Hospital Recruiting Turku, Finland, 20520 Contact: Minna Koskenvuo, MD, PhD +358 50 3624430 minna.koskenvuo@utu.fi Principal Investigator: Minna Koskenvuo Hong Kong Dept of Paediatrics & Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Shau-Yin Ha, MD, PhD syha@hku.hk Iceland Children´s Hospital, Landspitali University Hospital Not yet recruiting Reykjavik, Iceland Contact: Olafur Jonsson, MD, PhD olafurgi@landspitali.is Netherlands VU University Medical Center Department of Pediatric Oncology/Hematology Recruiting Amsterdam, Netherlands, 1007 Contact: Gertjan Kaspers, MD, PhD GJL.Kaspers@vumc.nl Emma Children's Hospital/ Amsterdam Medical Center Department of Pediatric Oncology Recruiting Amsterdam, Netherlands, 1100 DD Contact: Huib Caron, MD, PhD h.n.caron@amc.uva.nl Department of Pediatric Oncology/Hematology Beatrix childrens hospital / University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Eveline de Bont, MD, PhD e.de.bont@bkk.umcg.nl University Medical Center Nijmegen Department of Pediatric Oncology/Hematolog Recruiting Nijmegen, Netherlands, 6500 HB Contact: Dunja te Loo, MD, PhD m.teloo@cukz.umcn.nl Erasmus MC - Sophia Childrens Hospital University Medical Center Rotterdam Recruiting Rotterdam, Netherlands, 3000 CB Contact: Marry van den Heuvel-Eibrink, MD, PhD m.vandenheuvel@erasmusmc.nl Norway Department of Pediatrics, Haukeland University Hospital, Bergen Recruiting Bergen, Norway, 5021 Contact: Dorota , Wojcik +47 55 97 50 00 dorota.malgorzata.wojcik@helse-bergen.no Principal Investigator: Dorota Wojcik Pediatric Dept, Women and Children's Division, Oslo University Hospital Rikshospitalet Recruiting Oslo, Norway, N-0424 Contact: Bernward Zeller, MD, PhD bernward.zeller@ous-hf.no Department of Pediatrics, University Hospital of North Norway, Tromsoe Recruiting Tromsoe, Norway, N-9038 Contact: Trond Flaegstad +47 91507766 Trond.Flaegstad@unn.no Principal Investigator: Trond Flaegstad Department of Cancer and Haemathology, St Olavs Hospital, Trondheim University Hospital Recruiting Trondheim, Norway, N-7006 Contact: Svein Kolmannskog +47 815 55 850 svein.kolmannskog@ntnu.no Principal Investigator: Svein Kolmannskog Sweden Queen Silvias Childrens and Adolescents Hospital Recruiting Gothenburg, Sweden, 41685 Contact: Jonas Abrahamsson, MD, PhD jonas.abrahamsson@vgregion.se Principal Investigator: Jonas Abrahamsson Dept of Pediatrics, Linköpings University Hospital Recruiting Linköping, Sweden, 58185 Contact: Mikael Behrendtz, MD, PhD Principal Investigator: Mikael Behrendtz Dept of Pediatrics, Skåne University Hospital Recruiting Lund, Sweden, 22241 Contact: Cornelis Pronk, MD, PhD kees-jan.pronk@med.lu.se Astrid Lindgrens Barnsjukhus, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Karin Belander-Strålin, MD karin.belander-stralin@karolinska.se Dept of Pediatrics, Norrlands University Hospital Recruiting Umeå, Sweden, 90185 Contact: Ulrika Norén-Nyström, MD, PhD Ulrika.norennystrom@pediatri.umu.se Dept of Pediatrics, Akademiska barnsjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Josefine Palle, MD, PhD josefine.palle@akademiska.se 收起 << |
NCT01252667 | Acute Myeloid Leukemia | Phase 2 | Active, not recruiting | - | United States, Colorado ... 展开 >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Louisiana Ochsner Medical Center Jefferson New Orleans, Louisiana, United States, 70121 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01790295 | Primary Myelofibrosis ... 展开 >> Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis 收起 << | Phase 2 | Active, not recruiting | February 2021 | United States, Georgia ... 展开 >> Emory Hospital Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University, Robert h. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27103 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada Princess Margaret Cancer Centre, University of Toronto Toronto, Canada, M5G 2M9 United Kingdom University of Oxford Oxford, United Kingdom, OX3 9DS 收起 << |
NCT00179764 | Tumors Malign... 展开 >>ant Melanoma Hematological Malignancies Myelogenous Leukemia, Chronic Leukemia, Lymphoblastic, Acute 收起 << | Phase 2 | Unknown | December 2016 | United States, Illinois ... 展开 >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Morris Kletzel, M.D. 收起 << |
NCT01745913 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10026 收起 << |
NCT00040417 | Sickle Cell Anemia ... 展开 >> Hemoglobinopathy Thalassemia 收起 << | Phase 2 | Terminated | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT02950051 | Chronic Lymphocytic Leukemia | Phase 3 | Recruiting | January 2024 | - |
NCT01745913 | - | Terminated(Slow accrual) | - | - | |
NCT00051311 | Hematologic Neoplasms | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00972101 | Stem Cell Transplantation ... 展开 >> Leukemia Lymphoma Pediatric Disorders 收起 << | Phase 1 | Withdrawn(Development of other... 展开 >> studies led to termination without recruitment.) 收起 << | - | - |
NCT03361748 | Multiple Myeloma | Phase 2 | Active, not recruiting | November 1, 2023 | United States, California ... 展开 >> University of California - San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Belgium Universitaire Ziekenhuizen Leuven Leuven, Flemish Brabant, Belgium, 3000 Canada Princess Margaret Cancer Centre Toronto, Canada, M5G 2M9 France Centre Hospitalier Regional Universitaire de Lille-Hopital Calude Huriez Service des Maladies du Sang Lille, Hauts-de-France, France, 59037 Centre Hospitalier Universitaire de Nantes - Hotel Dieu Nantes, Pays De La Loire, France, 44093 Germany Universitatsklinikum Heidelberg Medizinische Klinik Krehl-Klinik Haematologie, Onkologie, Rheumato Heidelberg, Baden-Württemberg, Germany, 69120 University of Tübingen Tübingen, Baden-Württemberg, Germany, 72076 Universitatsklinikum Würzburg Würzburg, Bavaria, Germany, 97080 Italy Azienda Ospedaliero Universitaria Di Bologna Policlinico Bologna, Emilia-Romagna, Italy, 40138 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Spain Hospital Universitari Germans Trias i Pujol Can Ruti Badalona, Barcelona, Spain, 08916 Clinica Universidad de Navarra Pamplona, Navarre, Spain, 31008 收起 << |
NCT02220985 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Donor Lymphoblastic Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia 收起 << | Phase 2 | Recruiting | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Alison Sehgal 412-864-7764 sehgalar@upmc.edu Principal Investigator: Alison Sehgal United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley 206-667-6572 mbleakle@fredhutch.org Principal Investigator: Marie Bleakley 收起 << |
NCT01005745 | Metastatic Melanoma | Not Applicable | Active, not recruiting | December 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00004485 | Sickle Cell Anemia | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Children's Hospital of Oakland Oakland, California, United States, 94609 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT02153580 | Post-transplant Lymphoprolifer... 展开 >>ative Disorder B-Cell Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Lymphoplasmacytic Lymphoma 收起 << | Phase 1 | Recruiting | December 2021 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Tanya Siddiqi 800-826-4673 Principal Investigator: Tanya Siddiqi 收起 << |
NCT03670966 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia in Remission Chronic Myelomonocytic Leukemia Myeloproliferative Neoplasm, Unclassifiable 收起 << | Phase 1 Phase 2 | Not yet recruiting | September 1, 2024 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Phuong Vo Principal Investigator: Phuong Vo 收起 << |
NCT00053014 | Leukemia | Phase 2 | Terminated(Poor accrual) | - | - |
NCT00053014 | - | Terminated(Poor accrual) | - | - | |
NCT01005745 | - | Active, not recruiting | - | - | |
NCT01342289 | Hodgkin's Lymphoma ... 展开 >> Leukemia Myelodysplastic Syndrome(MDS) Multiple Myeloma Non Hodgkin's Lymphoma 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 收起 << |
NCT00079625 | Breast Neoplasms | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03480360 | Acute Myeloid Leukemia ... 展开 >> Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelodysplasia Myeloproliferative Disorder Myelofibrosis Lymphoma Lymphoma, Non-Hodgkin Plasma Cell Disorder 收起 << | Phase 3 | Recruiting | December 31, 2022 | United States, New Hampshire ... 展开 >> Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse 800-639-6918 cancer.research.nurse@dartmouth.edu Contact: Michael Sainz 603-650-5153 michael.sainz@hitchcock.org 收起 << |
NCT00566696 | - | Active, not recruiting | - | - | |
NCT00566696 | Leukemia, Acute Lymphocytic (A... 展开 >>LL) Leukemia, Myeloid, Acute(AML) Leukemia, Myeloid, Chronic(CML) Juvenile Myelomonocytic Leukemia (JMML) Hemoglobinuria, Paroxysmal Nocturnal (PNH) Hodgkin Lymphoma Lymphoma, Non-Hodgkin (NHL) Myelodysplastic Syndrome (MDS) 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01500161 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hodgkins Disease Non-Hodgkins Lymphoma Aplastic Anemia Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(Insufficient accrua... 展开 >>ls) 收起 << | - | United States, Texas ... 展开 >> Texas Oncology Amarillo, Texas, United States, 79106 收起 << |
NCT01682226 | Leukemia Myel... 展开 >>odysplastic Syndrome Lymphoma 收起 << | Phase 2 | Active, not recruiting | September 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02652455 | Melanoma (Skin) ... 展开 >> Skin Cancer 收起 << | Early Phase 1 | Active, not recruiting | August 2020 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT02406092 | Non-Hodgkin Lymphoma | Phase 3 | Active, not recruiting | July 16, 2019 | Algeria ... 展开 >> Hôpital Dorban CHU Annaba, Service d'Hématologie Annaba, Algeria, 23000 EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria, 09000 EHU Oran, Service d'Hématologie et de Thérapie Cellulaire Oran, Algeria, 31000 Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria, 15000 Morocco CHU 20 Aout Service D'Onco-Hematologie Pediatrique Casablanca, Morocco, 20100 Clinique AlMadina; Service hematologie Casablanca, Morocco, 20340 Centre Hospitalier Uni Ire de Marrakech; Oncologie-Hématologie Marrakech, Morocco, 40000 CHU Ibn Sina Rabat Service de medecine interne Rabat, Morocco, 10090 Tunisia CHU Fattouma Bourguiba, Monastir; Service d'hématologie Monastir, Tunisia, 5000 CHU Hédi Chacker; Service d'hématologie Sfax, Tunisia, 3025 CHU Farhat Hached; Service d'hématologie Sousse, Tunisia, 4000 Aziza Othmana Hospital; Clinical Haematology Tunis, Tunisia, 1008 Hopital Militaire d'instruction de Tunis; Service d'hématologie Tunis, Tunisia, 1008 收起 << |
NCT00923351 | Neuroblastoma ... 展开 >> Sarcoma Rhabdomyosarcoma-Embryonal Rhabdomyosarcoma- Alveolar Neuroectodermal Tumors, Primitive, Peripheral 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01652092 | SCID Omenn's ... 展开 >>Syndrome Reticular Dysgenesis Wiskott-Aldrich Syndrome Bare Lymphocyte Syndrome Common Variable Immunodeficiency Chronic Granulomatous Disease CD40 Ligand Deficiency Hyper IgM Syndrome X-linked Lymphoproliferative Disease Hemophagocytic Lymphohistiocytosis Griscelli Syndrome Chediak-Higashi Syndrome Langerhan's Cell Histiocytosis 收起 << | Not Applicable | Recruiting | December 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela R. Smith, M.D. 612-626-2778 smith719@umn.edu Principal Investigator: Angela R. Smith, M.D. 收起 << |
NCT00923195 | Melanoma Skin... 展开 >> Cancer 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00923351 | - | Completed | - | - | |
NCT00923195 | - | Completed | - | - | |
NCT01810588 | Hematologic Malignancies | Not Applicable | Recruiting | December 2019 | United States, Illinois ... 展开 >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Linda Schroeder, MS, RN 773-834-0982 lschroed@medicine.bsd.uchicago.edu Principal Investigator: Andrew Artz,, MD, PhD United States, New York Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: June Greenberg, RN 212-746-2651 jdg2002@med.cornell.edu 收起 << |
NCT00258427 | Fanconi Anemia | Phase 2 | Recruiting | January 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Margaret MacMillan, M.D. 收起 << |
NCT02294552 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoid Leukemia Lymphoma Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Immune System Diseases 收起 << | Phase 2 | Completed | - | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT01384513 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Aplastic Anemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Mastocytosis Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Waldenström Macroglobulinemia 收起 << | Phase 2 | Recruiting | July 2020 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP 215-955-8874 Principal Investigator: Dolores Grosso, DNP, CRNP Principal Investigator: Neal Flomenberg, MD Sub-Investigator: S. Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Margaret Kasner, MD Sub-Investigator: Ubaldo Martinez-Outschoorn, MD Sub-Investigator: John L Wagner, MD Sub-Investigator: Mark Weiss, MD Sub-Investigator: Maria Werner-Wasik, MD Sub-Investigator: Wenyin Shi, MD, PhD Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Thomas Klumpp, MD Sub-Investigator: Manish Sharma, MD 收起 << |
NCT01087398 | Osteopetrosis | Phase 2 Phase 3 | Unknown | December 2012 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD 84902645 ext +98-21 aahamidieh@sina.tums.ac.ir Sub-Investigator: Ardeshir Ghavamzadeh, MD Sub-Investigator: Mahdi Jalili, MD 收起 << |
NCT01807611 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Recruiting | July 2020 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon M. Triplett, MD 866-278-5833 referralinfo@stjude.org Principal Investigator: Brandon M. Triplett, MD 收起 << |
NCT00031655 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Remission Childhood Acute Lymphoblastic Leukemia in Remission Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Oregon Health and Sciences University Portland, Oregon, United States United States, Washington Veterans Affairs Puget Sound Healthcare System Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03449108 | Malignant Neoplasms of Bone an... 展开 >>d Articular Cartilage Malignant Neoplasms of Female Genital Organs 收起 << | Phase 2 | Recruiting | December 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations CR_Study_Registration@mdanderson.org 收起 << |
NCT00795132 | Acute Leukaemia ... 展开 >> Chronic Disease Leukemia Myelodysplasia Lymphoma 收起 << | Phase 2 | Completed | - | United States, Utah ... 展开 >> Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 收起 << |
NCT01181271 | - | Completed | - | - | |
NCT02790515 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myeloid Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) 收起 << | Phase 2 | Recruiting | June 2020 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon Triplett, MD 866-278-5833 referralinfo@stjude.org Principal Investigator: Brandon Triplett, MD 收起 << |
NCT00795132 | - | Completed | - | - | |
NCT01088048 | Indolent Non-Hodgkin's Lymphom... 展开 >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 收起 << |
NCT00295971 | Congenital Amegakaryocytic Thr... 展开 >>ombocytopenia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 收起 << |
NCT01760655 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Cytopenia With Multilineage Dysplasia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Recruiting | January 2020 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, RN, CRNP, DNP 215-955-8874 Principal Investigator: Dolores Grosso, RN, CRNP, DNP Principal Investigator: Neal Flomenberg, MD Sub-Investigator: S. Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Margaret Kasner, MD Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Ubaldo Outschoorn Martinez, MD Sub-Investigator: John Wagner, MD Sub-Investigator: Mark Weiss, MD 收起 << |
NCT03128996 | Severe Sickle Cell Disease ... 展开 >> Bone Marrow Failure Syndromes Metabolic Disorders Immunologic Disorders Hemoglobinopathies Non-malignant Disorders 收起 << | Phase 1 Phase 2 | Recruiting | April 2024 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD 314-454-6018 shalinishenoy@wustl.edu Contact: Lisa Murray, MA, CCRP 314-454-4240 murraylm@wustl.edu Principal Investigator: Shalini Shenoy, MD 收起 << |
NCT00925821 | Multiple Myeloma | Phase 2 | Completed | - | Germany ... 展开 >> Charité University Hospital - Virchow Klinikum Berlin, Germany Dresden University Hospital Dresden, Germany, 01307 Erlangen University Hospital Erlangen, Germany, 91054 Freiburg University Hospital Freiburg, Germany, 79106 Jena University Hospital Jena, Germany Kiel University Hospital Kiel, Germany, 24105 Munich Grosshadern University Hospital Munich, Germany, 81377 University Hospital of Munich Technical University Munich, Germany, 81675 Klinikum Nuremberg Nuremberg, Germany, 90419 Regensburg University Hospital Regensburg, Germany, 93053 Rostock University Hospital Rostock, Germany, 18057 Ulm University Hospital Ulm, Germany, 89081 收起 << |
NCT03247309 | Solid Tumor C... 展开 >>ancer Head and Neck Squamous Cell Carcinoma Non-small Cell Lung Cancer 收起 << | Phase 1 | Recruiting | December 2033 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT02229266 | Acute Myeloid Leukemia | Phase 2 | Recruiting | September 2020 | Germany ... 展开 >> Klinikum Bayreuth Not yet recruiting Bayreuth, Germany Contact: Alexander Kiani, Prof. Dr. med. alexander.kiani@klinikum-bayreuth.de Principal Investigator: Alexander Kiani, Prof. Dr. med. Klinikum Chemnitz Not yet recruiting Chemitz, Germany Contact: Regina Herbst, Dr. med. r.herbst@skc.de Principal Investigator: Mathias Hänel, PD Dr. med. Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Malte von Bonin, Dr. med. Malte.Bonin@uniklinikum-dresden.de Principal Investigator: Malte von Bonin, Dr. med. 收起 << |
NCT01181271 | Diffuse, Large B-Cell, Lymphom... 展开 >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01969942 | Ewing Sarcoma | Phase 1 | Withdrawn(No subjects meeting ... 展开 >>study inclusion were enrolled.) 收起 << | - | United States, Kentucky ... 展开 >> Pediatric Hematology/Oncology University of Louisville Louisville, Kentucky, United States, 40202 收起 << |
NCT00916045 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes Leukemia, Lymphoblastic, Acute Lymphoma, Non-Hodgkin Hodgkin Disease Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Terminated(Recruitment issues) | - | United Kingdom ... 展开 >> King's College Hosptial NHS Foundation Trust London, United Kingdom, SE5 9RS 收起 << |
NCT00003816 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 Phase 3 | Active, not recruiting | December 1, 2019 | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT00113646 | Lymphoma Leuk... 展开 >>emia Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(Expiration of MEDI-... 展开 >>507) 收起 << | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02116 收起 << |
NCT00910650 | Metastatic Melanoma | Phase 2 | Recruiting | December 2019 | United States, California ... 展开 >> University of California Los Angeles, David Geffen School of Medicine Recruiting Los Angeles, California, United States, 90095 收起 << |
NCT02013167 | Relapsed/Refractory B-precurso... 展开 >>r Acute Lymphoblastic Leukemia 收起 << | Phase 3 | Terminated | - | - |
NCT03643276 | Acute Lymphoblastic Leukemia, ... 展开 >>Pediatric 收起 << | Phase 3 | Recruiting | July 14, 2028 | - |
NCT02013167 | - | Terminated | - | - | |
NCT03240731 | Sickle Cell Disease | Phase 2 | Recruiting | September 2020 | France ... 展开 >> CHU Henri-Mondor Recruiting Créteil, France, 94000 Contact: Sébastien Maury intercommunal hospital of Créteil Recruiting Créteil, France, 94000 Contact: Corinne Pondarre Contact: Françoise Bernaudin CHU La Timone Not yet recruiting Marseille, France Contact: Claire Galambrun Hospital Necker Recruiting Paris, France Contact: Felipe Suarez Hospital Robert-Debré Recruiting Paris, France Contact: Jean-Hugue Dalle Saint-Louis hospital Recruiting Paris, France Contact: Nathalie Dhédin, MD, PhD Contact: Gérard Socie CHU Strasbourg Recruiting Strasbourg, France Contact: Catherine Paillard 收起 << |
NCT00594308 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplasia Lymphoma, Non-Hodgkin's Mantle-Cell Lymphoma Hodgkin's Disease Multiple Myeloma Myelofibrosis 收起 << | Not Applicable | Terminated(Treatment ineffecti... 展开 >>ve) 收起 << | - | United States, Indiana ... 展开 >> Indiana Universtiy Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT00048893 | Breast Neoplasms ... 展开 >> Metastases, Neoplasm 收起 << | Phase 1 Phase 2 | Terminated(The study was close... 展开 >>d to accrual due to very poor enrollment.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT00048893 | - | Terminated(The study was close... 展开 >>d to accrual due to very poor enrollment.) 收起 << | - | - | |
NCT00745420 | Sickle Cell Disease | Phase 2 | Completed | - | - |
NCT01050764 | Leukemia, Acute ... 展开 >> Chronic Myelogenous Leukemia (CML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) Acute Myelogenous Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) 收起 << | Phase 1 Phase 2 | Terminated(Safety) | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00594308 | - | Terminated(Treatment ineffecti... 展开 >>ve) 收起 << | - | - | |
NCT01050764 | - | Terminated(Safety) | - | - | |
NCT00745420 | - | Completed | - | - | |
NCT00912223 | Lymphoma, Non-Hodgkin | Phase 2 | Completed | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California, San Diego (UCSD) Medical Center La Jolla, California, United States, 92093 University of California, Davis Medical Center Sacramento, California, United States, 95817 Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610-0277 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Dana-Farber Cancer Institute (DFCI)/Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI)/Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 United States, North Carolina University of North Carolina Hospital at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7305 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio University Hospitals of Cleveland/Case Western Cleveland, Ohio, United States, 44106-5061 Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Oklahoma University of Oklahoma Medical Center Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas University of Texas, MD Anderson Cancer Research Center Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506-9162 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 收起 << |
NCT01593696 | ALL B Cell Ly... 展开 >>mphoma Leukemia Large Cell Lymphoma Non-Hodgkin Lymphoma 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03462316 | Bone Sarcoma ... 展开 >>Soft Tissue Sarcoma 收起 << | Phase 1 | Recruiting | February 15, 2020 | China, Guangdong ... 展开 >> Sun Yat-Sen Univerisity Recruiting Guangzhou, Guangdong, China, 510000 Contact: Xing Zhang, PhD,MD 86-020-87343192 zhangxing@sysucc.org.cn Principal Investigator: Xing Zhang 收起 << |
NCT00912223 | - | Completed | - | - | |
NCT02759822 | - | Recruiting | - | Brazil ... 展开 >> Instituto Nacional de Cancer Recruiting Rio de Janeiro, Brazil, 20230-130 Contact: Leonardo J Arcuri, MD +55(21)3207-1304 leonardojavier@gmail.com Contact: Simone Lermontov +55(21)3207-1261 simonelermontov@globo.com 收起 << | |
NCT01121029 | Type 1 Diabetes Mellitus | Phase 1 Phase 2 | Completed | - | Mexico ... 展开 >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo Leon, Mexico, 64460 收起 << |
NCT01037764 | Acute Lymphoid Leukemia | Phase 2 | Terminated(The PI resigned the... 展开 >> institute, and the rest investigators at the institute decided to terminate the study.) 收起 << | - | Korea, Republic of ... 展开 >> Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT00604136 | Metastatic Melanoma | Phase 2 | Recruiting | July 2020 | Israel ... 展开 >> Hadassah Medical Organization, Jerusalem, Israel Recruiting Jerusalem, Israel, 91120 Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il Sub-Investigator: Shoshana Frankenburg, PhD Principal Investigator: Michal Lotem, MD 收起 << |
NCT03321123 | Precursor B-Lymphoblastic Lymp... 展开 >>homa/Leukaemia Refractory 收起 << | Phase 2 | Not yet recruiting | December 31, 2019 | - |
NCT00793351 | Neuroblastoma | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT00881920 | Lymphoma Myel... 展开 >>oma Leukemia 收起 << | Phase 1 | Recruiting | July 2034 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Vicky Torrano 832-824-7821 vxtorran@txch.org Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD 832-824-4817 caramos@bcm.edu Contact: Vicky Torrano 832-824-7821 vxtorran@txch.org 收起 << |
NCT01814488 | Acute Leukemia | Phase 2 | Completed | - | Italy ... 展开 >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Policlinico Bari, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy Ospedale San Orsola Bologna, Italy Ospedale Regionale Generale- Divisione Ematologia Bolzano, Italy Ospedale Binaghi Cagliari, Italy Ospedale Oncologico Businco Cagliari, Italy Ospedale Ferrarotto - Ematologia Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy Ospedale Policlinico San Martino - IST Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy Ospedale Niguarda Ca' Grande Milano, Italy Ospedale San Raffaele Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy Cattedra di Medicina Interna ed Ematologia - Ospedale S. Gerardo de' i Tintori - Università degli Studi di Milano Monza, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Ospedale G. Da Saliceto di Piacenza Piacenza, Italy Cattedra di Ematologia - Policlinico Roma, Italy Policlinico A. Gemelli Roma, Italy Policlinico Universitario Tor Vergata Roma, Italy U.O. di Ematologia e Trapianti di Midollo Osseo - Azienda Osp. S. Camillo-Forlanini / Padiglione Morgagni Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Azienda ospedaliera Città della Salute e della Scienza Torino, Italy Centro Trapianti Metropolitano Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy 收起 << |
NCT03213964 | Epithelial Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Primary Peritoneal Cancer 收起 << | Phase 1 | Recruiting | April 1, 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Melissa Geller, MD 612-624-0123 gelle005@umn.edu Principal Investigator: Melissa Geller, MD 收起 << |
NCT01966367 | Bone Marrow Failure Syndrome ... 展开 >> Severe Aplastic Anemia Severe Congenital Neutropenia Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Schwachman Diamond Syndrome Primary Immunodeficiency Syndromes Acquired Immunodeficiency Syndromes Histiocytic Syndrome Familial Hemophagocytic Lymphocytosis Lymphohistiocytosis Macrophage Activation Syndrome Langerhans Cell Histiocytosis (LCH) Hemoglobinopathies Sickle Cell Disease Sickle Cell-beta-thalassemia 收起 << | Early Phase 1 | Recruiting | December 2019 | United States, New York ... 展开 >> Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN js4403@columbia.edu Contact: Danielle Dietzen, CPNP 212-305-8443 dad9025@nyp.org Principal Investigator: Diane George, MD 收起 << |
NCT02014506 | Haploidentical Hematopoietic S... 展开 >>tem Cell Transplantation Malignant Disease Non-malignant Disease 收起 << | Phase 1 Phase 2 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD 82-2-3010-3371 hojim@amc.seoul.kr Principal Investigator: Ho Joon Im, MD & PhD 收起 << |
NCT01998633 | Hemophagocytic Lymphohistiocyt... 展开 >>osis Chronic Active Epstein-Barr Virus Infection Chronic Granulomatous Disease HIGM-1 Leukocyte Adhesion Deficiency IPEX 收起 << | Phase 2 | Completed | - | - |
NCT01484470 | Hematologic Malignancies | Phase 2 | Active, not recruiting | September 2018 | United States, Illinois ... 展开 >> Loyola University Medical Center Maywood, Illinois, United States, 60153 收起 << |
NCT03672318 | Multiple Myeloma ... 展开 >> Immune System Diseases 收起 << | Phase 1 | Recruiting | October 2032 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 ssblaing@email.unc.edu Principal Investigator: Sacha Tuchman, MD, MPS 收起 << |
NCT03263767 | Graft Versus Host Disease | Phase 2 | Not yet recruiting | February 2022 | - |
NCT01861106 | GATA2 Immunod... 展开 >>eficiency MDS 收起 << | Phase 2 | Recruiting | December 31, 2021 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT01464359 | Acute Myelogenous Leukemia ... 展开 >> Refractory Acute Myelogenous Leukemia 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01464359 | - | Terminated(Slow accrual) | - | - | |
NCT01033552 | Epidermolysis Bullosa | Phase 2 | Recruiting | October 2019 | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN 612-273-2925 knelso62@fairview.org Principal Investigator: Jakub Tolar, MD, PhD 收起 << |
NCT00997529 | Metastatic Solid Tumor | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 收起 << |
NCT01065545 | Acute Myeloid Leukemia | Phase 1 | Withdrawn(Due to funding issue... 展开 >>s.) 收起 << | - | - |
NCT01751997 | Acute Myeloid Leukemia | Phase 2 Phase 3 | Recruiting | December 2019 | Korea, Republic of ... 展开 >> Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 收起 << |
NCT00054236 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT02737384 | Combined Immunodeficiencies | Phase 2 | Terminated | - | France ... 展开 >> Hôpital Necker-Enfants Malades Paris, France, 75015 收起 << |
NCT00278512 | Vasculitis | Phase 1 | Terminated(No participant enro... 展开 >>lled over five years. No plan to continue the study.) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT03615313 | Advanced Solid Tumor | Phase 1 Phase 2 | Recruiting | December 3, 2020 | China, Shanghai ... 展开 >> China Recruiting Shanghai, Shanghai, China, 200072 Contact: Xue Yang 0086-021-66301147 shsyiec@126.com Contact: Juemin Fang 0086-021-39590256 收起 << |
NCT00278512 | - | Terminated(No participant enro... 展开 >>lled over five years. No plan to continue the study.) 收起 << | - | - | |
NCT01974479 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia 收起 << | Phase 1 | Suspended(Suspended for 12 mon... 展开 >>ths - an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.) 收起 << | February 2018 | Singapore ... 展开 >> Department of Paediatrics, National University Health System Singapore, Singapore, 119228 Department of Haematology, NCIS, National University Health System Singapore, Singapore Department of Hematology, Singapore General Hospital Singapore, Singapore 收起 << |
NCT03560908 | Relapsed AML ... 展开 >>T(8;21) C-KIT Mutation 收起 << | Phase 1 | Recruiting | December 31, 2020 | China, Tianjin ... 展开 >> HBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Hui Wei 收起 << |
NCT02409576 | Ewing Sarcoma ... 展开 >> Osteosarcoma Rhabdomyosarcoma 收起 << | Phase 1 Phase 2 | Unknown | September 2018 | Singapore ... 展开 >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Chetan Dhamne (65) 6772 3361 chetan_dhamne@nuhs.edu.sg Contact: Clarice Chan (65) 67726586 chan_zi_ying_clarice@nuhs.edu.sg Principal Investigator: Chetan Dhamne Sub-Investigator: Dario Campana KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore Contact: Tan Ah Moy tan.ah.moy@kkh.com.sg Contact: Jillian Teo +65 6394-5025 Jillian.Teo.CL@kkh.com.sg 收起 << |
NCT00597714 | Hodgkin's Disease ... 展开 >> Non Hodgkin's Lymphoma Myeloma Leukemia Myelodysplasia 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Health System Durham, North Carolina, United States, 27710 收起 << |
NCT03441958 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | March 1, 2024 | Canada, Quebec ... 展开 >> CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Recruiting Montréal, Quebec, Canada, H1T2M4 Contact: Séverine Landais, PhD 514-252-3400 ext 3609 slandais.hmr@ssss.gouv.qc.ca Contact: Jean Roy, MD 514-252-3400 jroy.hmr@ssss.gouv.qc.ca 收起 << |
NCT01998633 | - | Completed | - | - | |
NCT02991898 | Acute Lymphoblastic Leukemia ... 展开 >> Burkitt Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndromes Large-cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Hodgkin Lymphoma Multiple Myeloma Acute Myelogenous Leukemia Biphenotypic Leukemia Undifferentiated Leukemia 收起 << | Phase 2 | Suspended(Considering new tech... 展开 >>nology for product.) 收起 << | January 2025 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00597714 | - | Completed | - | - | |
NCT00544115 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT02535364 | Acute Lymphoblastic Leukemia | Phase 2 | Terminated(Safety reasons) | - | United States, Alabama ... 展开 >> University of Alabama Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35295 United States, California City of Hope Duarte, California, United States, 91010 University of California San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver -- Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, Florida Sylvester Comprehensive Cancer Center/UMHC Miami, Florida, United States, 33136 United States, Georgia The Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Illinois Northwestern University Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03146234 | Hepatocellular Carcinoma | Not Applicable | Recruiting | June 15, 2020 | China, Shanghai ... 展开 >> Renji Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 20001 Contact: Bo Zhai, MD +86-021-68383134 zhaiboshi@sina.com Principal Investigator: Bo Zhai, MD Sub-Investigator: Donghua Shi, MD 收起 << |
NCT00244010 | Anemia, Aplastic ... 展开 >> Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Kostmann Syndrome 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00244010 | - | Completed | - | - | |
NCT02535364 | - | Terminated(Safety reasons) | - | - | |
NCT00890500 | Hematologic Malignancies ... 展开 >> Allogeneic Stem Cell Transplantation 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01597778 | Acute Lymphocytic Leukemia ... 展开 >> Acute Myelogenous Leukemia Burkitt's Lymphoma Follicular Lymphoma Hodgkin Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma 收起 << | Phase 3 | Active, not recruiting | June 2020 | - |
NCT03441100 | Solid Tumor, Adult ... 展开 >> Cancer Hepatocellular Carcinoma Hepatocellular Cancer Nonsmall Cell Lung Cancer Liver Cancer Lung Cancer 收起 << | Phase 1 | Recruiting | June 2033 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT03540303 | Relapsed Non Hodgkin Lymphoma | Phase 1 | Recruiting | April 30, 2020 | China, Henan ... 展开 >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Quanli Gao, M.D +86-15038171966 gaoquanli2015@126.com Contact: Lu Han, M.D +86-13838583031 luhan0377@163.com 收起 << |
NCT00966810 | Philadelphia Chromosome-positi... 展开 >>ve Chronic Myelocytic Leukemia 收起 << | Phase 2 Phase 3 | Unknown | January 2011 | Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel, 31096 收起 << |
NCT02706392 | Estrogen Receptor Negative ... 展开 >> HER2/Neu Negative Progesterone Receptor Negative Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage IV Breast Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Triple-Negative Breast Carcinoma 收起 << | Phase 1 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA 206-606-4668 immunotherapy@seattlecca.org Principal Investigator: David G. Maloney 收起 << |
NCT03259516 | Myelodysplastic Syndromes | Phase 1 Phase 2 | Recruiting | December 25, 2021 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, MD, PhD +79217961951 moisiv@mail.ru Contact: Elena V Morozova, MD, PhD +79119278229 dr_morozova@mail.ru Principal Investigator: Boris V Afanasyev, MD, Prof Sub-Investigator: Elena V Morozova, MD, PhD Sub-Investigator: Yulia V Rudnizkaya, MD, PhD Sub-Investigator: Ivan S Moiseev, MD, PhD Sub-Investigator: Nikolai Yu Tcvetkov, MD 收起 << |
NCT03270748 | Myeloid Malignancies | Phase 2 | Not yet recruiting | January 1, 2021 | Italy ... 展开 >> Ospedale San Orsola Bologna, Italy AOU-IRCCS San Martino-IST Genova, Italy A.O.U. Citta della Salute e della Scienza Not yet recruiting Torino, Italy Principal Investigator: Benedetto Bruno 收起 << |
NCT01804634 | Refractory and/or Relapsed Met... 展开 >>astatic Solid Tumors 收起 << | Phase 2 | Recruiting | December 2020 | United States, Maryland ... 展开 >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Heather Symons, MD, MHS 410-502-4997 hsymons2@jhmi.edu Principal Investigator: Heather Symons, MD, MHS 收起 << |
NCT03664661 | Relapsed/Refractory Myeloma | Phase 1 | Recruiting | April 30, 2020 | China, Henan ... 展开 >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Yongping Song +86-13521186987 ph200811@163.com Principal Investigator: Yongping Song 收起 << |
NCT03686124 | Refractory Cancer ... 展开 >> Recurrent Cancer Solid Tumor, Adult Cancer 收起 << | Phase 1 | Not yet recruiting | January 2035 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Apostolia Tsimberidou, M.D., Ph.D. 收起 << |
NCT03539406 | Recurrent Ovarian Carcinoma ... 展开 >> Recurrent Fallopian Tube Carcinoma Recurrent Primary Peritoneal Carcinoma 收起 << | Phase 1 | Not yet recruiting | May 2020 | - |
NCT03355859 | Non Hodgkin Lymphoma | Phase 1 | Recruiting | March 2022 | China, Shanghai ... 展开 >> Ruijin hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili ZHAO, MD, PhD 86-21-64370045 ext 610707 zhao.weili@yahoo.com Contact: Shu CHENG, MD, PhD 86-21-64370045 ext 665251 orenge@medmail.com.cn Principal Investigator: Weili ZHAO, MD, PhD Sub-Investigator: Shu CHENG, MD, PhD 收起 << |
NCT03344367 | Non Hodgkin Lymphoma | Phase 1 | Recruiting | March 2022 | China ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD +86-10-88196596 zj@bjcancer.org Contact: Zhitao Ying, MD +86-10-88196109 yingzhitao001@163.com Principal Investigator: Jun Zhu, MD Sub-Investigator: Zhitao Ying, MD 收起 << |
NCT03081780 | Refractory Acute Myelogenous L... 展开 >>eukemia Relapsed Acute Myelogenous Leukemia 收起 << | Phase 1 | Recruiting | January 1, 2021 | United States, Minnesota ... 展开 >> University of Minnesota, Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Sarah Cooley, MD 收起 << |
NCT03393936 | Renal Cell Carcinoma | Phase 1 Phase 2 | Recruiting | March 30, 2035 | China, Shanghai ... 展开 >> Shanghai Public Health Clinical Center Recruiting Shanghai, Shanghai, China, 200000 Contact: Tongyu Zhu 13816002121 tyzhu@fudan.edu.cn Contact: Hongliang Zong +8613817903385 zonghl@PerHum.com Principal Investigator: Tongyu Zhu 收起 << |
NCT03068819 | Acute Myeloid Leukemia in Chil... 展开 >>dren 收起 << | Phase 1 | Recruiting | November 30, 2024 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D. 314-454-8323 acashen@wustl.edu Principal Investigator: Amanda Cashen, M.D. Sub-Investigator: Jeffrey Bednarski, M.D., Ph.D. Sub-Investigator: Todd Fehniger, M.D., Ph.D. Sub-Investigator: Shalini Shenoy, M.D. Sub-Investigator: Robert Hayashi, M.D. Sub-Investigator: Andrew Cluster, M.D. Sub-Investigator: John DiPersio, M.D., Ph.D. Sub-Investigator: Peter Westervelt, M.D., Ph.D. Sub-Investigator: Geoffrey Uy, M.D. Sub-Investigator: Ravi Vij, M.D. Sub-Investigator: Camille Abboud, M.D. Sub-Investigator: Rizwan Romee, M.D. Sub-Investigator: Meagan Jacoby, M.D., Ph.D. Sub-Investigator: Iskra Pusic, M.D. Sub-Investigator: Armin Ghobadi, M.D. Sub-Investigator: Mark Schroeder, M.D. Sub-Investigator: Keith Stockerl-Goldstein, M.D. 收起 << |
NCT02360111 | Leukemia Myel... 展开 >>odysplastic Syndrome Non-Hodgkin's Lymphoma 收起 << | Not Applicable | Terminated(Lack of accrual) | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02582775 | Epidermolysis Bullosa | Phase 2 | Recruiting | September 2022 | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN 612-273-2925 knelso62@fairview.org Principal Investigator: Jakub Tolar, MD, PhD 收起 << |
NCT02842138 | B-cell Lymphoma | Phase 1 | Recruiting | June 2019 | China ... 展开 >> Peking University Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD +86-10-88196596 zj@bjcancer.org 收起 << |
NCT02360111 | - | Terminated(Lack of accrual) | - | - | |
NCT00578942 | Lymphoma Myel... 展开 >>oma Leukemia Myelodysplasia Solid Tumors 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Health Systems Durham, North Carolina, United States, 27710 收起 << |
NCT00318110 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 2 | Terminated(Unable to meet subj... 展开 >>ect enrollment goal.) 收起 << | - | United States, California ... 展开 >> University of California - Los Angeles Los Angeles, California, United States, 90095 United States, Florida Shands - University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00578942 | - | Completed | - | - | |
NCT03298828 | Acute Lymphoblastic Leukemia ... 展开 >> Burkitt Lymphoma 收起 << | Phase 1 | Not yet recruiting | October 2022 | - |
NCT01349101 | Hematological Malignancies | Phase 2 | Recruiting | February 2020 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: John L Wagner, MD 215-955-8874 Contact: Donna Zuccarello 215-955-6612 Principal Investigator: John L Wagner, MD Sub-Investigator: Neal Flomenberg, MD Sub-Investigator: Seyfettin Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Beth Colombe, PhD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Dolores Grosso, DNP, CRNP Sub-Investigator: Margaret Kasner, MD Sub-Investigator: Lisa Kearns, CRNP Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Mark Weiss, MD Sub-Investigator: Maria Werner-Wasik, MD Sub-Investigator: Ubaldo Martinez-Outschoorn, MD Sub-Investigator: Manish Sharma, MD Sub-Investigator: Thomas Klumpp, MD Sub-Investigator: Sameh Gaballa, MD 收起 << |
NCT02996773 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | April 2022 | United States, Arizona ... 展开 >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz (520) 694-4767 oambriz@email.arizona.edu Principal Investigator: Emmanuel Katsanis, MD Sub-Investigator: Faiz Anwer, MD Sub-Investigator: Daniel Persky, MD Sub-Investigator: Soham Puvvada, MD Sub-Investigator: Ali McBride, PharmD, MS, BCPS Sub-Investigator: Denise J. Roe, DrPH Sub-Investigator: Murali Kodali, MD Sub-Investigator: Lisa Kopp, DO Sub-Investigator: Ravitharan Krishnadasan, MD Sub-Investigator: Sandra Kurtin, NPC Sub-Investigator: Laura McPheeters, NP Sub-Investigator: Jana Montez, NP Sub-Investigator: Lauren Nichols, MD Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP Sub-Investigator: Lauren Sapp, NP Sub-Investigator: Katherine Whitney, NP Sub-Investigator: Andrew Yeager, MD Sub-Investigator: Yi Zeng, MD 收起 << |
NCT00113828 | Lymphoma Leuk... 展开 >>emia Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT01208896 | Lymphoma, Follicular ... 展开 >> Stem Cell Transplantation 收起 << | Phase 2 | Completed | - | France ... 展开 >> University Hospital Angers Angers Cedex 01, Angers, France, 49033 Service Hématologie, Hôpital Minjoz Besançon, France, 25030 Service Hématologie, Hôpital Augustin Morvan Brest, France, 29609 University Hospital, Caen Caen, France Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand Clermont-Ferrand, France, 63000 CHU Grenoble Grenoble, France, 38043 CHRU Lille Lille, France, 59037 CHU Limoges Limoges, France, 87042 Hôpital Edouard Herriot Lyon, France, 69374 Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier Montpellier, France, 34295 CHU Nancy Nancy, France, 54511 Service Hématologie Clinique, CHU -Hôtel Dieu Nantes, France, 44093 Service Hématologie Clinique, Hôpital Archet 1 Nice, France, 06202 APHP Hôpital Necker-Enfants malades Paris, France, 75015 APHP Hôpital Saint Louis Paris, France, 75475 APHP Hôpital Pitié-Salpêtrière Paris, France, 75651 APHP Hôpital Henri-Mondor Paris, France, 94010 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Pessac, France, 33600 CHU Poitiers - La Milétrie Poitiers, France, 86000 Service Hématologie Clinique, Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France Institut de Cancérologie de la Loire Saint Etienne, France, 60008 Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre Strasbourg, France, 67098 Service Hématologie, Hôpital Purpan Toulouse, France, 31059 CHRU Tours Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT02273856 | - | Terminated(The study was termi... 展开 >>nated due to insufficient subject enrollment and very slow enrollment.) 收起 << | - | Jordan ... 展开 >> Site JO96201 King Abdullah University Hospital Irbid, Jordan, 22110 Kuwait Site KW96501 Kuwait Cancer Control Center Shuwaikh, Kuwait, 70653 Lebanon Site Hammoud Hospital University Medical Center Beirut, Lebanon, 1600 Site Hotel Dieu De France Beirut, Lebanon, 166830 Oman Site OM96801 Sultan Qaboos University Hospital Muscat, Oman, 123 Qatar Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital Doha, Qatar, 3050 Saudi Arabia Site SA96601 Aseer Central Hospital Abha, Aseer, Saudi Arabia, 61421 United Arab Emirates Site AE97101 Sheikh Khalifa Medical City Abu Dhabi, United Arab Emirates, 51900 收起 << | |
NCT02504047 | Hematologic Neoplasms | Not Applicable | Recruiting | July 2019 | Canada, Alberta ... 展开 >> Foothills Medical Center / Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Andrew Daly, MD 4035213706 andrew.daly@albertahealthservices.ca Contact: Mamta Kantharia mamta.kantharia@albertahealthservices.ca Principal Investigator: Andrew Daly, MD Canada, Manitoba Health Sciences Center Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Contact: Kristjan Paulson, MD kpaulson@cancercare.mb.ca Principal Investigator: Kristjan Paulson, MD Sub-Investigator: Donna Wall, MD Sub-Investigator: David Szwajcer, MD Canada, Ontario Ottawa General Hospital Not yet recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Bredeson, MD cbredeson@toh.on.ca Principal Investigator: Christopher Bredeson, MD Canada, Quebec McGill University Health Centre Not yet recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Gizelle Popradi, MD gizelle.popradi@mcgill.ca Principal Investigator: Gizelle Popradi, MD Canada, Saskatchewan Royal University Hospital Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N 0W8 Contact: Mark Bosch, MD Mark.Bosch@saskcancer.ca Principal Investigator: Mark Bosch 收起 << |
NCT02386332 | - | Not yet recruiting | March 2020 | - | |
NCT03467516 | Uveal Neoplasms ... 展开 >> Melanoma, Uveal 收起 << | Phase 2 | Recruiting | August 1, 2021 | United States, Pennsylvania ... 展开 >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Krystle L Eaton, BSN 412-623-7957 mientkiewiczk@upmc.edu 收起 << |
NCT03047811 | Advanced Malignant Solid Tumor... 展开 >>s 收起 << | Not Applicable | Recruiting | December 31, 2017 | China, Shanghai ... 展开 >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Wu X hua, doctor 13482888167 xhwu2011@yahoo.com 收起 << |
NCT00084695 | Childhood Langerhans Cell Hist... 展开 >>iocytosis Fanconi Anemia Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 | Unknown | - | United States, Pennsylvania ... 展开 >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Kenneth G. Lucas, MD 717-531-6012 klucas@psu.edu 收起 << |
NCT00807196 | Non-Hodgkins Lymphoma | Phase 1 Phase 2 | Unknown | December 2012 | Canada, Quebec ... 展开 >> Hopital Maisonneuve-Rosemont Recruiting Montreal, Quebec, Canada, H2V 1W7 Contact: Thomas Kiss, MD (514)252-3404 thomas.kiss@umontreal.ca Contact: Dominique Beaupré, BSc nursing (514)252-3400 ext 5605 dbeaupré.hmr@ssss.gouv.qc.ca Principal Investigator: Thomas Kiss, M.D. 收起 << |
NCT03590574 | T Cell Non-Hodgkin Lymphoma ... 展开 >> Peripheral T-Cell Lymphoma, Not Otherwise Specified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | December 2022 | United Kingdom ... 展开 >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dr Kate Cwynarski The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Contact: Professor John Radford Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Dr Tobias Menne 收起 << |
NCT03373071 | CD19-ALL CD19... 展开 >>-LNH 收起 << | Phase 1 Phase 2 | Recruiting | December 2027 | Italy ... 展开 >> Ospedale Pediatrico Bambino Gesù Recruiting Roma, Italy Contact: Franco Locatelli, MD, PhD 066859 ext 2678 franco.locatelli@opbg.net Principal Investigator: Franco Locatelli, MD, PhD 收起 << |
NCT02706405 | BCL2 Gene Rearrangement ... 展开 >> BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High-Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements MYC Gene Rearrangement Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma 收起 << | Phase 1 | Recruiting | December 1, 2033 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA 206-606-4668 immunotherapy@seattlecca.org Principal Investigator: Cameron J. Turtle 收起 << |
NCT03287804 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | October 2020 | Netherlands ... 展开 >> VU University Medical Centre Amsterdam Recruiting Amsterdam, Netherlands Principal Investigator: Professor Sonja Zweegman United Kingdom University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rakesh Popat The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Principal Investigator: Dr James Cavet Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Tobias Menne 收起 << |
NCT03672851 | Acute Leukemia ... 展开 >> Acute Leukemia in Relapse Acute Myeloid Leukemia Relapsed or Refractory Acute Leukemia 收起 << | Phase 1 | Recruiting | December 31, 2020 | China, Shaanxi ... 展开 >> Second Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shaanxi, China, 710000 Contact: Aili He, MD, PhD 86-29-87679459 heaili@mail.xjtu.edu.cn Contact: Jian-Li Wang, MD, PhD 86-29-87679457 wangjianli73@sina.cn Principal Investigator: Aili He, MD, PhD 收起 << |
NCT02665065 | Acute Myeloid Leukemia ... 展开 >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute 收起 << | Phase 3 | Recruiting | June 2020 | United States, Arizona ... 展开 >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada 收起 << |
NCT02199301 | End Stage Renal Disease | Not Applicable | Unknown | December 2017 | Korea, Republic of ... 展开 >> Samsung Medical Center, Organ Transplant Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Sung Joo Kim, MD, PhD 82-2-3410-3476 kmhyj.kim@samsung.com Contact: Jae Berm Park, MD, PhD 82-2-3410-3647 jbparkmd@gmail.com Principal Investigator: Sung Joo Kim, MD, PhD Sub-Investigator: Jae Berm Park, MD, PhD 收起 << |
NCT00275678 | Blood Stem Cell Transplant | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01067300 | Leukemia | Phase 3 | Unknown | January 2016 | France ... 展开 >> Assistance Publique - Hôpitaux de Marseille Marseille, France 收起 << |
NCT01461837 | Sickle Cell Disease | Phase 2 | Recruiting | April 2019 | United States, California ... 展开 >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Theodore Moore, MD 310-825-6708 tbmoore@mednet.ucla.edu Contact: LaMarr Taylor, CCRP 310-794-8929 LaMarrTaylor@mednet.ucla.edu Principal Investigator: Theodore Moore, MD Children's Hospital and Research Center Oakland Completed Oakland, California, United States, 94609 United States, Illinois Lurie Children's Hospital Completed Chicago, Illinois, United States, 60611-2605 United States, Missouri Washington University/St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD 314-454-6018 Shenoy@kids.wustl.edu Contact: Megan Holtmann 314-454-6018 Principal Investigator: Shalini Shenoy, MD United States, New York New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD 914-594-2150 mitchell_cairo@nymc.edu Contact: Sandi Fabricatore, RN, PNP 914-594-2152 Fabricatores@wcmc.com Principal Investigator: Mitchell S Cairo, MD United States, Ohio Cincinnati Children's Hospital Withdrawn Cincinnati, Ohio, United States, 45229 United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Julie Talano, MD 414-955-4185 jtalano@mcw.edu Contact: Kathy Jodarski 414-266-2681 kjodarski@chw.org Principal Investigator: Julie Talano, MD 收起 << |
NCT02672501 | Leukemia, B-Cell | Phase 1 Phase 2 | Recruiting | December 2019 | China, Shanghai ... 展开 >> Shanghai Changhai Hospital,The Second Military Medical University Recruiting Shanghai, Shanghai, China, 200090 Contact: Jianmin Yang, Doctor 18317172636 yangjianmin@csco.org.cn 收起 << |
NCT00775931 | Severe Osteopetrosis | Phase 2 Phase 3 | Unknown | October 2015 | United States, Minnesota ... 展开 >> University of MInnesota, Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01218867 | - | Completed | - | - | |
NCT02013817 | Lymphocytic Leukemia, Chronic | Phase 2 | Completed | - | Austria ... 展开 >> Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria, 6020 LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria, 8700 Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria, 4010 A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria, 4020 Kepler Universitätskliniken GmbH - Med Campus III; I. Medizinische Abteilung Linz, Austria, 4020 Landeskrankenhaus Rankweil; Interne E Rankweil, Austria, 6830 Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt. Salzburg, Austria, 5020 Klinikum Kreuzschwestern Wels; Iii. Interne Abt. Wels, Austria, 4600 收起 << |
NCT01218867 | Metastatic Cancer ... 展开 >> Metastatic Melanoma Renal Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02199041 | Hematological Malignancies | Phase 2 | Terminated(The study was halte... 展开 >>d early due to slow accrual.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT02013817 | - | Completed | - | - | |
NCT00255710 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT00078858 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Childhood Renal Cell Carcinoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, California ... 展开 >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Italy University of Torino Torino, Italy, 10126 收起 << |
NCT03767725 | Multiple Myeloma in Relapse | Phase 1 | Recruiting | September 1, 2021 | China, Guangdong ... 展开 >> Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Weihong Chen 86-755-83366388 ext 8199 whitney-cindy@hotmail.com Contact: Xin Du 86-755-83366388 ext 8197 duxingz@medmail.com.cn 收起 << |
NCT02199041 | - | Terminated(The study was halte... 展开 >>d early due to slow accrual.) 收起 << | - | - | |
NCT00670748 | - | Terminated(A more highly selec... 展开 >>ted protocol with ESO TCR opened for pts with melanoma) 收起 << | - | - | |
NCT02395822 | Acute Myelogenous Leukemia | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00670748 | Metastatic Melanoma ... 展开 >> Metastatic Renal Cell Cancer Metastatic Cancer 收起 << | Phase 2 | Terminated(A more highly selec... 展开 >>ted protocol with ESO TCR opened for pts with melanoma) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01231412 | - | Completed | - | - | |
NCT01385423 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03531736 | Myeloid Diseases | Phase 1 | Recruiting | May 2020 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roni Tamari, MD 212-639-5987 Contact: Miguel-Angel Perales, MD 212-639-8682 Principal Investigator: Roni Tamari, MD 收起 << |
NCT02395822 | - | Completed | - | - | |
NCT01231412 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Hodgkin Lymphoma Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia 收起 << | Phase 3 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver, Colorado, United States, 80217-3364 Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Denmark Aarhus University Hospital Arhus, Denmark, 8200 Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 收起 << |
NCT03593902 | Systemic Sclerosis ... 展开 >> Scleroderma 收起 << | Phase 2 Phase 3 | Recruiting | January 2026 | United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley 312-695-4960 k-quigley@northwestern.edu Principal Investigator: Richard Burt, MD Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley, RN 312-695-8192 kathleen.quigley@nm.org Principal Investigator: Richard Burt, MD 收起 << |
NCT01898793 | Leukemia, Myeloid, Acute | Phase 1 Phase 2 | Recruiting | December 31, 2020 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D. 314-434-8323 acashen@wustl.edu Principal Investigator: Amanda Cashen, M.D. Sub-Investigator: Camille Abboud, M.D. Sub-Investigator: Todd Fehniger, M.D., Ph.D. Sub-Investigator: John DiPersio, M.D., Ph.D. Sub-Investigator: Meagan Jacoby, M.D., Ph.D. Sub-Investigator: Iskra Pusic, M.D. Sub-Investigator: Mark Schroeder, M.D. Sub-Investigator: Keith Stockerl-Goldstein, M.D. Sub-Investigator: Geoffrey Uy, M.D. Sub-Investigator: Ravi Vij, M.D. Sub-Investigator: Lukas Wartman, M.D. Sub-Investigator: John Welch, M.D.,Ph.D. Sub-Investigator: Peter Westervelt, M.D., Ph.D. Sub-Investigator: Armin Ghobadi, M.D. Sub-Investigator: Michael Tomasson, M.D. Sub-Investigator: Matthew Walter, M.D. Sub-Investigator: Tanya Wildes, M.D. Sub-Investigator: Brad Kahl, M.D. Sub-Investigator: Terrence Wong, M.D. Ph.D. Sub-Investigator: Jeffery Bednarski, M.D., Ph.D. Sub-Investigator: Shalini Shenoy, M.D. Sub-Investigator: Robert Hayashi, M.D. Sub-Investigator: Sima Bhatt, M.D. 收起 << |
NCT00691015 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << |
NCT03050216 | Acute Myeloid Leukemia | Phase 2 | Suspended(Interim Analysis) | September 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00691015 | - | Completed | - | - | |
NCT00505921 | Lymphoma | Phase 2 | Terminated(Slow Accrual.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03610490 | High Grade Ovarian Serous Aden... 展开 >>ocarcinoma Oligometastasis Ovarian Carcinosarcoma Pancreatic Ductal Adenocarcinoma Recurrent Osteosarcoma Recurrent Ovarian Carcinoma Refractory Osteosarcoma Refractory Ovarian Carcinoma 收起 << | Phase 2 | Recruiting | September 30, 2021 | United States, Texas ... 展开 >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ljiljana Milojevic 713-792-8578 lmilojev@mdanderson.org Principal Investigator: Amir A. Jazaeri 收起 << |
NCT02080195 | - | Terminated(Study was unable to... 展开 >> accrue subjects) 收起 << | - | - | |
NCT02080195 | Lupus Erythematosus ... 展开 >> Graft-versus-host Disease 收起 << | Phase 1 Phase 2 | Terminated(Study was unable to... 展开 >> accrue subjects) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 收起 << |
NCT03597594 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 1 Phase 2 | Recruiting | July 1, 2028 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Ewelina Mamcarz, MD 866-278-5833 referralinfo@stjude.org 收起 << |
NCT02259348 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myelogenous Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) 收起 << | Phase 2 | Terminated(Investigator's deci... 展开 >>sion.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00505921 | - | Terminated(Slow Accrual.) | - | - | |
NCT00741455 | Hematologic Malignancies | Not Applicable | Active, not recruiting | December 2023 | United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 收起 << |
NCT01527045 | Aggressive Non-Hodgkin Lymphom... 展开 >>a Blasts Under 5 Percent of Bone Marrow Nucleated Cells Chronic Lymphocytic Leukemia Loss of Chromosome 17p Myelodysplastic/Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Aggressive Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> Presbyterian - Saint Lukes Medical Center - Health One Completed Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marco Mielcarek 206-667-2827 mmielcar@fhcrc.org Principal Investigator: Marco Mielcarek 收起 << |
NCT02259348 | - | Terminated(Investigator's deci... 展开 >>sion.) 收起 << | - | - | |
NCT00924287 | - | Terminated(This study was term... 展开 >>inated after the first patient treated on study died as a result of the treatment.) 收起 << | - | - | |
NCT01050855 | Non Malignant Diseases ... 展开 >> Immunodeficiencies Hemoglobinopathies 收起 << | Phase 2 | Recruiting | December 2018 | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn 215-590-1303 mcglynn@email.chop.edu Contact: Patricia Hankins, RN 215 590-5168 hankinsp@email.chop.edu Principal Investigator: Nancy J Bunin, MD 收起 << |
NCT03526185 | Metastatic Melanoma | Early Phase 1 | Recruiting | December 1, 2019 | United States, Connecticut ... 展开 >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Michael E Hurwitz, MD, PhD 收起 << |
NCT00924287 | Metastatic Cancer | Phase 1 Phase 2 | Terminated(This study was term... 展开 >>inated after the first patient treated on study died as a result of the treatment.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02888301 | Malignant Neoplasm | Not Applicable | Recruiting | June 12, 2021 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Martin Allen-Auerbach 310-983-1444 Principal Investigator: Martin Allen-Auerbach 收起 << |
NCT02925351 | Autoimmune Disease ... 展开 >> Crohn Disease Inflammatory Disorder Rheumatoid Arthritis Systemic Lupus Erythematosus Takayasu Arteritis 收起 << | Not Applicable | Recruiting | January 25, 2022 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Martin Allen-Auerbach 310-983-1444 Principal Investigator: Martin Allen-Auerbach 收起 << |
NCT00189488 | Graft Versus Host Disease ... 展开 >> Hematologic Malignancies 收起 << | Phase 2 | Completed | - | - |
NCT03296137 | Cancer | Phase 1 Phase 2 | Recruiting | March 13, 2020 | Denmark ... 展开 >> Center for Cancer immune Therapy (CCIT), Dept. of Hematology and dept. of Oncology Recruiting Copenhagen, Denmark, 2730 Contact: Anders H Kverneland, MD anders.kverneland@regionh.dk 收起 << |
NCT00328237 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Non-Hodgkin Lymphoma Myelodysplastic Syndromes 收起 << | Phase 2 | Unknown | - | United States, Colorado ... 展开 >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Sub-Investigator: Scott Bearman, MD Sub-Investigator: Robert Rifkin, MD Sub-Investigator: Mark Brunvand, MD Sub-Investigator: Jeffrey Matous, MD Sub-Investigator: Michael Maris, MD 收起 << |
NCT02765243 | Neuroblastoma ... 展开 >> Effects of Immunotherapy 收起 << | Phase 2 | Recruiting | December 30, 2019 | China, Guangdong ... 展开 >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Wu xiaoxiao +86-13826084545 zjllwyh@sina.com Contact: Wang liqing, MD +86-15918421985 wliqing2014@163.com 收起 << |
NCT00189488 | - | Completed | - | - | |
NCT00317096 | Lymphoma, Follicular ... 展开 >> Lymphoma, Low-Grade Lymphoma, Intermediate-Grade 收起 << | Phase 3 | Active, not recruiting | June 2021 | Germany ... 展开 >> German Low Grade Study Group (Glsg) Munich, Germany, D-81377 收起 << |
NCT00117598 | Lymphoma | Phase 3 | Completed | - | - |
NCT02282904 | Chronic Granulomatous Disease | Early Phase 1 | Active, not recruiting | March 1, 2023 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00810602 | Hematologic Malignancies ... 展开 >> Graft vs Host Disease 收起 << | Phase 1 Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT00810602 | - | Completed | - | - | |
NCT01497002 | Acute Myeloid Leukaemia | Phase 3 | Unknown | December 2013 | Germany ... 展开 >> University of Leipzig, Hematology Recruiting Leipzig, Germany, 04103 Principal Investigator: Dietger Niederwieser 收起 << |
NCT00145587 | Osteopetrosis | Not Applicable | Terminated(Due to the principa... 展开 >>l investigator having left the institution.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00117598 | - | Completed | - | - | |
NCT01238328 | Mucopolysaccharidosis | Phase 2 Phase 3 | Unknown | December 2012 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Teharn, Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD 84902645 ext +9821 aahamidieh@sina.tums.ac.ir Principal Investigator: Amir Ali Hmidieh, MD Sub-Investigator: Ardeshir Ghavamzadeh, MD Sub-Investigator: Kamran Alimoghaddam, MD Sub-Investigator: Mahdi Jalili, MD 收起 << |
NCT00145613 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) Acute Myeloid Leukemia (AML) Secondary AML Myelodysplastic Syndrome (MDS) Secondary MDS Chronic Myeloid Leukemia Juvenile Myelomonocytic Leukemia (JMML) Paroxysmal Nocturnal Hemoglobinuria (PNH) Lymphoma, Non-Hodgkin Hodgkin Disease 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00145587 | - | Terminated(Due to the principa... 展开 >>l investigator having left the institution.) 收起 << | - | - | |
NCT00198991 | Adult Acute Lymphocytic Leukem... 展开 >>ia 收起 << | Phase 4 | Unknown | - | Germany ... 展开 >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD ++49(0)69 6301 5194 hoelzer@em.uni-frankfurt.de Contact: Nicola Goekbuget, MD ++49(0)69 6301 6365 goekbuget@em.uni-frankfurt.de Principal Investigator: Dieter Hoelzer, MD,PhD Sub-Investigator: Nicola Goekbuget, MD 收起 << |
NCT00133367 | Multiple Myeloma ... 展开 >> Non-Hodgkin's Lymphoma Hodgkin's Disease Myelogenous Leukemia Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00199056 | Adult Acute Lymphocytic Leukem... 展开 >>ia 收起 << | Phase 4 | Completed | - | Germany ... 展开 >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 收起 << |
NCT00143559 | Leukemia Acut... 展开 >>e Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myeloid Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Paroxysmal Nocturnal Hemoglobinuria Hodgkin's Lymphoma Non-Hodgkin Lymphoma 收起 << | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT03579875 | Fanconi Anemia ... 展开 >> Severe Aplastic Anemia Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | February 2029 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN 612-273-2925 knelso62@fairview.org 收起 << |
NCT01117441 | Leukemia | Phase 3 | Active, not recruiting | December 2021 | - |
NCT03674411 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphocytic Leukemia Biphenotypic/Undifferentiated Leukemia Chronic Myelogenous Leukemia Myelodysplasia Relapsed Large Cell Lymphoma Mantle Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma Relapsed T-Cell Lymphoma Lymphoplasmacytic Lymphoma 收起 << | Phase 2 | Not yet recruiting | July 2023 | - |
NCT02894645 | Acute Lymphoblastic Leukemia (... 展开 >>ALL) 收起 << | Phase 4 | Unknown | - | Malaysia ... 展开 >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS +603 7949 6785 hany@ummc.edu.my Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS flslhp@gmail.com Contact: Lee Lee Chan, MBBS drchanleelee@gmail.com Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS (+65) 6772 4406 allen_yeoh@nuhs.edu.sg KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS (+65) 63941039 tan.ah.moy01@singhealth.com.sg 收起 << |
NCT00080925 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 收起 << |
NCT00778882 | Chronic Granulomatous Disease | Phase 1 Phase 2 | Active, not recruiting | October 2022 | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT00005802 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00055653 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | - |
NCT00027547 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Oregon ... 展开 >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Germany Universitaet Leipzig Leipzig, Germany, D-04103 收起 << |
NCT00004255 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 Phase 3 | Completed | - | United States, California ... 展开 >> University of California San Diego Cancer Center La Jolla, California, United States, 92093-0658 United States, Colorado Presbyterian-St Luke's Medical Center Denver, Colorado, United States, 80218 United States, District of Columbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Florida Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States, 32610-100277 United States, Indiana Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States, 46202 United States, Kentucky James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73190 United States, Oregon Oregon Cancer Center Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 South Texas Cancer Institute San Antonio, Texas, United States, 78229 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 收起 << |
NCT00295997 | Chronic Myeloproliferative Dis... 展开 >>orders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Not Applicable | Unknown | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 收起 << |
NCT00276809 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | Germany ... 展开 >> Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, D-12200 Universitaetsklinikum Essen Essen, Germany, D-45122 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, 55101 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 收起 << |
NCT00089453 | Multiple Myeloma | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 收起 << |
NCT00425802 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00066417 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(Trial was withdrawn... 展开 >> for drug availability issues.) 收起 << | - | United States, Maryland ... 展开 >> NIH - Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States, 20892-1182 收起 << |
NCT01085617 | Leukemia Muco... 展开 >>sitis Oral Complications 收起 << | Phase 3 | Recruiting | July 2023 | United Kingdom ... 展开 >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person 44-207-830-2833 收起 << |
NCT00454480 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00425802 | - | Completed | - | - | |
NCT01020734 | Leukemia | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Inje University - Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00187083 | Acute Lymphoblastic Leukemia | Phase 3 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00521430 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00365287 | Breast Cancer ... 展开 >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT01027000 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT01279616 | Sickle Cell Disease | Phase 2 | Terminated(PI moving to a diff... 展开 >>erent institution.) 收起 << | - | United States, Ohio ... 展开 >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 收起 << |
NCT00275015 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | - |
NCT00574496 | Lymphoma | Phase 2 | Active, not recruiting | November 2019 | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02098512 | Hodgkin Lymphoma | Phase 1 Phase 2 | Recruiting | December 2019 | United States, New York ... 展开 >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo 914-594-2150 mitchell_cairo@nymc.edu Contact: Jessica Hochberg, MD 914-594-2132 jessica_hochberg@nymc.edu 收起 << |
NCT03070327 | Multiple Myeloma | Phase 1 | Recruiting | February 2020 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sham Mailankody, MD 212-639-2131 Contact: Craig Sauter, MD 212-639-3460 Principal Investigator: Sham Mailankody, MD 收起 << |
NCT00582816 | Leukemia Soli... 展开 >>d Tumors 收起 << | Phase 1 Phase 2 | Terminated(toxicity) | - | United States, Wisconsin ... 展开 >> Kenneth DeSantes., MD Madison, Wisconsin, United States, 53972 收起 << |
NCT00028600 | Multiple Myeloma ... 展开 >> Plasma Cell Neoplasm 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Maryland Union Hospital Cancer Program at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 收起 << |
NCT02876679 | Graft vs Host Disease | Phase 2 | Recruiting | February 2020 | France ... 展开 >> Saint Antoine Hospital - Hematology Department Recruiting Paris, France, 75012 Contact: Mohamad MOHTY, PU-PH 01.49.28.26.20 ext +33 mohamad.mohty@inserm.fr Contact: Florent MALARD, CCU-AH 01.49.28.26.20 ext +33 malardf@yahoo.fr 收起 << |
NCT01027000 | - | Active, not recruiting | - | - | |
NCT00582816 | - | Terminated(toxicity) | - | - | |
NCT00262886 | Kidney Cancer | Phase 2 | Completed | - | United States, New York ... 展开 >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 收起 << |
NCT00004878 | Graft Versus Host Disease ... 展开 >> Leukemia 收起 << | Phase 2 | Withdrawn(study never opened) | - | - |
NCT00744692 | Non Malignant Disorders ... 展开 >> Immunodeficiencies Congenital Marrow Failures Hemoglobinopathies Inborn Errors of Metabolism Sickle Cell Thalassemia Lysosomal Storage Disease 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Pediatric Blood and Marrow Transplant Program Durham, North Carolina, United States, 27705 收起 << |
NCT00744692 | - | Completed | - | - | |
NCT00104975 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 收起 << |
NCT02512679 | Stem Cell Transplantation ... 展开 >> Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Allogeneic Transplantation Genetic Diseases Thalassemia Pediatrics Diamond-Blackfan Anemia Combined Immune Deficiency Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Lymphoproliferative Disease Metabolic Diseases 收起 << | Phase 2 | Terminated(Optimal dose obtain... 展开 >>ed for engraftment and minimizing toxicity) 收起 << | - | - |
NCT01252784 | - | Unknown | October 2014 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse 82-2-3010-6378 redpin75@paran.com 收起 << | |
NCT02512679 | - | Terminated(Optimal dose obtain... 展开 >>ed for engraftment and minimizing toxicity) 收起 << | - | - | |
NCT00005863 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS 收起 << |
NCT03250338 | Relapsed/Refractory Acute Myel... 展开 >>oid Leukemia With FLT3 Activating Mutations 收起 << | Phase 3 | Recruiting | October 2021 | United States, California ... 展开 >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD 916-734-5959 United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD Principal Investigator: Sunil Abhyankar, MD United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD yangj@karmanos.org Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD Principal Investigator: Yue Guo, MD United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD Principal Investigator: Eunice Wang, MD 收起 << |
NCT00005803 | Prolymphocytic Leukemia ... 展开 >> Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | September 1, 2018 | United States, Utah ... 展开 >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 收起 << |
NCT02428517 | - | Terminated(The PI resigned the... 展开 >> institute, and the rest investigators at the institute decided to terminate the study.) 收起 << | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae Paik Hospital Busan, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of 收起 << | |
NCT00005803 | - | Active, not recruiting | - | - | |
NCT01343043 | Synovial Sarcoma | Phase 1 | Recruiting | May 31, 2020 | United States, Florida ... 展开 >> GSK Investigational Site Recruiting Tampa, Florida, United States, 33612 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Maryland GSK Investigational Site Recruiting Bethesda, Maryland, United States, 20892 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Massachusetts GSK Investigational Site Recruiting Boston, Massachusetts, United States, 02114 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Missouri GSK Investigational Site Recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10065 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00028730 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT00085462 | Melanoma (Skin) | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 收起 << |
NCT01786018 | B-cell Lymphoma Refractory | Phase 2 | Unknown | February 2015 | Italy ... 展开 >> Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Benedetto Bruno, MD +390116336728 benedetto.bruno@unito.it 收起 << |
NCT00006042 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT00793572 | Refractory Plasma Cell Myeloma | Phase 2 | Active, not recruiting | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT02844530 | CD22+ Relapsed/Refractory B-AL... 展开 >>L 收起 << | Phase 2 | Withdrawn | - | France ... 展开 >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63000 收起 << |
NCT00096460 | - | Terminated(lower than anticipa... 展开 >>ted accrual) 收起 << | - | - | |
NCT00014508 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207-8554 Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 United States, Ohio Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-5065 MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00793572 | - | Active, not recruiting | - | - | |
NCT00025519 | Kidney Cancer | Phase 2 | Withdrawn | - | - |
NCT00849147 | - | Completed | - | - | |
NCT00096460 | Recurrent Grade 1 Follicular L... 展开 >>ymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Follicular Lymphoma 收起 << | Phase 2 Phase 3 | Terminated(lower than anticipa... 展开 >>ted accrual) 收起 << | - | - |
NCT01008462 | B-Cell Prolymphocytic Leukemia... 展开 >> Hypodiploidy Loss of Chromosome 17p Plasma Cell Leukemia Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Non-Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma t(14;16) t(4;14) T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia 收起 << | Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mohamed L. Sorror 206-667-6298 msorror@fhcrc.org Principal Investigator: Mohamed L. Sorror United States, Wisconsin Froedtert and the Medical College of Wisconsin Completed Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT01158118 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes Lymphoma, Non-Hodgkin Hodgkin Disease Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma 收起 << | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT03456817 | Graft-versus-host-disease ... 展开 >> Relapse 收起 << | Phase 2 | Not yet recruiting | September 2023 | - |
NCT02520908 | - | Recruiting | December 2024 | France ... 展开 >> Saint Louis hospital Recruiting Paris, France, 75010 Contact: Adèle de Masson, MD adele.de-masson@inserm.fr 收起 << | |
NCT01256398 | Acute Lymphoblastic Leukemia ... 展开 >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT01158118 | - | Completed | - | - | |
NCT02251821 | Primary Myelofibrosis ... 展开 >> Secondary Myelofibrosis 收起 << | Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit 206-667-1317 rsalit@fredhutch.org Principal Investigator: Rachel B. Salit 收起 << |
NCT00864227 | - | Completed | - | - | |
NCT00209833 | De Novo Akute Myeloid Leukemia... 展开 >> (AML) Secondary Acute Myeloid Leukemia (AML) Refractory Anemia With Excess of Blasts in Transformation 收起 << | Phase 2 Phase 3 | Unknown | - | Germany ... 展开 >> Hannover Medical School Hannover, Germany, 30625 收起 << |
NCT00849147 | Precursor B-Cell Lymphoblastic... 展开 >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California San Diego Medical Center La Jolla, California, United States, 92093 United States, Florida University of Florida College of Medicine (Shands) Gainesville, Florida, United States, 32610-0277 United States, Georgia Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States, 30342 United States, Hawaii Kapi'olani Medical Center for Women and Children, University of Hawaii Honolulu, Hawaii, United States, 96826 United States, Maryland University of Maryland, Greenbaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC) Baltimore, Maryland, United States, 21231 United States, Massachusetts DFCI, Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute, Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Fox Chase, Temple University Philadelphia, Pennsylvania, United States, 19111-2442 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT03602898 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Blasts 5 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Minimal Residual Disease Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia 收起 << | Phase 2 | Not yet recruiting | September 17, 2023 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda 206-667-4546 Principal Investigator: Masumi Ueda 收起 << |
NCT02756572 | Blasts 10 Percent or More of B... 展开 >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia 收起 << | Not Applicable | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival 206-606-1320 mperciva@seattlecca.org Principal Investigator: Mary-Elizabeth M. Percival 收起 << |
NCT00199147 | Acute Myeloid Leukemia | Phase 4 | Unknown | - | Germany ... 展开 >> University Hospital, Medical Department II Recruiting Frankfurt, Germany, 60590 Contact: Oliver G Ottmann, MD ++49-69-6301-4802 ottmann@em.uni-frankfurt.de Contact: Gesine Bug, MD ++49-69-6301-4802 g.bug@em.uni-frankfurt.de Principal Investigator: Oliver G Ottmann, MD Sub-Investigator: Gesine Bug, MD 收起 << |
NCT00914849 | - | Completed | - | - | |
NCT00998270 | Multiple Myeloma | Phase 2 Phase 3 | Unknown | October 2017 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of Contact: Ardeshir Ghavamzadeh, MD 84902635 ext +98-21 ghavamza@sina.tums.ac.ir Principal Investigator: Ardeshir Ghavamzadeh, MD Sub-Investigator: Kamran Alimoghaddam, MD Sub-Investigator: Mahdi Jalili, MD 收起 << |
NCT00864227 | Precursor B-Cell Lymphoblastic... 展开 >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida University of Florida College of Medicine, Shands Gainesville, Florida, United States, 32610-3633 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242-1009 United States, Kansas University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, Massachusetts Dana-Farber Cancer Institute (DFCI), Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College, NY Presbyterian Hospital New York, New York, United States, 10065 United States, Ohio Ohio State, Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Virginia Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital Richmond, Virginia, United States, 23298 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 收起 << |
NCT00020176 | Breast Cancer | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 收起 << |
NCT00580034 | Lymphoma Myel... 展开 >>oma Leukemia Myelodysplasia Solid Tumors 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Health Systems Durham, North Carolina, United States, 27710 收起 << |
NCT00580034 | - | Completed | - | - | |
NCT00914849 | Hematologic Neoplasms | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT01949129 | Acute Lymphoblastic Leukaemia | Phase 2 Phase 3 | Recruiting | April 2023 | - |
NCT00056095 | Kidney Cancer | Phase 2 | Unknown | - | France ... 展开 >> Centre Hospitalier Regional et Universitaire d'Angers Recruiting Angers, France, 49033 Contact: Norbert Ifrah, MD 33-2-41-35-4472 Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva 33-49-800-918-507 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact: Contact Person 33-81-668-240 Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Alain Ravaud, MD, PhD 33-5-5679-5808 alain.ravaud@chu-bordeaux.fr Chu-Hopital Gabriel Montpied Recruiting Clermont-Ferrand, France, 63003 Contact: Laurent Guy, MD 33-0473-750-750 lguy@chu-clermontferrand.fr Centre Jean Perrin Recruiting Clermont-Ferrand, France, 63011 Contact: Jean Olivier 33-73-278-080 CHU de Grenoble - Hopital Michallon Recruiting Grenoble, France, 38043 Contact: Frederic Garban, MD, PhD 33-4-7676-5028 Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD 33-32-029-5959 acaty@o-lambret.fr Centre Hospital Universitaire Hop Huriez Recruiting Lille, France, 59037 Contact: J.P. Jouet, MD 33 3 20 444197 jpjouet@chru-lille.fr Centre Hospital Regional Universitaire de Limoges Recruiting Limoges, France, 87042 Contact: Dominique Bordessoule, MD, PhD 33-5-5505-6642 bordessoule@unilim.fr Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie Negrier, MD 33-4-7878-2751 negrier@lyon.fnclcc.fr Hopital Edouard Herriot - Lyon Recruiting Lyon, France, 69437 Contact: Mauricette Michallet, MD 33-472117401 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Didier Blaise, MD 33-4-91-22-37-54 blaised@marseille.fnclcc.fr Hopital Lapeyronie-CHU Montpellier Recruiting Montpellier, France, 34295 Contact: Eric Legouffe, MD 33-4-67-33-80-79 e-legouffe@chu-montpellier.fr Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD 33-4-6761-3755 stculine@valdorel.fnclcc.fr Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD 33-04-9203-1538 antoine.thyss@cal.nice.fnclcc.fr Hopital de l'Archet CHU de Nice Recruiting Nice, France, F-06202 Contact: Contact Person 33-49-203-9267 Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Pierre T. Dorval, MD 33-1-44-324-679 thierry.dorval@curie.net Hopital Haut Leveque Recruiting Pessac, France, 33604 Contact: Reza Tabrizi, MD 33-57-656-511 Hopital Jean Bernard Recruiting Poitiers, France, 86021 Contact: Jean-Marc Tourani, MD 33-549-444-534 jm.tourani@chu.poitiers.frs.fr Centre Hospitalier Universitaire de Rennes Recruiting Rennes, France, 35033 Contact: Thiery Lamy, MD, PhD 33-2-99-28-42-91 thierry.lamy@univ-rennes1.fr Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Brigitte Laguerre 33-2-9925-3000 Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Nathalie Contentin 33-2-3208-2222 Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD 33-3-8359-8400 Hopitaux de Brabois Recruiting Vandoeuvre-Les-Nancy, France, 54511 Contact: Pierre Bordigoni Not Available Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Jean-Henri Bourhis, MD, PhD 33-1-42-11-4507 jhb@igr.fr 收起 << |
NCT00006126 | Breast Cancer ... 展开 >> Kidney Cancer Lung Cancer Melanoma (Skin) Testicular Germ Cell Tumor 收起 << | Phase 1 | Withdrawn(Unable to accrue sub... 展开 >>jects.) 收起 << | - | - |
NCT03570892 | Non-Hodgkin Lymphoma | Phase 3 | Not yet recruiting | May 26, 2025 | - |
NCT01860170 | - | Active, not recruiting | - | - | |
NCT00068523 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Not Applicable | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT01423500 | Lymphoblastic Leukemia, Acute,... 展开 >> Childhood; 收起 << | Phase 3 | Unknown | September 2016 | Austria ... 展开 >> Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie Graz, Austria, 8036 Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria, 6020 St. Anna Children's Hospital Vienna, Austria, A-1090 Czech Republic Department of Paediatric Haematology and Oncology HSCT-Unit Prague, Czech Republic, 15006 Denmark Pediatric Clinic II, Rigshospitalet Copenhagen, Denmark, 4074 France Pediatric Immuno-Hematology Unit Robert Debré Hospital Paris, France, 75935 Israel Rambam Medical Center Haifa, Israel, 31096 Schneider Children`s Medical Center of Israel Petach-Tikva, Israel, 49202 Italy Clinica Pediatrica dell`Universita di Milano Bicocca, Hospitale San Gerardo Monza, Italy, 20052 Netherlands Leiden University Hospital Leiden, Netherlands, 2300 Radboud University - Nijmegen Medical Centre Nijmegen, Netherlands, 6500 Department of Paediatric Haematology and Oncology, Wilhelmina Children's Hospital Utrecht, Netherlands, 3584 Poland University Hospital, Collegium Medicum UMK, Pediatric Hematology and Oncology Bydgoszcz, Poland, 85-094 Department of Transplantation, University Children's Hospital Cracow, Poland, 30-663 Children`s University Hospital - Hematology - Oncology Lublin, Poland, 20-093 Department of Pediadric Oncology, Hematology and Transplantology, University of Medical Sciences Poznan, Poland, 60-572 Wroclaw Medical University, Dept. of Children Hematology and Oncology Wroclaw, Poland, 50-345 Slovakia Department of Pediatric Bone Marrow Transplantation Unit, University Childrens´ Hospital Bratislava, Slovakia, 833 40 Sweden Department of Pediatric Oncology, Lund University Hospital Lund, Sweden, 221-85 Turkey Department of Pediatrics, Gülhane Military Medical Academy Ankara, Turkey, 06018 Dept. of Paediatrics - BMT Unit, School of Medicine, University of Ankara Ankara, Turkey, 06100 Department of Pediatric Hematology-Oncology and Pediatric Stem Cell Transplantation, Akdeniz University School of Medicine Antalya, Turkey, 07070 Department of Pediatric Hematology, Oncology and BMT, Istanbul School of Medicine Istanbul, Turkey, 343990 Pediatric BMT Centre, Ege University Izmir, Turkey, 35100 收起 << |
NCT01338987 | Myelodysplastic Syndrome RAEB ... 展开 >>2 Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome RAEB 1 收起 << | Phase 2 | Active, not recruiting | November 19, 2020 | United States, District of Col... 展开 >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT01860170 | Hematological Malignancy | Phase 1 Phase 2 | Active, not recruiting | March 2018 | United States, Michigan ... 展开 >> Spectrum Health Grand Rapids, Michigan, United States, 49503 收起 << |
NCT01423747 | Lymphoblastic Leukemia, Acute,... 展开 >> Childhood; 收起 << | Phase 3 | Unknown | September 2016 | Austria ... 展开 >> Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie Graz, Austria, 8036 Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria, 6020 St. Anna Kinderspital Vienna, Austria, 1090 Germany Charité Campus Virchow- Klinikum, Klinikum der Pädiatrie, Onkologie/Hämatologie/KMT Berlin, Germany, 13353 Klinik und Poliklinik für Kinderheilkunde, Hämatologie, Onkologie Dresden, Germany, 01307 Universitätsklinikum Düsseldorf, Klinik f. Kinderonkologie, Hämatologie u. Immunologie Düsseldorf, Germany, 40001 Klinik für Kinder und Jugendliche der Universität Erlangen-Nürnberg Erlangen, Germany, 91054 Universitätsklinikum Essen, Zentrum für Kinderheilkunde, Abt. für Hämatologie/Onkologie Essen, Germany, 45122 Klinik für Kinderheilkunde III, Hämatologie und Onkologie, Johann Wolfgang Goethe Universität Frankfurt am Main, Germany, 60590 Universitätsklinikum Freiburg, Zentrum für Kinderheilkunde und Jugendmedizin, Klinik IV: Päd. Hämatologie und Onkologie Freiburg, Germany, 79106 Zentrum für Kinderheilkunde, Abt. Hämatologie und Onkologie Giessen, Germany, 35385 Klinkum der Med. Fakultät der Martin-Luther-Universität Halle-Wittenberg, Uni. Klinik un Poliklinik für Kinder- und Jugendmedizin Halle, Germany, 06097 Universitätsklinikum Hamburg-Eppendorf, Kinderklinik, Abt. für Hämatologie und Onkologie Hamburg, Germany, 20246 Med. Hochschule Hannover, Päd. Hämatologie und Onkologie Hannover, Germany, 30625 Universitätskinderklinik, Päd. Hämatologie, Onkologie und Immunologie Heidelberg, Germany, 69120 Klinik für Knochenmarktransplantation Idar-Oberstein, Germany, 55743 Klinik für Kinder- und Jugendmedizin Jena, Germany, 07724 Universitätsklinikum Kiel, Klinik für Allgemeine Pädiatrie Kiel, Germany, 24105 Klinikum der Universität München, Dr. von Haunersches Kinderspital, Abt. für Hämatologie / Onkologie München, Germany, 80337 Städt. Krankenhaus München-Schwabing, Universitätskinderklinik der TU München, Germany, 80804 Universitätsklinikum Münster, Klinik und Poliklinik für Kinderheilkunde, päd. Hämatologie / Onkologie Münster, Germany, 48149 Univ.-Klinik für Kinderheilkunde und Jugendmedizin Tübingen, Germany, 72076 Universitätskinderklinik Ulm, Germany, 89075 Universitätsklinik, päd. Onkologie/Stammzelltransplantation Würzburg, Germany, 97080 收起 << |
NCT02788201 | Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00513474 | - | Completed | - | - | |
NCT02881086 | Acute Lymphoblastic Leukemia ... 展开 >> Lymphoblastic Lymphoma 收起 << | Phase 3 | Recruiting | June 2025 | Germany ... 展开 >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 收起 << |
NCT00513474 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 收起 << |
NCT02039726 | AML | Phase 3 | Active, not recruiting | July 2019 | - |
NCT02179359 | Sickle Cell Disease ... 展开 >> Transfusion Dependent Alpha- or Beta- Thalassemia Diamond Blackfan Anemia Paroxysmal Nocturnal Hemoglobinuria Glanzmann Thrombasthenia Severe Congenital Neutropenia Shwachman-Diamond Syndrome Non-Malignant Hematologic Disorders 收起 << | Not Applicable | Recruiting | August 2021 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT01422603 | Acute Myeloid Leukaemia ... 展开 >> Myelodysplasia 收起 << | Phase 1 Phase 2 | Completed | - | United Kingdom ... 展开 >> Wessex Blood and Marrow Transplant Unit, Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom, SO16 6YD 收起 << |
NCT03575351 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | January 13, 2023 | - |
NCT02627573 | Leukemia, Chronic Myeloid ... 展开 >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 收起 << | Phase 2 | Suspended | July 2020 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT02766465 | Sickle Cell Disease | Phase 2 | Recruiting | March 2023 | - |
NCT01049854 | Leukemia Lymp... 展开 >>homa Bone Marrow Failure Immunodeficiencies Histiocytosis Sickle Cell Disease Beta Thalassemia Inborn Errors of Metabolism 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> New York Medical College Valhalla, New York, United States, 10595 收起 << |
NCT01244906 | Hematologic Neoplasms | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT01625351 | Ewing Sarcoma ... 展开 >> Gastrointestinal Tumor Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carcinoma Renal Cell Carcinoma Melanoma Neuroblastoma Rhabdomyosarcoma Non-rhabdomyosarcoma 收起 << | Phase 1 | Active, not recruiting | August 19, 2019 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00101140 | Adult Acute Erythroid Leukemia... 展开 >> Adult Acute Monoblastic and Acute Monocytic Leukemia Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Withdrawn | - | - |
NCT02248597 | Graft Versus Host Disease ... 展开 >> Hematopoietic/Lymphoid Cancer 收起 << | Phase 2 | Recruiting | January 2019 | United States, North Carolina ... 展开 >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zachariah A. McIver 336-713-5440 zmciver@wakehealth.edu Principal Investigator: Zachariah A. McIver 收起 << |
NCT01244906 | - | Completed | - | - | |
NCT00003204 | Stage III Grade 1 Follicular L... 展开 >>ymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 收起 << |
NCT00719849 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(A new protocol was ... 展开 >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) 收起 << | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT01451515 | Lymphoblastic Lymphoma | Phase 2 | Active, not recruiting | June 30, 2021 | United States, California ... 展开 >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT03018223 | Non-Hodgkin's Lymphoma ... 展开 >> Acute Leukemia in Remission Chronic Myeloid Leukemia Primary Myelofibrosis Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Hodgkin Lymphoma Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | January 2021 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01621477 | - | Terminated(Study was terminate... 展开 >>d in August 2016 due to replacement by a new study.) 收起 << | - | - | |
NCT01621477 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid 收起 << | Phase 2 | Terminated(Study was terminate... 展开 >>d in August 2016 due to replacement by a new study.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00372619 | - | Completed | - | - | |
NCT02224872 | Severe Aplastic Anemia ... 展开 >> Bone Marrow Failure Syndromes 收起 << | Phase 2 | Recruiting | - | United States, Maryland ... 展开 >> The Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy DeZern, MD 410-502-7208 adezern1@jhmi.edu Contact: Clinical Trials Office- SKCCC 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Amy DeZern, MD United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: David Margolis, MD 414-337-7066 dmargoli@mcw.edu Contact: Monica Thakar, MD 414-955-7546 mthakar@mcw.edu 收起 << |
NCT01178086 | - | Completed | - | Germany ... 展开 >> PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany, 50226 收起 << | |
NCT02084563 | Acute Myeloid Leukemia ... 展开 >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm 收起 << | Phase 2 | Completed | - | Brazil ... 展开 >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 收起 << |
NCT00372619 | Leukemia | Phase 1 Phase 2 | Completed | - | - |
NCT00989664 | Lymphoma, Non-Hodgkin | Phase 2 | Completed | - | - |
NCT02316613 | - | Completed | - | France ... 展开 >> Neuilly-sur-seine, France, 92521 收起 << | |
NCT01178086 | - | Completed | - | - | |
NCT03446638 | Myelodysplastic Syndromes | Not Applicable | Not yet recruiting | September 2022 | United States, Florida ... 展开 >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 收起 << |
NCT00989664 | - | Completed | - | - | |
NCT01364363 | Severe Aplastic Anemia ... 展开 >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia 收起 << | Not Applicable | Recruiting | January 2023 | United States, California ... 展开 >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian 858-554-2845 Burian.Carol@scrippshealth.org Principal Investigator: Jeffrey W. Andrey, MD 收起 << |
NCT02316613 | - | Completed | - | - | |
NCT02520895 | - | Completed | - | France ... 展开 >> Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69310 收起 << | |
NCT03035422 | Refractory Acute Myeloid Leuke... 展开 >>mia 收起 << | Not Applicable | Recruiting | January 2021 | France ... 展开 >> Service d'hématologie Clinique Hôpital Saint Antoine Recruiting Paris, France, 75012 Contact: Rémy DULERY, PH 01.49.28.26.20 remy.dulery@aphp.fr Contact: Mohamad MOHTY, PUPH 01.49.28.26.20 mohamad.mohty@inserm.fr 收起 << |
NCT02272478 | Acute Myeloid Leukaemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 Phase 3 | Recruiting | October 2020 | United Kingdom ... 展开 >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD 收起 << |
NCT00560053 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT02356159 | Myelodysplastic Syndrome ... 展开 >> Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Acute Leukemia Multiple Myeloma 收起 << | Phase 1 Phase 2 | Recruiting | January 1, 2023 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT02551718 | Acute Leukemia of Ambiguous Li... 展开 >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 << | Not Applicable | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker 收起 << |
NCT03079089 | Refractory or Relapsed Lymphoi... 展开 >>d Haemopathy 收起 << | Not Applicable | Recruiting | June 15, 2022 | France ... 展开 >> Service d'hématologie clinique Hôpital Saint Antoine Recruiting Paris, France Contact: Rémy DULERY, PH 01.49.28.26.20 remy.dulery@aphp.fr Contact: Mohamad MOHTY, PUPH 01.49.28.26.20 mohamad.mohty@inserm.fr 收起 << |
NCT00001637 | Chronic Lymphocytic Leukemia ... 展开 >> Graft vs Host Disease Leukemia Myelodysplastic Syndrome Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00025662 | Graft vs Host Disease ... 展开 >> Myelodysplastic Syndromes Leukemia Leukemia, Myeloid Leukemia, Myelomonocytic, Chronic Leukemia, Lymphocytic Lymphoma Lymphoma, Mantle-cell Lymphoma, Non-Hodgkin Hodgkin Disease 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03114670 | Adult Acute Myeloid Leukemia | Phase 1 | Recruiting | March 18, 2021 | China ... 展开 >> Fengtai District Recruiting Beijing Shi, China Contact: Hu Chen, M.D., Ph.D. +86-010-6694-7108 chenhu217@aliyun.com 收起 << |
NCT00025662 | - | Completed | - | - | |
NCT00419250 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia, B-Cell, Chronic 收起 << | Phase 1 | Completed | - | - |
NCT00003838 | Myeloproliferative Disorders ... 展开 >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | December 31, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00122005 | Prostate Cancer | Phase 1 Phase 2 | Unknown | July 2005 | United States, Oregon ... 展开 >> Providence Portland Medical Center Portland, Oregon, United States, 97213 收起 << |
NCT02670564 | Acute Lymphoblastic Leukemia | Phase 4 | Recruiting | April 2023 | Switzerland ... 展开 >> Hôpital Cantonal de Genève, Département de Pédiatrie Recruiting Geneva, Cansearch Laboratory, Switzerland, 1211 Contact: Marc Ansari, MD, PD +41 22 382 47 31 Marc.Ansari@hcuge.ch Universitäts-Kinderspital beider Basel (UKBB), Onkologie/Hämatologie Recruiting Basel, Switzerland, 4056 Contact: Nicolas Von der Weid + 41 61 704 12 12 nicolas.vonderweid@ukbb.ch HUG Hôpitaux Universitaire de Genève, Unité d'onco-hématologie pédiatrique Recruiting Geneva, Switzerland, 1211 Contact: Marc Ansari +41 22 372 47 31 Marc.Ansari@hcuge.ch Universitäts-Kinderspital Recruiting Zurich, Switzerland, 8032 Contact: Güngör Tayfun +41 44 266 74 92 tayfun.guengoer@kispi.uzh.ch 收起 << |
NCT03103971 | Adult B Acute Lymphoblastic Le... 展开 >>ukemia BCL2 Gene Rearrangement BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified MYC Gene Rearrangement Recurrent Adult Acute Lymphoblastic Leukemia Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Adult Acute Lymphoblastic Leukemia Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma 收起 << | Phase 1 | Recruiting | July 17, 2033 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Cameron J. Turtle 206-667-7073 cturtle@fredhutch.org Principal Investigator: Cameron J. Turtle 收起 << |
NCT03391466 | Relapsed/Refractory Diffuse La... 展开 >>rge B-Cell Lymphoma (DLBCL) 收起 << | Phase 3 | Recruiting | January 15, 2035 | - |
NCT00105001 | Myelodysplastic/Myeloprolifera... 展开 >>tive Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Refractory Chronic Lymphocytic Leukemia Refractory Plasma Cell Myeloma Waldenstrom Macroglobulinemia Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Lymphoma Childhood Myelodysplastic Syndrome Stage II Contiguous Adult Burkitt Lymphoma Stage II Contiguous Adult Diffuse Large Cell Lymphoma Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Contiguous Immunoblastic Lymphoma Stage II Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Contiguous Follicular Lymphoma Stage II Grade 2 Contiguous Follicular Lymphoma Stage II Grade 3 Contiguous Follicular Lymphoma Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Adult Burkitt Lymphoma Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Non-Contiguous Immunoblastic Lymphoma Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage II Grade 3 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage II Small Lymphocytic Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Burkitt Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Myelodysplastic Syndrome Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Burkitt Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Burkitt Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Burkitt Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 2 | Completed | - | United States, Colorado ... 展开 >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Denmark Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 收起 << |
NCT02750254 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia 收起 << | Phase 1 | Active, not recruiting | October 14, 2020 | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT03602157 | Lymphoma Lymp... 展开 >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms 收起 << | Phase 1 | Recruiting | May 30, 2036 | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 spencer.laing@med.unc.edu 收起 << |
NCT00719849 | - | Terminated(A new protocol was ... 展开 >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) 收起 << | - | - | |
NCT00105001 | - | Completed | - | - | |
NCT02588612 | Neoplasms | Phase 1 | Active, not recruiting | September 19, 2019 | United States, Florida ... 展开 >> GSK Investigational Site Tampa, Florida, United States, 33612 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 收起 << |
NCT02727803 | Leukemia Lymp... 展开 >>homa Myeloma Myeloproliferative Diseases 收起 << | Phase 2 | Recruiting | May 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT03326921 | HLA-A*0201 HA-1 Positive Cells... 展开 >> Present Juvenile Myelomonocytic Leukemia Recurrent Acute Biphenotypic Leukemia Recurrent Acute Undifferentiated Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Donor Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Recurrent Myelodysplastic Syndrome Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory Myelodysplastic Syndrome 收起 << | Phase 1 | Recruiting | October 16, 2020 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley 206-667-6572 mbleakle@fredhutch.org Principal Investigator: Marie Bleakley 收起 << |
NCT02876510 | Cancer Solid ... 展开 >>Tumor 收起 << | Phase 1 | Recruiting | September 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Apostolia M. Tsimberidou, M.D., Ph.D. 收起 << |
NCT00533923 | AML ALL ... 展开 >> CLL Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Hodgkin's Lymphoma Multiple Myeloma Aplastic Anemia Myeloproliferative Disorder 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT00103558 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | United States, Alabama ... 展开 >> Research Site Birmingham, Alabama, United States United States, California Research Site San Diego, California, United States United States, Maryland Research Site Baltimore, Maryland, United States United States, Ohio Research Site Columbus, Ohio, United States United States, Texas Research Site Houston, Texas, United States 收起 << |
NCT03380039 | Refractory or Relapsed Multipl... 展开 >>e Myeloma 收起 << | Not Applicable | Recruiting | September 30, 2020 | China, Shanghai ... 展开 >> Xin Hua Hospital of Shanghai Jiao Tong University of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Siguo Hao, MD +86-021-25077600 haosghj88@hotmail.com Principal Investigator: Siguo Hao, MD 收起 << |
NCT02861417 | Other Diseases of Blood and Bl... 展开 >>ood-forming Organs Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndrome Myeloproliferative Syndrome Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma 收起 << | Phase 2 | Recruiting | August 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT03666000 | Non-Hodgkin Lymphoma ... 展开 >> B-cell Acute Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Not yet recruiting | August 2021 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 收起 << |
NCT03716856 | Refractory or Relapsed Multipl... 展开 >>e Myeloma 收起 << | Phase 1 | Recruiting | August 31, 2020 | China, Zhejiang ... 展开 >> First Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310006, Contact: Jin Jie, MD +86-0571-87236896 jiej0503@163.com Contact: Haitao Meng, MD +86-0571-87236896 menghait2004@163.com 收起 << |
NCT02960646 | Leukemia | Phase 1 | Recruiting | January 1, 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact sciurea@mdanderson.org 收起 << |
NCT00961142 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Terminated(slow recruitment) | - | Germany ... 展开 >> University of Dresden Medical Center Dresden, Germany, D-01307 Center for Marrow Transplantation, University of Essen Essen, Germany, 45122 Medical Center University of Halle Halle, Germany, 06120 Medical Center University of Hamburg Hamburg, Germany, 20246 Medical Center University of Muenster Muenster, Germany, 48149 South West German Cancer Center, University of Tuebingen Medical Center Tuebingen, Germany, 72076 Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 University of Wuerzburg Medical Center Wuerzburg, Germany, D-97070 收起 << |
NCT00947388 | Recurrent Small Lymphocytic Ly... 展开 >>mphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 1 | Terminated(No more eligible pa... 展开 >>tients) 收起 << | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT01141543 | - | Completed | - | Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << | |
NCT02118311 | Hematologic Malignancies | Phase 2 | Withdrawn(Changing study desig... 展开 >>n. Will replace with a different protocol.) 收起 << | September 2018 | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03170141 | Glioblastoma Multiforme of Bra... 展开 >>in Glioblastoma Multiforme 收起 << | Phase 1 | Enrolling by invitation | December 2020 | China, Guangdong ... 展开 >> Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China, 518000 收起 << |
NCT01985061 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 2 | Recruiting | December 2018 | France ... 展开 >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Dominique GENRE, MD 33491223778 drci.up@ipc.unicancer.fr Contact: Jihane PAKRADOUNI, PharmD, PhD 33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Didier BLAISE, MD PhD 收起 << |
NCT03233854 | B Acute Lymphoblastic Leukemia... 展开 >> CD19 Positive Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma 收起 << | Phase 1 | Recruiting | September 1, 2035 | United States, California ... 展开 >> Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Matthew Abramian 650-736-3351 abramian@stanford.edu Principal Investigator: David B. Miklos 收起 << |
NCT01478074 | Acute Myeloid Leukemia | Phase 1 | Withdrawn(The treatment planne... 展开 >>d was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects) 收起 << | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02566304 | Acute Myeloid Leukemia ... 展开 >> Acute Myeloid Leukemia in Remission Aplastic Anemia Chronic Myelomonocytic Leukemia Hodgkin Lymphoma Indolent Non-Hodgkin Lymphoma Malignant Neoplasm Myelodysplastic Syndrome Myeloproliferative Neoplasm Plasma Cell Myeloma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts 收起 << | Phase 2 | Recruiting | January 2021 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP 215-955-8874 Principal Investigator: Dolores Grosso, DNP, CRNP Principal Investigator: Neal Flomenberg, MD Sub-Investigator: S. Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Margaret Kasner, MD Sub-Investigator: Thomas Klumpp, MD Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Ubaldo Martinez Outschoorn, MD Sub-Investigator: Manish Sharma, MD Sub-Investigator: John Wagner, MD Sub-Investigator: Mark Weiss, MD 收起 << |
NCT03241940 | B Acute Lymphoblastic Leukemia... 展开 >> CD19 Positive Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia 收起 << | Phase 1 | Recruiting | August 1, 2035 | United States, California ... 展开 >> Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Christin New 650-497-8815 newc@stanford.edu Principal Investigator: Crystal L. Mackall 收起 << |
NCT00924326 | Primary Mediastinal B-cell Lym... 展开 >>phoma Diffuse, Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma Mantle Cell 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 31, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02439788 | Neuroblastoma | Phase 1 | Withdrawn(Based on newly avail... 展开 >>able preclinical data we changed the CAR construct to a more effective version and will now study that product on a different protocol.) 收起 << | October 2030 | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02763475 | Acute Myeloid Leukemia ... 展开 >> Leukemia Myeloid Leukemia 收起 << | Phase 2 | Recruiting | February 2022 | Spain ... 展开 >> Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Principal Investigator: Itciar Astigarraga Aguirre, MD Hospital Materno Infantil de Badajoz Recruiting Badajoz, Spain, 06010 Principal Investigator: Jose Manuel Vagace Valero, MD Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact 0034913908868 Principal Investigator: José Luis Vivanco Martínez, MD. Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: María Posada, MSc. 0034912071466 maria.posada@idipaz.es Contact: Alicia Herranz Estelles, MD, MSc 0034912071466 alicia.herranz@idipaz.es Principal Investigator: Antonio Pérez Martínez, MD, PhD Hospital de la Arrixaca Recruiting Murcia, Spain, 30120 Principal Investigator: José Luis Fuster, MD Hospital Materno-Infantil de Málaga Recruiting Málaga, Spain, 29011 Principal Investigator: Antonia Pascual Martínez, MD 收起 << |
NCT01619761 | Leukemia Chro... 展开 >>nic Lymphocytic Leukemia 收起 << | Phase 1 | Recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT02791919 | CNS 2a CNS 2b... 展开 >> CNS 2c CNS1 Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia 收起 << | Phase 1 | Withdrawn(Other - Protocol mov... 展开 >>ed to Disapproved) 收起 << | May 31, 2019 | - |
NCT02007863 | Leukemia Myel... 展开 >>odysplasia Acute Lymphocytic Leukemia Acute Myelogenous Leukemia 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> Jackson Memorial Hospital Miami, Florida, United States, 33136 University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 收起 << |
NCT03502577 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 1 | Recruiting | July 30, 2034 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA 206-606-4668 immunotherapy@seattlecca.org Principal Investigator: Andrew J. Cowan 收起 << |
NCT02007863 | - | Completed | - | - | |
NCT01953900 | Osteosarcoma ... 展开 >>Neuroblastoma 收起 << | Phase 1 | Recruiting | April 2036 | United States, Texas ... 展开 >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Lisa L Wang, MD 832-824-4822 llwang@texaschildrens.org Contact: Jacqueline Castello 832-824-4391 jxcastel@texaschildrens.org Principal Investigator: Lisa L Wang, MD Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD 832-824-1471 sbwhittl@txch.org Contact: Jacqueline Castello 832-824-4391 jxcastel@texaschildrens.org Principal Investigator: Sara Whittle, MD 收起 << |
NCT01493453 | CD19 Positive Non-Hodgkin Lymp... 展开 >>homa 收起 << | Phase 1 | Unknown | December 2014 | United Kingdom ... 展开 >> The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 3EE Contact: Ian Emerson, BA 01619187443 ian.emerson@christie.nhs.uk Principal Investigator: Robert E Hawkins, BA, MB BS, MCRP, Phd, FRCP Sub-Investigator: Fiona C Thistlethwaite, MB BChir, PhD, MRCP 收起 << |
NCT02333058 | Acute Lymphoblastic Leukaemias... 展开 >> (ALL) Acute Myeloid Leukaemias (AML) Myelodysplastic Syndromes (MDS) Juvenile Myelomonocytic Leukaemias (JMML) 收起 << | Phase 2 | Active, not recruiting | September 2019 | Austria ... 展开 >> St. Anna Children Hospital Vienna, Austria, A-1090 Czechia University Hospital Motol, Charles University, Prague Prague, Czechia, 150-06 Germany University Clinic Düsseldorf Düsseldorf, Germany, 40225 University Clinic Erlangen-Nürnberg Erlangen, Germany, 91054 University Hospital Johann Wolfgang Goethe Frankfurt, Germany, 60590 University Clinic Hamburg-Eppendorf Hamburg, Germany, 20246 Medical University Hannover Hannover, Germany, 30625 University Clinic Heidelberg Heidelberg, Germany, 69120 University Clinic Jena Jena, Germany, 07740 University Clinic München München, Germany, 80804 Univercity Clinic Münster Münster, Germany, 48129 University Clinic Regensburg Regensburg, Germany, 93053 University Clinic Ulm Ulm, Germany, 89075 University Clinic Würzburg Würzburg, Germany, 97080 Italy Ospedale Bambino Gesu Roma Rome, Italy, 00165 Ospedale Infantile Regina Margherita Torino Turin, Italy, 10126 Poland Bydgoszcz Medical University Bydgoszcz, Poland, 85-094 Kraków Medical University Kraków, Poland, 30-663 Lublin Medical University Lublin, Poland, 20-093 Wroclaw Medical University Wroclaw, Poland, 50-368 United Kingdom Birmingham Children's Hospital Birmingham, United Kingdom, B4 6NH Central Manchester University Hospital Manchester, United Kingdom, M13 9WL Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TH 收起 << |
NCT00714259 | - | Terminated(Accrual goals could... 展开 >> not be met within a timely manner) 收起 << | - | - | |
NCT03101709 | B Cell Lymphoma | Phase 1 | Recruiting | July 2019 | China, Henan ... 展开 >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song -86-13521186987 ph200811@163.com Contact: Yongping Song Principal Investigator: Yongping Song, MD 收起 << |
NCT00714259 | Multiple Myeloma ... 展开 >> CLL / SLL Non Hodgkin's Lymphoma Waldenstroms Mantle Cell Lymphoma 收起 << | Phase 2 Phase 3 | Terminated(Accrual goals could... 展开 >> not be met within a timely manner) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama in Birmingham BMT/CT Program Outpatient Clinic Birmingham, Alabama, United States, 35249-6979 收起 << |
NCT03528421 | Non Hodgkin Lymphoma | Phase 1 | Recruiting | May 2020 | China, Beijing ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr. Principal Investigator: Jun Zhu 收起 << |
NCT02127905 | Fanconi Anemia | Not Applicable | Withdrawn(Study was stopped du... 展开 >>e to non-enrollment of subjects due to rarity of disease.) 收起 << | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 收起 << |
NCT00376805 | Breast Cancer | Phase 2 | Terminated(Withdrawn due to to... 展开 >>xicity) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00060684 | Lymphoma, Low-Grade ... 展开 >> Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New Mexico New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States, 87109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02924753 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia 收起 << | Phase 1 | Recruiting | December 2019 | China, Henan ... 展开 >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song ph200811@163.com 收起 << |
NCT00376805 | - | Terminated(Withdrawn due to to... 展开 >>xicity) 收起 << | - | - | |
NCT03044743 | Stage IV Gastric Carcinoma ... 展开 >> Stage IV Nasopharyngeal Carcinoma T-Cell Lymphoma Stage IV Stage IV Adult Hodgkin Lymphoma Stage IV Diffuse Large B-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | March 2022 | China, Jiangsu ... 展开 >> The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR 0086-18602568379 wing_young7@hotmail.com Contact: Jing Yan, MD 0086-15805182426 firefreebird@163.com The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang 18602568379 wing_young7@hotmail.com 收起 << |
NCT02626715 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) Hematopoietic Stem Cell Transplant (HSCT) 收起 << | Phase 2 | Recruiting | September 2021 | United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Randy Windreich, MD 412-692-5055 收起 << |
NCT03146533 | B Cell Lymphoma | Phase 1 Phase 2 | Recruiting | October 2019 | China, Guangdong ... 展开 >> The Second People's Hospital of Shenzhen Recruiting Shenzhen, Guangdong, China Contact: geng tian 13724395569 tiangeng666@aliyun.com Principal Investigator: geng tian 收起 << |
NCT03426969 | Myelofibrosis | Early Phase 1 | Recruiting | November 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact sciurea@mdanderson.org 收起 << |
NCT01246557 | Chronic Lymphatic Leukemia | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Centro Médico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Universitari Valle Hebron Barcelona, Spain, 08035 Hospital Clinico Universitario de Barcelona Barcelona, Spain, 08036 Hospital Joan XXIII Tarragona, Spain, 43007 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 收起 << |
NCT03263208 | B-cell Acute Lymphocytic Leuke... 展开 >>mia 收起 << | Phase 1 Phase 2 | Recruiting | July 2019 | China, Henan ... 展开 >> The First Affiliated Hospital of Henan University of Science and Technology Not yet recruiting Luoyang, Henan, China Contact: Haiping Yang +86 13938820189 13938820189@163.com Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song +86 13521186987 ph200811@163.com 收起 << |
NCT00524667 | Chronic Lymphocytic Leukemia | Phase 2 | Terminated(Terminated due to p... 展开 >>oor accrual.) 收起 << | - | Canada, Manitoba ... 展开 >> CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 收起 << |
NCT03600558 | - | Recruiting | May 2019 | China, Tianjin ... 展开 >> Tianjin Medical University General Hospital Recruiting Tianjin, Tianjin, China, 300000 Contact: Zonghong Shao, MD 收起 << | |
NCT03344705 | Hematological Malignancies | Phase 1 | Recruiting | December 1, 2020 | China, Beijing ... 展开 >> Peking University Third Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr 86-189-1157-6946 luxian@immunochina.com 收起 << |
NCT00683046 | - | Completed | - | - | |
NCT03214562 | Other Diseases of Blood and Bl... 展开 >>ood-forming Organs Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Recruiting | September 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact cdinardo@mdanderson.org 收起 << |
NCT01490723 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Active, not recruiting | January 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01962636 | Acute Myeloid Leukemia (AML) ... 展开 >> Acute Lymphocytic Leukemia (ALL) Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelofibrosis Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large B Cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma 收起 << | Not Applicable | Recruiting | October 2023 | United States, Minnesota ... 展开 >> University of Minnesota Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD 612-625-3918 bruns072@umn.edu Principal Investigator: Claudio Brunstein, MD 收起 << |
NCT01129323 | Severe Aplastic Anemia | Not Applicable | Withdrawn(This study did not a... 展开 >>ccrue any subjects and due to this will be closed.) 收起 << | - | - |
NCT00683046 | Acute Myelogenous Leukemia ... 展开 >> Lymphoid Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Chronic Lymphocytic Leukemia Myeloproliferative Disorder Anemia, Aplastic Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT01113632 | - | Completed | - | - | |
NCT00881556 | Epidermolysis Bullosa | Early Phase 1 | Unknown | July 2014 | United States, Colorado ... 展开 >> The Children's Hospital Aurora, Colorado, United States, 80045 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, New York Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 收起 << |
NCT00899431 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01113632 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Los Robles Thousand Oaks, California, United States, 91360 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 34236 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 The Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 收起 << |
NCT00056966 | Hematologic Malignancy | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT01445821 | Scleroderma, Systemic | Phase 3 | Recruiting | September 2019 | United States, Illinois ... 展开 >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Sub-Investigator: Sanjiv Shah, MD Sub-Investigator: Eric Ruderman, MD Principal Investigator: Richard Burt, MD 收起 << |
NCT02379195 | Metastatic Melanoma | Phase 1 Phase 2 | Active, not recruiting | January 2020 | Denmark ... 展开 >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 收起 << |
NCT01156350 | Neuroblastoma | Phase 2 | Unknown | September 2014 | France ... 展开 >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr 收起 << |
NCT02111863 | Melanoma Skin... 展开 >> Cancer 收起 << | Phase 2 | Terminated(Study terminated du... 展开 >>e to low accrual and change in research focus.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03697824 | Neoplasms | Phase 2 | Not yet recruiting | July 17, 2022 | - |
NCT00950846 | Congenital Pediatric Disorders | Not Applicable | Recruiting | January 2025 | United States, Texas ... 展开 >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD 832-824-4692 camartin@txch.org Contact: Marlen Dinu 832-824-4881 mxdinu@txch.org 收起 << |
NCT02500576 | Melanoma | Phase 2 | Recruiting | August 1, 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT02111863 | - | Terminated(Study terminated du... 展开 >>e to low accrual and change in research focus.) 收起 << | - | - | |
NCT00531310 | Chronic Myeloid Leukemia | Phase 2 | Terminated(Poor accrual) | - | United States, New York ... 展开 >> Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 收起 << |
NCT00140569 | Follicular Lymphoma | Phase 3 | Completed | - | Belgium ... 展开 >> Groupe d'atude des lymphome de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France 收起 << |
NCT02529813 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 1 | Recruiting | December 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01389427 | Mantle Cell Lymphoma Refractor... 展开 >>y 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 收起 << |
NCT02280525 | Leukemia | Phase 1 | Active, not recruiting | March 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00153985 | Hemoglobinopathies ... 展开 >> Sickle Cell Disease Thalassemia 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Winship Cancer Institute-Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana Feist-Weiller Cancer Center-LSU Shreveport, Louisiana, United States, 71130 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State University College of Medicine Columbus, Ohio, United States, 43210 收起 << |
NCT00003619 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic Syndromes Thrombocytopenia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19129 Medical College of Pennsylvania Philadelphia, Pennsylvania, United States, 19129 收起 << |
NCT00153985 | - | Completed | - | - | |
NCT01236573 | Skin Cancer M... 展开 >>etastatic Melanoma 收起 << | Phase 1 Phase 2 | Terminated(Unexpected toxiciti... 展开 >>es, likely due to TIL/IL-12 & low % of durable responses.) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT03661515 | Acute Myeloid Leukemia | Phase 1 | Recruiting | December 2019 | Spain ... 展开 >> Hospital Germans Tries i Pujol, Badalona Recruiting Badalona, Spain Contact: Susana Vives, Dr svives@iconcologia.net Hospital San Pedro de Alcántara, Recruiting Cáceres, Spain Contact: Juan Bergua, Dr jmbergua@icloud.com Hospital Universitario 12 de Octubre, Recruiting Madrid, Spain Contact: Pilar Martinez-Sanchez, Dr mpmartinezsa@yahoo.es Hospital la Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr montesinos_pau@gva.es 收起 << |
NCT03196414 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | December 2026 | China, Jiangsu ... 展开 >> First Affiliated Hospital, Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Ling zhi Yan, Phd 13584821140 yanlingzhi@suda.edu.cn 收起 << |
NCT00918450 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 2 | Withdrawn(Sponsor has decided ... 展开 >>to not proceed with this study.) 收起 << | - | - |
NCT01236573 | - | Terminated(Unexpected toxiciti... 展开 >>es, likely due to TIL/IL-12 & low % of durable responses.) 收起 << | - | - | |
NCT02280811 | - | Completed | - | - | |
NCT00378534 | - | Completed | - | - | |
NCT02280811 | Vaginal Cancer ... 展开 >> Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00590460 | - | Terminated(slow accrual) | - | - | |
NCT00590460 | Fanconi Anemia ... 展开 >> Severe Aplastic Anemia 收起 << | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Texas ... 展开 >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00378534 | Chronic Myelogenous Leukemia ... 展开 >> Acute Myelogenous Leukemia Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01740557 | Melanoma | Phase 1 Phase 2 | Recruiting | January 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01822652 | Neuroblastoma | Phase 1 | Active, not recruiting | October 2030 | United States, Texas ... 展开 >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT01639456 | Acute Myelogenous Leukemia | Phase 2 | Withdrawn(study was abandoned ... 展开 >>and a new study was written to replace this one) 收起 << | January 2017 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT01518153 | Leukemia Lymp... 展开 >>homa Myeloma Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(Objectives not met.... 展开 >>) 收起 << | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00684255 | - | Terminated(inactive) | - | - | |
NCT03158935 | Advanced Ovarian Cancer ... 展开 >> Malignant Melanoma 收起 << | Phase 1 | Recruiting | June 2020 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D. 416-946-4521 marcus.butler@uhn.ca Principal Investigator: Marcus Butler, M.D. 收起 << |
NCT02926053 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 1 | Recruiting | December 2018 | Denmark ... 展开 >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Recruiting Herlev, Denmark, 2730 Contact: Inge Marie, Prof., MD +4538683868 inge.marie.svane@regionh.dk Contact: Magnus Pedersen, MD +4538683868 magnus.pedersen@regionh.dk 收起 << |
NCT01518153 | - | Terminated(Objectives not met.... 展开 >>) 收起 << | - | - | |
NCT03676504 | Acute Lymphoblastic Leukemia, ... 展开 >>Adult Acute Lymphoblastic Leukemia, Pediatric Chronic Lymphocytic Leukemia Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | October 1, 2020 | Germany ... 展开 >> University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt +49-6221-566614 michael.schmitt@med.uni-heidelberg.de University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt +49-6221-566614 michael.schmitt@med.uni-heidelberg.de Principal Investigator: Prof. Dr. Michael Schmitt Principal Investigator: Prof. Dr. Andreas Kulozik 收起 << |
NCT01795976 | Oesophageal Cancer | Phase 2 | Terminated(Withdrawal of fundi... 展开 >>ng) 收起 << | - | United Kingdom ... 展开 >> The Christie NHS Foundation Trust Manchester, United Kingdom, M20 3EE 收起 << |
NCT00005941 | Cervical Cancer ... 展开 >> Vaginal Cancer 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00684255 | Systemic Lupus Erythematosus ... 展开 >> Systemic Sclerosis 收起 << | Phase 1 | Terminated(inactive) | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00003729 | Leukemia | Phase 2 | Terminated(low accrual) | - | Belgium ... 展开 >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels (Bruxelles), Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels (Bruxelles), Belgium, 1090 Universitair Ziekenhuis Gent Ghent (Gent), Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege (Luik), Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 收起 << |
NCT02781467 | Leukemia, Myeloid, Acute | Phase 1 | Terminated(Business Decision) | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Center Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt Univ Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Wisconsin Froedtert Hospital BMT Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226-3522 收起 << |
NCT00006233 | Melanoma (Skin) | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1023 收起 << |
NCT02162420 | Dyskeratosis Congenita ... 展开 >> Aplastic Anemia 收起 << | Not Applicable | Recruiting | July 2024 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Jakub Tolar, MD 收起 << |
NCT01877837 | Sickle Cell Disease | Phase 3 | Active, not recruiting | August 2019 | United States, New Jersey ... 展开 >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT00004218 | Leukemia | Phase 3 | Completed | - | - |
NCT01106950 | - | Terminated(study drug (Ontak) ... 展开 >>no longer available) 收起 << | - | - | |
NCT01749293 | Hematologic Malignancies | Phase 2 | Terminated(The protocol design... 展开 >> is being reconfigured in order to open a new study.) 收起 << | June 2017 | United States, Illinois ... 展开 >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 收起 << |
NCT01106950 | Leukemia, Myelogenous, Acute | Phase 2 | Terminated(study drug (Ontak) ... 展开 >>no longer available) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00041288 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Unknown | - | - |
NCT00290641 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Myelodysplastic Syndromes 收起 << | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!